<SEC-DOCUMENT>0001140361-25-005858.txt : 20250225
<SEC-HEADER>0001140361-25-005858.hdr.sgml : 20250225
<ACCEPTANCE-DATETIME>20250225161746
ACCESSION NUMBER:		0001140361-25-005858
CONFORMED SUBMISSION TYPE:	POSASR
PUBLIC DOCUMENT COUNT:		27
FILED AS OF DATE:		20250225
DATE AS OF CHANGE:		20250225
EFFECTIVENESS DATE:		20250225

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			BEYOND, INC.
		CENTRAL INDEX KEY:			0001130713
		STANDARD INDUSTRIAL CLASSIFICATION:	RETAIL-CATALOG & MAIL-ORDER HOUSES [5961]
		ORGANIZATION NAME:           	07 Trade & Services
		IRS NUMBER:				870634302
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		POSASR
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	333-280076
		FILM NUMBER:		25663503

	BUSINESS ADDRESS:	
		STREET 1:		799 W. COLISEUM WAY
		CITY:			MIDVALE
		STATE:			UT
		ZIP:			84047
		BUSINESS PHONE:		8019473100

	MAIL ADDRESS:	
		STREET 1:		799 W. COLISEUM WAY
		CITY:			MIDVALE
		STATE:			UT
		ZIP:			84047

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	OVERSTOCK.COM, INC
		DATE OF NAME CHANGE:	20060203

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	OVERSTOCK COM INC
		DATE OF NAME CHANGE:	20001227
</SEC-HEADER>
<DOCUMENT>
<TYPE>POSASR
<SEQUENCE>1
<FILENAME>ny20042541x1_posasr.htm
<DESCRIPTION>POSASR
<TEXT>
<html><head>
    <title></title>
    <!-- Licensed to: Broadridge Financial Solutions, Inc.
         Document created using Broadridge PROfile 25.1.1.5279
         Copyright 1995 - 2025 Broadridge -->
  </head><body style="color: #000000;" bgcolor="#ffffff">
<!--Begin Page 1-->
<div class="BRDSX_page" style="text-align: left; margin: auto; line-height: initial; width: 540pt;"><a name="ny20042541x1_posasr_100-regcov_pg1"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="BRDSX_page-content"><div class="BRDSX_block-main" style="width: 540pt; margin-left: 0pt;"><div class="BRDSX_h1" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 25pt; text-align: center;">As filed with the Securities and Exchange Commission on February&#160;25, 2025 </div><div class="BRDSX_regno" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 1pt; text-align: right;">Registration No. 333-280076 </div></div></div><div class="BRDSX_block-frill" style="width: 540pt; margin-left: 0pt;"><div><div class="BRDSX_rule-full" style="height: 0pt; width: 100%; border-bottom: 2pt solid #000000; margin-top: 1pt; margin-bottom: 1pt; margin-left: auto; margin-right: auto;"> </div><div class="BRDSX_rule-full" style="height: 0pt; width: 100%; border-bottom: 1pt solid #000000; margin-bottom: 1pt; margin-left: auto; margin-right: auto; margin-top: 4pt;"> </div></div></div><div class="BRDSX_block-main" style="width: 540pt; margin-left: 0pt;"><div class="BRDSX_h1" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 13pt; font-weight: bold; margin-top: 8.75pt; text-align: center;">UNITED STATES <br></div><div class="BRDSX_h1" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 13pt; font-weight: bold; margin-top: 0pt; text-align: center;">SECURITIES AND EXCHANGE COMMISSION <br></div><div class="BRDSX_h1" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-weight: bold; margin-top: 0pt; text-align: center; font-size: 11pt;"><font style="font-size: 11pt;">Washington, D.C. 20549 </font></div><div><div class="BRDSX_rule-partial" style="height: 0pt; width: 96pt; border-bottom: 1pt solid #000000; margin-bottom: 2pt; margin-left: auto; margin-right: auto; margin-top: 3.75pt;"> </div></div><div class="BRDSX_h1" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 12pt; font-weight: bold; margin-top: 8pt; text-align: center;">Post-Effective Amendment No. 1 </div><div class="BRDSX_h1" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 6pt; text-align: center;">to </div><div class="BRDSX_h1" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 16pt; font-weight: bold; margin-top: 7.5pt; text-align: center;">Form S-3 <br></div><div class="BRDSX_h1" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-weight: bold; margin-top: 0pt; text-align: center; font-size: 12pt;"><font style="font-size: 12pt;">REGISTRATION STATEMENT </font><br></div><div class="BRDSX_h1" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-weight: bold; margin-top: 0pt; text-align: center; font-size: 12pt;"><font style="font-size: 12pt; font-style: italic;">UNDER </font><br></div><div class="BRDSX_h1" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-weight: bold; margin-top: 0pt; text-align: center; font-size: 12pt;"><font style="font-size: 12pt; font-style: italic;">THE SECURITIES ACT OF 1933</font><font style="font-size: 12pt; font-weight: normal;"> </font></div><div><div class="BRDSX_rule-partial" style="height: 0pt; width: 96pt; border-bottom: 1pt solid #000000; margin-bottom: 2pt; margin-left: auto; margin-right: auto; margin-top: 3.75pt;"> </div></div><div class="BRDSX_h1" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 18pt; font-weight: bold; margin-top: 10.5pt; text-align: center;">BEYOND, INC. <br></div><div class="BRDSX_h1" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-weight: bold; margin-top: 0pt; text-align: center; font-size: 10pt;"><font style="font-size: 10pt;">(Exact name of registrant as specified in its charter) </font></div><div><div class="BRDSX_rule-partial" style="height: 0pt; width: 96pt; border-bottom: 1pt solid #000000; margin-bottom: 2pt; margin-left: auto; margin-right: auto; margin-top: 3.75pt;"> </div></div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: -3pt; margin-left: 0pt; text-align: left;"> </div><table cellspacing="0" cellpadding="0" class="BRDSX_txttab" style="margin-top: -3pt; width: 540pt; margin-left: auto; margin-right: auto;"><tr class="BRDSX_boxspacer"><td style="height: 6pt; width: 264pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 264pt;"><div style="font-size: 1pt;">&#8194;</div></td></tr><tr><td style="width: 264pt; padding-bottom: 0.48pt; text-align: left; vertical-align: top;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 9.3pt; font-weight: bold; margin-top: 0pt; text-align: center;">Delaware</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 264pt; padding-bottom: 0.48pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 9.3pt; font-weight: bold; margin-top: 0pt; text-align: center;">87-0634302 </div></td></tr><tr><td style="width: 264pt; padding-top: 0.13pt; text-align: left; vertical-align: top;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 9.3pt; font-weight: bold; margin-top: 0pt; text-align: center;">(State or other jurisdiction of <br></div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 9.3pt; font-weight: bold; margin-top: 0pt; text-align: center;">incorporation or organization)</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 264pt; padding-top: 0.13pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 9.3pt; font-weight: bold; margin-top: 0pt; text-align: center;">(I.R.S. Employer<br></div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 9.3pt; font-weight: bold; margin-top: 0pt; text-align: center;">Identification Number)</div></td></tr><tr class="BRDSX_boxspacer"><td style="height: 2.95pt; width: 264pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.95pt; width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.95pt; width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.95pt; width: 264pt;"><div style="font-size: 1pt;">&#8194;</div></td></tr></table><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 9.3pt; font-weight: bold; margin-top: 3pt; text-align: center;">433 W. Ascension Way, 3<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">rd</sup> Floor <br></div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 9.3pt; font-weight: bold; margin-top: 0pt; text-align: center;">Murray, Utah 84123 <br></div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 9.3pt; font-weight: bold; margin-top: 0pt; text-align: center;">(801) 947-3100<font style="font-weight: normal;"> </font></div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 9.3pt; font-weight: bold; margin-top: 3pt; text-align: center;">(Address, including zip code, and telephone number, including area code, of registrant&#8217;s principal executive offices)<font style="font-weight: normal;"> </font></div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 9.3pt; font-weight: bold; margin-top: 3pt; text-align: center;">Allison Fletcher <br></div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 9.3pt; font-weight: bold; margin-top: 0pt; text-align: center;">Acting General Counsel <br></div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 9.3pt; font-weight: bold; margin-top: 0pt; text-align: center;">Vice President, Legal <br></div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 9.3pt; font-weight: bold; margin-top: 0pt; text-align: center;">433 W. Ascension Way, 3<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">rd</sup> Floor <br></div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 9.3pt; font-weight: bold; margin-top: 0pt; text-align: center;">Murray, Utah 84123 <br></div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 9.3pt; font-weight: bold; margin-top: 0pt; text-align: center;">(801) 947-3100 </div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 9.3pt; font-weight: bold; margin-top: 3pt; text-align: center;">(Address, including zip code, and telephone number, including area code, of agent for service)<font style="font-weight: normal;"> </font></div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 9.3pt; font-style: italic; font-weight: bold; margin-top: 3pt; text-align: center;">Copies to<font style="font-style: normal;">: </font></div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 9.3pt; font-weight: bold; margin-top: 3pt; text-align: center;">Benjamin J. Cohen, Esq. <br></div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 9.3pt; font-weight: bold; margin-top: 0pt; text-align: center;">Lindsey A. Mills, Esq. <br></div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 9.3pt; font-weight: bold; margin-top: 0pt; text-align: center;">Latham &amp; Watkins LLP <br></div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 9.3pt; font-weight: bold; margin-top: 0pt; text-align: center;">1271 Avenue of the Americas <br></div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 9.3pt; font-weight: bold; margin-top: 0pt; text-align: center;">New York, New York 10020 <br></div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 9.3pt; font-weight: bold; margin-top: 0pt; text-align: center;">(212) 906-1200 </div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 9.3pt; font-weight: bold; margin-top: 3pt; margin-left: 0pt; text-align: justify; line-height: 10.8pt;">APPROXIMATE DATE OF COMMENCEMENT OF PROPOSED SALE TO THE PUBLIC: <font style="font-weight: normal;">From time to time after the effective date of this registration statement. </font></div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 9.3pt; margin-top: 3pt; margin-left: 0pt; text-align: justify; line-height: 10.8pt;">If the only securities being registered on this Form are being offered pursuant to dividend or interest reinvestment plans, please check the following box. <font style="font-size: 1pt;">&#8201;</font>&#x2610; </div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 9.3pt; margin-top: 3pt; margin-left: 0pt; text-align: justify; line-height: 10.8pt;">If any of the securities being registered on this Form are to be offered on a delayed or continuous basis pursuant to Rule 415 under the Securities Act of 1933, other than securities offered only in connection with dividend or interest reinvestment plans, check the following box. &#x2612; </div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 9.3pt; margin-top: 3pt; margin-left: 0pt; text-align: justify; line-height: 10.8pt;">If this Form is filed to register additional securities for an offering pursuant to Rule 462(b) under the Securities Act, please check the following box and list the Securities Act registration statement number of the earlier effective registration statement for the same offering. <font style="font-size: 1pt;">&#8201;</font>&#x2610; </div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 9.3pt; margin-top: 3pt; margin-left: 0pt; text-align: justify; line-height: 10.8pt;">If this Form is a post-effective amendment filed pursuant to Rule 462(c) under the Securities Act, check the following box and list the Securities Act registration statement number of the earlier effective registration statement for the same offering. <font style="font-size: 1pt;">&#8201;</font>&#x2610; </div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 9.3pt; margin-top: 3pt; margin-left: 0pt; text-align: justify; line-height: 10.8pt;">If this Form is a registration statement pursuant to General Instruction I.D. or a post-effective amendment thereto that shall become effective on filing with the Commission pursuant to Rule 462(e) under the Securities Act, check the following box. &#x2612; </div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 9.3pt; margin-top: 3pt; margin-left: 0pt; text-align: justify; line-height: 10.8pt;">If this Form is a post-effective amendment to a registration statement filed pursuant to General Instruction I.D. filed to register additional securities or additional classes of securities pursuant to Rule 413(b) under the Securities Act, check the following box. <font style="font-size: 1pt;">&#8201;</font>&#x2610; </div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 9.3pt; margin-top: 3pt; margin-left: 0pt; text-align: justify; line-height: 10.8pt;">Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, smaller reporting company, or an emerging growth company. See the definitions of &#8220;large accelerated filer,&#8221; &#8220;accelerated filer,&#8221; &#8220;smaller reporting company,&#8221; and &#8220;emerging growth company&#8221; in Rule 12b-2 of the Exchange Act. </div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: -3pt; margin-left: 0pt; text-align: left;"> </div><table cellspacing="0" cellpadding="0" class="BRDSX_txttab" style="margin-top: -3pt; width: 540pt; margin-left: auto; margin-right: auto;"><tr class="BRDSX_boxspacer"><td style="height: 6pt; width: 240pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 12pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 240pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 12pt;"><div style="font-size: 1pt;">&#8194;</div></td></tr><tr><td style="width: 240pt; padding-bottom: 0.48pt; text-align: left; vertical-align: top;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 9.3pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Large accelerated filer </div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 12pt; padding-bottom: 0.48pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 9.3pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">&#x2612;</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 240pt; padding-bottom: 0.48pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 9.3pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Accelerated filer </div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 12pt; padding-bottom: 0.48pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 1pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">&#8201;<font style="font-size: 9.3pt;">&#x2610; </font></div></td></tr><tr><td style="width: 240pt; padding-top: 0.13pt; padding-bottom: 0.48pt; text-align: left; vertical-align: top;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 9.3pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Non-accelerated filer </div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 12pt; padding-top: 0.44pt; padding-bottom: 0.48pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 1pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">&#8201;<font style="font-size: 9.3pt;">&#x2610;</font></div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 240pt; padding-top: 0.13pt; padding-bottom: 0.48pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 9.3pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Smaller reporting company </div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 12pt; padding-top: 0.44pt; padding-bottom: 0.48pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 1pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">&#8201;<font style="font-size: 9.3pt;">&#x2610; </font></div></td></tr><tr><td style="width: 240pt; padding-top: 0.13pt; text-align: left; vertical-align: top;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 9.3pt;">&#160;</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 12pt; padding-top: 0.13pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 9.3pt;">&#160;</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 240pt; padding-top: 0.13pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 9.3pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Emerging growth company </div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 12pt; padding-top: 0.44pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 1pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">&#8201;<font style="font-size: 9.3pt;">&#x2610;</font></div></td></tr><tr class="BRDSX_boxspacer"><td style="height: 2.95pt; width: 240pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.95pt; width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.95pt; width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.95pt; width: 12pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.95pt; width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.95pt; width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.95pt; width: 240pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.95pt; width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.95pt; width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.95pt; width: 12pt;"><div style="font-size: 1pt;">&#8194;</div></td></tr></table><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 9.3pt; margin-top: 3pt; margin-left: 0pt; text-align: justify; line-height: 10.8pt;">If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for comply with any new or revised financial accounting standards provided pursuant to Section 7(a)(2)(B) of Securities Act. &#8201;<font style="font-size: 1pt;">&#8201;</font>&#x2610; </div></div><div class="BRDSX_block-frill" style="width: 540pt; margin-top: 12pt; margin-left: 0pt;"><div><div class="BRDSX_rule-full" style="height: 0pt; width: 100%; border-bottom: 1pt solid #000000; margin-top: 1pt; margin-bottom: 1pt; margin-left: auto; margin-right: auto;"> </div><div class="BRDSX_rule-full" style="height: 0pt; width: 100%; border-bottom: 2pt solid #000000; margin-bottom: 1pt; margin-left: auto; margin-right: auto; margin-top: 4pt;"> </div></div></div></div>
<!--End Page 1-->
<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div class="BRPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 2-->
<div class="BRDSX_page" style="text-align: left; margin: auto; line-height: initial; width: 468pt;"><a name="ny20042541x1_posasr_101-note_pg1"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="BRDSX_page-content"><div class="BRDSX_block-main" style="width: 468pt; margin-left: 0pt;"><div class="BRDSX_h1" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 6.75pt; text-align: center;">EXPLANATORY NOTE </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">This Post-Effective Amendment No. 1 relates to the Registration Statement on Form&#160;S-3 (File No. 333-280076) originally filed by Beyond, Inc. with the Securities and Exchange Commission on June&#160;10, 2024 (as amended, the &#8220;Registration Statement&#8221;) and is being filed for the purpose of registering a specific amount of securities, paying the associated filing fee and adding the disclosure in the Registration Statement required for a registrant other than a well-known seasoned issuer. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 8.5pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">This Post-Effective Amendment No. 1 contains two prospectuses: </div><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">a base prospectus covering the offering, issuance and sale by the registrant of up to $156,128,866 in the aggregate of the registrant&#8217;s common stock, preferred stock, debt securities, warrants, purchase contracts and units, in each case from time to time in one or more offerings; and </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">a sales agreement prospectus supplement covering the offering, issuance and sale by the registrant of shares of the registrant&#8217;s common stock having an aggregate offering price of up to $156,128,866, which shares may be issued and sold under a Capital on Demand<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">TM</sup> Sales Agreement (the &#8220;Sales Agreement&#8221;) with JonesTrading Institutional Services LLC. </div></td></tr></table><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">The base prospectus immediately follows this explanatory note. The specific terms of any securities to be offered pursuant to the base prospectus will be specified in a prospectus supplement to the base prospectus. The specific terms of the securities to be issued and sold under the Sales Agreement are specified in the sales agreement prospectus supplement that immediately follows the base prospectus. The $156,128,866 of common stock that may be offered, issued and sold by the registrant under the sales agreement prospectus supplement is included in the aggregate dollar amount of securities that may be offered, issued and sold by the registrant under the base prospectus. Upon termination of the Sales Agreement, any portion of the $156,128,866 included in the sales agreement prospectus supplement that is not sold pursuant to the Sales Agreement will be available for sale in other offerings pursuant to the base prospectus and a corresponding prospectus supplement, and if no additional shares are sold under the Sales Agreement, the full $156,128,866 of securities may be sold in other offerings pursuant to the base prospectus and a corresponding prospectus supplement. </div></div></div></div>
<!--End Page 2-->
<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div class="BRPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 3-->
<div class="BRDSX_page" style="text-align: left; margin: auto; line-height: initial; width: 456pt;"><a name="ny20042541x1_posasr_102-cov_pg1"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="BRDSX_page-content"><div class="BRDSX_block-main" style="width: 456pt; margin-left: 0pt;"><div class="BRDSX_h2" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 6.75pt; margin-left: 0pt; text-align: left;">PROSPECTUS </div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 13.75pt; text-align: center;"><img style="height: 57px; width: 243px;" src="logo_beyondv2.jpg"><br></div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">&#8201;</div><div class="BRDSX_h1" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 12pt; font-weight: bold; margin-top: 20pt; text-align: center;">BEYOND, INC.<br></div><div class="BRDSX_h1" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 12pt; font-weight: bold; margin-top: 0pt; text-align: center;">&#8195; <br></div><div class="BRDSX_h1" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 12pt; font-weight: bold; margin-top: 0pt; text-align: center;">$156,128,866<br></div><div class="BRDSX_h1" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 12pt; font-weight: bold; margin-top: 0pt; text-align: center;">&#8195; <br></div><div class="BRDSX_h1" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 12pt; font-weight: bold; margin-top: 0pt; text-align: center;">Common Stock <br></div><div class="BRDSX_h1" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 12pt; font-weight: bold; margin-top: 0pt; text-align: center;">Preferred Stock <br></div><div class="BRDSX_h1" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 12pt; font-weight: bold; margin-top: 0pt; text-align: center;">Debt Securities <br></div><div class="BRDSX_h1" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 12pt; font-weight: bold; margin-top: 0pt; text-align: center;">Warrants <br></div><div class="BRDSX_h1" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 12pt; font-weight: bold; margin-top: 0pt; text-align: center;">Purchase Contracts <br></div><div class="BRDSX_h1" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 12pt; font-weight: bold; margin-top: 0pt; text-align: center;">Units </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">This prospectus is part of a registration statement that we filed with the SEC, using a &#8220;shelf&#8221; registration process. By using a shelf registration statement, we may offer and sell up to $156,128,866 in the aggregate of the securities identified above, from time to time in one or more offerings. This prospectus provides you with a general description of the securities. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Each time we offer and sell securities, we will provide a supplement to this prospectus that contains specific information about the offering and the amounts, prices and terms of the securities. The supplement may also add, update or change information contained in this prospectus with respect to that offering. You should carefully read this prospectus and the applicable prospectus supplement before you invest in any of our securities. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">We may offer and sell the securities described in this prospectus and any prospectus supplement to or through one or more underwriters, dealers and agents, or directly to purchasers, or through a combination of these methods. If any underwriters, dealers or agents are involved in the sale of any of the securities, their names and any applicable purchase price, fee, commission or discount arrangement between or among them will be set forth, or will be calculable from the information set forth, in the applicable prospectus supplement. See the sections of this prospectus entitled &#8220;About this Prospectus&#8221; and &#8220;Plan of Distribution&#8221; for more information. No securities may be sold without delivery of this prospectus and the applicable prospectus supplement describing the method and terms of the offering of such securities. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">INVESTING IN OUR SECURITIES INVOLVES RISKS. SEE THE &#8220;RISK FACTORS&#8221; ON PAGE <a href="#tRF">8</a> OF THIS PROSPECTUS AND ANY SIMILAR SECTION CONTAINED IN THE APPLICABLE PROSPECTUS SUPPLEMENT CONCERNING FACTORS YOU SHOULD CONSIDER BEFORE INVESTING IN OUR SECURITIES.<font style="font-weight: normal;"> </font></div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Our common stock is listed on the New York Stock Exchange under the symbol &#8220;BYON.&#8221; On February 24, 2025, the last reported sale price of our common stock on the New York Stock Exchange was $6.92 per share. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Neither the Securities and Exchange Commission nor any state securities commission has approved or disapproved of these securities or passed upon the adequacy or accuracy of this prospectus. Any representation to the contrary is a criminal offense.<font style="font-weight: normal;"> </font></div><div class="BRDSX_h1" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 176pt; text-align: center;">The date of this prospectus is February&#160;25, 2025.</div></div></div></div>
<!--End Page 3-->
<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div class="BRPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 4-->
<div class="BRDSX_page" style="text-align: left; margin: auto; line-height: initial; width: 468pt;"><a name="ny20042541x1_posasr_103-toc_pg1"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="BRDSX_page-content"><div class="BRDSX_block-main" style="width: 468pt; margin-left: 0pt;"><div class="BRDSX_h1" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 6.75pt; text-align: center;">TABLE OF CONTENTS </div><a name="TOC"><!--Anchor--></a><table cellspacing="0" cellpadding="0" class="BRDSX_fintab" style="margin-top: 4pt; width: 468pt; margin-left: auto; margin-right: auto;"><tr class="BRDSX_boxspacer"><td style="height: 6pt; width: 432pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 13pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 13pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 10pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td></tr><tr><td style="width: 432pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><a href="#tATP">ABOUT THIS PROSPECTUS<font style="padding-left: 4.33pt;"></font></a></div></td><td style="width: 13pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 13pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 10pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><a href="#tATP"><font style="padding-left: 5pt;">1</font> </a></div></td></tr><tr><td style="width: 432pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><a href="#tTRA">TRADEMARKS<font style="padding-left: 0.63pt;"></font></a></div></td><td style="width: 13pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 13pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 10pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><a href="#tTRA"><font style="padding-left: 5pt;">2</font> </a></div></td></tr><tr><td style="width: 432pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><a href="#tFLS">SPECIAL CAUTIONARY NOTE REGARDING FORWARD-LOOKING STATEMENTS<font style="padding-left: 1.69pt;"></font></a></div></td><td style="width: 13pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 13pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 10pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><a href="#tFLS"><font style="padding-left: 5pt;">3</font> </a></div></td></tr><tr><td style="width: 432pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><a href="#tWYC">WHERE YOU CAN FIND MORE INFORMATION; INCORPORATION BY REFERENCE<font style="padding-left: 4.8pt;"></font></a></div></td><td style="width: 13pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 13pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 10pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><a href="#tWYC"><font style="padding-left: 5pt;">5</font> </a></div></td></tr><tr><td style="width: 432pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><a href="#tTC">THE COMPANY<font style="padding-left: 2.66pt;"></font></a></div></td><td style="width: 13pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 13pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 10pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><a href="#tTC"><font style="padding-left: 5pt;">7</font> </a></div></td></tr><tr><td style="width: 432pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><a href="#tRF">RISK FACTORS<font style="padding-left: 4.32pt;"></font></a></div></td><td style="width: 13pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 13pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 10pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><a href="#tRF"><font style="padding-left: 5pt;">8</font> </a></div></td></tr><tr><td style="width: 432pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><a href="#tUOP">USE OF PROCEEDS<font style="padding-left: 0.07pt;"></font></a></div></td><td style="width: 13pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 13pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 10pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><a href="#tUOP"><font style="padding-left: 5pt;">9</font> </a></div></td></tr><tr><td style="width: 432pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><a href="#tDOC">DESCRIPTION OF CAPITAL STOCK<font style="padding-left: 3.11pt;"></font></a></div></td><td style="width: 13pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 13pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 10pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><a href="#tDOC">10 </a></div></td></tr><tr><td style="width: 432pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><a href="#tDOD">DESCRIPTION OF DEBT SECURITIES<font style="padding-left: 4.16pt;"></font></a></div></td><td style="width: 13pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 13pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 10pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><a href="#tDOD">13 </a></div></td></tr><tr><td style="width: 432pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><a href="#tDOW">DESCRIPTION OF WARRANTS<font style="padding-left: 0.27pt;"></font></a></div></td><td style="width: 13pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 13pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 10pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><a href="#tDOW">20 </a></div></td></tr><tr><td style="width: 432pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><a href="#tDOP">DESCRIPTION OF PURCHASE CONTRACTS<font style="padding-left: 0.1pt;"></font></a></div></td><td style="width: 13pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 13pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 10pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><a href="#tDOP">21 </a></div></td></tr><tr><td style="width: 432pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><a href="#tDOU">DESCRIPTION OF UNITS<font style="padding-left: 0.64pt;"></font></a></div></td><td style="width: 13pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 13pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 10pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><a href="#tDOU">22 </a></div></td></tr><tr><td style="width: 432pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><a href="#tGS">GLOBAL SECURITIES<font style="padding-left: 4.34pt;"></font></a></div></td><td style="width: 13pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 13pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 10pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><a href="#tGS">23 </a></div></td></tr><tr><td style="width: 432pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><a href="#tPOD">PLAN OF DISTRIBUTION<font style="padding-left: 3.98pt;"></font></a></div></td><td style="width: 13pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 13pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 10pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><a href="#tPOD">26 </a></div></td></tr><tr><td style="width: 432pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><a href="#tLM">LEGAL MATTERS<font style="padding-left: 3.22pt;"></font></a></div></td><td style="width: 13pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 13pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 10pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><a href="#tLM">28 </a></div></td></tr><tr><td style="width: 432pt; padding-top: 1.01pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><a href="#tEXP">EXPERTS<font style="padding-left: 1.77pt;"></font></a></div></td><td style="width: 13pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 13pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 10pt; padding-top: 1.01pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><a href="#tEXP">28</a></div></td></tr><tr class="BRDSX_boxspacer"><td style="height: 2.75pt; width: 432pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 13pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 13pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 10pt;"><div style="font-size: 1pt;">&#8194;</div></td></tr></table></div></div><div class="BRDSX_block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"><div class="BRDSX_unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">i<br></div></div></div>
<!--End Page 4-->
<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div class="BRPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 5-->
<div class="BRDSX_page" style="text-align: left; margin: auto; line-height: initial; width: 468pt;"><a name="ny20042541x1_posasr_104-about_pg1"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="BRDSX_page-content"><div class="BRDSX_block-main" style="width: 468pt; margin-left: 0pt;"><div class="BRDSX_h1" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 6.75pt; text-align: center;"><a name="tATP"><!--Anchor--></a>ABOUT THIS PROSPECTUS </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">This prospectus is part of a registration statement that we filed with the U.S. Securities and Exchange Commission, or the SEC using a &#8220;shelf&#8221; registration process. By using a shelf registration statement, we may sell securities from time to time and in one or more offerings up to a total dollar amount of $156,128,866 as described in this prospectus. Each time that we offer and sell securities, we will provide a prospectus supplement to this prospectus that contains specific information about the securities being offered and sold and the specific terms of that offering. We may also authorize one or more free writing prospectuses to be provided to you that may contain material information relating to these offerings. The prospectus supplement or free writing prospectus may also add, update or change information contained in this prospectus with respect to that offering. If there is any inconsistency between the information in this prospectus and the applicable prospectus supplement or free writing prospectus, you should rely on the prospectus supplement or free writing prospectus, as applicable. Before purchasing any securities, you should carefully read both this prospectus and the applicable prospectus supplement (and any applicable free writing prospectuses), together with the additional information described under the heading &#8220;Where You Can Find More Information; Incorporation by Reference.&#8221; </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">We have not authorized anyone to provide you with any information or to make any representations other than those contained in this prospectus, any applicable prospectus supplement or any free writing prospectuses prepared by or on behalf of us or to which we have referred you. We take no responsibility for, and can provide no assurance as to the reliability of, any other information that others may give you. We will not make an offer to sell these securities in any jurisdiction where the offer or sale is not permitted. You should assume that the information appearing in this prospectus and the applicable prospectus supplement to this prospectus is accurate only as of the date on its respective cover, that the information appearing in any applicable free writing prospectus is accurate only as of the date of that free writing prospectus, and that any information incorporated by reference is accurate only as of the date of the document incorporated by reference, unless we indicate otherwise. Our business, financial condition, results of operations and prospects may have changed since those dates. This prospectus incorporates by reference, and any prospectus supplement or free writing prospectus may contain and incorporate by reference, market data and industry statistics and forecasts that are based on independent industry publications and other publicly available information. Although we believe these sources are reliable, we do not guarantee the accuracy or completeness of this information and we have not independently verified this information. In addition, the market and industry data and forecasts that may be included or incorporated by reference in this prospectus, any prospectus supplement or any applicable free writing prospectus may involve estimates, assumptions and other risks and uncertainties and are subject to change based on various factors, including those discussed under the heading &#8220;Risk&#160;Factors&#8221; contained in this prospectus, the applicable prospectus supplement and any applicable free writing prospectus, and under similar headings in other documents that are incorporated by reference into this prospectus. Accordingly, investors should not place undue reliance on this information. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">When we refer to &#8220;Beyond,&#8221; &#8220;we,&#8221; &#8220;our,&#8221; &#8220;us&#8221; and the &#8220;Company&#8221; in this prospectus, we mean Beyond, Inc. and its controlled subsidiaries, unless otherwise specified. When we refer to &#8220;you,&#8221; we mean the potential holders of the applicable series of securities. </div></div></div><div class="BRDSX_block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"><div class="BRDSX_unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">1<br></div></div></div>
<!--End Page 5-->
<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div class="BRPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 6-->
<div class="BRDSX_page" style="text-align: left; margin: auto; line-height: initial; width: 468pt;"><a name="ny20042541x1_posasr_105-trade_pg1"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="BRDSX_page-content"><div class="BRDSX_block-main" style="width: 468pt; margin-left: 0pt;"><div class="BRDSX_h1" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 6.75pt; text-align: center;"><a name="tTRA"><!--Anchor--></a>TRADEMARKS </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">This prospectus includes, or incorporates by reference, our trademarks, service marks, brand names and trade names, including, without limitation, Bed Bath &amp; Beyond&#174;, Overstock.com&#174;, and Zulily&#174;, which are our property and are protected under applicable intellectual property laws. This prospectus also contains, or incorporates by reference, trademarks, service marks, brand names and trade names of other companies, which are the property of their respective owners. Any use or display of other parties&#8217; trademarks, service marks, brand names or trade names in this prospectus, or any documents incorporated by reference herein, does not imply, and such use or display should not be construed to imply, any affiliation with, or endorsement of or by, such third parties. Solely for convenience, trademarks, service marks, brand names, and trade names referred to in this prospectus, or any documents incorporated by reference herein, may appear with or without the &#174;, <sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">SM</sup> or <sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">TM</sup> symbols, but use (or omission) of such symbols is not intended to limit in any way our rights, or the rights of the applicable owner or any applicable licensor, in and to these trademarks, service marks, brand names, and trade names. </div></div></div><div class="BRDSX_block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"><div class="BRDSX_unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">2<br></div></div></div>
<!--End Page 6-->
<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div class="BRPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 7-->
<div class="BRDSX_page" style="text-align: left; margin: auto; line-height: initial; width: 468pt;"><a name="ny20042541x1_posasr_106-fls_pg1"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="BRDSX_page-content"><div class="BRDSX_block-main" style="width: 468pt; margin-left: 0pt;"><div class="BRDSX_h1" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 6.75pt; text-align: center;"><a name="tFLS"><!--Anchor--></a>SPECIAL CAUTIONARY NOTE REGARDING FORWARD-LOOKING STATEMENTS </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">This prospectus and the documents incorporated herein by reference, and our other public documents and statements our officers and representatives may make from time to time, contain forward-looking statements within the meaning of the federal securities laws. These statements are intended to be covered by the safe harbor provisions of these laws. You can find many of these statements by looking for words such as &#8220;may,&#8221; &#8220;would,&#8221; &#8220;could,&#8221; &#8220;should,&#8221; &#8220;will,&#8221; &#8220;expect,&#8221; &#8220;anticipate,&#8221; &#8220;predict,&#8221; &#8220;project,&#8221; &#8220;potential,&#8221; &#8220;continue,&#8221; &#8220;contemplate,&#8221; &#8220;seek,&#8221; &#8220;assume,&#8221; &#8220;believe,&#8221; &#8220;intend,&#8221; &#8220;plan,&#8221; &#8220;forecast,&#8221; &#8220;goal,&#8221; &#8220;estimate,&#8221; or other similar terms or expressions or the negative of these terms or expressions, although not all forward-looking statements contain these identifying terms or expressions. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">These forward-looking statements involve known and unknown risks and uncertainties and relate to future events or our future financial or operating performance. These forward-looking statements are not historical facts, and are based on current expectations, estimates and projections about our industry and business, and on management's beliefs and certain assumptions made by management, many of which, by their nature, are inherently uncertain and beyond our control. Accordingly, you are cautioned that any such forward-looking statements are not guarantees of future performance and are subject to assumptions, risks, uncertainties, and other important factors that are difficult to predict, and that actual results and outcomes may be materially different from the results, performance, achievements, or outcomes expressed or implied by any of our forward-looking statements for a variety of reasons, including among others: </div><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">any difficulties we may encounter as a result of our reliance on third-parties that we do not control for the performance of critical functions material to our business, such as carriers, fulfillment partners, and SaaS/IaaS providers; </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">any inability to compete successfully against existing or future competitors or to effectively market our business and generate customer traffic; </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">our ability to realize the benefits of any investment in new business strategies, partnerships, ventures, acquisitions, or other transactions; </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">a recession or other economic downturn, inflation, high interest rates, our exposure to the U.S. housing market, or other changes in U.S. and global economic conditions or U.S. consumer spending; </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">any increases in the price of importing goods into the U.S. or transporting to our customers the types of merchandise we sell or other supply chain challenges that limit our ability to deliver merchandise to our customers in a timely and cost-effective manner; </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">any difficulties or negative consequences we may encounter as a result of our changed company name, changed stock ticker symbol, changed stock exchange on which our common stock trades, or as a result of the use of our various brands including Beyond, Overstock, Bed Bath &amp; Beyond, Zulily, Backyard, and College Living and the platforms on which they operate; </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">any problems associated with the changing job market, changing job structure, organizational changes or restructuring, reductions in force, changing compensation structure, or ability to attract and retain key personnel; </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">any inability to generate and maintain unpaid natural traffic to our websites; </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">any inability to become profitable or generate positive cash flow from operations; </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">the relocation or third-party maintenance of our data center or any other risks or challenges that could result in loss of functionality or unavailability of our websites or reduced performance of our transaction systems; </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">our exposure to cybersecurity risks, risks of data loss and other security breaches; the risk that we may incur or be required to recognize losses relating to our equity and other investments, including new investments; </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">the impacts that we would experience if governmental entities or providers of consumer devices and internet browsers further restrict or regulate the use of &#8220;cookie&#8221; tracking technologies; </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">the impact that any litigation, claims, or regulatory matters could have on our business, financial condition, results of operations, and cash flows; </div></td></tr></table></div></div><div class="BRDSX_block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"><div class="BRDSX_unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">3<br></div></div></div>
<!--End Page 7-->
<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div class="BRPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 8-->
<div class="BRDSX_page" style="text-align: left; margin: auto; line-height: initial; width: 468pt;"><a name="ny20042541x1_posasr_106-fls_pg2"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="BRDSX_page-content"><div class="BRDSX_block-main" style="width: 468pt; margin-left: 0pt;"><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6.75pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">any inability to optimize and effectively operate our distribution center, warehouse, and customer service operations; </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">any failures to effectively utilize technological advancements; </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">negative economic consequences of political events such as the U.S. presidential election, various global conflicts, and macroeconomic factors; </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">negative consequences associated with our determination to partially self-insure our employee's health insurance; </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">the possibility that we may be unable to protect our proprietary technology and to obtain trademark protection for our marks; </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">current and future claims of intellectual property infringement to which we are subject; </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">any difficulties we may encounter as a result of our reliance on third-parties that we do not control for their representations regarding product compliance with various laws and regulations; </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">any difficulties we may encounter as a result of our evolving business practices, including strategic ventures, the expansion of our products and service offerings, our continuing expansion into international markets, our changing approach to holding inventory, content creation, and sales through our various websites and brands; </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">any problems associated with our lack of visibility into, and our lack of influence over, our equity method investments, including our reliance on third-parties to timely and accurately report material events to us; </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">any inability of Pelion Venture Partners to successfully manage the Medici Ventures, L.P. fund, in which we are the limited partner, or any other entity in which we also have a direct minority interest; and </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">the other risks described in this prospectus and the documents incorporated by reference herein. </div></td></tr></table><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">In evaluating all forward-looking statements, you should specifically consider the risks outlined above and in this prospectus and the documents incorporated by reference herein, especially under the headings &#8220;Special Cautionary Note Regarding Forward-Looking Statements,&#8221; &#8220;Risk Factors,&#8221; &#8220;Legal Proceedings,&#8221; and &#8220;Management's Discussion and Analysis of Financial Condition and Results of Operations,&#8221; and similar headings. Although we believe that our assumptions and expectations reflected in the forward-looking statements are reasonable as of the date of this prospectus, we cannot guarantee or offer any assurance of future results, levels of activity, performance or achievements or other future events. Our forward-looking statements contained in this prospectus and the documents incorporated by reference herein speak only as of the date of this prospectus and the documents incorporated by reference herein, respectively, and, except as required by law, we undertake no obligation to update forward-looking statements to reflect events or circumstances occurring after the date of this prospectus or any changes in our expectations or any change in any events, conditions or circumstances on which any of our forward-looking statements are based. </div></div></div><div class="BRDSX_block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"><div class="BRDSX_unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">4<br></div></div></div>
<!--End Page 8-->
<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div class="BRPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 9-->
<div class="BRDSX_page" style="text-align: left; margin: auto; line-height: initial; width: 468pt;"><a name="ny20042541x1_posasr_107-incorp_pg1"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="BRDSX_page-content"><div class="BRDSX_block-main" style="width: 468pt; margin-left: 0pt;"><div class="BRDSX_h1" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 6.75pt; text-align: center;"><a name="tWYC"><!--Anchor--></a>WHERE YOU CAN FIND MORE INFORMATION; INCORPORATION BY REFERENCE </div><div class="BRDSX_h2" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 13pt; margin-left: 0pt; text-align: left;">Available Information </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">We file reports, proxy statements and other information with the SEC. The SEC maintains a web site that contains reports, proxy and information statements and other information about issuers, such as us, who file electronically with the SEC. The address of that website is https://www.sec.gov. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Our web site address is https://beyond.com, and our reports, proxy statements and other information we have incorporated by reference in this prospectus and filed electronically with the SEC are available on our Investor Relations website at https://investors.beyond.com. The information on our web site, however, is not, and should not be deemed to be, a part of this prospectus. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">This prospectus and any prospectus supplement are part of a registration statement that we filed with the SEC and do not contain all of the information in the registration statement. The full registration statement may be obtained from the SEC or us, as provided below. Forms of the indenture and other documents establishing the terms of the offered securities are or may be filed as exhibits to the registration statement or documents incorporated by reference in the registration statement. Statements in this prospectus or any prospectus supplement about these documents are summaries and each statement is qualified in all respects by reference to the document to which it refers. You should refer to the actual documents for a more complete description of the relevant matters. You may inspect a copy of the registration statement through the SEC&#8217;s website, as provided above. </div><div class="BRDSX_h2" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 14pt; margin-left: 0pt; text-align: left;">Incorporation by Reference </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">The SEC&#8217;s rules allow us to &#8220;incorporate by reference&#8221; information into this prospectus, which means that we can disclose important information to you by referring you to another document filed separately with the SEC. The information incorporated by reference is deemed to be part of this prospectus, and subsequent information that we file with the SEC will automatically update and supersede that information. Any statement contained in this prospectus or a previously filed document incorporated by reference will be deemed to be modified or superseded for purposes of this prospectus to the extent that a statement contained in this prospectus or a subsequently filed document incorporated by reference modifies or replaces that statement. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">This prospectus and any accompanying prospectus supplement incorporate by reference the documents set forth below that have previously been filed with the SEC: </div><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">Our Annual Report on Form&#160;10-K for the year ended <a href="https://www.sec.gov/ix?doc=/Archives/edgar/data/1130713/000113071324000013/byon-20231231.htm">December&#160;31, 2023</a>, filed with the SEC on February&#160;23, 2024, as amended by Amendment No. 1 to our Annual Report on Form&#160;10-K, filed with the SEC on <a href="https://www.sec.gov/ix?doc=/Archives/edgar/data/1130713/000113071324000047/byon-20231231.htm">June&#160;24, 2024</a>, and Amendment No. 2 to our Annual Report on Form&#160;10-K, filed with the SEC on <a href="https://www.sec.gov/ix?doc=/Archives/edgar/data/1130713/000113071324000085/byon-20231231.htm">October 31, 2024</a>. </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">The information specifically incorporated by reference into our Annual Report on Form&#160;10-K from our Definitive Proxy Statement on Schedule 14A, filed with the SEC on <a href="https://www.sec.gov/ix?doc=/Archives/edgar/data/1130713/000114036124015808/ny20022615x2_def14a.htm">March&#160;28, 2024</a>. </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">Our Quarterly Reports on Form&#160;10-Q for the quarters ended <a href="https://www.sec.gov/ix?doc=/Archives/edgar/data/1130713/000113071324000033/byon-20240331.htm">March&#160;31, 2024</a>, <a href="https://www.sec.gov/ix?doc=/Archives/edgar/data/1130713/000113071324000057/byon-20240630.htm">June&#160;30, 2024</a> and <a href="https://www.sec.gov/ix?doc=/Archives/edgar/data/1130713/000113071324000075/byon-20240930.htm">September&#160;30, 2024</a>, filed with the SEC on May&#160;8, 2024, July&#160;31, 2024 and October&#160;25, 2024, respectively. </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">Our Current Reports on Form&#160;8-K filed with the SEC on February&#160;20, 2024 (but only the <a href="https://www.sec.gov/ix?doc=/Archives/edgar/data/1130713/000113071324000003/ostk-20240216.htm">first</a> and <a href="https://www.sec.gov/ix?doc=/Archives/edgar/data/1130713/000113071324000004/ostk-20240216.htm">second</a> Current Reports on Form&#160;8-K filed on such date, and excluding, in each case, the information and related exhibit furnished pursuant to Item&#160;7.01), <a href="https://www.sec.gov/ix?doc=/Archives/edgar/data/1130713/000113071324000017/ostk-20240306.htm">March&#160;7, 2024</a> (excluding the information and related exhibit furnished pursuant to Item&#160;7.01), <a href="https://www.sec.gov/ix?doc=/Archives/edgar/data/1130713/000113071324000024/ostk-20240418.htm">April&#160;18, 2024</a>, <a href="https://www.sec.gov/ix?doc=/Archives/edgar/data/1130713/000113071324000037/ostk-20240521.htm">May&#160;24, 2024</a>, <a href="https://www.sec.gov/ix?doc=/Archives/edgar/data/1130713/000114036124029420/ny20030476x3_8k.htm">June&#160;10, 2024</a>, <a href="https://www.sec.gov/ix?doc=/Archives/edgar/data/1130713/000114036124030258/ny20030476x5_8k.htm">June&#160;17, 2024</a>, <a href="https://www.sec.gov/ix?doc=/Archives/edgar/data/1130713/000113071324000060/ostk-20240916.htm">September&#160;17, 2024</a>, <a href="https://www.sec.gov/ix?doc=/Archives/edgar/data/1130713/000113071324000063/ostk-20241015.htm">October&#160;16, 2024</a> (excluding the information and related exhibit furnished pursuant to Item&#160;7.01), <a href="https://www.sec.gov/ix?doc=/Archives/edgar/data/1130713/000113071324000067/ostk-20241021.htm">October&#160;21, 2024</a>, <a href="https://www.sec.gov/ix?doc=/Archives/edgar/data/1130713/000113071324000069/ostk-20241022.htm">October&#160;22, 2024</a>, <a href="https://www.sec.gov/ix?doc=/Archives/edgar/data/1130713/000113071324000077/ostk-20241027.htm">October&#160;28, 2024</a>, <a href="https://www.sec.gov/ix?doc=/Archives/edgar/data/1130713/000113071324000080/ostk-20241028.htm">October&#160;29, 2024</a>, <a href="https://www.sec.gov/ix?doc=/Archives/edgar/data/1130713/000113071324000088/ostk-20241121.htm">November&#160;22, 2024</a>, <a href="https://www.sec.gov/ix?doc=/Archives/edgar/data/1130713/000113071324000091/ostk-20241220.htm">December&#160;20, 2024</a>, <a href="https://www.sec.gov/ix?doc=/Archives/edgar/data/1130713/000113071325000006/ostk-20250131.htm">January&#160;31, 2025</a>, <a href="https://www.sec.gov/ix?doc=/Archives/edgar/data/1130713/000113071325000010/ostk-20250130.htm">February&#160;3, 2025</a> (excluding the information and related exhibit furnished pursuant to Item&#160;7.01), <a href="https://www.sec.gov/ix?doc=/Archives/edgar/data/1130713/000113071325000012/ostk-20250205.htm">February&#160;5, 2025</a> and <a href="https://www.sec.gov/ix?doc=/Archives/edgar/data/1130713/000113071325000015/ostk-20250221.htm">February&#160;24, 2025</a> (but only the first Current Report on Form 8-K filed on such date, and excluding the information and related exhibit furnished pursuant to Item 7.01). </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">The description of our common stock contained in the Registration Statement on Form&#160;8-A12B, filed with the SEC on <a href="https://www.sec.gov/Archives/edgar/data/1130713/000114036123049418/ny20013062x1_8a12b.htm">October&#160;25, 2023</a>, and any amendment or report filed with the SEC for the purpose of updating such description. </div></td></tr></table></div></div><div class="BRDSX_block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"><div class="BRDSX_unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">5<br></div></div></div>
<!--End Page 9-->
<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div class="BRPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 10-->
<div class="BRDSX_page" style="text-align: left; margin: auto; line-height: initial; width: 468pt;"><a name="ny20042541x1_posasr_107-incorp_pg2"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="BRDSX_page-content"><div class="BRDSX_block-main" style="width: 468pt; margin-left: 0pt;"><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6.75pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">All reports and other documents we subsequently file pursuant to Section 13(a), 13(c), 14 or 15(d) of the Securities Exchange Act of 1934, as amended, which we refer to as the &#8220;Exchange Act&#8221; in this prospectus, prior to the termination of this offering, but excluding any information furnished to, rather than filed with, the SEC, will also be incorporated by reference into this prospectus and deemed to be part of this prospectus from the date of the filing of such reports and documents. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">You may request a free copy of any of the documents incorporated by reference in this prospectus by writing or telephoning us at the following address: </div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 8.5pt; text-align: center;">BEYOND, INC. <br></div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; text-align: center;">433 W. ASCENSION WAY, 3<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">RD</sup> FLOOR <br></div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; text-align: center;">MURRAY, UTAH 84123 <br></div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; text-align: center;">ATTN: INVESTOR RELATIONS <br></div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; text-align: center;">(801) 947-3100 </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Exhibits to the filings will not be sent, however, unless those exhibits have specifically been incorporated by reference in this prospectus or any accompanying prospectus supplement. </div></div></div><div class="BRDSX_block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"><div class="BRDSX_unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">6<br></div></div></div>
<!--End Page 10-->
<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div class="BRPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 11-->
<div class="BRDSX_page" style="text-align: left; margin: auto; line-height: initial; width: 468pt;"><a name="ny20042541x1_posasr_108-company_pg1"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="BRDSX_page-content"><div class="BRDSX_block-main" style="width: 468pt; margin-left: 0pt;"><div class="BRDSX_h1" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 6.75pt; text-align: center;"><a name="tTC"><!--Anchor--></a>THE COMPANY </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">We are an e-commerce expert with a singular focus: connecting consumers with products and services they love. As the owner of the iconic Bed Bath &amp; Beyond, Overstock and Zulily brands, as well as several other brands, we strive to curate an exceptional online shopping experience. Our suite of premier online retail brands allow us to offer a comprehensive array of products and services, catering to customers in the United States and Canada. Our e-commerce platform, accessible through our mobile app, www.bedbathandbeyond.com, www.bedbathandbeyond.ca, www.overstock.com, and www.zulily.com (collectively referred to as the &#8220;Website&#8221;) serves as a gateway for those seeking a diverse array of top-tier, on-trend products that enable its customers to unlock their homes&#8217; potential at competitive prices. From furniture, bedding, and bath essentials to patio and outdoor gear, area rugs, tabletop and cookware, d&#233;cor, storage and organization solutions, small appliances, and home improvement items &#8211; we offer an extensive range of furniture and home furnishings to elevate our customers' living spaces within the four corners of their home and the four corners of their property. We have included our Website addresses only as inactive textual references and do not intend them to be an active link to our Website or incorporate information from our Website into this prospectus. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Our company, based in Murray, Utah, was founded as a Utah limited liability company in 1997, reorganized as a C corporation in the State of Utah in 1998, and reincorporated in Delaware in 2002. We launched our initial website in March 1999. In November 2023, we changed our corporate name from Overstock.com, Inc. to Beyond, Inc., and transferred the principal listing of our common stock from the Nasdaq Global Market to the New York Stock Exchange. Our common stock ceased trading under the ticker symbol &#8220;OSTK&#8221; on the Nasdaq Global Market at the close of market November 3, 2023 and on November 6, 2023, our common stock began trading under the ticker symbol &#8220;BYON&#8221; on the New York Stock Exchange. We will not distinguish between our prior and current corporate name and will refer to our current corporate name throughout this prospectus and any accompanying prospectus supplement. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Our principal executive offices are located at 433 W. Ascension Way, 3<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">rd</sup> Floor, Murray, Utah 84123, and our telephone number is (801) 947-3100. </div></div></div><div class="BRDSX_block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"><div class="BRDSX_unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">7<br></div></div></div>
<!--End Page 11-->
<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div class="BRPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 12-->
<div class="BRDSX_page" style="text-align: left; margin: auto; line-height: initial; width: 468pt;"><a name="ny20042541x1_posasr_109-risk_pg1"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="BRDSX_page-content"><div class="BRDSX_block-main" style="width: 468pt; margin-left: 0pt;"><div class="BRDSX_h1" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 6.75pt; text-align: center;"><a name="tRF"><!--Anchor--></a>RISK FACTORS </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Investment in any securities offered pursuant to this prospectus and the applicable prospectus supplement involves risks. Before deciding whether to invest in our securities, you should carefully consider the risk factors incorporated by reference to our most recent Annual Report on Form&#160;10-K and any subsequent Quarterly Reports on Form&#160;10-Q or Current Reports on Form&#160;8-K, and all other information contained or incorporated by reference into this prospectus, as updated by our subsequent filings under the Exchange Act, and the risk factors and other information contained in the applicable prospectus supplement and any applicable free writing prospectus. The occurrence of any of these risks might cause you to lose all or part of your investment in the offered securities. There may be other unknown or unpredictable economic, business, competitive, regulatory or other factors that could have material adverse effects on our future results. Past financial performance may not be a reliable indicator of future performance, and historical trends should not be used to anticipate results or trends in future periods. If any of these risks actually occurs, our business, financial condition, results of operations or cash flow could be seriously harmed. This could cause the trading price of our securities to decline, resulting in a loss of all or part of your investment. Please also carefully read the section entitled &#8220;Special Cautionary Note Regarding Forward-Looking Statements&#8221; included in our most recent Annual Report on Form&#160;10-K and any subsequent Quarterly Reports on Form&#160;10-Q or Current Reports on Form&#160;8-K. </div></div></div><div class="BRDSX_block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"><div class="BRDSX_unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">8<br></div></div></div>
<!--End Page 12-->
<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div class="BRPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 13-->
<div class="BRDSX_page" style="text-align: left; margin: auto; line-height: initial; width: 468pt;"><a name="ny20042541x1_posasr_110-use_pg1"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="BRDSX_page-content"><div class="BRDSX_block-main" style="width: 468pt; margin-left: 0pt;"><div class="BRDSX_h1" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 6.75pt; text-align: center;"><a name="tUOP"><!--Anchor--></a>USE OF PROCEEDS </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">We intend to use the net proceeds from the sale of the securities as set forth in the applicable prospectus supplement. </div></div></div><div class="BRDSX_block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"><div class="BRDSX_unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">9<br></div></div></div>
<!--End Page 13-->
<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div class="BRPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 14-->
<div class="BRDSX_page" style="text-align: left; margin: auto; line-height: initial; width: 468pt;"><a name="ny20042541x1_posasr_111-description_pg1"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="BRDSX_page-content"><div class="BRDSX_block-main" style="width: 468pt; margin-left: 0pt;"><div class="BRDSX_h1" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 6.75pt; text-align: center;"><a name="tDOC"><!--Anchor--></a>DESCRIPTION OF CAPITAL STOCK </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">The following information describes our common stock, par value $0.0001 per share, as well as certain provisions of our amended and restated certificate of incorporation and amended and restated bylaws. This description is only a summary. For a complete statement of the terms and rights of the common stock, you should also refer to our amended and restated certificate of incorporation and amended and restated bylaws which have been publicly filed with the SEC, as well as the General Corporation Law of the State of Delaware (&#8220;DGCL&#8221;). See &#8220;Where You Can Find More Information; Incorporation by Reference.&#8221; </div><div class="BRDSX_h2" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 12pt; margin-left: 0pt; text-align: left;">Capital Stock </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Our authorized capital stock consists of 100,000,000 shares of common stock, par value $0.0001 per share, and 5,000,000 shares of preferred stock, par value $0.0001 per share. Our board of directors may establish the rights, powers and preferences of undesignated preferred stock from time to time. Our board of directors is authorized, without stockholder approval, except as required by the listing standards of the New York Stock Exchange, to issue additional shares of our authorized capital stock. </div><div class="BRDSX_h2" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 12pt; margin-left: 0pt; text-align: left;">Common Stock </div><div class="BRDSX_h4" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; margin-top: 7pt; margin-left: 0pt; text-align: left;">Voting Rights </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">The holders of our common stock are entitled to one vote per share on all matters to be voted upon by the stockholders. Our amended and restated certificate of incorporation prohibits cumulative voting. Pursuant to our amended and restated bylaws, the election of directors shall be decided by a plurality vote of the shares present in person or represented by proxy at the meeting and entitled to vote on the election of directors. With respect to matters other than the election of directors, if a quorum is present, the affirmative vote of a majority of the shares represented and voting at a duly held meeting (which shares voting affirmatively also constitute at least a majority of the required quorum) shall be the act of the stockholders, unless the vote of a greater number or a vote by classes is required by law, by our amended and restated certificate of incorporation or by our amended and restated bylaws. The holders of a majority of the shares issued and outstanding and entitled to vote thereat, present in person or represented by proxy, shall constitute a quorum for the transaction of business at all meetings of the stockholders. Our amended and restated certificate of incorporation prohibits stockholders from taking action by written consent in lieu of a meeting. </div><div class="BRDSX_h4" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; margin-top: 12pt; margin-left: 0pt; text-align: left;">Dividend Rights </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">We have never declared or paid any cash dividends on our common stock. We currently intend to retain any earnings for future growth and do not anticipate paying any cash dividends in the foreseeable future. Any future determination to pay dividends will be at the discretion of our board of directors and will depend on our results of operations, financial conditions, contractual and legal restrictions and other factors the board deems relevant. </div><div class="BRDSX_h4" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; margin-top: 12pt; margin-left: 0pt; text-align: left;">Preemption, Conversion, and Redemption Rights </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Holders of our common stock have no preemptive or conversion rights or other subscription rights, and there are no redemption provisions applicable to the common stock. The outstanding shares of common stock are fully paid and non-assessable. The rights, preferences and privileges of the holders of our common stock are subject to, and may be adversely affected by, the rights of the holders of any series of preferred stock that we may designate and/or issue in the future. </div><div class="BRDSX_h2" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 12pt; margin-left: 0pt; text-align: left;">Board of Directors </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">The number of directors is fixed by, or in the manner provided in, our amended and restated certificate of incorporation and amended and restated bylaws. Commencing at the 2025 annual meeting of stockholders, all of our directors elected at an annual meeting of stockholders shall hold office for a term that expires at the next annual meeting of stockholders (or until their respective successors shall have been elected and qualified or until their earlier death, resignation or removal). The term of each director serving as of and immediately following the date of the 2024 annual meeting of stockholders shall expire at the 2025 annual meeting of stockholders, notwithstanding that such director may have been elected for a term that extended beyond the date of the 2025 annual meeting of stockholders. </div><div class="BRDSX_h2" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 12pt; margin-left: 0pt; text-align: left;">Anti-Takeover Effects of Certain Provisions of Delaware Law </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Provisions of Delaware law and of our amended and restated certificate of incorporation and amended and restated bylaws could make the acquisition of the Company through a tender offer, a proxy contest or other means more difficult and could make the removal of incumbent officers and directors more difficult. These provisions can </div></div></div><div class="BRDSX_block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"><div class="BRDSX_unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">10<br></div></div></div>
<!--End Page 14-->
<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div class="BRPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 15-->
<div class="BRDSX_page" style="text-align: left; margin: auto; line-height: initial; width: 468pt;"><a name="ny20042541x1_posasr_111-description_pg2"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="BRDSX_page-content"><div class="BRDSX_block-main" style="width: 468pt; margin-left: 0pt;"><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6.75pt; margin-left: 0pt; text-align: justify;">discourage inadequate takeover bids and encourage persons seeking to acquire control of the Company to first&#160;negotiate with our board of directors. We believe that the benefits provided by our ability to negotiate with the proponent of an unsolicited proposal would outweigh the disadvantages of discouraging these proposals. We believe the negotiation of an unsolicited proposal could result in terms more favorable to our stockholders. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">We are subject to Section 203 of the DGCL, which prohibits persons deemed to be &#8220;interested stockholders&#8221; from engaging in a &#8220;business combination&#8221; with a publicly held Delaware corporation for three years following the date these persons become interested stockholders unless the business combination is, or the transaction in which the person became an interested stockholder was, approved in a prescribed manner or another prescribed exception applies. Generally, an &#8220;interested stockholder&#8221; is a person who, together with affiliates and associates, owns, or within three years prior to the determination of interested stockholder status did own, 15% or more of a corporation's voting stock. Generally, a &#8220;business combination&#8221; includes a merger, asset or stock sale, or other transaction resulting in a financial benefit to the interested stockholder. The existence of this law may have an anti-takeover effect with respect to transactions not approved in advance by the board of directors. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">This summary of the provisions of Section 203 of the DGCL does not purport to be complete and is qualified in its entirety by reference to our amended and restated certificate of incorporation, our amended and restated bylaws, and the DGCL. </div><div class="BRDSX_h2" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 12pt; margin-left: 0pt; text-align: left;">Anti-Takeover Provisions of the Company&#8217;s Amended and Restated Certificate of Incorporation and Amended and Restated Bylaws </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Certain provisions in our amended and restated certificate of incorporation and amended and restated bylaws summarized below could discourage, delay or prevent a change in control of our Company or changes in our management that the stockholders of our Company may deem advantageous. </div><div class="BRDSX_h4" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; margin-top: 12pt; margin-left: 0pt; text-align: left;">Preferred Stock </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Under our amended and restated certificate of incorporation, the board of directors may issue, without further stockholder approval, shares of preferred stock in one or more series and may also set forth the voting powers, full or limited or none, of each such series of preferred stock, which the board could use to implement a stockholder rights plan (also known as a &#8220;poison pill&#8221;). The board of directors shall fix the designations, preferences and relative, participating, optional or other special rights of each such series of preferred stock and the qualifications, limitations or restrictions of such powers, designations, preferences or rights. </div><div class="BRDSX_h4" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; margin-top: 12pt; margin-left: 0pt; text-align: left;">No Action by Written Consent </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Under our amended and restated certificate of incorporation and amended and restated bylaws, stockholders of the Company may not take action by written consent in lieu of a meeting. </div><div class="BRDSX_h4" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; margin-top: 12pt; margin-left: 0pt; text-align: left;">Special Meetings of Stockholders </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Under our amended and restated bylaws, special meetings of our stockholders may be called only by the board of directors, the chairman of the board, the chief executive officer, or the president of the Company. </div><div class="BRDSX_h4" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; margin-top: 12pt; margin-left: 0pt; text-align: left;">Advance Notice Requirements for Stockholders Proposals and Director Nominations </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Our amended and restated bylaws establish advance notice procedures with respect to stockholder proposals to be brought before a stockholder meeting and the nomination of candidates for election as directors, other than nominations made by or at the direction of the board of directors or a committee of the board of directors. </div><div class="BRDSX_h4" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; margin-top: 12pt; margin-left: 0pt; text-align: left;">Board of Directors and Vacancies </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">The authorized number of directors on the board of directors will be established from time to time by resolution of the board of directors. Vacancies arising through death, resignation, removal, an increase in the number of directors or otherwise may be filled only by a majority of the directors then in office, though less than a quorum, or by a sole remaining director. </div><div class="BRDSX_h4" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; margin-top: 12pt; margin-left: 0pt; text-align: left;">Amendment of Our Amended and Restated Bylaws </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">The board of directors is expressly authorized to make, alter or repeal our amended and restated bylaws. Our amended and restated bylaws provide that stockholders are permitted to amend the amended and restated bylaws only with the approval of the holders of sixty-six and two-thirds percent (66 2/3%) of the voting power of outstanding capital stock entitled to vote at an election of directors. </div></div></div><div class="BRDSX_block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"><div class="BRDSX_unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">11<br></div></div></div>
<!--End Page 15-->
<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div class="BRPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 16-->
<div class="BRDSX_page" style="text-align: left; margin: auto; line-height: initial; width: 468pt;"><a name="ny20042541x1_posasr_111-description_pg3"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="BRDSX_page-content"><div class="BRDSX_block-main" style="width: 468pt; margin-left: 0pt;"><div class="BRDSX_h4" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; margin-top: 6.75pt; margin-left: 0pt; text-align: left;">Forum Selection Clause </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Under the amended and restated certificate of incorporation and the amended and restated bylaws, unless the Company consents in writing to the selection of an alternative forum, the sole and exclusive forum for making certain types of claims will be a state or federal court located within the State of Delaware. This provision applies to (i) any derivative action or proceeding brought on behalf of the company, (ii) any action asserting a claim of breach of a fiduciary duty owed by any director or officer or other employee of the Company to the Company or its stockholders, (iii) any action asserting a claim against the company or any director or officer or other employee of the Company arising pursuant to any provision of the DGCL or our amended and restated certificate of incorporation and the amended and restated bylaws, or (iv) any action asserting a claim against the company or any director or officer or other employee of the company governed by the internal affairs doctrine. </div><div class="BRDSX_h2" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 20.5pt; margin-left: 0pt; text-align: left;">Transfer Agent and Registrar </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 7.5pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">Our transfer agent and registrar for our common stock is Computershare Trust Company, N.A. </div><div class="BRDSX_h2" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 20.5pt; margin-left: 0pt; text-align: left;">Listing </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 7.5pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">Our common stock is listed on the New York Stock Exchange under the trading symbol &#8220;BYON.&#8221; </div></div></div><div class="BRDSX_block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"><div class="BRDSX_unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">12<br></div></div></div>
<!--End Page 16-->
<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div class="BRPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 17-->
<div class="BRDSX_page" style="text-align: left; margin: auto; line-height: initial; width: 468pt;"><a name="ny20042541x1_posasr_111-description_pg4"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="BRDSX_page-content"><div class="BRDSX_block-main" style="width: 468pt; margin-left: 0pt;"><div class="BRDSX_h1" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 6.75pt; text-align: center;"><a name="tDOD"><!--Anchor--></a>DESCRIPTION OF DEBT SECURITIES </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">The following description, together with the additional information we include in any applicable prospectus supplement or free writing prospectus, summarizes certain general terms and provisions of the debt securities that we may offer under this prospectus. When we offer to sell a particular series of debt securities, we will describe the specific terms of the series in a supplement to this prospectus. We will also indicate in the supplement to what extent the general terms and provisions described in this prospectus apply to a particular series of debt securities. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">We may issue debt securities either separately, or together with, or upon the conversion or exercise of or in exchange for, other securities described in this prospectus. Debt securities may be our senior, senior subordinated or subordinated obligations and, unless otherwise specified in a supplement to this prospectus, the debt securities will be our direct, unsecured obligations and may be issued in one or more series. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">The debt securities will be issued under an indenture between us and a trustee named in a prospectus supplement. We have summarized select portions of the indenture below. The summary is not complete. The form of the indenture has been filed as an exhibit to the registration statement and you should read the indenture for provisions that may be important to you. In the summary below, we have included references to the section numbers of the indenture so that you can easily locate these provisions. Capitalized terms used in the summary and not defined herein have the meanings specified in the indenture. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">As used in this section only, &#8220;Beyond,&#8221; &#8220;we,&#8221; &#8220;our&#8221; or &#8220;us&#8221; refer to Beyond, Inc. excluding our subsidiaries, unless expressly stated or the context otherwise requires. </div><div class="BRDSX_h2" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 12pt; margin-left: 0pt; text-align: left;">General </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">The terms of each series of debt securities will be established by or pursuant to a resolution of our board of directors and set forth or determined in the manner provided in a resolution of our board of directors, in an officer&#8217;s certificate or by a supplemental indenture. (Section 2.2) The particular terms of each series of debt securities will be described in a prospectus supplement relating to such series (including any pricing supplement or term sheet). </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">We can issue an unlimited amount of debt securities under the indenture that may be in one or more series with the same or various maturities, at par, at a premium, or at a discount. (Section 2.1) We will set forth in a prospectus supplement (including any pricing supplement or term sheet) relating to any series of debt securities being offered, the aggregate principal amount and the following terms of the debt securities, if applicable: </div><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">the title and ranking of the debt securities (including the terms of any subordination provisions); </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">the price or prices (expressed as a percentage of the principal amount) at which we will sell the debt securities; </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">any limit on the aggregate principal amount of the debt securities; </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">the date or dates on which the principal of the securities of the series is payable; </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">the rate or rates (which may be fixed or variable) per annum or the method used to determine the rate or rates (including any commodity, commodity index, stock exchange index or financial index) at which the debt securities will bear interest, the date or dates from which interest will accrue, the date or dates on which interest will commence and be payable and any regular record date for the interest payable on any interest payment date; </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">the place or places where principal of, and interest, if any, on the debt securities will be payable (and the method of such payment), where the securities of such series may be surrendered for registration of transfer or exchange, and where notices and demands to us in respect of the debt securities may be delivered; </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">the period or periods within which, the price or prices at which and the terms and conditions upon which we may redeem the debt securities; </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">any obligation we have to redeem or purchase the debt securities pursuant to any sinking fund or analogous provisions or at the option of a holder of debt securities and the period or periods within which, the price or prices at which and in the terms and conditions upon which securities of the series shall be redeemed or purchased, in whole or in part, pursuant to such obligation; </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">the dates on which and the price or prices at which we will repurchase debt securities at the option of the holders of debt securities and other detailed terms and provisions of these repurchase obligations; </div></td></tr></table></div></div><div class="BRDSX_block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"><div class="BRDSX_unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">13<br></div></div></div>
<!--End Page 17-->
<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div class="BRPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 18-->
<div class="BRDSX_page" style="text-align: left; margin: auto; line-height: initial; width: 468pt;"><a name="ny20042541x1_posasr_111-description_pg5"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="BRDSX_page-content"><div class="BRDSX_block-main" style="width: 468pt; margin-left: 0pt;"><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6.75pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">the denominations in which the debt securities will be issued, if other than denominations of $1,000 and any integral multiple thereof; </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">whether the debt securities will be issued in the form of certificated debt securities or global debt securities; </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">the portion of principal amount of the debt securities payable upon declaration of acceleration of the maturity date, if other than the principal amount; </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">the currency of denomination of the debt securities, which may be United States Dollars or any foreign currency, and if such currency of denomination is a composite currency, the agency or organization, if any, responsible for overseeing such composite currency; </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">the designation of the currency, currencies or currency units in which payment of principal of, premium and interest on the debt securities will be made; </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">if payments of principal of, premium or interest on the debt securities will be made in one or more currencies or currency units other than that or those in which the debt securities are denominated, the manner in which the exchange rate with respect to these payments will be determined; </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">the manner in which the amounts of payment of principal of, premium, if any, or interest on the debt securities will be determined, if these amounts may be determined by reference to an index based on a currency or currencies or by reference to a commodity, commodity index, stock exchange index or financial index; </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">any provisions relating to any security provided for the debt securities; </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">any addition to, deletion of or change in the Events of Default described in this prospectus or in the indenture with respect to the debt securities and any change in the acceleration provisions described in this prospectus or in the indenture with respect to the debt securities; </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">any addition to, deletion of or change in the covenants described in this prospectus or in the indenture with respect to the debt securities; </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">any depositaries, interest rate calculation agents, exchange rate calculation agents or other agents with respect to the debt securities; </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">the provisions, if any, relating to conversion or exchange of any debt securities of such series, including if applicable, the conversion or exchange price and period, provisions as to whether conversion or exchange will be mandatory, the events requiring an adjustment of the conversion or exchange price and provisions affecting conversion or exchange; </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">any other terms of the debt securities, which may supplement, modify or delete any provision of the indenture as it applies to that series, including any terms that may be required under applicable law or regulations or advisable in connection with the marketing of the securities; and </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">whether any of our direct or indirect subsidiaries will guarantee the debt securities of that series, including the terms of subordination, if any, of such guarantees. (Section&#160;2.2) </div></td></tr></table><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">We may issue debt securities that provide for an amount less than their stated principal amount to be due and payable upon declaration of acceleration of their maturity pursuant to the terms of the indenture. We will provide you with information on the federal income tax considerations and other special considerations applicable to any of these debt securities in the applicable prospectus supplement. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">If we denominate the purchase price of any of the debt securities in a foreign currency or currencies or a foreign currency unit or units, or if the principal of and any premium and interest on any series of debt securities is payable in a foreign currency or currencies or a foreign currency unit or units, we will provide you with information on the restrictions, elections, general tax considerations, specific terms and other information with respect to that issue of debt securities and such foreign currency or currencies or foreign currency unit or units in the applicable prospectus supplement. </div></div></div><div class="BRDSX_block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"><div class="BRDSX_unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">14<br></div></div></div>
<!--End Page 18-->
<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div class="BRPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 19-->
<div class="BRDSX_page" style="text-align: left; margin: auto; line-height: initial; width: 468pt;"><a name="ny20042541x1_posasr_111-description_pg6"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="BRDSX_page-content"><div class="BRDSX_block-main" style="width: 468pt; margin-left: 0pt;"><div class="BRDSX_h2" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 6.75pt; margin-left: 0pt; text-align: left;">Transfer and Exchange </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Each debt security will be represented by either one or more global securities registered in the name of The Depository Trust Company, or the Depositary, or a nominee of the Depositary (we will refer to any debt security represented by a global debt security as a &#8220;book-entry debt security&#8221;), or a certificate issued in definitive registered form (we will refer to any debt security represented by a certificated security as a &#8220;certificated debt security&#8221;) as set forth in the applicable prospectus supplement. Except as set forth under the heading &#8220;Global Debt Securities and Book-Entry System&#8221; below, book-entry debt securities will not be issuable in certificated form. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Certificated Debt Securities. You may transfer or exchange certificated debt securities at any office we maintain for this purpose in accordance with the terms of the indenture. (Section 2.4) No service charge will be made for any transfer or exchange of certificated debt securities, but we may require payment of a sum sufficient to cover any tax or other governmental charge payable in connection with a transfer or exchange. (Section 2.7) </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">You may effect the transfer of certificated debt securities and the right to receive the principal of, premium and interest on certificated debt securities only by surrendering the certificate representing those certificated debt securities and either reissuance by us or the trustee of the certificate to the new holder or the issuance by us or the trustee of a new certificate to the new holder. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Global Debt Securities and Book-Entry System. Each global debt security representing book-entry debt securities will be deposited with, or on behalf of, the Depositary, and registered in the name of the Depositary or a nominee of the Depositary. Please see &#8220;Global Securities.&#8221; </div><div class="BRDSX_h2" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 14pt; margin-left: 0pt; text-align: left;">Covenants </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">We will set forth in the applicable prospectus supplement any restrictive covenants applicable to any issue of debt securities. (Article IV) </div><div class="BRDSX_h2" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 14pt; margin-left: 0pt; text-align: left;">No Protection in the Event of a Change of Control </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Unless we state otherwise in the applicable prospectus supplement, the debt securities will not contain any provisions which may afford holders of the debt securities protection in the event we have a change in control or in the event of a highly leveraged transaction (whether or not such transaction results in a change in control) which could adversely affect holders of debt securities. </div><div class="BRDSX_h2" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 14pt; margin-left: 0pt; text-align: left;">Consolidation, Merger and Sale of Assets </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">We may not consolidate with or merge with or into, or convey, transfer or lease all or substantially all of our properties and assets to any person (a &#8220;successor person&#8221;) unless: </div><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">we are the surviving entity or the successor person (if other than Beyond) is a corporation, partnership, trust or other entity organized and validly existing under the laws of any U.S. domestic jurisdiction and expressly assumes our obligations on the debt securities and under the indenture; and </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">immediately after giving effect to the transaction, no Default or Event of Default, shall have occurred and be continuing. </div></td></tr></table><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Notwithstanding the above, any of our subsidiaries may consolidate with, merge into or transfer all or part of its properties to us. (Section 5.1) </div><div class="BRDSX_h2" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 14pt; margin-left: 0pt; text-align: left;">Events of Default </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 7pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">&#8220;Event of Default&#8221; means with respect to any series of debt securities, any of the following: </div><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">default in the payment of any interest upon any debt security of that series when it becomes due and payable, and continuance of such default for a period of 30 days (unless the entire amount of the payment is deposited by us with the trustee or with a paying agent prior to the expiration of the 30-day period); </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">default in the payment of principal of any security of that series at its maturity; </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">default in the performance or breach of any other covenant or warranty by us in the indenture (other than a covenant or warranty that has been included in the indenture solely for the benefit of a series of debt securities other than that series), which default continues uncured for a period of 60 days after we receive </div></td></tr></table></div></div><div class="BRDSX_block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"><div class="BRDSX_unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">15<br></div></div></div>
<!--End Page 19-->
<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div class="BRPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 20-->
<div class="BRDSX_page" style="text-align: left; margin: auto; line-height: initial; width: 468pt;"><a name="ny20042541x1_posasr_111-description_pg7"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="BRDSX_page-content"><div class="BRDSX_block-main" style="width: 468pt; margin-left: 0pt;"><div class="BRDSX_bl" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6.75pt; margin-left: 40pt; text-align: justify;">written notice from the trustee or Beyond and the trustee receive written notice from the holders of not less than 25% in principal amount of the outstanding debt securities of that series as provided in the indenture; </div><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">certain voluntary or involuntary events of bankruptcy, insolvency or reorganization of Beyond; or </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">any other Event of Default provided with respect to debt securities of that series that is described in the applicable prospectus supplement. (Section&#160;6.1) </div></td></tr></table><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">No Event of Default with respect to a particular series of debt securities (except as to certain events of bankruptcy, insolvency or reorganization) necessarily constitutes an Event of Default with respect to any other series of debt securities. (Section 6.1) The occurrence of certain Events of Default or an acceleration under the indenture may constitute an event of default under certain indebtedness of ours or our subsidiaries outstanding from time to time. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">We will provide the trustee written notice of any Default or Event of Default within 30 days of becoming aware of the occurrence of such Default or Event of Default, which notice will describe in reasonable detail the status of such Default or Event of Default and what action we are taking or propose to take in respect thereof. (Section 6.1) </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">If an Event of Default with respect to debt securities of any series at the time outstanding occurs and is continuing, then the trustee or the holders of not less than 25% in principal amount of the outstanding debt securities of that series may, by a notice in writing to us (and to the trustee if given by the holders), declare to be due and payable immediately the principal of (or, if the debt securities of that series are discount securities, that portion of the principal amount as may be specified in the terms of that series) and accrued and unpaid interest, if any, on all debt securities of that series. In the case of an Event of Default resulting from certain events of bankruptcy, insolvency or reorganization, the principal (or such specified amount) of and accrued and unpaid interest, if any, on all outstanding debt securities will become and be immediately due and payable without any declaration or other act on the part of the trustee or any holder of outstanding debt securities. At any time after a declaration of acceleration with respect to debt securities of any series has been made, but before a judgment or decree for payment of the money due has been obtained by the trustee, the holders of a majority in principal amount of the outstanding debt securities of that series may rescind and annul the acceleration if all Events of Default, other than the non-payment of accelerated principal and interest, if any, with respect to debt securities of that series, have been cured or waived as provided in the indenture. (Section 6.2) We refer you to the prospectus supplement relating to any series of debt securities that are discount securities for the particular provisions relating to acceleration of a portion of the principal amount of such discount securities upon the occurrence of an Event of Default. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">The indenture provides that the trustee may refuse to perform any duty or exercise any of its rights or powers under the indenture unless the trustee receives indemnity satisfactory to it against any cost, liability or expense which might be incurred by it in performing such duty or exercising such right or power. (Section 7.1(e)) Subject to certain rights of the trustee, the holders of a majority in principal amount of the outstanding debt securities of any series will have the right to direct the time, method and place of conducting any proceeding for any remedy available to the trustee or exercising any trust or power conferred on the trustee with respect to the debt securities of that series. (Section 6.12) </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">No holder of any debt security of any series will have any right to institute any proceeding, judicial or otherwise, with respect to the indenture or for the appointment of a receiver or trustee, or for any remedy under the indenture, unless: </div><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">that holder has previously given to the trustee written notice of a continuing Event of Default with respect to debt securities of that series; and </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">the holders of not less than 25% in principal amount of the outstanding debt securities of that series have made written request, and offered indemnity or security satisfactory to the trustee, to the trustee to institute the proceeding as trustee, and the trustee has not received from the holders of not less than a majority in principal amount of the outstanding debt securities of that series a direction inconsistent with that request and has failed to institute the proceeding within 60 days. (Section&#160;6.7) </div></td></tr></table><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Notwithstanding any other provision in the indenture, the holder of any debt security will have an absolute and unconditional right to receive payment of the principal of, premium and any interest on that debt security on or after the due dates expressed in that debt security and to institute suit for the enforcement of payment. (Section 6.8) </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">The indenture requires us, within 120 days after the end of our fiscal year, to furnish to the trustee a statement as to compliance with the indenture. (Section 4.3) If a Default or Event of Default occurs and is continuing with respect to the securities of any series and if it is known to a responsible officer of the trustee, the trustee shall mail </div></div></div><div class="BRDSX_block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"><div class="BRDSX_unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">16<br></div></div></div>
<!--End Page 20-->
<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div class="BRPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 21-->
<div class="BRDSX_page" style="text-align: left; margin: auto; line-height: initial; width: 468pt;"><a name="ny20042541x1_posasr_111-description_pg8"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="BRDSX_page-content"><div class="BRDSX_block-main" style="width: 468pt; margin-left: 0pt;"><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6.75pt; margin-left: 0pt; text-align: justify;">to each Securityholder of the securities of that series notice of a Default or Event of Default within 90 days after it occurs or, if later, after a responsible officer of the trustee has knowledge of such Default or Event of Default. The indenture provides that the trustee may withhold notice to the holders of debt securities of any series of any Default or Event of Default (except in payment on any debt securities of that series) with respect to debt securities of that series if the trustee determines in good faith that withholding notice is in the interest of the holders of those debt securities. (Section 7.5) </div><div class="BRDSX_h2" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 14pt; margin-left: 0pt; text-align: left;">Modification and Waiver </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">We and the trustee may modify, amend or supplement the indenture or the debt securities of any series without the consent of any holder of any debt security: </div><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">to cure any ambiguity, defect or inconsistency; </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">to comply with covenants in the indenture described above under the heading &#8220;Consolidation, Merger and Sale of Assets;&#8221; </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">to provide for uncertificated securities in addition to or in place of certificated securities; </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">to add guarantees with respect to debt securities of any series or secure debt securities of any series; </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">to surrender any of our rights or powers under the indenture; </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">to add covenants or events of default for the benefit of the holders of debt securities of any series; </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">to comply with the applicable procedures of the applicable depositary; </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">to make any change that does not adversely affect the rights of any holder of debt securities; </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">to provide for the issuance of and establish the form and terms and conditions of debt securities of any series as permitted by the indenture; </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">to effect the appointment of a successor trustee with respect to the debt securities of any series and to add to or change any of the provisions of the indenture to provide for or facilitate administration by more than one trustee; or </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">to comply with requirements of the SEC in order to effect or maintain the qualification of the indenture under the Trust Indenture Act. (Section&#160;9.1) </div></td></tr></table><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">We may also modify and amend the indenture with the consent of the holders of at least a majority in principal amount of the outstanding debt securities of each series affected by the modifications or amendments. We may not make any modification or amendment without the consent of the holders of each affected debt security then outstanding if that amendment will: </div><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">reduce the amount of debt securities whose holders must consent to an amendment, supplement or waiver; </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">reduce the rate of or extend the time for payment of interest (including default interest) on any debt security; </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">reduce the principal of or premium on or change the fixed maturity of any debt security or reduce the amount of, or postpone the date fixed for, the payment of any sinking fund or analogous obligation with respect to any series of debt securities; </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">reduce the principal amount of discount securities payable upon acceleration of maturity; </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">waive a default in the payment of the principal of, premium or interest on any debt security (except a rescission of acceleration of the debt securities of any series by the holders of at least a majority in aggregate principal amount of the then outstanding debt securities of that series and a waiver of the payment default that resulted from such acceleration); </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">make the principal of or premium or interest on any debt security payable in currency other than that stated in the debt security; </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">make any change to certain provisions of the indenture relating to, among other things, the right of holders of debt securities to receive payment of the principal of, premium and interest on those debt securities and to institute suit for the enforcement of any such payment and to waivers or amendments; or </div></td></tr></table></div></div><div class="BRDSX_block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"><div class="BRDSX_unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">17<br></div></div></div>
<!--End Page 21-->
<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div class="BRPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 22-->
<div class="BRDSX_page" style="text-align: left; margin: auto; line-height: initial; width: 468pt;"><a name="ny20042541x1_posasr_111-description_pg9"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="BRDSX_page-content"><div class="BRDSX_block-main" style="width: 468pt; margin-left: 0pt;"><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6.75pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">waive a redemption payment with respect to any debt security. (Section&#160;9.3) </div></td></tr></table><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Except for certain specified provisions, the holders of at least a majority in principal amount of the outstanding debt securities of any series may on behalf of the holders of all debt securities of that series waive our compliance with provisions of the indenture. (Section 9.2) The holders of a majority in principal amount of the outstanding debt securities of any series may on behalf of the holders of all the debt securities of such series waive any past default under the indenture with respect to that series and its consequences, except a default in the payment of the principal of, premium or any interest on any debt security of that series; provided, however, that the holders of a majority in principal amount of the outstanding debt securities of any series may rescind an acceleration and its consequences, including any related payment default that resulted from the acceleration. (Section 6.13) </div><div class="BRDSX_h2" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 20.5pt; margin-left: 0pt; text-align: left;">Defeasance of Debt Securities and Certain Covenants in Certain Circumstances </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Legal Defeasance<font style="font-style: normal;">. The indenture provides that, unless otherwise provided by the terms of the applicable series of debt securities, we may be discharged from any and all obligations in respect of the debt securities of any series (subject to certain exceptions). We will be so discharged upon the irrevocable deposit with the trustee, in trust, of money and/or U.S. government obligations or, in the case of debt securities denominated in a single currency other than U.S. Dollars, government obligations of the government that issued or caused to be issued such currency, that, through the payment of interest and principal in accordance with their terms, will provide money or U.S. government obligations in an amount sufficient in the opinion of a nationally recognized firm of independent public accountants or investment bank to pay and discharge each installment of principal, premium and interest on and any mandatory sinking fund payments in respect of the debt securities of that series on the stated maturity of those payments in accordance with the terms of the indenture and those debt securities. </font></div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">This discharge may occur only if, among other things, we have delivered to the trustee an opinion of counsel stating that we have received from, or there has been published by, the United States Internal Revenue Service a ruling or, since the date of execution of the indenture, there has been a change in the applicable United States federal income tax law, in either case to the effect that, and based thereon such opinion shall confirm that, the holders of the debt securities of that series will not recognize income, gain or loss for United States federal income tax purposes as a result of the deposit, defeasance and discharge and will be subject to United States federal income tax on the same amounts and in the same manner and at the same times as would have been the case if the deposit, defeasance and discharge had not occurred. (Section 8.3) </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Defeasance of Certain Covenants<font style="font-style: normal;">. The indenture provides that, unless otherwise provided by the terms of the applicable series of debt securities, upon compliance with certain conditions: </font></div><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">we may omit to comply with the covenant described under the heading &#8220;Consolidation, Merger and Sale of Assets&#8221; and certain other covenants set forth in the indenture, as well as any additional covenants which may be set forth in the applicable prospectus supplement; and </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">any omission to comply with those covenants will not constitute a Default or an Event of Default with respect to the debt securities of that series (&#8220;covenant defeasance&#8221;). </div></td></tr></table><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 8.5pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">The conditions include: </div><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">depositing with the trustee money and/or U.S. government obligations or, in the case of debt securities denominated in a single currency other than U.S. Dollars, government obligations of the government that issued or caused to be issued such currency, that, through the payment of interest and principal in accordance with their terms, will provide money in an amount sufficient in the opinion of a nationally recognized firm of independent public accountants or investment bank to pay and discharge each installment of principal of, premium and interest on and any mandatory sinking fund payments in respect of the debt securities of that series on the stated maturity of those payments in accordance with the terms of the indenture and those debt securities; and </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">delivering to the trustee an opinion of counsel to the effect that the holders of the debt securities of that series will not recognize income, gain or loss for United States federal income tax purposes as a result of </div></td></tr></table></div></div><div class="BRDSX_block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"><div class="BRDSX_unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">18<br></div></div></div>
<!--End Page 22-->
<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div class="BRPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 23-->
<div class="BRDSX_page" style="text-align: left; margin: auto; line-height: initial; width: 468pt;"><a name="ny20042541x1_posasr_111-description_pg10"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="BRDSX_page-content"><div class="BRDSX_block-main" style="width: 468pt; margin-left: 0pt;"><div class="BRDSX_bl" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6.75pt; margin-left: 40pt; text-align: justify;">the deposit and related covenant defeasance and will be subject to United States federal income tax on the same amounts and in the same manner and at the same times as would have been the case if the deposit and related covenant defeasance had not occurred. (Section&#160;8.4) </div><div class="BRDSX_h2" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 20.5pt; margin-left: 0pt; text-align: left;">No Personal Liability of Directors, Officers, Employees or Securityholders </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">None of our past, present or future directors, officers, employees or securityholders, as such, will have any liability for any of our obligations under the debt securities or the indenture or for any claim based on, or in respect or by reason of, such obligations or their creation. By accepting a debt security, each holder waives and releases all such liability. This waiver and release is part of the consideration for the issue of the debt securities. However, this waiver and release may not be effective to waive liabilities under U.S. federal securities laws, and it is the view of the SEC that such a waiver is against public policy. </div><div class="BRDSX_h2" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 20.5pt; margin-left: 0pt; text-align: left;">Governing Law </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">The indenture and the debt securities, including any claim or controversy arising out of or relating to the indenture or the securities, will be governed by the laws of the State of New York. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">The indenture will provide that we, the trustee and the holders of the debt securities (by their acceptance of the debt securities) irrevocably waive, to the fullest extent permitted by applicable law, any and all right to trial by jury in any legal proceeding arising out of or relating to the indenture, the debt securities or the transactions contemplated thereby. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">The indenture will provide that any legal suit, action or proceeding arising out of or based upon the indenture or the transactions contemplated thereby may be instituted in the federal courts of the United States of America located in the City of New York or the courts of the State of New York in each case located in the City of New York, and we, the trustee and the holder of the debt securities (by their acceptance of the debt securities) irrevocably submit to the non-exclusive jurisdiction of such courts in any such suit, action or proceeding. The indenture will further provide that service of any process, summons, notice or document by mail (to the extent allowed under any applicable statute or rule of court) to such party&#8217;s address set forth in the indenture will be effective service of process for any suit, action or other proceeding brought in any such court. The indenture will further provide that we, the trustee and the holders of the debt securities (by their acceptance of the debt securities) irrevocably and unconditionally waive any objection to the laying of venue of any suit, action or other proceeding in the courts specified above and irrevocably and unconditionally waive and agree not to plead or claim any such suit, action or other proceeding has been brought in an inconvenient forum. (Section 10.10) </div></div></div><div class="BRDSX_block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"><div class="BRDSX_unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">19<br></div></div></div>
<!--End Page 23-->
<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div class="BRPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 24-->
<div class="BRDSX_page" style="text-align: left; margin: auto; line-height: initial; width: 468pt;"><a name="ny20042541x1_posasr_111-description_pg11"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="BRDSX_page-content"><div class="BRDSX_block-main" style="width: 468pt; margin-left: 0pt;"><div class="BRDSX_h1" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 6.75pt; text-align: center;"><a name="tDOW"><!--Anchor--></a>DESCRIPTION OF WARRANTS</div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">We may issue warrants for the purchase of shares of our common stock or preferred stock or of debt securities. We may issue warrants independently or together with other securities, and the warrants may be attached to or separate from any offered securities. Each series of warrants will be issued under a separate warrant agreement to be entered into between us and the investors or a warrant agent. The following summary of material provisions of the warrants and warrant agreements are subject to, and qualified in their entirety by reference to, all the provisions of the warrant agreement and warrant certificate applicable to a particular series of warrants. The terms of any warrants offered under a prospectus supplement may differ from the terms described below. We urge you to read the applicable prospectus supplement and any related free writing prospectus, as well as the complete warrant agreements and warrant certificates that contain the terms of the warrants. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">The particular terms of any issue of warrants will be described in the prospectus supplement relating to the issue. Those terms may include: </div><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">the number of shares of common stock or preferred stock purchasable upon the exercise of warrants to purchase such shares and the price at which such number of shares may be purchased upon such exercise; </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">the designation, stated value and terms (including, without limitation, liquidation, dividend, conversion and voting rights) of the series of preferred stock purchasable upon exercise of warrants to purchase preferred stock; </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">the principal amount of debt securities that may be purchased upon exercise of a debt warrant and the exercise price for the warrants, which may be payable in cash, securities or other property; </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">the date, if any, on and after which the warrants and the related debt securities, preferred stock or common stock will be separately transferable; </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">the terms of any rights to redeem or call the warrants; </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">the date on which the right to exercise the warrants will commence and the date on which the right will expire; </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">United States Federal income tax consequences applicable to the warrants; and </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">any additional terms of the warrants, including terms, procedures, and limitations relating to the exchange, exercise and settlement of the warrants. </div></td></tr></table><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 8.5pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">Holders of equity warrants will not be entitled: </div><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">to vote, consent or receive dividends; </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">receive notice as shareholders with respect to any meeting of shareholders for the election of our directors or any other matter; or </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">exercise any rights as shareholders of Beyond. </div></td></tr></table><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Each warrant will entitle its holder to purchase the principal amount of debt securities or the number of shares of preferred stock or common stock at the exercise price set forth in, or calculable as set forth in, the applicable prospectus supplement. Unless we otherwise specify in the applicable prospectus supplement, holders of the warrants may exercise the warrants at any time up to the specified time on the expiration date that we set forth in the applicable prospectus supplement. After the close of business on the expiration date, unexercised warrants will become void. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">A holder of warrant certificates may exchange them for new warrant certificates of different denominations, present them for registration of transfer and exercise them at the corporate trust office of the warrant agent or any other office indicated in the applicable prospectus supplement. Until any warrants to purchase debt securities are exercised, the holder of the warrants will not have any rights of holders of the debt securities that can be purchased upon exercise, including any rights to receive payments of principal, premium or interest on the underlying debt securities or to enforce covenants in the applicable indenture. Until any warrants to purchase common stock or preferred stock are exercised, the holders of the warrants will not have any rights of holders of the underlying common stock or preferred stock, including any rights to receive dividends or payments upon any liquidation, dissolution or winding up on the common stock or preferred stock, if any. </div></div></div><div class="BRDSX_block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"><div class="BRDSX_unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">20<br></div></div></div>
<!--End Page 24-->
<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div class="BRPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 25-->
<div class="BRDSX_page" style="text-align: left; margin: auto; line-height: initial; width: 468pt;"><a name="ny20042541x1_posasr_111-description_pg12"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="BRDSX_page-content"><div class="BRDSX_block-main" style="width: 468pt; margin-left: 0pt;"><div class="BRDSX_h1" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 6.75pt; text-align: center;"><a name="tDOP"><!--Anchor--></a>DESCRIPTION OF PURCHASE CONTRACTS </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">We may issue purchase contracts for the purchase or sale of debt or equity securities issued by us. Each purchase contract will entitle the holder thereof to purchase or sell, and obligate us to sell or purchase, on specified dates, such securities at a specified purchase price, which may be based on a formula, all as set forth in the applicable prospectus supplement. Any purchase contracts we issue will be physically settled by delivery of such securities. The applicable prospectus supplement will also specify the methods by which the holders may purchase or sell such securities and any acceleration, cancellation or termination provisions or other provisions relating to the settlement of a purchase contract. </div></div></div><div class="BRDSX_block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"><div class="BRDSX_unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">21<br></div></div></div>
<!--End Page 25-->
<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div class="BRPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 26-->
<div class="BRDSX_page" style="text-align: left; margin: auto; line-height: initial; width: 468pt;"><a name="ny20042541x1_posasr_111-description_pg13"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="BRDSX_page-content"><div class="BRDSX_block-main" style="width: 468pt; margin-left: 0pt;"><div class="BRDSX_h1" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 6.75pt; text-align: center;"><a name="tDOU"><!--Anchor--></a>DESCRIPTION OF UNITS </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">We may issue units consisting of any combination of the other types of securities offered under this prospectus in one or more series. We may evidence each series of units by unit certificates that we will issue under a separate agreement. We may enter into unit agreements with a unit agent. Each unit agent will be a bank or trust company that we select. We will indicate the name and address of the unit agent in the applicable prospectus supplement relating to a particular series of units. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">The following description, together with the additional information included in any applicable prospectus supplement, summarizes the general features of the units that we may offer under this prospectus. You should read any prospectus supplement and any free writing prospectus that we may authorize to be provided to you related to the series of units being offered, as well as the complete unit agreements that contain the terms of the units. Specific unit agreements will contain additional important terms and provisions and we will file as an exhibit to the registration statement of which this prospectus is a part, or will incorporate by reference from another report that we file with the SEC, the form of each unit agreement relating to units offered under this prospectus. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">If we offer any units, certain terms of that series of units will be described in the applicable prospectus supplement, including, without limitation, the following, as applicable: </div><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">the title of the series of units; </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">identification and description of the separate constituent securities comprising the units; </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">the price or prices at which the units will be issued; </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">the date, if any, on and after which the constituent securities comprising the units will be separately transferable; </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">a discussion of certain United States federal income tax considerations applicable to the units; and </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">any other terms of the units and their constituent securities. </div></td></tr></table></div></div><div class="BRDSX_block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"><div class="BRDSX_unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">22<br></div></div></div>
<!--End Page 26-->
<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div class="BRPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 27-->
<div class="BRDSX_page" style="text-align: left; margin: auto; line-height: initial; width: 468pt;"><a name="ny20042541x1_posasr_112-securities_pg1"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="BRDSX_page-content"><div class="BRDSX_block-main" style="width: 468pt; margin-left: 0pt;"><div class="BRDSX_h1" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 6.75pt; text-align: center;"><a name="tGS"><!--Anchor--></a>GLOBAL SECURITIES </div><div class="BRDSX_h2" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 14pt; margin-left: 0pt; text-align: left;">Book-Entry, Delivery and Form </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Unless we indicate differently in any applicable prospectus supplement or free writing prospectus, the securities initially will be issued in book-entry form and represented by one or more global notes or global securities, or, collectively, global securities. The global securities will be deposited with, or on behalf of, The Depository Trust Company, New York, New York, as depositary, or DTC, and registered in the name of Cede &amp; Co., the nominee of DTC. Unless and until it is exchanged for individual certificates evidencing securities under the limited circumstances described below, a global security may not be transferred except as a whole by the depositary to its nominee or by the nominee to the depositary, or by the depositary or its nominee to a successor depositary or to a nominee of the successor depositary. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 8pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">DTC has advised us that it is: </div><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">a limited-purpose trust company organized under the New York Banking Law; </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">a &#8220;banking organization&#8221; within the meaning of the New York Banking Law; </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">a member of the Federal Reserve System; </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">a &#8220;clearing corporation&#8221; within the meaning of the New York Uniform Commercial Code; and </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">a &#8220;clearing agency&#8221; registered pursuant to the provisions of Section&#160;17A of the Exchange Act. </div></td></tr></table><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">DTC holds securities that its participants deposit with DTC. DTC also facilitates the settlement among its participants of securities transactions, such as transfers and pledges, in deposited securities through electronic computerized book-entry changes in participants&#8217; accounts, thereby eliminating the need for physical movement of securities certificates. &#8220;Direct participants&#8221; in DTC include securities brokers and dealers, including underwriters, banks, trust companies, clearing corporations and other organizations. DTC is a wholly-owned subsidiary of The Depository Trust &amp; Clearing Corporation, or DTCC. DTCC is the holding company for DTC, National Securities Clearing Corporation and Fixed Income Clearing Corporation, all of which are registered clearing agencies. DTCC is owned by the users of its regulated subsidiaries. Access to the DTC system is also available to others, which we sometimes refer to as indirect participants, that clear through or maintain a custodial relationship with a direct participant, either directly or indirectly. The rules applicable to DTC and its participants are on file with the SEC. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Purchases of securities under the DTC system must be made by or through direct participants, which will receive a credit for the securities on DTC&#8217;s records. The ownership interest of the actual purchaser of a security, which we sometimes refer to as a beneficial owner, is in turn recorded on the direct and indirect participants&#8217; records. Beneficial owners of securities will not receive written confirmation from DTC of their purchases. However, beneficial owners are expected to receive written confirmations providing details of their transactions, as well as periodic statements of their holdings, from the direct or indirect participants through which they purchased securities. Transfers of ownership interests in global securities are to be accomplished by entries made on the books of participants acting on behalf of beneficial owners. Beneficial owners will not receive certificates representing their ownership interests in the global securities, except under the limited circumstances described below. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">To facilitate subsequent transfers, all global securities deposited by direct participants with DTC will be registered in the name of DTC&#8217;s partnership nominee, Cede &amp; Co., or such other name as may be requested by an authorized representative of DTC. The deposit of securities with DTC and their registration in the name of Cede &amp; Co. or such other nominee will not change the beneficial ownership of the securities. DTC has no knowledge of the actual beneficial owners of the securities. DTC&#8217;s records reflect only the identity of the direct participants to whose accounts the securities are credited, which may or may not be the beneficial owners. The participants are responsible for keeping account of their holdings on behalf of their customers. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">So long as the securities are in book-entry form, you will receive payments and may transfer securities only through the facilities of the depositary and its direct and indirect participants. We will maintain an office or agency in the location specified in the prospectus supplement for the applicable securities, where notices and demands in respect of the securities and the indenture may be delivered to us and where certificated securities may be surrendered for payment, registration of transfer or exchange. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Conveyance of notices and other communications by DTC to direct participants, by direct participants to indirect participants and by direct participants and indirect participants to beneficial owners will be governed by arrangements among them, subject to any legal requirements in effect from time to time. </div></div></div><div class="BRDSX_block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"><div class="BRDSX_unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">23<br></div></div></div>
<!--End Page 27-->
<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div class="BRPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 28-->
<div class="BRDSX_page" style="text-align: left; margin: auto; line-height: initial; width: 468pt;"><a name="ny20042541x1_posasr_112-securities_pg2"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="BRDSX_page-content"><div class="BRDSX_block-main" style="width: 468pt; margin-left: 0pt;"><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6.75pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Redemption notices will be sent to DTC. If less than all of the securities of a particular series are being redeemed, DTC&#8217;s practice is to determine by lot the amount of the interest of each direct participant in the securities of such series to be redeemed. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Neither DTC nor Cede &amp; Co. (or such other DTC nominee) will consent or vote with respect to the securities. Under its usual procedures, DTC will mail an omnibus proxy to us as soon as possible after the record date. The omnibus proxy assigns the consenting or voting rights of Cede &amp; Co. to those direct participants to whose accounts the securities of such series are credited on the record date, identified in a listing attached to the omnibus proxy. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">So long as securities are in book-entry form, we will make payments on those securities to the depositary or its nominee, as the registered owner of such securities, by wire transfer of immediately available funds. If securities are issued in definitive certificated form under the limited circumstances described below and unless if otherwise provided in the description of the applicable securities herein or in the applicable prospectus supplement, we will have the option of making payments by check mailed to the addresses of the persons entitled to payment or by wire transfer to bank accounts in the United States designated in writing to the applicable trustee or other designated party at least 15 days before the applicable payment date by the persons entitled to payment, unless a shorter period is satisfactory to the applicable trustee or other designated party. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Redemption proceeds, distributions and dividend payments on the securities will be made to Cede &amp; Co., or such other nominee as may be requested by an authorized representative of DTC. DTC&#8217;s practice is to credit direct participants&#8217; accounts upon DTC&#8217;s receipt of funds and corresponding detail information from us on the payment date in accordance with their respective holdings shown on DTC records. Payments by participants to beneficial owners will be governed by standing instructions and customary practices, as is the case with securities held for the account of customers in bearer form or registered in &#8220;street name.&#8221; Those payments will be the responsibility of participants and not of DTC or us, subject to any statutory or regulatory requirements in effect from time to time. Payment of redemption proceeds, distributions and dividend payments to Cede &amp; Co., or such other nominee as may be requested by an authorized representative of DTC, is our responsibility, disbursement of payments to direct participants is the responsibility of DTC, and disbursement of payments to the beneficial owners is the responsibility of direct and indirect participants. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Except under the limited circumstances described below, purchasers of securities will not be entitled to have securities registered in their names and will not receive physical delivery of securities. Accordingly, each beneficial owner must rely on the procedures of DTC and its participants to exercise any rights under the securities and the indenture. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">The laws of some jurisdictions may require that some purchasers of securities take physical delivery of securities in definitive form. Those laws may impair the ability to transfer or pledge beneficial interests in securities. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">DTC may discontinue providing its services as securities depositary with respect to the securities at any time by giving reasonable notice to us. Under such circumstances, in the event that a successor depositary is not obtained, securities certificates are required to be printed and delivered. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">As noted above, beneficial owners of a particular series of securities generally will not receive certificates representing their ownership interests in those securities. However, if: </div><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">DTC notifies us that it is unwilling or unable to continue as a depositary for the global security or securities representing such series of securities or if DTC ceases to be a clearing agency registered under the Exchange Act at a time when it is required to be registered and a successor depositary is not appointed within 90 days of the notification to us or of our becoming aware of DTC&#8217;s ceasing to be so registered, as the case may be; </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">we determine, in our sole discretion, not to have such securities represented by one or more global securities; or </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">an Event of Default has occurred and is continuing with respect to such series of securities, </div></td></tr></table><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: justify;">we will prepare and deliver certificates for such securities in exchange for beneficial interests in the global securities. Any beneficial interest in a global security that is exchangeable under the circumstances described in the preceding sentence will be exchangeable for securities in definitive certificated form registered in the names that the depositary directs. It is expected that these directions will be based upon directions received by the depositary from its participants with respect to ownership of beneficial interests in the global securities. </div></div></div><div class="BRDSX_block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"><div class="BRDSX_unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">24<br></div></div></div>
<!--End Page 28-->
<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div class="BRPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 29-->
<div class="BRDSX_page" style="text-align: left; margin: auto; line-height: initial; width: 468pt;"><a name="ny20042541x1_posasr_112-securities_pg3"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="BRDSX_page-content"><div class="BRDSX_block-main" style="width: 468pt; margin-left: 0pt;"><div class="BRDSX_h3" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 6.75pt; margin-left: 20pt; text-align: left;">Euroclear and Clearstream </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">If so provided in the applicable prospectus supplement, you may hold interests in a global security through Clearstream Banking S.A., which we refer to as &#8220;Clearstream,&#8221; or Euroclear Bank S.A./N.V., as operator of the Euroclear System, which we refer to as &#8220;Euroclear,&#8221; either directly if you are a participant in Clearstream or Euroclear or indirectly through organizations which are participants in Clearstream or Euroclear. Clearstream and Euroclear will hold interests on behalf of their respective participants through customers&#8217; securities accounts in the names of Clearstream and Euroclear, respectively, on the books of their respective U.S. depositaries, which in turn will hold such interests in customers&#8217; securities accounts in such depositaries&#8217; names on DTC&#8217;s books. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Clearstream and Euroclear are securities clearance systems in Europe. Clearstream and Euroclear hold securities for their respective participating organizations and facilitate the clearance and settlement of securities transactions between those participants through electronic book-entry changes in their accounts, thereby eliminating the need for physical movement of certificates. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Payments, deliveries, transfers, exchanges, notices and other matters relating to beneficial interests in global securities owned through Euroclear or Clearstream must comply with the rules and procedures of those systems. Transactions between participants in Euroclear or Clearstream, on one hand, and other participants in DTC, on the other hand, are also subject to DTC&#8217;s rules and procedures. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Investors will be able to make and receive through Euroclear and Clearstream payments, deliveries, transfers and other transactions involving any beneficial interests in global securities held through those systems only on days when those systems are open for business. Those systems may not be open for business on days when banks, brokers and other institutions are open for business in the United States. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Cross-market transfers between participants in DTC, on the one hand, and participants in Euroclear or Clearstream, on the other hand, will be effected through DTC in accordance with the DTC&#8217;s rules on behalf of Euroclear or Clearstream, as the case may be, by their respective U.S. depositaries; however, such cross-market transactions will require delivery of instructions to Euroclear or Clearstream, as the case may be, by the counterparty in such system in accordance with the rules and procedures and within the established deadlines (European time) of such system. Euroclear or Clearstream, as the case may be, will, if the transaction meets its settlement requirements, deliver instructions to its U.S. depositary to take action to effect final settlement on its behalf by delivering or receiving interests in the global securities through DTC, and making or receiving payment in accordance with normal procedures for same-day fund settlement. Participants in Euroclear or Clearstream may not deliver instructions directly to their respective U.S. depositaries. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Due to time zone differences, the securities accounts of a participant in Euroclear or Clearstream purchasing an interest in a global security from a direct participant in DTC will be credited, and any such crediting will be reported to the relevant participant in Euroclear or Clearstream, during the securities settlement processing day (which must be a business day for Euroclear or Clearstream) immediately following the settlement date of DTC. Cash received in Euroclear or Clearstream as a result of sales of interests in a global security by or through a participant in Euroclear or Clearstream to a direct participant in DTC will be received with value on the settlement date of DTC but will be available in the relevant Euroclear or Clearstream cash account only as of the business day for Euroclear or Clearstream following DTC&#8217;s settlement date. </div><div class="BRDSX_h3" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 20pt; margin-left: 20pt; text-align: left;">Other </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">The information in this section of this prospectus concerning DTC, Clearstream, Euroclear and their respective book-entry systems has been obtained from sources that we believe to be reliable, but we do not take responsibility for this information. This information has been provided solely as a matter of convenience. The rules and procedures of DTC, Clearstream and Euroclear are solely within the control of those organizations and could change at any time. Neither we nor the trustee nor any agent of ours or of the trustee has any control over those entities and none of us takes any responsibility for their activities. You are urged to contact DTC, Clearstream and Euroclear or their respective participants directly to discuss those matters. In addition, although we expect that DTC, Clearstream and Euroclear will perform the foregoing procedures, none of them is under any obligation to perform or continue to perform such procedures and such procedures may be discontinued at any time. Neither we nor any agent of ours will have any responsibility for the performance or nonperformance by DTC, Clearstream and Euroclear or their respective participants of these or any other rules or procedures governing their respective operations. </div></div></div><div class="BRDSX_block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"><div class="BRDSX_unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">25<br></div></div></div>
<!--End Page 29-->
<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div class="BRPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 30-->
<div class="BRDSX_page" style="text-align: left; margin: auto; line-height: initial; width: 468pt;"><a name="ny20042541x1_posasr_113-plan_pg1"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="BRDSX_page-content"><div class="BRDSX_block-main" style="width: 468pt; margin-left: 0pt;"><div class="BRDSX_h1" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 6.75pt; text-align: center;"><a name="tPOD"><!--Anchor--></a>PLAN OF DISTRIBUTION </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">We may sell the securities from time to time pursuant to underwritten public offerings, negotiated transactions, block trades or a combination of these methods or through underwriters or dealers, through agents and/or directly to one or more purchasers. The securities may be distributed from time to time in one or more transactions: </div><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">at a fixed price or prices, which may be changed; </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">at market prices prevailing at the time of sale; </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">at prices related to such prevailing market prices; or </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">at negotiated prices. </div></td></tr></table><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Each time that we sell securities covered by this prospectus, we will provide a prospectus supplement or supplements that will describe the method of distribution and set forth the terms and conditions of the offering of such securities, including the offering price of the securities and the proceeds to us, if applicable. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Offers to purchase the securities being offered by this prospectus may be solicited directly. Agents may also be designated to solicit offers to purchase the securities from time to time. Any agent involved in the offer or sale of our securities will be identified in a prospectus supplement. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">If a dealer is utilized in the sale of the securities being offered by this prospectus, the securities will be sold to the dealer, as principal. The dealer may then resell the securities to the public at varying prices to be determined by the dealer at the time of resale. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">If an underwriter is utilized in the sale of the securities being offered by this prospectus, an underwriting agreement will be executed with the underwriter at the time of sale and the name of any underwriter will be provided in the prospectus supplement that the underwriter will use to make resales of the securities to the public. In connection with the sale of the securities, we or the purchasers of securities for whom the underwriter may act as agent, may compensate the underwriter in the form of underwriting discounts or commissions. The underwriter may sell the securities to or through dealers, and those dealers may receive compensation in the form of discounts, concessions or commissions from the underwriters and/or commissions from the purchasers for which they may act as agent. Unless otherwise indicated in a prospectus supplement, an agent will be acting on a best efforts basis and a dealer will purchase securities as a principal, and may then resell the securities at varying prices to be determined by the dealer. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Any compensation paid to underwriters, dealers or agents in connection with the offering of the securities, and any discounts, concessions or commissions allowed by underwriters to participating dealers will be provided in the applicable prospectus supplement. Underwriters, dealers and agents participating in the distribution of the securities may be deemed to be underwriters within the meaning of the Securities Act of 1933, as amended, and any discounts and commissions received by them and any profit realized by them on resale of the securities may be deemed to be underwriting discounts and commissions. We may enter into agreements to indemnify underwriters, dealers and agents against civil liabilities, including liabilities under the Securities Act, or to contribute to payments they may be required to make in respect thereof and to reimburse those persons for certain expenses. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Any common stock will be listed on the New York Stock Exchange, but any other securities may or may not be listed on a national securities exchange. To facilitate the offering of securities, certain persons participating in the offering may engage in transactions that stabilize, maintain or otherwise affect the price of the securities. This may include over-allotments or short sales of the securities, which involve the sale by persons participating in the offering of more securities than were sold to them. In these circumstances, these persons would cover such over-allotments or short positions by making purchases in the open market or by exercising their over-allotment option, if any. In addition, these persons may stabilize or maintain the price of the securities by bidding for or purchasing securities in the open market or by imposing penalty bids, whereby selling concessions allowed to dealers participating in the offering may be reclaimed if securities sold by them are repurchased in connection with stabilization transactions. The effect of these transactions may be to stabilize or maintain the market price of the securities at a level above that which might otherwise prevail in the open market. These transactions may be discontinued at any time. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">We may engage in at the market offerings into an existing trading market in accordance with Rule&#160;415(a)(4) under the Securities Act. In addition, we may enter into derivative transactions with third parties, or sell securities not covered by this prospectus to third parties in privately negotiated transactions. If the applicable prospectus supplement so indicates, in connection with those derivatives, the third parties may sell securities covered by this </div></div></div><div class="BRDSX_block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"><div class="BRDSX_unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">26<br></div></div></div>
<!--End Page 30-->
<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div class="BRPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 31-->
<div class="BRDSX_page" style="text-align: left; margin: auto; line-height: initial; width: 468pt;"><a name="ny20042541x1_posasr_113-plan_pg2"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="BRDSX_page-content"><div class="BRDSX_block-main" style="width: 468pt; margin-left: 0pt;"><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6.75pt; margin-left: 0pt; text-align: justify;">prospectus and the applicable prospectus supplement, including in short sale transactions. If so, the third party may use securities pledged by us or borrowed from us or others to settle those sales or to close out any related open borrowings of stock, and may use securities received from us in settlement of those derivatives to close out any related open borrowings of stock. The third party in such sale transactions will be an underwriter and, if not identified in this prospectus, will be named in the applicable prospectus supplement (or a post-effective amendment). In addition, we may otherwise loan or pledge securities to a financial institution or other third party that in turn may sell the securities short using this prospectus and an applicable prospectus supplement. Such financial institution or other third party may transfer its economic short position to investors in our securities or in connection with a concurrent offering of other securities. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">The specific terms of any lock-up provisions in respect of any given offering will be described in the applicable prospectus supplement. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">The underwriters, dealers and agents may engage in transactions with us, or perform services for us, in the ordinary course of business for which they receive compensation. </div></div></div><div class="BRDSX_block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"><div class="BRDSX_unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">27<br></div></div></div>
<!--End Page 31-->
<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div class="BRPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 32-->
<div class="BRDSX_page" style="text-align: left; margin: auto; line-height: initial; width: 468pt;"><a name="ny20042541x1_posasr_114-legal_pg1"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="BRDSX_page-content"><div class="BRDSX_block-main" style="width: 468pt; margin-left: 0pt;"><div class="BRDSX_h1" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 6.75pt; text-align: center;"><a name="tLM"><!--Anchor--></a>LEGAL MATTERS </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Latham &amp; Watkins LLP will pass upon certain legal matters relating to the issuance and sale of the securities offered hereby on behalf of Beyond, Inc. Additional legal matters may be passed upon for us or any underwriters, dealers or agents, by counsel that we will name in the applicable prospectus supplement. </div><div class="BRDSX_h1" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 20.5pt; text-align: center;"><a name="tEXP"><!--Anchor--></a>EXPERTS </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">The consolidated financial statements of Beyond, Inc. as of December 31, 2023 and 2022, and for each of the years in the three-year period ended December 31, 2023, and management&#8217;s assessment of the effectiveness of internal control over financial reporting as of December 31, 2023 have been incorporated by reference herein and in the registration statement in reliance upon the reports of KPMG LLP, independent registered public accounting firm, incorporated by reference herein, and upon the authority of said firm as experts in accounting and auditing. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">The financial statements of Medici Ventures, L.P. as of September&#160;30, 2021 and for the period from April&#160;23, 2021 to September&#160;30, 2021, have been incorporated by reference herein and in the registration statement in reliance upon the report of KPMG LLP, independent auditors, incorporated by reference herein, and upon the authority of said firm as experts in accounting and auditing. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">The financial statements of Medici Ventures, L.P. as of September&#160;30, 2022 and for the year then ended, have been audited by Ernst &amp; Young LLP, independent auditors, as set forth in their report thereon, and are included in the Annual Report (Form&#160;10-K) of Beyond, Inc., for the year ended December&#160;31, 2023, which is incorporated herein by reference. Such financial statements are incorporated herein by reference in reliance upon such report given on the authority of such firm as experts in accounting and auditing. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">The financial statements of Medici Ventures, L.P. as of September&#160;30, 2023 and for the year then ended, have been audited by Ernst &amp; Young LLP, independent auditors, as set forth in their report thereon, and are included in the Annual Report (Form&#160;10-K) of Beyond, Inc., for the year ended December&#160;31, 2023, which is incorporated herein by reference. Such financial statements are incorporated herein by reference in reliance upon such report given on the authority of such firm as experts in accounting and auditing. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">The financial statements of tZERO Group, Inc. as of December&#160;31, 2022 and 2021 and for the years then ended have been incorporated by reference herein and in the registration statement in reliance upon the report of Baker Tilly US, LLP, independent auditors, incorporated by reference herein, and upon the authority of said firm as experts in accounting and auditing. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">The financial statements of tZERO Group, Inc. as of December&#160;31, 2023 and 2022 and for the years then ended have been incorporated by reference herein and in the registration statement in reliance upon the report of Baker Tilly US, LLP, independent auditors, incorporated by reference herein, and upon the authority of said firm as experts in accounting and auditing. </div></div></div><div class="BRDSX_block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"><div class="BRDSX_unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">28<br></div></div></div>
<!--End Page 32-->
<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div class="BRPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 33-->
<div class="BRDSX_page" style="text-align: left; margin: auto; line-height: initial; width: 456pt;"><a name="ny20042541x1_posasr_200-cov_pg1"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="BRDSX_page-content"><div class="BRDSX_block-main" style="width: 456pt; margin-left: 0pt;"><div class="BRDSX_h2" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 6.75pt; margin-left: 0pt; text-align: left;">PROSPECTUS SUPPLEMENT <br></div><div class="BRDSX_h2" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 0pt; margin-left: 0pt; text-align: left;">(To Prospectus Dated February 25, 2025) </div><div class="BRDSX_h1" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 16pt; font-weight: bold; margin-top: 11pt; text-align: center;">$156,128,866</div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 12.75pt; text-align: center;"><img style="height: 57px; width: 243px;" src="logo_beyondv2.jpg"><br></div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">&#8201; <br></div><div class="BRDSX_h1" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 12pt; font-weight: bold; margin-top: 12pt; text-align: center;">Beyond, Inc.<br></div><div class="BRDSX_h1" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 12pt; font-weight: bold; margin-top: 0pt; text-align: center;">&#8195; <br></div><div class="BRDSX_h1" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 12pt; font-weight: bold; margin-top: 0pt; text-align: center;">Common Stock </div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 9.5pt; margin-top: 4pt; margin-left: 0pt; text-align: left; line-height: 10.5pt;">This prospectus supplement relates to the offer and sale of shares of our common stock, par value $0.0001 per share, having an aggregate offering price of up to $156,128,866, offered from time to time through or to JonesTrading Institutional Services LLC as sales agent or principal, which we refer to herein as Jones or the Sales Agent. These sales, if any, will be made under a Capital on Demand<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">TM</sup> Sales Agreement, dated June&#160;10, 2024, between us and Jones (the &#8220;Sales Agreement&#8221;), under which we may issue and sell from time to time shares of our common stock having an aggregate offering price of up to $200,000,000. We originally filed a prospectus supplement, dated June&#160;10, 2024 (the &#8220;Prior Prospectus Supplement&#8221;) relating to the offering, issuance and sale of such shares pursuant to the Sales Agreement. As of the date of this prospectus supplement, we have issued and sold shares of our common stock having an aggregate offering price of $43,871,134 pursuant to the Sales Agreement and the Prior Prospectus Supplement. The $156,128,866 of shares of our common stock that remain available under the Sales Agreement and the Prior Prospectus Supplement will no longer be offered and sold under the Prior Prospectus Supplement, but will instead be offered and sold under this prospectus supplement.</div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 9.5pt; margin-top: 4pt; margin-left: 0pt; text-align: left; line-height: 10.5pt;">The shares of our common stock will be offered at market prices prevailing at the time of sale. We will pay Jones a commission of up to 2.0% of the sales price of all shares sold under the Sales Agreement as sales agent or principal. The net proceeds, if any, that we receive from the sale of the shares will depend on the number of shares actually sold and the offering price for such shares. Our common stock is traded on the New York Stock Exchange under the symbol &#8220;BYON.&#8221; On February 24, 2025, the last reported sale price of our common stock on the New&#160;York Stock Exchange was $6.92 per share. We estimate the offering expenses, other than the Sales Agent&#8217;s commission, will be approximately $0.5&#160;million. There is no arrangement for funds to be received in any escrow, trust, or similar arrangement. </div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 9.5pt; margin-top: 4pt; margin-left: 0pt; text-align: left; line-height: 10.5pt;">The offering of shares pursuant to this prospectus supplement and the accompanying prospectus will terminate upon the earlier of (i) the sale of all of our common stock subject to the Sales Agreement, or (ii) termination of the Sales Agreement as provided therein. </div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 9.5pt; margin-top: 4pt; margin-left: 0pt; text-align: left; line-height: 10.5pt;">Sales of our common stock, if any, under this prospectus supplement may be made by any method that is deemed to be an &#8220;at the market offering&#8221; as defined in Rule&#160;415(a)(4) under the Securities Act of 1933, as amended (the &#8220;Securities Act&#8221;). Jones is not required to sell any specific number or dollar amount of shares but will act as our sales agent using commercially reasonable efforts consistent with its normal trading and sales practices, on mutually agreeable terms between Jones and us. </div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 9.5pt; margin-top: 4pt; margin-left: 0pt; text-align: left; line-height: 10.5pt;">In connection with the sale of the shares on our behalf, Jones will be deemed to be an &#8220;underwriter&#8221; within the meaning of the Securities Act and the compensation of Jones will be deemed to be underwriting commissions or discounts. We have agreed to provide indemnification and contribution to Jones with respect to certain liabilities, including liabilities under the Securities Act or the Securities Exchange Act of 1934, as amended (the &#8220;Exchange Act&#8221;). </div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 9.5pt; margin-top: 4pt; margin-left: 0pt; text-align: left; line-height: 10.5pt;">We are offering and selling the shares only where offers and sales are permitted. The distribution of this document and the sale of the shares in certain jurisdictions may be restricted by law. Persons outside the United States must observe any applicable restrictions. This is not an offer to sell, or a solicitation of an offer to buy, any securities anywhere it would be unlawful for us to make such an offer or solicitation. </div><div><div class="BRDSX_rule-partial" style="height: 0pt; width: 96pt; border-bottom: 1pt solid #000000; margin-bottom: 2pt; margin-left: auto; margin-right: auto; margin-top: 4.75pt;"> </div></div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 9.5pt; font-weight: bold; margin-top: 4pt; margin-left: 0pt; text-align: left; line-height: 10.5pt;">Investing in our common stock involves a high degree of risk. You should carefully consider the information under the heading &#8220;<font style="font-style: italic;">Risk Factors</font>&#8221; beginning on page S-<a href="#sRFA">7</a> of this prospectus supplement and in the documents incorporated by reference into this prospectus supplement and the accompanying prospectus, before buying shares of our common stock.<font style="font-weight: normal;"> </font></div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 9.5pt; font-weight: bold; margin-top: 4pt; margin-left: 0pt; text-align: left; line-height: 10.5pt;">Neither the Securities and Exchange Commission nor any state securities commission has approved or disapproved of these securities or passed upon the accuracy or adequacy of this prospectus supplement or the accompanying prospectus. Any representation to the contrary is a criminal offense.<font style="font-weight: normal;"> </font></div><div><div class="BRDSX_rule-partial" style="height: 0pt; width: 96pt; border-bottom: 1pt solid #000000; margin-bottom: 2pt; margin-left: auto; margin-right: auto; margin-top: 4.75pt;"> </div></div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 14.75pt; text-align: center;"><img style="height: 64px; width: 159px;" src="logo_jones.jpg"><br></div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">&#8201;</div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 9.5pt; font-weight: bold; margin-top: 6pt; text-align: center;">The date of this prospectus supplement is February 25, 2025.</div></div></div></div>
<!--End Page 33-->
<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div class="BRPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 34-->
<div class="BRDSX_page" style="text-align: left; margin: auto; line-height: initial; width: 468pt;"><a name="ny20042541x1_posasr_201-toc_pg1"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="BRDSX_page-content"><div class="BRDSX_block-main" style="width: 468pt; margin-left: 0pt;"><div class="BRDSX_h1" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 6.75pt; text-align: center;">TABLE OF CONTENTS </div><table cellspacing="0" cellpadding="0" class="BRDSX_fintab" style="margin-top: 4pt; width: 468pt; margin-left: auto; margin-right: auto;"><tr class="BRDSX_boxspacer"><td style="height: 6pt; width: 432pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 8.56pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 8.56pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 18.89pt;"><div style="font-size: 1pt;">&#8194;</div></td></tr><tr class="BRDSX_header"><td style="width: 432pt; padding-bottom: 2.38pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;">&#160;</div></td><td style="width: 8.56pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 8.56pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 18.89pt; padding-bottom: 2.38pt; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Page </div></td></tr><tr><td style="width: 432pt; padding-top: 2.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><a href="#sAPS">ABOUT THIS PROSPECTUS SUPPLEMENT<font style="padding-left: 1.56pt;"></font></a></div></td><td style="width: 8.56pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 8.56pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 18.89pt; padding-top: 2.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><a href="#sAPS"><font style="padding-left: 5pt;">S-1 </font></a></div></td></tr><tr><td style="width: 432pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><a href="#sTRD">TRADEMARKS<font style="padding-left: 0.63pt;"></font></a></div></td><td style="width: 8.56pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 8.56pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 18.89pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><a href="#sTRD"><font style="padding-left: 5pt;">S-2 </font></a></div></td></tr><tr><td style="width: 432pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><a href="#sSCR">SPECIAL CAUTIONARY NOTE REGARDING FORWARD LOOKING STATEMENTS<font style="padding-left: 1.69pt;"></font></a></div></td><td style="width: 8.56pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 8.56pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 18.89pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><a href="#sSCR"><font style="padding-left: 5pt;">S-3 </font></a></div></td></tr><tr><td style="width: 432pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><a href="#sAOC">ABOUT BEYOND, INC.<font style="padding-left: 4.72pt;"></font></a></div></td><td style="width: 8.56pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 8.56pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 18.89pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><a href="#sAOC"><font style="padding-left: 5pt;">S-5 </font></a></div></td></tr><tr><td style="width: 432pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><a href="#sTO">THE OFFERING<font style="padding-left: 2.85pt;"></font></a></div></td><td style="width: 8.56pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 8.56pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 18.89pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><a href="#sTO"><font style="padding-left: 5pt;">S-6 </font></a></div></td></tr><tr><td style="width: 432pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><a href="#sRFA">RISK FACTORS<font style="padding-left: 4.32pt;"></font></a></div></td><td style="width: 8.56pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 8.56pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 18.89pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><a href="#sRFA"><font style="padding-left: 5pt;">S-7 </font></a></div></td></tr><tr><td style="width: 432pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><a href="#sUP">USE OF PROCEEDS<font style="padding-left: 0.07pt;"></font></a></div></td><td style="width: 8.56pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 8.56pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 18.89pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><a href="#sUP"><font style="padding-left: 5pt;">S-9 </font></a></div></td></tr><tr><td style="width: 432pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><a href="#sDP">DIVIDEND POLICY<font style="padding-left: 1.2pt;"></font></a></div></td><td style="width: 8.56pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 8.56pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 18.89pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><a href="#sDP">S-10 </a></div></td></tr><tr><td style="width: 432pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><a href="#sMFI">MATERIAL U.S. FEDERAL INCOME TAX CONSEQUENCES TO NON-U.S. HOLDERS<font style="padding-left: 0.57pt;"></font></a></div></td><td style="width: 8.56pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 8.56pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 18.89pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><a href="#sMFI"><font style="padding-left: 0.37pt;">S-11 </font></a></div></td></tr><tr><td style="width: 432pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><a href="#sPDT">PLAN OF DISTRIBUTION<font style="padding-left: 3.98pt;"></font></a></div></td><td style="width: 8.56pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 8.56pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 18.89pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><a href="#sPDT">S-15 </a></div></td></tr><tr><td style="width: 432pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><a href="#sVTS">VALIDITY OF THE SECURITIES<font style="padding-left: 4.72pt;"></font></a></div></td><td style="width: 8.56pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 8.56pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 18.89pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><a href="#sVTS">S-16 </a></div></td></tr><tr><td style="width: 432pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><a href="#sEX">EXPERTS<font style="padding-left: 1.77pt;"></font></a></div></td><td style="width: 8.56pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 8.56pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 18.89pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><a href="#sEX">S-16 </a></div></td></tr><tr><td style="width: 432pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><a href="#sWYF">WHERE YOU CAN FIND MORE INFORMATION<font style="padding-left: 3.84pt;"></font></a></div></td><td style="width: 8.56pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 8.56pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 18.89pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><a href="#sWYF">S-17 </a></div></td></tr><tr><td style="width: 432pt; padding-top: 1.01pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><a href="#sIIR">INFORMATION INCORPORATED BY REFERENCE<font style="padding-left: 3.81pt;"></font></a></div></td><td style="width: 8.56pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 8.56pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 18.89pt; padding-top: 1.01pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><a href="#sIIR">S-18</a></div></td></tr><tr class="BRDSX_boxspacer"><td style="height: 2.75pt; width: 432pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 8.56pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 8.56pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 18.89pt;"><div style="font-size: 1pt;">&#8194;</div></td></tr></table></div></div><div class="BRDSX_block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"><div class="BRDSX_unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">S-i<br></div></div></div>
<!--End Page 34-->
<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div class="BRPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 35-->
<div class="BRDSX_page" style="text-align: left; margin: auto; line-height: initial; width: 468pt;"><a name="ny20042541x1_posasr_202-about_pg1"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="BRDSX_page-content"><div class="BRDSX_block-main" style="width: 468pt; margin-left: 0pt;"><div class="BRDSX_h1" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 6.75pt; text-align: center;"><a name="sAPS"><!--Anchor--></a>ABOUT THIS PROSPECTUS SUPPLEMENT </div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;">This document is in two parts. The first part is this prospectus supplement, which describes the specific terms of this offering of shares of our common stock and updates the information contained in the accompanying prospectus and the documents incorporated by reference herein and therein. The second part is the accompanying prospectus, which provides more general information, some of which does not apply to this offering. If there is any inconsistency between the information contained in this prospectus supplement, on the one hand, and the information contained in the accompanying prospectus or information incorporated by reference therein, on the other hand, you should rely on the information in this prospectus supplement, which supersedes any such inconsistent information in the accompanying prospectus and the documents incorporated by reference therein. You should read carefully both this prospectus supplement and the accompanying prospectus (and any applicable free writing prospectuses), together with any documents incorporated by reference herein and therein and the additional information described below under the headings &#8220;Information Incorporated by Reference&#8221; and &#8220;Where&#160;You Can Find More Information&#8221; in its entirety before making an investment decision. </div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;">This prospectus supplement is part of a registration statement that we have filed with the U.S. Securities and Exchange Commission (the &#8220;SEC&#8221;) using a &#8220;shelf&#8221; registration process. This prospectus supplement does not contain all of the information included in the registration statement. For a more complete understanding of the offering of the shares of our common stock, you should refer to the registration statement, including its exhibits. </div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;">We have provided you only the information contained in this prospectus supplement, the accompanying prospectus, the documents we have incorporated by reference herein and therein, along with the information contained in any permitted free writing prospectus we have authorized for use in connection with this offering. We have not, and the Sales Agent has not, authorized anyone to provide you with different information. We do not, and the Sales Agent does not, take responsibility for, or provide any assurance as to the reliability of, any other information that others may give you. We and the Sales Agent are offering to sell, and seeking offers to buy, shares of common stock only in jurisdictions where such offers and sales are permitted. The distribution of this prospectus supplement, the accompanying prospectus and any applicable free writing prospectus and the offering of our common stock in certain jurisdictions may be restricted by law. Persons outside the United States who come into possession of this prospectus supplement, the accompanying prospectus or any applicable free writing prospectus must inform themselves about, and observe any restrictions relating to, the offering of the shares and the distribution of such documents outside the United States. This prospectus supplement does not constitute an offer to sell or a solicitation of an offer to buy the shares in any jurisdiction in which it is unlawful to make such an offering or solicitation. </div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;">You should read the entire prospectus supplement and the accompanying prospectus, as well as the documents incorporated by reference into this prospectus supplement and the accompanying prospectus, along with the information contained in any permitted free writing prospectus we have authorized for use in connection with this offering. Neither the delivery of this prospectus supplement and the accompanying prospectus, or any permitted free writing prospectus we have authorized for use in connection with this offering, nor any sale made under such documents shall under any circumstances imply that the information contained or incorporated by reference in such documents is correct as of any date subsequent to the respective dates thereof. You should assume that the information appearing in this prospectus supplement and the accompanying prospectus, any document incorporated by reference herein or therein, or any permitted free writing prospectus we have authorized for use in connection with this offering is accurate only as of the date of the applicable documents, regardless of the time of delivery of this prospectus supplement, the accompanying prospectus and any applicable free writing prospectus or the time of any sale or distribution of securities. Our business, financial condition, results of operations and prospects may have changed since those dates. </div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;">As used in this prospectus supplement, &#8220;Beyond,&#8221; the &#8220;Company,&#8221; &#8220;we,&#8221; &#8220;our&#8221; and similar terms include Beyond, Inc. and its controlled subsidiaries, unless the context indicates otherwise. </div></div></div><div class="BRDSX_block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"><div class="BRDSX_unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">S-1<br></div></div></div>
<!--End Page 35-->
<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div class="BRPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 36-->
<div class="BRDSX_page" style="text-align: left; margin: auto; line-height: initial; width: 468pt;"><a name="ny20042541x1_posasr_203-trade_pg1"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="BRDSX_page-content"><div class="BRDSX_block-main" style="width: 468pt; margin-left: 0pt;"><div class="BRDSX_h1" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 6.75pt; text-align: center;"><a name="sTRD"><!--Anchor--></a>TRADEMARKS </div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;">This prospectus supplement and the accompanying prospectus include, or incorporate by reference, our trademarks, service marks, brand names and trade names, including, without limitation, Bed Bath &amp; Beyond&#174;, Overstock.com&#174;, and Zulily&#174;, which are our property and are protected under applicable intellectual property laws. This prospectus supplement and the accompanying prospectus also contain, or incorporate by reference, trademarks, service marks, brand names and trade names of other companies, which are the property of their respective owners. Any use or display of other parties&#8217; trademarks, service marks, brand names or trade names in this prospectus supplement, the accompanying prospectus, or any documents incorporated by reference herein or therein does not imply, and such use or display should not be construed to imply, any affiliation with, or endorsement of or by, such third parties. Solely for convenience, trademarks, service marks, brand names, and trade names referred to in this prospectus supplement, the accompanying prospectus, or any documents incorporated by reference herein or therein may appear with or without the &#174;, <sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">SM</sup> or <sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">TM</sup> symbols, but use (or omission) of such symbols is not intended to limit in any way our rights, or the rights of the applicable owner or any applicable licensor, in and to these trademarks, service marks, brand names, and trade names. </div></div></div><div class="BRDSX_block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"><div class="BRDSX_unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">S-2<br></div></div></div>
<!--End Page 36-->
<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div class="BRPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 37-->
<div class="BRDSX_page" style="text-align: left; margin: auto; line-height: initial; width: 468pt;"><a name="ny20042541x1_posasr_204-fls_pg1"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="BRDSX_page-content"><div class="BRDSX_block-main" style="width: 468pt; margin-left: 0pt;"><div class="BRDSX_h1" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 6.75pt; text-align: center;"><a name="sSCR"><!--Anchor--></a>SPECIAL CAUTIONARY NOTE REGARDING FORWARD-LOOKING STATEMENTS </div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;">This prospectus supplement, the accompanying prospectus and the documents incorporated by reference in this prospectus supplement, the accompanying prospectus, and our other public documents and statements our officers and representatives may make from time to time, contain forward-looking statements within the meaning of the federal securities laws. These statements are intended to be covered by the safe harbor provisions of these laws. You can find many of these statements by looking for words such as &#8220;may,&#8221; &#8220;would,&#8221; &#8220;could,&#8221; &#8220;should,&#8221; &#8220;will,&#8221; &#8220;expect,&#8221; &#8220;anticipate,&#8221; &#8220;predict,&#8221; &#8220;project,&#8221; &#8220;potential,&#8221; &#8220;continue,&#8221; &#8220;contemplate,&#8221; &#8220;seek,&#8221; &#8220;assume,&#8221; &#8220;believe,&#8221; &#8220;intend,&#8221; &#8220;plan,&#8221; &#8220;forecast,&#8221; &#8220;goal,&#8221; &#8220;estimate,&#8221; or other similar terms or expressions or the negative of these terms or expressions, although not all forward-looking statements contain these identifying terms or expressions. </div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;">These forward-looking statements involve known and unknown risks and uncertainties and relate to future events or our future financial or operating performance. These forward-looking statements are not historical facts, and are based on current expectations, estimates and projections about our industry and business, and on management&#8217;s beliefs and certain assumptions made by management, many of which, by their nature, are inherently uncertain and beyond our control. Accordingly, you are cautioned that any such forward-looking statements are not guarantees of future performance and are subject to assumptions, risks, uncertainties, and other important factors that are difficult to predict, and that actual results and outcomes may be materially different from the results, performance, achievements, or outcomes expressed or implied by any of our forward-looking statements for a variety of reasons, including among others: </div><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">any difficulties we may encounter as a result of our reliance on third-parties that we do not control for the performance of critical functions material to our business, such as carriers, fulfillment partners, and SaaS/IaaS providers; </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">any inability to compete successfully against existing or future competitors or to effectively market our business and generate customer traffic; </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">our ability to realize the benefits of any investment in new business strategies, partnerships, ventures, acquisitions, or other transactions; </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">a recession or other economic downturn, inflation, high interest rates, our exposure to the U.S. housing market, or other changes in U.S. and global economic conditions or U.S. consumer spending; </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">any increases in the price of importing goods into the U.S. or transporting to our customers the types of merchandise we sell or other supply chain challenges that limit our ability to deliver merchandise to our customers in a timely and cost-effective manner; </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">any difficulties or negative consequences we may encounter as a result of our changed company name, changed stock ticker symbol, changed stock exchange on which our common stock trades, or as a result of the use of our various brands including Beyond, Overstock, Bed Bath &amp; Beyond, Zulily, Backyard, and College Living and the platforms on which they operate; </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">any problems associated with the changing job market, changing job structure, organizational changes or restructuring, reductions in force, changing compensation structure, or ability to attract and retain key personnel; </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">any inability to generate and maintain unpaid natural traffic to our websites; </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">any inability to become profitable or generate positive cash flow from operations; </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">the relocation or third-party maintenance of our data center or any other risks or challenges that could result in loss of functionality or unavailability of our websites or reduced performance of our transaction systems; </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">our exposure to cybersecurity risks, risks of data loss and other security breaches; the risk that we may incur or be required to recognize losses relating to our equity and other investments, including new investments; </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">the impacts that we would experience if governmental entities or providers of consumer devices and internet browsers further restrict or regulate the use of &#8220;cookie&#8221; tracking technologies; </div></td></tr></table></div></div><div class="BRDSX_block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"><div class="BRDSX_unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">S-3<br></div></div></div>
<!--End Page 37-->
<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div class="BRPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 38-->
<div class="BRDSX_page" style="text-align: left; margin: auto; line-height: initial; width: 468pt;"><a name="ny20042541x1_posasr_204-fls_pg2"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="BRDSX_page-content"><div class="BRDSX_block-main" style="width: 468pt; margin-left: 0pt;"><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6.75pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">the impact that any litigation, claims, or regulatory matters could have on our business, financial condition, results of operations, and cash flows; </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">any inability to optimize and effectively operate our distribution center, warehouse, and customer service operations; </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">any failures to effectively utilize technological advancements; </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">negative economic consequences of political events such as the U.S. presidential election, various global conflicts, and macroeconomic factors; </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">negative consequences associated with our determination to partially self-insure our employee's health insurance; </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">the possibility that we may be unable to protect our proprietary technology and to obtain trademark protection for our marks; </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">current and future claims of intellectual property infringement to which we are subject; </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">any difficulties we may encounter as a result of our reliance on third-parties that we do not control for their representations regarding product compliance with various laws and regulations; </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">any difficulties we may encounter as a result of our evolving business practices, including strategic ventures, the expansion of our products and service offerings, our continuing expansion into international markets, our changing approach to holding inventory, content creation, and sales through our various websites and brands; </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">any problems associated with our lack of visibility into, and our lack of influence over, our equity method investments, including our reliance on third-parties to timely and accurately report material events to us; </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">any inability of Pelion Venture Partners to successfully manage the Medici Ventures, L.P. fund, in which we are the limited partner, or any other entity in which we also have a direct minority interest; and </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">the other risks described in this prospectus supplement and the documents incorporated by reference herein. </div></td></tr></table><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;">In evaluating all forward-looking statements, you should specifically consider the risks outlined above and in this prospectus supplement and the accompanying prospectus and the documents incorporated by reference herein and therein, especially under the headings &#8220;Special Cautionary Note Regarding Forward-Looking Statements,&#8221; &#8220;Risk&#160;Factors,&#8221; &#8220;Legal Proceedings,&#8221; and &#8220;Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations,&#8221; and similar headings. Although we believe that our assumptions and expectations reflected in the forward-looking statements are reasonable as of the date hereof, we cannot guarantee or offer any assurance of future results, levels of activity, performance or achievements or other future events. Our forward-looking statements contained in this prospectus supplement, the accompanying prospectus and the documents incorporated by reference herein and therein speak only as of the date of this prospectus supplement, the accompanying prospectus and the documents incorporated by reference herein, respectively, and, except as required by law, we undertake no obligation to update forward-looking statements to reflect events or circumstances occurring after the date hereof or any changes in our expectations or any change in any events, conditions or circumstances on which any of our forward-looking statements are based. </div></div></div><div class="BRDSX_block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"><div class="BRDSX_unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">S-4<br></div></div></div>
<!--End Page 38-->
<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div class="BRPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 39-->
<div class="BRDSX_page" style="text-align: left; margin: auto; line-height: initial; width: 492pt;"><a name="ny20042541x1_posasr_205-summary_pg1"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="BRDSX_border-box" style="border-top: 1pt solid #000000; border-left: 1pt solid #000000; border-right: 1pt solid #000000; border-bottom: 1pt solid #000000; margin-bottom: 12pt; padding-top: 12pt; padding-bottom: 12pt; width: 492pt; margin-left: 0pt;"><div class="BRDSX_page-content" style="margin-left: 12pt;"><div class="BRDSX_block-main" style="width: 468pt; margin-left: 0pt;"><div class="BRDSX_h1" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 6.75pt; text-align: center;"><a name="sAOC"><!--Anchor--></a>ABOUT BEYOND, INC. </div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; margin-top: 6pt; margin-left: 0pt; text-align: left;">This summary highlights information contained elsewhere, or incorporated by reference, in this prospectus supplement and the accompanying prospectus. This summary does not contain all of the information you should consider before investing in our common stock. You should read this entire prospectus supplement, the accompanying prospectus and the documents incorporated by reference herein and therein carefully, especially the &#8220;Risk Factors&#8221; section beginning on page S-<a href="#sRFA">7</a> of this prospectus supplement and the corresponding section contained in our most recent Annual Report on Form 10-K, all of our subsequent Quarterly Reports on Form&#160;10-Q, and other filings we make with the SEC from time to time, which are incorporated by reference in this prospectus supplement and the accompanying prospectus, and our financial statements and the related notes thereto appearing in such filings, before making an investment decision.<font style="font-style: normal;"> </font></div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;">We are an e-commerce expert with a singular focus: connecting consumers with products and services they love. As the owner of the iconic Bed Bath &amp; Beyond, Overstock and Zulily brands, as well as several other brands, we strive to curate an exceptional online shopping experience. Our suite of premier online retail brands allow us to offer a comprehensive array of products and services, catering to customers in the United States and Canada. Our e-commerce platform, accessible through our mobile app, www.bedbathandbeyond.com, www.bedbathandbeyond.ca, www.overstock.com, and www.zulily.com (collectively referred to as the &#8220;Website&#8221;) serves as a gateway for those seeking a diverse array of top-tier, on-trend products that enable its customers to unlock their homes&#8217; potential at competitive prices. From furniture, bedding, and bath essentials to patio and outdoor gear, area rugs, tabletop and cookware, d&#233;cor, storage and organization solutions, small appliances, and home improvement items &#8211; we offer an extensive range of furniture and home furnishings to elevate our customers&#8217; living spaces within the four corners of their home and the four corners of their property. We have included our Website addresses only as inactive textual references and do not intend them to be an active link to our Website or incorporate information from our Website into this prospectus supplement. </div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;">Our company, based in Murray, Utah, was founded as a Utah limited liability company in 1997, reorganized as a C corporation in the State of Utah in 1998, and reincorporated in Delaware in 2002. We launched our initial website in March 1999. In November 2023, we changed our corporate name from Overstock.com, Inc. to Beyond, Inc., and transferred the principal listing of our common stock from the Nasdaq Global Market to the New York Stock Exchange. Our common stock ceased trading under the ticker symbol &#8220;OSTK&#8221; on the Nasdaq Global Market at the close of market November 3, 2023 and on November 6, 2023, our common stock began trading under the ticker symbol &#8220;BYON&#8221; on the New York Stock Exchange. We will not distinguish between our prior and current corporate name and will refer to our current corporate name throughout this prospectus supplement and the accompanying prospectus. </div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;">Our principal executive offices are located at 433 W. Ascension Way, 3rd Floor, Murray, Utah 84123, and our telephone number is (801) 947-3100. </div></div></div></div><div class="BRDSX_block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 12pt;"><div class="BRDSX_unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">S-5<br></div></div></div>
<!--End Page 39-->
<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div class="BRPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 40-->
<div class="BRDSX_page" style="text-align: left; margin: auto; line-height: initial; width: 492pt;"><a name="ny20042541x1_posasr_205-summary_pg2"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="BRDSX_border-box" style="border-top: 1pt solid #000000; border-left: 1pt solid #000000; border-right: 1pt solid #000000; border-bottom: 1pt solid #000000; margin-bottom: 12pt; padding-top: 12pt; padding-bottom: 12pt; width: 492pt; margin-left: 0pt;"><div class="BRDSX_page-content" style="margin-left: 12pt;"><div class="BRDSX_block-main" style="width: 468pt; margin-left: 0pt;"><div class="BRDSX_h1" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 6.75pt; text-align: center;"><a name="sTO"><!--Anchor--></a>THE OFFERING </div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; margin-top: 6pt; margin-left: 0pt; text-align: left;">The following is a brief summary of certain terms of this offering. For a more complete description of the terms of our common stock, see the &#8220;Description of Capital Stock&#8221; section of the accompanying prospectus.<font style="font-style: normal;"> </font></div><div class="BRDSX_sum1" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; width: 216pt; margin-top: 8pt; margin-left: 0pt; text-align: left;">Common stock offered by us: <font style="font-weight: normal; padding-left: 3.52pt;"></font></div><div class="BRDSX_sum2" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: -12pt; margin-left: 240pt; text-align: left;">Shares of our common stock having an aggregate offering price of up to $156,128,866. </div><div class="BRDSX_sum1" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; width: 216pt; margin-top: 6pt; margin-left: 10pt; text-indent: -10pt; text-align: left;">Shares to be outstanding immediately after this offering: <font style="font-weight: normal; padding-left: 0.97pt;"></font></div><div class="BRDSX_sum2" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: -12pt; margin-left: 240pt; text-align: left;">Assuming the sale of all shares of our common stock offered hereby at an assumed offering price of $6.92 per share, which was the last reported sale price of our common stock on the New York Stock Exchange on February 24, 2025, we would have had 75,706,764 shares of common stock outstanding.<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">(1)</sup> </div><div class="BRDSX_sum1" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; width: 216pt; margin-top: 8pt; margin-left: 0pt; text-align: left;">Manner of offering: <font style="font-weight: normal; padding-left: 3.72pt;"></font></div><div class="BRDSX_sum2" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: -12pt; margin-left: 240pt; text-align: left;">&#8220;At the market offering&#8221; that may be made from time to time through or to Jones, as sales agent or principal. See &#8220;Plan of Distribution&#8221; beginning on page S-<a href="#sPDT">15</a> of this prospectus supplement. </div><div class="BRDSX_sum1" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; width: 216pt; margin-top: 8pt; margin-left: 0pt; text-align: left;">Sales Agent: <font style="font-weight: normal; padding-left: 0.85pt;"></font></div><div class="BRDSX_sum2" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: -12pt; margin-left: 240pt; text-align: left;">JonesTrading Institutional Services LLC </div><div class="BRDSX_sum1" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; width: 216pt; margin-top: 8pt; margin-left: 0pt; text-align: left;">Use of proceeds: <font style="font-weight: normal; padding-left: 0.72pt;"></font></div><div class="BRDSX_sum2" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: -12pt; margin-left: 240pt; text-align: left;">We intend to use the net proceeds from this offering for working capital and other general corporate purposes. As a result, management will retain broad discretion over the allocation of net proceeds. See &#8220;Use of Proceeds&#8221; on page S-<a href="#sUP">9</a> of this prospectus supplement. </div><div class="BRDSX_sum1" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; width: 216pt; margin-top: 8pt; margin-left: 0pt; text-align: left;">Risk factors: <font style="font-weight: normal; padding-left: 4.64pt;"></font></div><div class="BRDSX_sum2" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: -12pt; margin-left: 240pt; text-align: left;">Investing in our common stock involves significant risks. See &#8220;Risk Factors&#8221; on page S-<a href="#sRFA">7</a> of this prospectus supplement and the other information included or incorporated by reference in this prospectus supplement and the accompanying prospectus for a discussion of certain factors you should carefully consider before deciding to invest in shares of our common stock. </div><div class="BRDSX_sum1" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; width: 216pt; margin-top: 8pt; margin-left: 0pt; text-align: left;">NYSE symbol: <font style="font-weight: normal; padding-left: 2.3pt;"></font></div><div class="BRDSX_sum2" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: -12pt; margin-left: 240pt; text-align: left;">&#8220;BYON&#8221;</div><div><div class="BRDSX_rule-partial" style="height: 0pt; width: 72pt; border-bottom: 1pt solid #000000; margin-bottom: 1pt; margin-right: auto; margin-left: 0pt; margin-top: 11.75pt;"> </div></div><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 3pt; margin-left: 0pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt;">(1)<br></div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; text-align: left;">The number of shares of our common stock that would be outstanding after this offering, assuming the sale of all shares of our common stock offered hereby at an assumed offering price of $6.92 per share, is based on 53,144,790 shares of common stock outstanding as of February 19, 2025. It excludes, as of such date, (i) 6,968,809 shares of our common stock that may be issued upon the vesting of outstanding restricted stock units and performance stock units, (ii) 337,899 shares of common stock issuable upon the exercise of outstanding stock options, (iii) 1,930,345 shares of our common stock that remain available for future equity grants under our equity incentive plan, and (iv) 2,679,318 shares of our common stock that remain available for issuance under our employee stock purchase plan. </div></td></tr></table></div></div></div><div class="BRDSX_block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 12pt;"><div class="BRDSX_unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">S-6<br></div></div></div>
<!--End Page 40-->
<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div class="BRPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 41-->
<div class="BRDSX_page" style="text-align: left; margin: auto; line-height: initial; width: 468pt;"><a name="ny20042541x1_posasr_206-risk_pg1"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="BRDSX_page-content"><div class="BRDSX_block-main" style="width: 468pt; margin-left: 0pt;"><div class="BRDSX_h1" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 6.75pt; text-align: center;"><a name="sRFA"><!--Anchor--></a>RISK FACTORS </div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; margin-top: 6pt; margin-left: 0pt; text-align: left;">An investment in our common stock involves a high degree of risk. Before deciding whether to invest in our common stock, you should consider carefully the risks and uncertainties described below and under the section captioned &#8220;Risk Factors&#8221; and &#8220;Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations&#8221; contained in our most recent Annual Report on Form 10-K, all of our subsequent Quarterly Reports on Form 10-Q, and other filings we make with the SEC from time to time, all of which are incorporated by reference in this prospectus supplement and the accompanying prospectus. If any of these risks actually occur, our business, financial condition, results of operations and cash flow could suffer materially. In such event, the trading price of our common stock could decline and you might lose all or part of your investment.<font style="font-style: normal;"> </font></div><div class="BRDSX_h2" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 20.5pt; margin-left: 0pt; text-align: left;">Risks Related to This Offering </div><div class="BRDSX_frisk" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 6pt; margin-left: 0pt; text-align: left;">If you purchase shares of common stock in this offering, you may suffer immediate dilution of your investment. </div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;">The shares sold in this offering, if any, will be sold from time to time at various prices. However, the offering price of our common stock from time to time is expected to be substantially higher than the net tangible book value per share of our common stock. Therefore, if you purchase shares of our common stock in this offering, you may pay a price per share that substantially exceeds our net tangible book value per share after this offering. The actual amount of dilution from this offering will be based on numerous factors, particularly the number of shares of common stock issued, the prices at which such shares are sold and our use of the net proceeds therefrom, and cannot be determined at this time. </div><div class="BRDSX_frisk" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 20.5pt; margin-left: 0pt; text-align: left;">You may experience future dilution as a result of future equity offerings. </div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;">In order to raise additional capital, we may in the future offer additional shares of our common stock or other securities convertible into or exchangeable for our common stock at prices that may be substantially different from the prices at which we may sell shares from time to time in this offering. We may sell shares or other securities in any other offering at prices per share that are less than some or all of the prices per share paid by investors in this offering, and investors purchasing shares or other securities in the future could have rights superior to existing stockholders. The price or prices per share at which we may sell additional shares of our common stock, or securities convertible or exchangeable into common stock, in future transactions may be higher or lower than the prices per share paid by investors in this offering. </div><div class="BRDSX_frisk" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 20pt; margin-left: 0pt; text-align: left;">We have broad discretion over the use of our cash, cash equivalents and marketable securities, including the net proceeds we receive in this offering, and may not use them effectively. </div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;">Our management has broad discretion to use our cash, cash equivalents and marketable securities, including the net proceeds we receive in this offering, to fund our operations and could spend these funds in ways that do not improve our results of operations or enhance the value of our common stock. The failure by our management to apply these funds effectively could result in financial losses that could have a material adverse effect on our business and cause the price of our common stock to decline. Pending their use to fund operations, we may invest our cash, cash equivalents and marketable securities in a manner that does not produce income or that loses value. </div><div class="BRDSX_frisk" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 20pt; margin-left: 0pt; text-align: left;">Future sales of our common stock may depress our stock price. </div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;">Sales of a substantial number of shares of our common stock or other securities convertible into or exchangeable for our common stock, or the perception that these sales may occur (including the shares of common stock in this offering), in the public market or otherwise, by us or by a significant stockholder, could depress the trading price of our common stock and impair our ability to raise capital through the sale of additional equity securities. </div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;">In addition, we may issue additional shares of our common stock or other securities convertible into or exchangeable for our common stock from time to time in the future in amounts that may be significant. The sale of substantial amounts of our common stock or such other securities, or the perception that these sales may occur, could adversely affect the trading price of our common stock. </div></div></div><div class="BRDSX_block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"><div class="BRDSX_unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">S-7<br></div></div></div>
<!--End Page 41-->
<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div class="BRPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 42-->
<div class="BRDSX_page" style="text-align: left; margin: auto; line-height: initial; width: 468pt;"><a name="ny20042541x1_posasr_206-risk_pg2"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="BRDSX_page-content"><div class="BRDSX_block-main" style="width: 468pt; margin-left: 0pt;"><div class="BRDSX_frisk" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 6.75pt; margin-left: 0pt; text-align: left;">The actual number of shares of common stock we will issue under the Sales Agreement, at any one time or in total, is uncertain. </div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;">Subject to certain limitations in the Sales Agreement and compliance with applicable law, we have the discretion to deliver a placement notice to the Sales Agent at any time throughout the term of the Sales Agreement. The number of shares of common stock that are sold by the Sales Agent after our delivery of a placement notice will depend on the market price of the shares of common stock during the sales period and limits we set with the Sales Agent. Because the price per share of each share sold will fluctuate based on the market price of shares of our common stock during the sales period, it is not possible at this stage to predict the number of shares of common stock that will or may be ultimately issued. </div><div class="BRDSX_frisk" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 20.5pt; margin-left: 0pt; text-align: left;">The shares of common stock offered hereby will be sold in &#8220;at the market offerings,&#8221; and investors who buy shares of our common stock at different times will likely pay different prices. </div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;">Investors who purchase shares of our common stock in this offering at different times will likely pay different prices, and so may experience different outcomes in their investment results. We will have discretion, subject to market demand, to vary the timing, prices, and numbers of shares of common stock offered for sale, and there is no minimum or maximum per share sales price. Investors in this offering may experience a decline in the value of their shares of common stock as a result of share sales made at prices lower than the prices they paid. </div></div></div><div class="BRDSX_block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"><div class="BRDSX_unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">S-8<br></div></div></div>
<!--End Page 42-->
<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div class="BRPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 43-->
<div class="BRDSX_page" style="text-align: left; margin: auto; line-height: initial; width: 468pt;"><a name="ny20042541x1_posasr_207-use_pg1"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="BRDSX_page-content"><div class="BRDSX_block-main" style="width: 468pt; margin-left: 0pt;"><div class="BRDSX_h1" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 6.75pt; text-align: center;"><a name="sUP"><!--Anchor--></a>USE OF PROCEEDS </div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;">We may issue and sell shares of our common stock having aggregate gross sales proceeds of up to $156,128,866 from time to time (before deducting Sales Agent commissions and expenses). Because there is no minimum offering amount required as a condition to this offering, the actual total public offering amount, commissions and proceeds to us, if any, are not determinable at this time. In addition, because we may make sales in this offering from time to time over a lengthy period of time, developments in our business and in our business objectives may occur and may affect our allocation of net proceeds of this offering from time to time. </div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;">We intend to use the net proceeds from this offering for working capital and other general corporate purposes. Pending our use of the net proceeds, we intend to hold them in demand deposit bank accounts, U.S. Treasuries or other short term cash equivalents. </div></div></div><div class="BRDSX_block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"><div class="BRDSX_unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">S-9<br></div></div></div>
<!--End Page 43-->
<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div class="BRPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 44-->
<div class="BRDSX_page" style="text-align: left; margin: auto; line-height: initial; width: 468pt;"><a name="ny20042541x1_posasr_207-use_pg2"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="BRDSX_page-content"><div class="BRDSX_block-main" style="width: 468pt; margin-left: 0pt;"><div class="BRDSX_h1" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 6.75pt; text-align: center;"><a name="sDP"><!--Anchor--></a>DIVIDEND POLICY </div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;">We have never declared or paid any cash dividends on our common stock. We currently intend to retain any earnings for future growth and do not anticipate paying any cash dividends on our common stock in the foreseeable future. Any future determination to declare and pay dividends on our common stock will be at the discretion of our board of directors and will depend on our results of operations, financial conditions, contractual and legal restrictions and other factors the board of directors deems relevant. </div></div></div><div class="BRDSX_block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"><div class="BRDSX_unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">S-10<br></div></div></div>
<!--End Page 44-->
<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div class="BRPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 45-->
<div class="BRDSX_page" style="text-align: left; margin: auto; line-height: initial; width: 468pt;"><a name="ny20042541x1_posasr_208-material_pg1"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="BRDSX_page-content"><div class="BRDSX_block-main" style="width: 468pt; margin-left: 0pt;"><div class="BRDSX_h1" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 6.75pt; text-align: center;"><a name="sMFI"><!--Anchor--></a>MATERIAL U.S. FEDERAL INCOME TAX CONSEQUENCES TO NON-U.S. HOLDERS </div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;">The following discussion is a summary of the material U.S. federal income tax consequences to Non-U.S.&#160;Holders (as defined below) of the purchase, ownership, and disposition of our common stock issued pursuant to this offering, but does not purport to be a complete analysis of all potential tax effects. The effects of other U.S.&#160;federal tax laws, such as estate and gift tax laws, and any applicable state, local, or non-U.S. tax laws are not discussed. This discussion is based on the U.S. Internal Revenue Code of 1986, as amended (the &#8220;Code&#8221;), Treasury Regulations promulgated thereunder, judicial decisions, and published rulings and administrative pronouncements of the U.S. Internal Revenue Service (the &#8220;IRS&#8221;), in each case in effect as of the date hereof. These authorities may change or be subject to differing interpretations. Any such change or differing interpretation may be applied retroactively in a manner that could adversely affect a Non-U.S. Holder. We have not sought and will not seek any rulings from the IRS regarding the matters discussed below. There can be no assurance the IRS or a court will not take a contrary position to that discussed below regarding the tax consequences of the purchase, ownership, and disposition of our common stock. </div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;">This discussion is limited to Non-U.S. Holders that hold our common stock as a &#8220;capital asset&#8221; within the meaning of Section&#160;1221 of the Code (generally, property held for investment). This discussion does not address all U.S. federal income tax consequences relevant to a Non-U.S. Holder&#8217;s particular circumstances, including the impact of the Medicare contribution tax on net investment income and the alternative minimum tax. In addition, it does not address consequences relevant to Non-U.S. Holders subject to special rules, including, without limitation: </div><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">U.S. expatriates and former citizens or long-term residents of the United States; </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">persons holding our common stock as part of a hedge, straddle, or other risk reduction strategy or as part of a conversion transaction or other integrated investment; </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">banks, insurance companies, and other financial institutions; </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">brokers, dealers, or traders in securities; </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">&#8220;controlled foreign corporations,&#8221; &#8220;passive foreign investment companies,&#8221; and corporations that accumulate earnings to avoid U.S. federal income tax; </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">partnerships or other entities or arrangements treated as partnerships for U.S. federal income tax purposes (and investors therein); </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">tax-exempt organizations or governmental organizations; </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">persons deemed to sell our common stock under the constructive sale provisions of the Code; </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">persons who hold or receive our common stock pursuant to the exercise of any employee stock option or otherwise as compensation; </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">tax-qualified retirement plans; </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">&#8220;qualified foreign pension funds&#8221; as defined in Section&#160;897(l)(2) of the Code and entities all of the interests of which are held by qualified foreign pension funds; and </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">persons subject to special tax accounting rules as a result of any item of gross income with respect to the stock being taken into account in an applicable financial statement. </div></td></tr></table><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;">If an entity treated as a partnership for U.S. federal income tax purposes holds our common stock, the tax treatment of a partner in the partnership will depend on the status of the partner, the activities of the partnership, and certain determinations made at the partner level. Accordingly, partnerships holding our common stock and the partners in such partnerships should consult their tax advisors regarding the U.S. federal income tax consequences to them. </div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 6pt; margin-left: 0pt; text-align: left;">THIS DISCUSSION IS FOR INFORMATIONAL PURPOSES ONLY AND IS NOT TAX ADVICE. INVESTORS SHOULD CONSULT THEIR TAX ADVISORS WITH RESPECT TO THE APPLICATION OF THE U.S. FEDERAL INCOME TAX LAWS TO THEIR PARTICULAR SITUATIONS AS WELL AS ANY TAX CONSEQUENCES OF THE PURCHASE, OWNERSHIP, AND DISPOSITION OF OUR COMMON STOCK ARISING UNDER THE U.S. FEDERAL ESTATE OR GIFT TAX LAWS OR UNDER THE LAWS OF ANY STATE, LOCAL, OR NON-U.S. TAXING JURISDICTION OR UNDER ANY APPLICABLE INCOME TAX TREATY.<font style="font-weight: normal;"> </font></div></div></div><div class="BRDSX_block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"><div class="BRDSX_unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">S-11<br></div></div></div>
<!--End Page 45-->
<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div class="BRPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 46-->
<div class="BRDSX_page" style="text-align: left; margin: auto; line-height: initial; width: 468pt;"><a name="ny20042541x1_posasr_208-material_pg2"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="BRDSX_page-content"><div class="BRDSX_block-main" style="width: 468pt; margin-left: 0pt;"><div class="BRDSX_h2" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 6.75pt; margin-left: 0pt; text-align: left;">Definition of a Non-U.S. Holder </div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;">For purposes of this discussion, a &#8220;Non-U.S. Holder&#8221; is any beneficial owner of our common stock that is neither a &#8220;U.S. person&#8221; nor an entity treated as a partnership for U.S. federal income tax purposes. A U.S.&#160;person is any person that, for U.S. federal income tax purposes, is or is treated as any of the following: </div><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 3pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">an individual who is a citizen or resident of the United States; </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 3pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">a corporation created or organized under the laws of the United States, any state thereof, or the District of Columbia; </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 3pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">an estate, the income of which is subject to U.S. federal income tax regardless of its source; or </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 3pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">a trust that (1) is subject to the primary supervision of a U.S. court and the control of one or more &#8220;United States persons&#8221; (within the meaning of Section&#160;7701(a)(30) of the Code), or (2) has a valid election in effect to be treated as a United States person for U.S. federal income tax purposes. </div></td></tr></table><div class="BRDSX_h2" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 16.5pt; margin-left: 0pt; text-align: left;">Distributions </div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;">As described in the section entitled &#8220;Dividend Policy,&#8221; we do not anticipate declaring or paying dividends to holders of our common stock in the foreseeable future. However, if we make distributions of cash or property on our common stock, such distributions will constitute dividends for U.S. federal income tax purposes to the extent paid from our current or accumulated earnings and profits, as determined under U.S. federal income tax principles. Amounts not treated as dividends for U.S. federal income tax purposes will constitute a return of capital and first be applied against and reduce a Non-U.S. Holder&#8217;s adjusted tax basis in its common stock, but not below zero. Any excess will be treated as capital gain and will be treated as described below under &#8220;&#8212;Sale or Other Taxable Disposition.&#8221; </div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;">Subject to the discussion below on effectively connected income, dividends paid to a Non-U.S. Holder will be subject to U.S. federal withholding tax at a rate of 30% of the gross amount of the dividends (or such lower rate specified by an applicable income tax treaty, provided the Non-U.S. Holder furnishes a valid IRS Form W-8BEN or W-8BEN-E (or other applicable documentation) certifying qualification for the lower treaty rate). A Non-U.S.&#160;Holder that does not timely furnish the required documentation, but that qualifies for a reduced treaty rate, may obtain a refund of any excess amounts withheld by timely filing an appropriate claim for refund with the IRS. Non-U.S. Holders should consult their tax advisors regarding their entitlement to benefits under any applicable income tax treaty. </div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;">If dividends paid to a Non-U.S. Holder are effectively connected with the Non-U.S. Holder&#8217;s conduct of a trade or business within the United States (and, if required by an applicable income tax treaty, the Non-U.S. Holder maintains a permanent establishment in the United States to which such dividends are attributable), the Non-U.S. Holder will be exempt from the U.S. federal withholding tax described above. To claim the exemption, the Non-U.S. Holder must furnish to the applicable withholding agent a valid IRS Form W-8ECI, certifying that the dividends are effectively connected with the Non-U.S. Holder&#8217;s conduct of a trade or business within the United States. </div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;">Any such effectively connected dividends will be subject to U.S. federal income tax on a net income basis at the regular rates. A Non-U.S. Holder that is a corporation also may be subject to a branch profits tax at a rate of 30% (or such lower rate specified by an applicable income tax treaty) on such effectively connected dividends, as adjusted for certain items. Non-U.S. Holders should consult their tax advisors regarding any applicable tax treaties that may provide for different rules. </div><div class="BRDSX_h2" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 16.5pt; margin-left: 0pt; text-align: left;">Sale or Other Taxable Disposition </div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;">A Non-U.S. Holder will not be subject to U.S. federal income tax on any gain realized upon the sale or other taxable disposition of our common stock unless: </div><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 3pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">the gain is effectively connected with the Non-U.S. Holder&#8217;s conduct of a trade or business within the United States (and, if required by an applicable income tax treaty, the Non-U.S. Holder maintains a permanent establishment in the United States to which such gain is attributable); </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 3pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">the Non-U.S. Holder is a nonresident alien individual present in the United States for 183 days or more during the taxable year of the disposition and certain other requirements are met; or </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 3pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">our common stock constitutes a U.S. real property interest (&#8220;USRPI&#8221;) by reason of our status as a U.S.&#160;real property holding corporation (&#8220;USRPHC&#8221;) for U.S. federal income tax purposes. </div></td></tr></table></div></div><div class="BRDSX_block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"><div class="BRDSX_unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">S-12<br></div></div></div>
<!--End Page 46-->
<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div class="BRPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 47-->
<div class="BRDSX_page" style="text-align: left; margin: auto; line-height: initial; width: 468pt;"><a name="ny20042541x1_posasr_208-material_pg3"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="BRDSX_page-content"><div class="BRDSX_block-main" style="width: 468pt; margin-left: 0pt;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6.75pt; margin-left: 0pt; text-align: left;">Gain described in the first bullet point above generally will be subject to U.S. federal income tax on a net income basis at the regular rates. A Non-U.S. Holder that is a corporation also may be subject to a branch profits tax at a rate of 30% (or such lower rate specified by an applicable income tax treaty) on such effectively connected gain, as adjusted for certain items. </div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;">A Non-U.S. Holder described in the second bullet point above will be subject to U.S. federal income tax at a rate of 30% (or such lower rate specified by an applicable income tax treaty) on gain realized upon the sale or other taxable disposition of our common stock, which may be offset by U.S. source capital losses of the Non-U.S.&#160;Holder (even though the individual is not considered a resident of the United States), provided the Non-U.S. Holder has timely filed U.S. federal income tax returns with respect to such losses. </div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;">With respect to the third bullet point above, we believe we currently are not, and do not anticipate becoming, a USRPHC. Because the determination of whether we are a USRPHC depends, however, on the fair market value of our USRPIs relative to the fair market value of our non-U.S. real property interests and our other business assets, there can be no assurance we currently are not a USRPHC or will not become one in the future. Even if we are or were to become a USRPHC, gain arising from the sale or other taxable disposition of our common stock by a Non-U.S. Holder will not be subject to U.S. federal income tax if our common stock is &#8220;regularly traded,&#8221; as defined by applicable Treasury Regulations, on an established securities market and such Non-U.S.&#160;Holder owned, actually and constructively, 5% or less of our common stock throughout the shorter of the five-year period ending on the date of the sale or other taxable disposition or the Non-U.S. Holder&#8217;s holding period. </div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;">Non-U.S. Holders should consult their tax advisors regarding potentially applicable income tax treaties that may provide for different rules. </div><div class="BRDSX_h2" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 17.5pt; margin-left: 0pt; text-align: left;">Information Reporting and Backup Withholding </div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;">Payments of dividends on our common stock will not be subject to backup withholding, provided the applicable withholding agent does not have actual knowledge or reason to know the holder is a United States person and the holder either certifies its non-U.S. status, such as by furnishing a valid IRS Form W-8BEN, W-8BEN-E, or W-8ECI, or otherwise establishes an exemption. However, information returns are required to be filed with the IRS in connection with any distributions on our common stock paid to the Non-U.S. Holder, regardless of whether such distributions constitute dividends or whether any tax was actually withheld. In addition, proceeds of the sale or other taxable disposition of our common stock within the United States or conducted through certain U.S.-related brokers generally will not be subject to backup withholding or information reporting if the applicable withholding agent receives the certification described above and does not have actual knowledge or reason to know that such holder is a United States person or the holder otherwise establishes an exemption. Proceeds of a disposition of our common stock conducted through a non-U.S. office of a non-U.S. broker generally will not be subject to backup withholding or information reporting. </div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;">Copies of information returns that are filed with the IRS may also be made available under the provisions of an applicable treaty or agreement to the tax authorities of the country in which the Non-U.S. Holder resides or is established. </div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;">Backup withholding is not an additional tax. Any amounts withheld under the backup withholding rules may be allowed as a refund or a credit against a Non-U.S. Holder&#8217;s U.S. federal income tax liability, provided the required information is timely furnished to the IRS. </div><div class="BRDSX_h2" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 17.5pt; margin-left: 0pt; text-align: left;">Additional Withholding Tax on Payments Made to Foreign Accounts </div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;">Withholding taxes may be imposed under Sections 1471 to 1474 of the Code (such Sections commonly referred to as the Foreign Account Tax Compliance Act, or &#8220;FATCA&#8221;) on certain types of payments made to non-U.S. financial institutions and certain other non-U.S. entities. Specifically, a 30% withholding tax may be imposed on dividends on, or (subject to the proposed Treasury Regulations discussed below) gross proceeds from the sale or other disposition of, our common stock paid to a &#8220;foreign financial institution&#8221; or a &#8220;non-financial foreign entity&#8221; (each as defined in the Code), unless (1) the foreign financial institution undertakes certain diligence and reporting obligations, (2) the non-financial foreign entity either certifies it does not have any &#8220;substantial United&#160;States owners&#8221; (as defined in the Code) or furnishes identifying information regarding each substantial United States owner, or (3) the foreign financial institution or non-financial foreign entity otherwise qualifies for </div></div></div><div class="BRDSX_block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"><div class="BRDSX_unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">S-13<br></div></div></div>
<!--End Page 47-->
<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div class="BRPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 48-->
<div class="BRDSX_page" style="text-align: left; margin: auto; line-height: initial; width: 468pt;"><a name="ny20042541x1_posasr_208-material_pg4"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="BRDSX_page-content"><div class="BRDSX_block-main" style="width: 468pt; margin-left: 0pt;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6.75pt; margin-left: 0pt; text-align: left;">an exemption from these rules. If the payee is a foreign financial institution and is subject to the diligence and reporting requirements in (1) above, it must enter into an agreement with the U.S. Department of the Treasury requiring, among other things, that it undertake to identify accounts held by certain &#8220;specified United States persons&#8221; or &#8220;United States owned foreign entities&#8221; (each as defined in the Code), annually report certain information about such accounts, and withhold 30% on certain payments to non-compliant foreign financial institutions and certain other account holders. Foreign financial institutions located in jurisdictions that have an intergovernmental agreement with the United States governing FATCA may be subject to different rules. </div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;">Under the applicable Treasury Regulations and administrative guidance, withholding under FATCA generally applies to payments of dividends on our common stock. While withholding under FATCA would have applied also to payments of gross proceeds from the sale or other disposition of stock, proposed Treasury Regulations eliminate FATCA withholding on payments of gross proceeds entirely. Taxpayers generally may rely on these proposed Treasury Regulations until final Treasury Regulations are issued. </div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;">Prospective investors should consult their tax advisors regarding the potential application of withholding under FATCA to their investment in our common stock. </div></div></div><div class="BRDSX_block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"><div class="BRDSX_unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">S-14<br></div></div></div>
<!--End Page 48-->
<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div class="BRPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 49-->
<div class="BRDSX_page" style="text-align: left; margin: auto; line-height: initial; width: 468pt;"><a name="ny20042541x1_posasr_209-plan_pg1"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="BRDSX_page-content"><div class="BRDSX_block-main" style="width: 468pt; margin-left: 0pt;"><div class="BRDSX_h1" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 6.75pt; text-align: center;"><a name="sPDT"><!--Anchor--></a>PLAN OF DISTRIBUTION </div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;">We are party to a Capital on Demand<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">TM</sup> Sales Agreement, dated June 10, 2024, between us and Jones (the &#8220;Sales Agreement&#8221;), under which we may issue and sell from time to time shares of our common stock having an aggregate offering price of up to $156,128,866 through or to Jones as sales agent or principal. Sales of our common stock, if any, will be made (i) by any method that is deemed to be an &#8220;at the market offering&#8221; as defined in Rule&#160;415(a)(4) under the Securities Act and (ii) with our prior written consent, by any other method permitted by law and the rules and regulations of the New York Stock Exchange. </div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;">Jones will offer our common stock subject to the terms and conditions of the Sales Agreement on a daily basis or as otherwise agreed upon by us and Jones. We will designate the maximum amount of common stock to be sold through Jones on a daily basis or otherwise determine such maximum amount together with Jones. Subject to the terms and conditions of the Sales Agreement, Jones will use its commercially reasonable efforts to sell on our behalf all of the shares of common stock requested to be sold by us. We may instruct Jones not to sell common stock if the sales cannot be effected at or above the price designated by us in any such instruction. Jones or we may suspend the offering of our common stock being made through Jones under the Sales Agreement upon proper notice to the other party. We have the right, by giving written notice as specified in the Sales Agreement, to terminate the Sales Agreement in our sole discretion at any time. Jones has the right to terminate the Sales Agreement under circumstances specified in the Sales Agreement. </div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;">This offering will commence on the effective date of this prospectus supplement and will terminate upon the earlier of (i) the sale of all of our common stock subject to the Sales Agreement, or (ii) termination of the Sales Agreement as provided therein. </div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;">The aggregate compensation payable to Jones as sales agent will be up to 2.0% of the gross sales price of the shares sold through Jones pursuant to the Sales Agreement. We have also agreed to reimburse Jones for the fees and disbursements of its legal counsel in connection with the execution and delivery of the Sales Agreement in an amount not to exceed $65,000, plus certain ongoing fees and disbursements of its legal counsel. We estimate that the total expenses of the offering payable by us, excluding commissions payable to Jones under the Sales Agreement and any reimbursement of ongoing fees and disbursements of its legal counsel, will be approximately $0.5&#160;million. The remaining sales proceeds, after deducting any expenses payable by us and any transaction fees imposed by any governmental, regulatory, or self-regulatory organization in connection with the sales, will equal our net proceeds for the sale of such common stock. </div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;">Jones will provide written confirmation to us following the close of trading on the New York Stock Exchange on each day on which common stock is sold through it as sales agent under the Sales Agreement. Each confirmation will include the number of shares of common stock sold through it as sales agent on that day, the volume weighted average price of the shares sold, the percentage of the daily trading volume and the net proceeds to us. </div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;">In any quarter in which shares of common stock are sold through Jones under the Sales Agreement, we will report the number of shares of common stock sold, the net proceeds to us and the compensation paid by us to Jones in connection with the sales of common stock. </div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;">Settlement for sales of common stock will occur, unless the parties agree otherwise, on the first business day that is also a trading day following the date on which any sales were made in return for payment of the net proceeds to us. There is no arrangement for funds to be received in an escrow, trust or similar arrangement. </div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;">In connection with the sales of our common stock on our behalf, Jones will be deemed to be an &#8220;underwriter&#8221; within the meaning of the Securities Act, and the compensation paid to Jones will be deemed to be underwriting commissions or discounts. We have agreed in the Sales Agreement to provide indemnification and contribution to Jones against certain liabilities, including liabilities under the Securities Act. As sales agent, Jones will not engage in any transactions that stabilize our common stock. </div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;">Jones and/or its affiliates have in the past and may in the future provide various investment banking and other financial services for us for which services they would receive customary fees. </div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 8pt; margin-left: 0pt; text-align: left;">Our common stock is listed on the New York Stock Exchange and trades under the symbol &#8220;BYON.&#8221; </div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;">The transfer agent and registrar for our common stock is Computershare Trust Company, N.A., 150 Royall Street, Canton, Massachusetts 02021. </div></div></div><div class="BRDSX_block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"><div class="BRDSX_unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">S-15<br></div></div></div>
<!--End Page 49-->
<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div class="BRPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 50-->
<div class="BRDSX_page" style="text-align: left; margin: auto; line-height: initial; width: 468pt;"><a name="ny20042541x1_posasr_210-securities_pg1"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="BRDSX_page-content"><div class="BRDSX_block-main" style="width: 468pt; margin-left: 0pt;"><div class="BRDSX_h1" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 6.75pt; text-align: center;"><a name="sVTS"><!--Anchor--></a>VALIDITY OF THE SECURITIES </div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;">The validity of the shares of common stock being offered by this prospectus supplement has been passed upon for us by Latham &amp; Watkins LLP, New York, New York. Duane Morris LLP, New York, New York is counsel for Jones in connection with this offering. </div><div class="BRDSX_h1" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 20.5pt; text-align: center;"><a name="sEX"><!--Anchor--></a>EXPERTS </div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;">The consolidated financial statements of Beyond, Inc. as of December 31, 2023 and 2022, and for each of the years in the three-year period ended December 31, 2023, and management&#8217;s assessment of the effectiveness of internal control over financial reporting as of December 31, 2023 have been incorporated by reference herein and in the registration statement in reliance upon the reports of KPMG LLP, independent registered public accounting firm, incorporated by reference herein, and upon the authority of said firm as experts in accounting and auditing. </div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;">The financial statements of Medici Ventures, L.P. as of September&#160;30, 2021 and for the period from April&#160;23, 2021 to September&#160;30, 2021, have been incorporated by reference herein and in the registration statement in reliance upon the report of KPMG LLP, independent auditors, incorporated by reference herein, and upon the authority of said firm as experts in accounting and auditing. </div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;">The financial statements of Medici Ventures, L.P. as of September&#160;30, 2022 and for the year then ended, have been audited by Ernst &amp; Young LLP, independent auditors, as set forth in their report thereon, and are included in the Annual Report (Form&#160;10-K) of Beyond, Inc., for the year ended December&#160;31, 2023, which is incorporated herein by reference. Such financial statements are incorporated herein by reference in reliance upon such report given on the authority of such firm as experts in accounting and auditing. </div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;">The financial statements of Medici Ventures, L.P. as of September&#160;30, 2023 and for the year then ended, have been audited by Ernst &amp; Young LLP, independent auditors, as set forth in their report thereon, and are included in the Annual Report (Form&#160;10-K) of Beyond, Inc., for the year ended December&#160;31, 2023, which is incorporated herein by reference. Such financial statements are incorporated herein by reference in reliance upon such report given on the authority of such firm as experts in accounting and auditing. </div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;">The financial statements of tZERO Group, Inc. as of December&#160;31, 2022 and 2021 and for the years then ended have been incorporated by reference herein and in the registration statement in reliance upon the report of Baker Tilly US, LLP, independent auditors, incorporated by reference herein, and upon the authority of said firm as experts in accounting and auditing. </div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;">The financial statements of tZERO Group, Inc. as of December&#160;31, 2023 and 2022 and for the years then ended have been incorporated by reference herein and in the registration statement in reliance upon the report of Baker Tilly US, LLP, independent auditors, incorporated by reference herein, and upon the authority of said firm as experts in accounting and auditing. </div></div></div><div class="BRDSX_block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"><div class="BRDSX_unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">S-16<br></div></div></div>
<!--End Page 50-->
<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div class="BRPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 51-->
<div class="BRDSX_page" style="text-align: left; margin: auto; line-height: initial; width: 468pt;"><a name="ny20042541x1_posasr_210-securities_pg2"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="BRDSX_page-content"><div class="BRDSX_block-main" style="width: 468pt; margin-left: 0pt;"><div class="BRDSX_h1" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 6.75pt; text-align: center;"><a name="sWYF"><!--Anchor--></a>WHERE YOU CAN FIND MORE INFORMATION </div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;">We file annual, quarterly and current reports, proxy statements and other information with the SEC. Our filings with the SEC are available to the public through the SEC&#8217;s Internet site at www.sec.gov. Our annual, quarterly and current reports and amendments to those reports are also available over the Internet on our Investor Relations website at https://investors.beyond.com All internet addresses provided in this prospectus supplement are for informational purposes only and are not intended to be hyperlinks. In addition, the information on, or accessible through, our Internet site, or any other Internet site described herein, is not a part of, and is not incorporated or deemed to be incorporated by reference in, this prospectus supplement or the accompanying prospectus. </div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;">We have filed with the SEC a registration statement under the Securities Act relating to the offering of these securities. The registration statement, including the attached exhibits, contains additional relevant information about us and the securities offered by this prospectus supplement and the accompanying prospectus. This prospectus supplement and the accompanying prospectus do not contain all of the information set forth in the registration statement or the exhibits and schedules filed therewith. For further information about us and the shares of common stock offered hereby, we refer you to the registration statement and the exhibits and schedules thereto. Statements contained, or incorporated by reference, in this prospectus supplement and the accompanying prospectus regarding the contents of any contract or any other document that is filed as an exhibit to the registration statement (or any document incorporated by reference therein) are not necessarily complete, and each such statement is qualified in all respects by reference to the full text of such contract or other document filed as an exhibit to the registration statement (or such other document incorporated by reference therein). The registration statement and the documents referred to below under &#8220;Information Incorporated by Reference&#8221; are also available on the SEC&#8217;s website and the investor relations section of our website, each as set forth above. </div></div></div><div class="BRDSX_block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"><div class="BRDSX_unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">S-17<br></div></div></div>
<!--End Page 51-->
<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div class="BRPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 52-->
<div class="BRDSX_page" style="text-align: left; margin: auto; line-height: initial; width: 468pt;"><a name="ny20042541x1_posasr_211-incorp_pg1"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="BRDSX_page-content"><div class="BRDSX_block-main" style="width: 468pt; margin-left: 0pt;"><div class="BRDSX_h1" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 6.75pt; text-align: center;"><a name="sIIR"><!--Anchor--></a>INFORMATION INCORPORATED BY REFERENCE </div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;">The SEC allows us to incorporate by reference into this prospectus supplement certain information we file with it, which means that we can disclose important information by referring you to those documents. The information incorporated by reference herein is considered to be a part of this prospectus supplement, and information that we file later with the SEC will automatically update and supersede information contained in this prospectus supplement and the accompanying prospectus. We incorporate by reference the documents listed below that we have previously filed with the SEC (excluding any portions of any Current Report on Form 8-K that are not deemed &#8220;filed&#8221; pursuant to the General Instructions of Form&#160;8-K): </div><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">Our Annual Report on Form&#160;10-K for the year ended <a href="https://www.sec.gov/ix?doc=/Archives/edgar/data/1130713/000113071324000013/byon-20231231.htm">December&#160;31, 2023</a>, filed with the SEC on February&#160;23, 2024, as amended by Amendment No. 1 to our Annual Report on Form&#160;10-K, filed with the SEC on <a href="https://www.sec.gov/ix?doc=/Archives/edgar/data/1130713/000113071324000047/byon-20231231.htm">June&#160;24, 2024</a>, and amendment No. 2 to our Annual Report on Form&#160;10-K, filed with the SEC on <a href="https://www.sec.gov/ix?doc=/Archives/edgar/data/1130713/000113071324000085/byon-20231231.htm">October&#160;31, 2024</a>. </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">The information specifically incorporated by reference into our Annual Report on Form&#160;10-K from our Definitive Proxy Statement on Schedule 14A, filed with the SEC on <a href="https://www.sec.gov/ix?doc=/Archives/edgar/data/1130713/000114036124015808/ny20022615x2_def14a.htm">March&#160;28, 2024</a>. </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">Our Quarterly Reports on Form&#160;10-Q for the quarters ended <a href="https://www.sec.gov/ix?doc=/Archives/edgar/data/1130713/000113071324000033/byon-20240331.htm">March&#160;31, 2024</a>, <a href="https://www.sec.gov/ix?doc=/Archives/edgar/data/1130713/000113071324000057/byon-20240630.htm">June&#160;30, 2024</a> and <a href="https://www.sec.gov/ix?doc=/Archives/edgar/data/1130713/000113071324000075/byon-20240930.htm">September&#160;30, 2024</a>, filed with the SEC on May&#160;8, 2024, July&#160;31, 2024 and October&#160;25, 2024, respectively. </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">Our Current Reports on Form&#160;8-K filed with the SEC on February&#160;20, 2024 (but only the <a href="https://www.sec.gov/ix?doc=/Archives/edgar/data/1130713/000113071324000003/ostk-20240216.htm">first</a> and <a href="https://www.sec.gov/ix?doc=/Archives/edgar/data/1130713/000113071324000004/ostk-20240216.htm">second</a> Current Reports on Form&#160;8-K filed on such date, and excluding, in each case, the information and related exhibit furnished pursuant to Item&#160;7.01), <a href="https://www.sec.gov/ix?doc=/Archives/edgar/data/1130713/000113071324000017/ostk-20240306.htm">March&#160;7, 2024</a> (excluding the information and related exhibit furnished pursuant to Item&#160;7.01), <a href="https://www.sec.gov/ix?doc=/Archives/edgar/data/1130713/000113071324000024/ostk-20240418.htm">April&#160;18, 2024,</a> <a href="https://www.sec.gov/ix?doc=/Archives/edgar/data/1130713/000113071324000037/ostk-20240521.htm">May&#160;24, 2024</a>, <a href="https://www.sec.gov/ix?doc=/Archives/edgar/data/1130713/000114036124029420/ny20030476x3_8k.htm">June&#160;10, 2024</a>,<a href="https://www.sec.gov/ix?doc=/Archives/edgar/data/1130713/000114036124030258/ny20030476x5_8k.htm"> June&#160;17, 2024</a>,<a href="https://www.sec.gov/ix?doc=/Archives/edgar/data/1130713/000113071324000060/ostk-20240916.htm"> September&#160;17, 2024</a>, <a href="https://www.sec.gov/ix?doc=/Archives/edgar/data/1130713/000113071324000063/ostk-20241015.htm">October&#160;16, 2024</a> (excluding the information and related exhibit furnished pursuant to Item&#160;7.01), <a href="https://www.sec.gov/ix?doc=/Archives/edgar/data/1130713/000113071324000067/ostk-20241021.htm">October&#160;21, 2024</a>, <a href="https://www.sec.gov/ix?doc=/Archives/edgar/data/1130713/000113071324000069/ostk-20241022.htm">October&#160;22, 2024</a>, <a href="https://www.sec.gov/ix?doc=/Archives/edgar/data/1130713/000113071324000077/ostk-20241027.htm">October&#160;28, 2024</a>, <a href="https://www.sec.gov/ix?doc=/Archives/edgar/data/1130713/000113071324000080/ostk-20241028.htm">October&#160;29, 2024</a>, <a href="https://www.sec.gov/ix?doc=/Archives/edgar/data/1130713/000113071324000088/ostk-20241121.htm">November&#160;22, 2024</a>, <a href="https://www.sec.gov/ix?doc=/Archives/edgar/data/1130713/000113071324000091/ostk-20241220.htm">December&#160;20, 2024</a>, <a href="https://www.sec.gov/ix?doc=/Archives/edgar/data/1130713/000113071325000006/ostk-20250131.htm">January&#160;31, 2025</a>, <a href="https://www.sec.gov/ix?doc=/Archives/edgar/data/1130713/000113071325000010/ostk-20250130.htm">February&#160;3, 2025</a> (excluding the information and related exhibit furnished pursuant to Item&#160;7.01), <a href="https://www.sec.gov/ix?doc=/Archives/edgar/data/1130713/000113071325000012/ostk-20250205.htm">February&#160;5, 2025</a> and <a href="https://www.sec.gov/ix?doc=/Archives/edgar/data/1130713/000113071325000015/ostk-20250221.htm">February 24, 2025</a> (but only the first Current Report on Form 8-K filed on such date, and excluding the information and related exhibit furnished pursuant to Item 7.01). </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">The description of our common stock contained in the Registration Statement on Form&#160;8-A12B, filed with the SEC on <a href="https://www.sec.gov/Archives/edgar/data/1130713/000114036123049418/ny20013062x1_8a12b.htm">October&#160;25, 2023</a>, and any amendment or report filed with the SEC for the purpose of updating such description. </div></td></tr></table><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;">We also incorporate by reference into this prospectus supplement additional documents that we may file with the SEC under Sections 13(a), 13(c), 14 or 15(d) of the Exchange Act prior to the completion or termination of the offering, but excluding any information that is (or is deemed to be) furnished to and not filed with the SEC. Any statements contained in a previously filed document incorporated by reference into this prospectus supplement or the accompanying prospectus is deemed to be modified or superseded for purposes of this prospectus supplement and the accompanying prospectus to the extent that a statement contained in this prospectus supplement, or in a subsequently filed document also incorporated by reference herein, modifies or supersedes that statement. Any statement so modified or superseded will not be deemed, except as so modified or superseded, to be a part of this prospectus supplement and the accompanying prospectus. </div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;">You should not assume that the information in this prospectus supplement or any document incorporated by reference herein is accurate as of any date other than the date of this prospectus supplement or the date of the documents incorporated by reference in this prospectus supplement. </div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;">We will provide to each person, including any beneficial owner, to whom this prospectus supplement is delivered, upon written or oral request, at no cost to the requester, a copy of any or all of the information that is incorporated by reference in this prospectus supplement, other than exhibits to such documents, unless such exhibits have been specifically incorporated by reference therein. Requests for such documents should be directed to: </div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 8pt; text-align: center;">Beyond, Inc. <br></div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; text-align: center;">433 W. Ascension Way, 3<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">rd</sup> Floor <br></div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; text-align: center;">Murray, Utah 84123 <br></div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; text-align: center;">Attn: Investor Relations <br></div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; text-align: center;">(801) 947-3100 </div></div></div><div class="BRDSX_block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"><div class="BRDSX_unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">S-18<br></div></div></div>
<!--End Page 52-->
<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div class="BRPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 53-->
<div class="BRDSX_page" style="text-align: left; margin: auto; line-height: initial; width: 468pt;"><a name="ny20042541x1_posasr_211-incorp_pg2"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="BRDSX_page-content"><div class="BRDSX_block-main" style="width: 468pt; margin-left: 0pt;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6.75pt; margin-left: 0pt; text-align: left;">You may also access the documents incorporated by reference in this prospectus supplement and the accompanying prospectus on our Investor Relations website at https://investors.beyond.com. The information on, or accessible through, our website, or any other website described herein, is not a part of, and is not incorporated or deemed to be incorporated by reference in, this prospectus supplement, the accompanying prospectus, or the registration statement of which they form a part. </div></div></div><div class="BRDSX_block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"><div class="BRDSX_unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">S-19<br></div></div></div>
<!--End Page 53-->
<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div class="BRPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 54-->
<div class="BRDSX_page" style="text-align: left; margin: auto; line-height: initial; width: 456pt;"><a name="ny20042541x1_posasr_300-bcv_pg1"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="BRDSX_block-frill" style="width: 456pt; margin-left: 0pt;"><div><div class="BRDSX_rule-full" style="height: 0pt; width: 100%; border-bottom: 2pt solid #000000; margin-top: 1pt; margin-bottom: 1pt; margin-left: auto; margin-right: auto;"> </div><div class="BRDSX_rule-full" style="height: 0pt; width: 100%; border-bottom: 1pt solid #000000; margin-bottom: 1pt; margin-left: auto; margin-right: auto; margin-top: 4pt;"> </div></div></div><div class="BRDSX_page-content"><div class="BRDSX_block-main" style="width: 456pt; margin-left: 0pt;"><div class="BRDSX_h1" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 15pt; font-weight: bold; margin-top: 106pt; text-align: center;">$156,128,866</div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 54.75pt; text-align: center;"><img style="height: 86px; width: 364px;" src="logo_beyondv2x1.jpg"><br></div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">&#8201; <br></div><div class="BRDSX_h1" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 16pt; font-weight: bold; margin-top: 48pt; text-align: center;">Beyond, Inc. </div><div class="BRDSX_h1" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 16pt; font-weight: bold; margin-top: 48pt; text-align: center;">Common Stock </div><div class="BRDSX_h1" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 12pt; font-weight: bold; margin-top: 48pt; text-align: center;">PROSPECTUS SUPPLEMENT </div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 54.75pt; text-align: center;"><img style="height: 80px; width: 199px;" src="logo_jonesx1.jpg"><br></div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">&#8201;</div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 158pt; text-align: center;">February 25, 2025<font style="font-weight: normal;"> </font></div></div></div><div class="BRDSX_block-frill" style="width: 456pt; margin-top: 12pt; margin-left: 0pt;"><div><div class="BRDSX_rule-full" style="height: 0pt; width: 100%; border-bottom: 1pt solid #000000; margin-top: 1pt; margin-bottom: 1pt; margin-left: auto; margin-right: auto;"> </div><div class="BRDSX_rule-full" style="height: 0pt; width: 100%; border-bottom: 2pt solid #000000; margin-bottom: 1pt; margin-left: auto; margin-right: auto; margin-top: 4pt;"> </div></div></div></div>
<!--End Page 54-->
<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div class="BRPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 55-->
<div class="BRDSX_page" style="text-align: left; margin: auto; line-height: initial; width: 468pt;"><a name="ny20042541x1_posasr_301-part2_pg1"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="BRDSX_page-content"><div class="BRDSX_block-main" style="width: 468pt; margin-left: 0pt;"><div class="BRDSX_h1" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 6.75pt; text-align: center;">PART II <br></div><div class="BRDSX_h1" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 0pt; text-align: center;">INFORMATION NOT REQUIRED IN PROSPECTUS </div><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 12pt; margin-left: 0pt;"><tr><td style="width: 50pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold;">Item 14.<br></div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; text-align: left;"><font style="font-style: italic;">Other Expenses of Issuance and Distribution</font><font style="font-weight: normal;"> </font></div></td></tr></table><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">The following is an estimate of the expenses (all of which are to be paid by the registrant) that we may incur in connection with the securities being registered hereby. </div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 8pt; margin-left: 0pt; text-align: left;"> </div><table cellspacing="0" cellpadding="0" class="BRDSX_fintab" style="width: 468pt; margin-left: auto; margin-right: auto;"><tr class="BRDSX_boxspacer"><td style="height: 6pt; width: 408pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 7.5pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 7.5pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 45pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td></tr><tr><td style="width: 408pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">SEC registration fee<font style="padding-left: 2.76pt;"></font></div></td><td style="width: 7.5pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 7.5pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 45pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">$23,903.33<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">(1)</sup> </div></td></tr><tr><td style="width: 408pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">FINRA filing fee<font style="padding-left: 0.52pt;"></font></div></td><td style="width: 7.5pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 7.5pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 45pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">$<font style="padding-left: 40pt;"><sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">(2)</sup></font></div></td></tr><tr><td style="width: 408pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">New York Stock Exchange supplemental listing fee<font style="padding-left: 4.73pt;"></font></div></td><td style="width: 7.5pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 7.5pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 45pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">$<font style="padding-left: 40pt;"><sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">(2)</sup></font></div></td></tr><tr><td style="width: 408pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Printing expenses<font style="padding-left: 3.86pt;"></font></div></td><td style="width: 7.5pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 7.5pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 45pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">$<font style="padding-left: 40pt;"><sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">(2)</sup></font></div></td></tr><tr><td style="width: 408pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Legal fees and expenses<font style="padding-left: 1.11pt;"></font></div></td><td style="width: 7.5pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 7.5pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 45pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">$<font style="padding-left: 40pt;"><sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">(2)</sup></font></div></td></tr><tr><td style="width: 408pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Accounting fees and expenses<font style="padding-left: 2.22pt;"></font></div></td><td style="width: 7.5pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 7.5pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 45pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">$<font style="padding-left: 40pt;"><sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">(2)</sup></font></div></td></tr><tr><td style="width: 408pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Blue Sky, qualification fees and expenses<font style="padding-left: 0.38pt;"></font></div></td><td style="width: 7.5pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 7.5pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 45pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">$<font style="padding-left: 40pt;"><sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">(2)</sup></font></div></td></tr><tr><td style="width: 408pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Transfer agent fees and expenses<font style="padding-left: 0.38pt;"></font></div></td><td style="width: 7.5pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 7.5pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 45pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">$<font style="padding-left: 40pt;"><sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">(2)</sup></font></div></td></tr><tr><td style="width: 408pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Trustee fees and expenses<font style="padding-left: 4.24pt;"></font></div></td><td style="width: 7.5pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 7.5pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 45pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">$<font style="padding-left: 40pt;"><sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">(2)</sup></font></div></td></tr><tr><td style="width: 408pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Warrant agent fees and expenses<font style="padding-left: 1.93pt;"></font></div></td><td style="width: 7.5pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 7.5pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 45pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">$<font style="padding-left: 40pt;"><sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">(2)</sup></font></div></td></tr><tr><td style="width: 408pt; padding-top: 1.01pt; padding-bottom: 2.63pt; text-align: left; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Miscellaneous<font style="padding-left: 2.74pt;"></font></div></td><td style="width: 7.5pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 7.5pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 45pt; padding-top: 1.01pt; padding-bottom: 2.63pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><font style="border-bottom: 1pt solid #000000; padding-bottom: 1.5pt;">$</font><font style="padding-left: 40pt; padding-bottom: 1.5pt;"><sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">(2)</sup></font></div></td></tr><tr><td style="width: 408pt; padding-top: 2.26pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Total<font style="padding-left: 0.09pt;"></font></div></td><td style="width: 7.5pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 7.5pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 45pt; padding-top: 2.26pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><font style="border-bottom: 3pt double #000000; padding-bottom: 0.5pt;">$</font><font style="padding-left: 40pt; padding-bottom: 0.5pt;"><sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">(2)</sup></font></div></td></tr><tr class="BRDSX_boxspacer"><td style="height: 2.75pt; width: 408pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 7.5pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 7.5pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 45pt;"><div style="font-size: 1pt;">&#8194;</div></td></tr></table><div><div class="BRDSX_rule-partial" style="height: 0pt; width: 72pt; border-bottom: 1pt solid #000000; margin-bottom: 1pt; margin-right: auto; margin-left: 0pt; margin-top: 12.75pt;"> </div></div><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 3pt; margin-left: 0pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt;">(1)<br></div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; text-align: justify;">The registrant previously paid a fee of $29,520 related to shares of the registrant&#8217;s common stock having an aggregate offering price of up to $200,000,000 in connection with the prospectus supplement to this registration statement previously filed by the registrant on June&#160;10, 2024. Of such shares of common stock, $156,128,866 of shares of common stock remain unsold, and the registration fee in the amount of $23,044.63 related thereto is applied to the registrant&#8217;s total registration fee hereunder. </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 3pt; margin-left: 0pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt;">(2)<br></div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; text-align: left;">These fees are calculated based on the securities offered and the number of issuances and accordingly cannot be estimated at this time. </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 12pt; margin-left: 0pt;"><tr><td style="width: 50pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold;">Item 15.<br></div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; text-align: left;"><font style="font-style: italic;">Indemnification of Directors and Officers</font><font style="font-weight: normal;"> </font></div></td></tr></table><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Subsection (a) of Section 145 of the General Corporation Law of the State of Delaware, or the DGCL, empowers a corporation to indemnify any person who was or is a party or who is threatened to be made a party to any threatened, pending or completed action, suit or proceeding, whether civil, criminal, administrative or investigative (other than an action by or in the right of the corporation) by reason of the fact that the person is or was a director, officer, employee or agent of the corporation, or is or was serving at the request of the corporation as a director, officer, employee or agent of another corporation, partnership, joint venture, trust or other enterprise, against expenses (including attorneys&#8217; fees), judgments, fines and amounts paid in settlement actually and reasonably incurred by the person in connection with such action, suit or proceeding if the person acted in good faith and in a manner the person reasonably believed to be in or not opposed to the best interests of the corporation, and, with respect to any criminal action or proceeding, had no reasonable cause to believe the person&#8217;s conduct was unlawful. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Subsection (b) of Section 145 empowers a corporation to indemnify any person who was or is a party or is threatened to be made a party to any threatened, pending or completed action or suit by or in the right of the corporation to procure a judgment in its favor by reason of the fact that the person acted in any of the capacities set forth above, against expenses (including attorneys&#8217; fees) actually and reasonably incurred by the person in connection with the defense or settlement of such action or suit if the person acted in good faith and in a manner the person reasonably believed to be in or not opposed to the best interests of the corporation, except that no indemnification shall be made in respect of any claim, issue or matter as to which such person shall have been adjudged to be liable to the corporation unless and only to the extent that the Court of Chancery or the court in which such action or suit was brought shall determine upon application that, despite the adjudication of liability but in view of all the circumstances of the case, such person is fairly and reasonably entitled to indemnity for such expenses which the Court of Chancery or such other court shall deem proper. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Section 145 further provides that to the extent a director or officer of a corporation has been successful on the merits or otherwise in the defense of any action, suit or proceeding referred to in subsections (a) and (b) of Section&#160;145, or in defense of any claim, issue or matter therein, such person shall be indemnified against expenses (including attorneys&#8217; fees) actually and reasonably incurred by such person in connection therewith; that indemnification provided for by Section 145 shall not be deemed exclusive of any other rights to which the </div></div></div><div class="BRDSX_block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"><div class="BRDSX_unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">II-1<br></div></div></div>
<!--End Page 55-->
<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div class="BRPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 56-->
<div class="BRDSX_page" style="text-align: left; margin: auto; line-height: initial; width: 468pt;"><a name="ny20042541x1_posasr_301-part2_pg2"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="BRDSX_page-content"><div class="BRDSX_block-main" style="width: 468pt; margin-left: 0pt;"><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6.75pt; margin-left: 0pt; text-align: justify;">indemnified party may be entitled; and the indemnification provided for by Section 145 shall, unless otherwise provided when authorized or ratified, continue as to a person who has ceased to be a director, officer, employee or agent and shall inure to the benefit of such person&#8217;s heirs, executors and administrators. Section 145 also empowers the corporation to purchase and maintain insurance on behalf of any person who is or was a director, officer, employee or agent of the corporation, or is or was serving at the request of the corporation as a director, officer, employee or agent of another corporation, partnership, joint venture, trust or other enterprise against any liability asserted against such person and incurred by such person in any such capacity, or arising out of such person&#8217;s status as such, whether or not the corporation would have the power to indemnify such person against such liabilities under Section 145. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Section 102(b)(7) of the DGCL provides that a corporation&#8217;s certificate of incorporation may contain a provision eliminating or limiting the personal liability of a director to the corporation or its stockholders for monetary damages for breach of fiduciary duty as a director, provided that such provision shall not eliminate or limit the liability of a director (i) for any breach of the director&#8217;s duty of loyalty to the corporation or its stockholders, (ii) for acts or omissions not in good faith or which involve intentional misconduct or a knowing violation of law, (iii) under Section&#160;174 of the DGCL, or (iv) for any transaction from which the director derived an improper personal benefit. Our amended and restated certificate of incorporation provides that, to the fullest extent permitted by the DGCL, as the same existed or may be amended, our directors shall not be personally liable to the Company or its stockholders for monetary damages for breach of fiduciary duty as a director. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Any underwriting agreement or distribution agreement that the registrant enters into with any underwriters or agents involved in the offering or sale of any securities registered hereby may require such underwriters or dealers to indemnify the registrant, some or all of its directors and officers and its controlling persons, if any, for specified liabilities, which may include liabilities under the Securities Act of 1933, as amended. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Our amended and restated certificate of incorporation provides that we shall indemnify to the fullest extent permitted by law, as in effect at the time of the adoption of our amended and restated certificate of incorporation or thereafter in effect, any person made or threatened to be made a party to an action or proceeding, whether criminal, civil, administrative or investigative, by reason of the fact that he, his testator or intestate is or was a director or officer of the Company or any predecessor of the Company or serves or served at any other enterprise as a director, officer, employee or agent at the request of the Company or any predecessor to the Company and such right to indemnification shall continue as to a person who has ceased to be a director or officer of the Company and shall inure to the benefit of his or her heirs, executors and personal and legal representatives; provided, however, that, except for proceedings to enforce rights to indemnification, the Company shall not be obligated to indemnify any director or officer (or his or her heirs, executors or personal or legal representatives) in connection with a proceeding (or part thereof) initiated by such person unless such proceeding (or part thereof) was authorized or consented to by our board of directors. The right to indemnification conferred by such provision shall include the right to be paid by the Company the expenses incurred in defending or otherwise participating in any proceeding in advance of its final disposition. Our amended and restated certificate of incorporation further provides that we may indemnify to the fullest extent permitted by law, as in effect at the time of the adoption of our amended and restated certificate of incorporation or thereafter in effect, any person made or threatened to be made a party to an action or proceeding, whether criminal, civil, administrative or investigative, by reason of the fact that he, his testator or intestate is or was an employee or agent of the Company or any predecessor of the Company or serves or served at any other enterprise as a director, officer, employee or agent at the request of the Company or any predecessor to the Company. The rights to indemnification and to the advancement of expenses conferred by such provision shall not be exclusive of any other right which any person may have or thereafter acquire under the amended and restated certificate of incorporation as amended from time to time, the amended and restated bylaws of the Company, as amended from time to time, any statute, agreement, vote of the stockholders of the Company or disinterested directors of the Company or otherwise. The amended and restated certificate of incorporation further provides that neither any amendment nor repeal of any section of the article in our amended and restated certificate of incorporation providing for indemnification, nor the adoption of any provision of the amended and restated certificate of incorporation inconsistent with such article, shall adversely affect any right or protection of any director or officer established pursuant to such article existing at the time of such amendment, repeal or adoption of an inconsistent provision, including without limitation by eliminating or reducing the effect of such article, for or in respect of any act, omission or other matter occurring, or any action or proceeding accruing or arising (or that, but for such article, would accrue or arise) prior to such amendment, repeal or adoption of an inconsistent provision. </div></div></div><div class="BRDSX_block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"><div class="BRDSX_unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">II-2<br></div></div></div>
<!--End Page 56-->
<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div class="BRPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 57-->
<div class="BRDSX_page" style="text-align: left; margin: auto; line-height: initial; width: 468pt;"><a name="ny20042541x1_posasr_301-part2_pg3"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="BRDSX_page-content"><div class="BRDSX_block-main" style="width: 468pt; margin-left: 0pt;"><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6.75pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Our amended and restated bylaws provide, among other provisions relating to indemnification and related matters, that: </div><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">(1)<br></div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">subject to the provisions described in (3) below, the Company shall indemnify any person who was or is a party or is threatened to be made a party to any threatened, pending or completed action, suit or proceeding, whether civil, criminal, administrative or investigative (other than an action by or in the right of the Company) by reason of the fact that such person is or was a director or officer of the Company, or is or was a director or officer of the Company serving at the request of the Company as a director or officer, employee or agent of another corporation, partnership, joint venture, trust, employee benefit plan or other enterprise, against expenses (including attorneys' fees), judgments, fines and amounts paid in settlement actually and reasonably incurred by such person in connection with such action, suit or proceeding if such person acted in good faith and in a manner such person reasonably believed to be in or not opposed to the best interests of the Company, and, with respect to any criminal action or proceeding, had no reasonable cause to believe such person's conduct was unlawful. The termination of any action, suit or proceeding by judgment, order, settlement, conviction, or upon a plea of nolo contendere or its equivalent, shall not, of itself, create a presumption that the person did not act in good faith and in a manner which such person reasonably believed to be in or not opposed to the best interests of the Company, and, with respect to any criminal action or proceeding, had reasonable cause to believe that such person's conduct was unlawful; </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">(2)<br></div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">subject to the provisions described in (3) below, the Company shall indemnify any person who was or is a party or is threatened to be made a party to any threatened, pending or completed action or suit by or in the right of the Company to procure a judgment in its favor by reason of the fact that such person is or was a director or officer of the Company, or is or was a director or officer of the company serving at the request of the Company as a director, officer, employee or agent of another corporation, partnership, joint venture, trust, employee benefit plan or other enterprise against expenses (including attorneys' fees) actually and reasonably incurred by such person in connection with the defense or settlement of such action or suit if such person acted in good faith and in a manner such person reasonably believed to be in or not opposed to the best interests of the Company; except that no indemnification shall be made in respect of any claim, issue or matter as to which such person shall have been adjudged to be liable to the Company unless and only to the extent that the Court of Chancery or the court in which such action or suit was brought shall determine upon application that, despite the adjudication of liability but in view of all the circumstances of the case, such person is fairly and reasonably entitled to indemnity for such expenses which the Court of Chancery or such other court shall deem proper; </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">(3)<br></div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">any indemnification under the provisions described in the article of the amended and restated bylaws providing for indemnification (unless ordered by a court) shall be made by the Company only as authorized in the specific case upon a determination that indemnification of the director or officer is proper in the circumstances because such person has met the applicable standard of conduct described in (1) and (2) above. Such determination shall be made, with respect to a person who is a director or officer at the time of such determination, (a) by a majority vote of the directors who are not parties to such action, suit or proceeding, even though less than a quorum, or (b) by a committee of such directors designated by a majority vote of such directors, even though less than a quorum, or (c) if there are no such directors, or if such directors so direct, by independent legal counsel in a written opinion or (d) by the stockholders (but only if a majority of the directors who are not parties to such action, suit or proceeding, if they constitute a quorum of the board of directors, presents the issue of entitlement to indemnification to the stockholders for their determination). Any person or persons having the authority to act on the matter on behalf of the Company shall make such determination, with respect to former directors and officers. To the extent, however, that a present or former director or officer of the company has been successful on the merits or otherwise in defense of any action, suit or proceeding described above, or in defense of any claim, issue or matter therein, such person shall be indemnified against expenses (including attorneys' fees) actually and reasonably incurred by such person in connection therewith, without the necessity of authorization in the specific case; </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">(4)<br></div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">for purposes of any determination under the provisions in (3) described above, a person shall be deemed to have acted in good faith and in a manner such person reasonably believed to be in or not opposed to the best interests of the Company, or, with respect to any criminal action or proceeding, to have had no reasonable cause to believe such person's conduct was unlawful, if such person's action is based on the </div></td></tr></table></div></div><div class="BRDSX_block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"><div class="BRDSX_unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">II-3<br></div></div></div>
<!--End Page 57-->
<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div class="BRPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 58-->
<div class="BRDSX_page" style="text-align: left; margin: auto; line-height: initial; width: 468pt;"><a name="ny20042541x1_posasr_301-part2_pg4"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="BRDSX_page-content"><div class="BRDSX_block-main" style="width: 468pt; margin-left: 0pt;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6.75pt; margin-left: 40pt; text-align: justify;">records or books of account of the Company or another enterprise, or on information supplied to such person by the officers of the Company or another enterprise in the course of their duties, or on the advice of legal counsel for the Company or another enterprise or on information or records given or reports made to the Company or another enterprise by an independent certified public accountant or by an appraiser or other expert selected with reasonable care by the Company or another enterprise. The term &#8220;another enterprise&#8221; as used in this subparagraph (4) means any other corporation or any partnership, joint venture, trust, employee benefit plan or other enterprise of which such person is or was serving at the request of the Company as a director, officer, employee or agent. The amended and restated bylaws further provide that the provisions described in this subparagraph (4) shall not be deemed to be exclusive or to limit in any way the circumstances in which a person may be deemed to have met the applicable standard of conduct in (2)&#160;or (3) described above, as the case may be; </div><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">(5)<br></div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">notwithstanding any contrary determination in the specific case under the provisions described in subparagraph (3) above, and notwithstanding the absence of any determination thereunder, any director or officer may apply to the Court of Chancery in the State of Delaware for indemnification to the extent otherwise permissible under the provisions described in subparagraphs (1) and (2) above. The basis of such indemnification by a court shall be a determination by such court that indemnification of the director or officer is proper in the circumstances because such person has met the applicable standards of conduct under the provisions described in subparagraphs (1) and (2) above, as the case may be. Neither a contrary determination in the specific case under the provisions described in subparagraph (3) above nor the absence of any determination thereunder shall be a defense to such application or create a presumption that the director or officer seeking indemnification has not met any applicable standard of conduct. Notice of any application for indemnification pursuant to the provisions described in this subparagraph (5) is required to be given to the Company promptly upon the filing of such application. If successful, in whole or in part, the director or officer seeking indemnification shall also be entitled to be paid the expense of prosecuting such application; </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">(6)<br></div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">expenses incurred by a director or officer in defending any civil, criminal, administrative or investigative action, suit or proceeding shall be paid by the Company in advance of the final disposition of such action, suit or proceeding upon receipt of an undertaking by or on behalf of such director or officer to repay such amount if it shall ultimately be determined that such person is not entitled to be indemnified by the Company as authorized by the amended and restated bylaws; and </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">(7)<br></div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">the indemnification and advancement of expenses provided by or granted pursuant to the provisions of the article in the amended and restated bylaws providing for indemnification shall not be deemed exclusive of any other rights to which those seeking indemnification or advancement of expenses may be entitled under our amended and restated certificate of incorporation, any other bylaw, agreement, vote of stockholders or disinterested directors or otherwise, both as to action in such person's official capacity and as to action in another capacity while holding such office, it being the policy of the Company that indemnification of the persons described in subparagraphs (1) and (2) above shall be made to the fullest extent permitted by law. The provisions of the article in the amended and restated bylaws providing for indemnification shall not be deemed to preclude the indemnification of any person who is not specified in subparagraphs (1) and (2) above but whom the Company has the power or obligation to indemnify under the provisions of the DGCL, or otherwise. </div></td></tr></table><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">As permitted by the DGCL, the Company has entered into separate indemnification agreements with each of its directors and certain of its officers which require the Company, among other things, to indemnify them against certain liabilities which may arise by reason of their status as directors, officers or certain employees. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">The Company has obtained and expects to maintain insurance policies under which the Company's directors and officers are insured, within the limits and subject to the limitations of those policies, against certain expenses in connection with the defense of, and certain liabilities which might be imposed as a result of, actions, suits or proceedings to which they are parties by reason of being or having been directors or officers. The coverage provided by these policies may apply whether or not the Company would have the power to indemnify such person against such liability under the provisions of the DGCL. </div></div></div><div class="BRDSX_block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"><div class="BRDSX_unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">II-4<br></div></div></div>
<!--End Page 58-->
<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div class="BRPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 59-->
<div class="BRDSX_page" style="text-align: left; margin: auto; line-height: initial; width: 468pt;"><a name="ny20042541x1_posasr_301-part2_pg5"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="BRDSX_page-content"><div class="BRDSX_block-main" style="width: 468pt; margin-left: 0pt;"><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6.75pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">These&#160;indemnification provisions and the indemnification agreements entered into between the Company and its officers and directors may be sufficiently broad to permit indemnification of the Company's officers and directors for liabilities (including reimbursement of expenses incurred) arising under the Securities Act. </div><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 12pt; margin-left: 0pt;"><tr><td style="width: 50pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold;">Item 16.<br></div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; text-align: left;"><font style="font-style: italic;">Exhibits</font><font style="font-weight: normal;"> </font></div></td></tr></table><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 7pt; margin-left: 0pt; text-align: left;"> </div><table cellspacing="0" cellpadding="0" class="BRDSX_fintab" style="width: 468pt; margin-left: auto; margin-right: auto;"><tr class="BRDSX_boxspacer"><td style="height: 6pt; width: 36pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 192pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 186pt;" colspan="10"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 36pt;"><div style="font-size: 1pt;">&#8194;</div></td></tr><tr class="BRDSX_header"><td rowspan="2" style="width: 36pt; padding-bottom: 1.88pt; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; margin-left: 0pt; text-align: left;">Exhibit <br></div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; margin-left: 0pt; text-align: left;">Number</div></td><td style="width: 3pt; border-bottom: none;" rowspan="2"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt; border-bottom: none;" rowspan="2"><div style="font-size: 1pt;">&#8194;</div></td><td rowspan="2" style="width: 192pt; padding-bottom: 1.88pt; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Exhibit&#160;Description</div></td><td style="width: 3pt; border-bottom: none;" rowspan="2"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td colspan="10" style="width: 186pt; padding-bottom: 1.88pt; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Incorporation by Reference</div></td><td style="width: 3pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 36pt; padding-bottom: 1.88pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;">&#160;</div></td></tr><tr class="BRDSX_header"><td style="width: 3pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 24pt; padding-top: 1.58pt; padding-bottom: 1.88pt; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Form</div></td><td style="width: 3pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 48pt; padding-top: 1.58pt; padding-bottom: 1.88pt; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">File <br></div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Number</div></td><td style="width: 3pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 36pt; padding-top: 1.58pt; padding-bottom: 1.88pt; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Exhibit<br></div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Number</div></td><td style="width: 3pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 60pt; padding-top: 1.58pt; padding-bottom: 1.88pt; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Filing <br></div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Date</div></td><td style="width: 3pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 36pt; padding-top: 1.58pt; padding-bottom: 1.88pt; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Filed <br></div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Herewith </div></td></tr><tr><td style="width: 36pt; padding-top: 1.51pt; padding-bottom: 0.88pt; text-align: left; vertical-align: top; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">1.1*</div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 192pt; padding-top: 1.51pt; padding-bottom: 0.88pt; text-align: center; vertical-align: top; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Form&#160;of Underwriting Agreement</div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 24pt; padding-top: 1.51pt; padding-bottom: 0.88pt; text-align: center; vertical-align: top; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 48pt; padding-top: 1.51pt; padding-bottom: 0.88pt; text-align: center; vertical-align: top; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 36pt; padding-top: 1.51pt; padding-bottom: 0.88pt; text-align: center; vertical-align: top; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 60pt; padding-top: 1.51pt; padding-bottom: 0.88pt; text-align: center; vertical-align: top; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 36pt; padding-top: 1.51pt; padding-bottom: 0.88pt; text-align: center; vertical-align: top; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td></tr><tr><td style="width: 36pt; padding-top: 0.51pt; padding-bottom: 0.88pt; text-align: left; vertical-align: top;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><a href="https://www.sec.gov/Archives/edgar/data/1130713/000114036124029420/ny20030476x3_ex1-1.htm">1.2</a></div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 192pt; padding-top: 0.51pt; padding-bottom: 0.88pt; text-align: center; vertical-align: top;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Capital on Demand<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">TM</sup> Sales Agreement, dated as of June&#160;10, 2024, by and between Beyond, Inc. and JonesTrading Institutional Services LLC</div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 24pt; padding-top: 0.51pt; padding-bottom: 0.88pt; text-align: center; vertical-align: top;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; text-align: center;">8-K</div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 48pt; padding-top: 0.51pt; padding-bottom: 0.88pt; text-align: center; vertical-align: top;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; text-align: center;">000-49799</div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 36pt; padding-top: 0.51pt; padding-bottom: 0.88pt; text-align: center; vertical-align: top;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; text-align: center;">1.1</div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 60pt; padding-top: 0.51pt; padding-bottom: 0.88pt; text-align: center; vertical-align: top;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; text-align: center;">June&#160;10, 2024</div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 36pt; padding-top: 0.51pt; padding-bottom: 0.88pt; text-align: center; vertical-align: top;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td></tr><tr><td style="width: 36pt; padding-top: 0.51pt; padding-bottom: 0.88pt; text-align: left; vertical-align: top; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><a href="https://www.sec.gov/Archives/edgar/data/1130713/000113071314000051/ex-31certificateofincorpor.htm">3.1</a></div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 192pt; padding-top: 0.51pt; padding-bottom: 0.88pt; text-align: center; vertical-align: top; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Amended and Restated Certificate of Incorporation</div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 24pt; padding-top: 0.51pt; padding-bottom: 0.88pt; text-align: center; vertical-align: top; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; text-align: center;">10-Q</div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 48pt; padding-top: 0.51pt; padding-bottom: 0.88pt; text-align: center; vertical-align: top; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; text-align: center;">000-49799</div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 36pt; padding-top: 0.51pt; padding-bottom: 0.88pt; text-align: center; vertical-align: top; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; text-align: center;">3.1</div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 60pt; padding-top: 0.51pt; padding-bottom: 0.88pt; text-align: center; vertical-align: top; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; text-align: center;">July&#160;29, 2014 </div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 36pt; padding-top: 0.51pt; padding-bottom: 0.88pt; text-align: center; vertical-align: top; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td></tr><tr><td style="width: 36pt; padding-top: 0.51pt; padding-bottom: 0.88pt; text-align: left; vertical-align: top;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><a href="https://www.sec.gov/Archives/edgar/data/1130713/000114036123051490/ef20013966_ex3-2.htm">3.2</a></div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 192pt; padding-top: 0.51pt; padding-bottom: 0.88pt; text-align: center; vertical-align: top;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Certificate of Amendment to Amended and Restated Certificate of Incorporation</div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 24pt; padding-top: 0.51pt; padding-bottom: 0.88pt; text-align: center; vertical-align: top;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; text-align: center;">8-K</div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 48pt; padding-top: 0.51pt; padding-bottom: 0.88pt; text-align: center; vertical-align: top;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; text-align: center;">000-49799</div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 36pt; padding-top: 0.51pt; padding-bottom: 0.88pt; text-align: center; vertical-align: top;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; text-align: center;">3.2</div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 60pt; padding-top: 0.51pt; padding-bottom: 0.88pt; text-align: center; vertical-align: top;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; text-align: center;">November&#160;6, 2023 </div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 36pt; padding-top: 0.51pt; padding-bottom: 0.88pt; text-align: center; vertical-align: top;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td></tr><tr><td style="width: 36pt; padding-top: 0.51pt; padding-bottom: 0.88pt; text-align: left; vertical-align: top; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><a href="https://www.sec.gov/Archives/edgar/data/1130713/000113071324000037/ex31.htm">3.3</a></div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 192pt; padding-top: 0.51pt; padding-bottom: 0.88pt; text-align: center; vertical-align: top; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Certificate of Amendment to Amended and Restated Certificate of Incorporation</div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 24pt; padding-top: 0.51pt; padding-bottom: 0.88pt; text-align: center; vertical-align: top; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; text-align: center;">8-K</div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 48pt; padding-top: 0.51pt; padding-bottom: 0.88pt; text-align: center; vertical-align: top; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; text-align: center;">001-41850</div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 36pt; padding-top: 0.51pt; padding-bottom: 0.88pt; text-align: center; vertical-align: top; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; text-align: center;">3.1</div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 60pt; padding-top: 0.51pt; padding-bottom: 0.88pt; text-align: center; vertical-align: top; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; text-align: center;">May&#160;24, 2024 </div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 36pt; padding-top: 0.51pt; padding-bottom: 0.88pt; text-align: center; vertical-align: top; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td></tr><tr><td style="width: 36pt; padding-top: 0.51pt; padding-bottom: 0.88pt; text-align: left; vertical-align: top;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><a href="https://www.sec.gov/Archives/edgar/data/1130713/000113071324000037/ex32.htm">3.4</a></div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 192pt; padding-top: 0.51pt; padding-bottom: 0.88pt; text-align: center; vertical-align: top;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Fourth Amended and Restated Bylaws</div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 24pt; padding-top: 0.51pt; padding-bottom: 0.88pt; text-align: center; vertical-align: top;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; text-align: center;">8-K</div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 48pt; padding-top: 0.51pt; padding-bottom: 0.88pt; text-align: center; vertical-align: top;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; text-align: center;">001-41850</div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 36pt; padding-top: 0.51pt; padding-bottom: 0.88pt; text-align: center; vertical-align: top;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; text-align: center;">3.2</div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 60pt; padding-top: 0.51pt; padding-bottom: 0.88pt; text-align: center; vertical-align: top;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; text-align: center;">May&#160;24, 2024</div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 36pt; padding-top: 0.51pt; padding-bottom: 0.88pt; text-align: center; vertical-align: top;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td></tr><tr><td style="width: 36pt; padding-top: 0.51pt; padding-bottom: 0.88pt; text-align: left; vertical-align: top; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><a href="https://www.sec.gov/Archives/edgar/data/1130713/000091205702018495/a2078361zex-4_1.htm">4.1</a></div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 192pt; padding-top: 0.51pt; padding-bottom: 0.88pt; text-align: center; vertical-align: top; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Form&#160;of Specimen Common Stock Certificate</div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 24pt; padding-top: 0.51pt; padding-bottom: 0.88pt; text-align: center; vertical-align: top; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; text-align: center;">S-1/A</div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 48pt; padding-top: 0.51pt; padding-bottom: 0.88pt; text-align: center; vertical-align: top; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; text-align: center;">333-83728</div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 36pt; padding-top: 0.51pt; padding-bottom: 0.88pt; text-align: center; vertical-align: top; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; text-align: center;">4.1</div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 60pt; padding-top: 0.51pt; padding-bottom: 0.88pt; text-align: center; vertical-align: top; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; text-align: center;">May&#160;6, 2002</div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 36pt; padding-top: 0.51pt; padding-bottom: 0.88pt; text-align: center; vertical-align: top; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td></tr><tr><td style="width: 36pt; padding-top: 0.51pt; padding-bottom: 0.88pt; text-align: left; vertical-align: top;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">4.2*</div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 192pt; padding-top: 0.51pt; padding-bottom: 0.88pt; text-align: center; vertical-align: top;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Form&#160;of Specimen Certificate Representing Preferred Stock</div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 24pt; padding-top: 0.51pt; padding-bottom: 0.88pt; text-align: center; vertical-align: top;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 48pt; padding-top: 0.51pt; padding-bottom: 0.88pt; text-align: center; vertical-align: top;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 36pt; padding-top: 0.51pt; padding-bottom: 0.88pt; text-align: center; vertical-align: top;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 60pt; padding-top: 0.51pt; padding-bottom: 0.88pt; text-align: center; vertical-align: top;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 36pt; padding-top: 0.51pt; padding-bottom: 0.88pt; text-align: center; vertical-align: top;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td></tr><tr><td style="width: 36pt; padding-top: 0.51pt; padding-bottom: 0.88pt; text-align: left; vertical-align: top; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><a href="https://www.sec.gov/Archives/edgar/data/1130713/000114036124029414/ny20030476x1_ex4-3.htm">4.3**</a></div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 192pt; padding-top: 0.51pt; padding-bottom: 0.88pt; text-align: center; vertical-align: top; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Form&#160;of Indenture</div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 24pt; padding-top: 0.51pt; padding-bottom: 0.88pt; text-align: center; vertical-align: top; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 48pt; padding-top: 0.51pt; padding-bottom: 0.88pt; text-align: center; vertical-align: top; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 36pt; padding-top: 0.51pt; padding-bottom: 0.88pt; text-align: center; vertical-align: top; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 60pt; padding-top: 0.51pt; padding-bottom: 0.88pt; text-align: center; vertical-align: top; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 36pt; padding-top: 0.51pt; padding-bottom: 0.88pt; text-align: center; vertical-align: top; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td></tr><tr><td style="width: 36pt; padding-top: 0.51pt; padding-bottom: 0.88pt; text-align: left; vertical-align: top;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">4.4*</div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 192pt; padding-top: 0.51pt; padding-bottom: 0.88pt; text-align: center; vertical-align: top;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Form&#160;of Debt Security</div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 24pt; padding-top: 0.51pt; padding-bottom: 0.88pt; text-align: center; vertical-align: top;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 48pt; padding-top: 0.51pt; padding-bottom: 0.88pt; text-align: center; vertical-align: top;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 36pt; padding-top: 0.51pt; padding-bottom: 0.88pt; text-align: center; vertical-align: top;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 60pt; padding-top: 0.51pt; padding-bottom: 0.88pt; text-align: center; vertical-align: top;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 36pt; padding-top: 0.51pt; padding-bottom: 0.88pt; text-align: center; vertical-align: top;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td></tr><tr><td style="width: 36pt; padding-top: 0.51pt; padding-bottom: 0.88pt; text-align: left; vertical-align: top; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">4.5*</div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 192pt; padding-top: 0.51pt; padding-bottom: 0.88pt; text-align: center; vertical-align: top; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Form&#160;of Warrant</div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 24pt; padding-top: 0.51pt; padding-bottom: 0.88pt; text-align: center; vertical-align: top; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 48pt; padding-top: 0.51pt; padding-bottom: 0.88pt; text-align: center; vertical-align: top; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 36pt; padding-top: 0.51pt; padding-bottom: 0.88pt; text-align: center; vertical-align: top; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 60pt; padding-top: 0.51pt; padding-bottom: 0.88pt; text-align: center; vertical-align: top; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 36pt; padding-top: 0.51pt; padding-bottom: 0.88pt; text-align: center; vertical-align: top; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td></tr><tr><td style="width: 36pt; padding-top: 0.51pt; padding-bottom: 0.88pt; text-align: left; vertical-align: top;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">4.6*</div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 192pt; padding-top: 0.51pt; padding-bottom: 0.88pt; text-align: center; vertical-align: top;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Form&#160;of Warrant Agreement</div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 24pt; padding-top: 0.51pt; padding-bottom: 0.88pt; text-align: center; vertical-align: top;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 48pt; padding-top: 0.51pt; padding-bottom: 0.88pt; text-align: center; vertical-align: top;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 36pt; padding-top: 0.51pt; padding-bottom: 0.88pt; text-align: center; vertical-align: top;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 60pt; padding-top: 0.51pt; padding-bottom: 0.88pt; text-align: center; vertical-align: top;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 36pt; padding-top: 0.51pt; padding-bottom: 0.88pt; text-align: center; vertical-align: top;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td></tr><tr><td style="width: 36pt; padding-top: 0.51pt; padding-bottom: 0.88pt; text-align: left; vertical-align: top; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">4.7*</div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 192pt; padding-top: 0.51pt; padding-bottom: 0.88pt; text-align: center; vertical-align: top; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Form&#160;of Purchase Contract Agreement</div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 24pt; padding-top: 0.51pt; padding-bottom: 0.88pt; text-align: center; vertical-align: top; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 48pt; padding-top: 0.51pt; padding-bottom: 0.88pt; text-align: center; vertical-align: top; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 36pt; padding-top: 0.51pt; padding-bottom: 0.88pt; text-align: center; vertical-align: top; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 60pt; padding-top: 0.51pt; padding-bottom: 0.88pt; text-align: center; vertical-align: top; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 36pt; padding-top: 0.51pt; padding-bottom: 0.88pt; text-align: center; vertical-align: top; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td></tr><tr><td style="width: 36pt; padding-top: 0.51pt; padding-bottom: 0.88pt; text-align: left; vertical-align: top;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">4.8*</div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 192pt; padding-top: 0.51pt; padding-bottom: 0.88pt; text-align: center; vertical-align: top;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Form&#160;of Unit Agreement</div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 24pt; padding-top: 0.51pt; padding-bottom: 0.88pt; text-align: center; vertical-align: top;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 48pt; padding-top: 0.51pt; padding-bottom: 0.88pt; text-align: center; vertical-align: top;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 36pt; padding-top: 0.51pt; padding-bottom: 0.88pt; text-align: center; vertical-align: top;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 60pt; padding-top: 0.51pt; padding-bottom: 0.88pt; text-align: center; vertical-align: top;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 36pt; padding-top: 0.51pt; padding-bottom: 0.88pt; text-align: center; vertical-align: top;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td></tr><tr><td style="width: 36pt; padding-top: 0.51pt; padding-bottom: 0.88pt; text-align: left; vertical-align: top; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><a href="ny20042541x1_ex5-1.htm">5.1</a></div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 192pt; padding-top: 0.51pt; padding-bottom: 0.88pt; text-align: center; vertical-align: top; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Opinion of Latham &amp; Watkins LLP</div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 24pt; padding-top: 0.51pt; padding-bottom: 0.88pt; text-align: center; vertical-align: top; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 48pt; padding-top: 0.51pt; padding-bottom: 0.88pt; text-align: center; vertical-align: top; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 36pt; padding-top: 0.51pt; padding-bottom: 0.88pt; text-align: center; vertical-align: top; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 60pt; padding-top: 0.51pt; padding-bottom: 0.88pt; text-align: center; vertical-align: top; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 36pt; padding-top: 0.51pt; padding-bottom: 0.88pt; text-align: center; vertical-align: top; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; text-align: center;">X </div></td></tr><tr><td style="width: 36pt; padding-top: 0.51pt; padding-bottom: 0.88pt; text-align: left; vertical-align: top;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><a href="ny20042541x1_ex5-1.htm">23.1</a></div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 192pt; padding-top: 0.51pt; padding-bottom: 0.88pt; text-align: center; vertical-align: top;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Consent of Latham &amp; Watkins LLP (included in Exhibit&#160;5.1)</div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 24pt; padding-top: 0.51pt; padding-bottom: 0.88pt; text-align: center; vertical-align: top;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 48pt; padding-top: 0.51pt; padding-bottom: 0.88pt; text-align: center; vertical-align: top;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 36pt; padding-top: 0.51pt; padding-bottom: 0.88pt; text-align: center; vertical-align: top;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 60pt; padding-top: 0.51pt; padding-bottom: 0.88pt; text-align: center; vertical-align: top;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 36pt; padding-top: 0.51pt; padding-bottom: 0.88pt; text-align: center; vertical-align: top;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; text-align: center;">X </div></td></tr><tr><td style="width: 36pt; padding-top: 0.51pt; padding-bottom: 0.88pt; text-align: left; vertical-align: top; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><a href="ny20042541x1_ex23-2.htm">23.2</a></div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 192pt; padding-top: 0.51pt; padding-bottom: 0.88pt; text-align: center; vertical-align: top; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Consent of KPMG LLP, independent registered public accounting firm</div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 24pt; padding-top: 0.51pt; padding-bottom: 0.88pt; text-align: center; vertical-align: top; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 48pt; padding-top: 0.51pt; padding-bottom: 0.88pt; text-align: center; vertical-align: top; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 36pt; padding-top: 0.51pt; padding-bottom: 0.88pt; text-align: center; vertical-align: top; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 60pt; padding-top: 0.51pt; padding-bottom: 0.88pt; text-align: center; vertical-align: top; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 36pt; padding-top: 0.51pt; padding-bottom: 0.88pt; text-align: center; vertical-align: top; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; text-align: center;">X </div></td></tr><tr><td style="width: 36pt; padding-top: 0.51pt; padding-bottom: 0.88pt; text-align: left; vertical-align: top;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><a href="ny20042541x1_ex23-3.htm">23.3</a></div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 192pt; padding-top: 0.51pt; padding-bottom: 0.88pt; text-align: center; vertical-align: top;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Consent of KPMG LLP with respect to specified financial statements of Medici Ventures, L.P.</div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 24pt; padding-top: 0.51pt; padding-bottom: 0.88pt; text-align: center; vertical-align: top;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 48pt; padding-top: 0.51pt; padding-bottom: 0.88pt; text-align: center; vertical-align: top;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 36pt; padding-top: 0.51pt; padding-bottom: 0.88pt; text-align: center; vertical-align: top;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 60pt; padding-top: 0.51pt; padding-bottom: 0.88pt; text-align: center; vertical-align: top;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 36pt; padding-top: 0.51pt; padding-bottom: 0.88pt; text-align: center; vertical-align: top;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; text-align: center;">X </div></td></tr><tr><td style="width: 36pt; padding-top: 0.51pt; padding-bottom: 0.88pt; text-align: left; vertical-align: top; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><a href="ny20042541x1_ex23-4.htm">23.4</a></div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 192pt; padding-top: 0.51pt; padding-bottom: 0.88pt; text-align: center; vertical-align: top; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Consent of Ernst &amp; Young LLP with respect to specified financial statements of Medici Ventures, L.P.</div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 24pt; padding-top: 0.51pt; padding-bottom: 0.88pt; text-align: center; vertical-align: top; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 48pt; padding-top: 0.51pt; padding-bottom: 0.88pt; text-align: center; vertical-align: top; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 36pt; padding-top: 0.51pt; padding-bottom: 0.88pt; text-align: center; vertical-align: top; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 60pt; padding-top: 0.51pt; padding-bottom: 0.88pt; text-align: center; vertical-align: top; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 36pt; padding-top: 0.51pt; padding-bottom: 0.88pt; text-align: center; vertical-align: top; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; text-align: center;">X </div></td></tr><tr><td style="width: 36pt; padding-top: 0.51pt; padding-bottom: 0.88pt; text-align: left; vertical-align: top;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><a href="ny20042541x1_ex23-5.htm">23.5</a></div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 192pt; padding-top: 0.51pt; padding-bottom: 0.88pt; text-align: center; vertical-align: top;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Consent of Ernst &amp; Young LLP with respect to specified financial statements of Medici Ventures, L.P.</div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 24pt; padding-top: 0.51pt; padding-bottom: 0.88pt; text-align: center; vertical-align: top;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 48pt; padding-top: 0.51pt; padding-bottom: 0.88pt; text-align: center; vertical-align: top;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 36pt; padding-top: 0.51pt; padding-bottom: 0.88pt; text-align: center; vertical-align: top;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 60pt; padding-top: 0.51pt; padding-bottom: 0.88pt; text-align: center; vertical-align: top;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 36pt; padding-top: 0.51pt; padding-bottom: 0.88pt; text-align: center; vertical-align: top;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; text-align: center;">X </div></td></tr><tr><td style="width: 36pt; padding-top: 0.51pt; padding-bottom: 0.88pt; text-align: left; vertical-align: top; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><a href="ny20042541x1_ex23-6.htm">23.6</a></div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 192pt; padding-top: 0.51pt; padding-bottom: 0.88pt; text-align: center; vertical-align: top; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Consent of Baker Tilly US, LLP with respect to specified financial statements of tZERO Group Inc. </div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 24pt; padding-top: 0.51pt; padding-bottom: 0.88pt; text-align: center; vertical-align: top; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 48pt; padding-top: 0.51pt; padding-bottom: 0.88pt; text-align: center; vertical-align: top; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 36pt; padding-top: 0.51pt; padding-bottom: 0.88pt; text-align: center; vertical-align: top; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 60pt; padding-top: 0.51pt; padding-bottom: 0.88pt; text-align: center; vertical-align: top; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 36pt; padding-top: 0.51pt; padding-bottom: 0.88pt; text-align: center; vertical-align: top; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; text-align: center;">X </div></td></tr><tr><td style="width: 36pt; padding-top: 0.51pt; padding-bottom: 0.88pt; text-align: left; vertical-align: top;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><a href="https://www.sec.gov/Archives/edgar/data/1130713/000114036124029414/ny20030476x1_s3asr.htm#tPT">24.1**</a></div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 192pt; padding-top: 0.51pt; padding-bottom: 0.88pt; text-align: center; vertical-align: top;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Powers of Attorney</div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 24pt; padding-top: 0.51pt; padding-bottom: 0.88pt; text-align: center; vertical-align: top;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 48pt; padding-top: 0.51pt; padding-bottom: 0.88pt; text-align: center; vertical-align: top;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 36pt; padding-top: 0.51pt; padding-bottom: 0.88pt; text-align: center; vertical-align: top;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 60pt; padding-top: 0.51pt; padding-bottom: 0.88pt; text-align: center; vertical-align: top;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 36pt; padding-top: 0.51pt; padding-bottom: 0.88pt; text-align: center; vertical-align: top;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td></tr><tr><td style="width: 36pt; padding-top: 0.51pt; padding-bottom: 0.88pt; text-align: left; vertical-align: top; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">25.1*</div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 192pt; padding-top: 0.51pt; padding-bottom: 0.88pt; text-align: center; vertical-align: top; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Statement of Eligibility of Trustee on Form&#160;T-1 under the Trust Indenture Act of 1939, as amended</div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 24pt; padding-top: 0.51pt; padding-bottom: 0.88pt; text-align: center; vertical-align: top; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 48pt; padding-top: 0.51pt; padding-bottom: 0.88pt; text-align: center; vertical-align: top; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 36pt; padding-top: 0.51pt; padding-bottom: 0.88pt; text-align: center; vertical-align: top; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 60pt; padding-top: 0.51pt; padding-bottom: 0.88pt; text-align: center; vertical-align: top; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 36pt; padding-top: 0.51pt; padding-bottom: 0.88pt; text-align: center; vertical-align: top; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td></tr><tr><td style="width: 36pt; padding-top: 0.51pt; text-align: left; vertical-align: top;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><a href="ny20042541x1_exfees.htm">107.1</a></div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 192pt; padding-top: 0.51pt; text-align: center; vertical-align: top;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Filing Fee Table</div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 24pt; padding-top: 0.51pt; text-align: center; vertical-align: top;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 48pt; padding-top: 0.51pt; text-align: center; vertical-align: top;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 36pt; padding-top: 0.51pt; text-align: center; vertical-align: top;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 60pt; padding-top: 0.51pt; text-align: center; vertical-align: top;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 36pt; padding-top: 0.51pt; text-align: center; vertical-align: top;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; text-align: center;">X</div></td></tr><tr class="BRDSX_boxspacer"><td style="height: 2.75pt; width: 36pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 192pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 24pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 48pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 36pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 60pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 36pt;"><div style="font-size: 1pt;">&#8194;</div></td></tr></table><div><div class="BRDSX_rule-partial" style="height: 0pt; width: 72pt; border-bottom: 1pt solid #000000; margin-bottom: 1pt; margin-right: auto; margin-left: 0pt; margin-top: 13.25pt;"> </div></div><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 3pt; margin-left: 0pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt;">*<br></div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; text-align: left;">To be filed by amendment or incorporated by reference in connection with the offering of the securities. </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 3pt; margin-left: 0pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt;">**<br></div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; text-align: left;">Previously filed. </div></td></tr></table></div></div><div class="BRDSX_block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"><div class="BRDSX_unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">II-5<br></div></div></div>
<!--End Page 59-->
<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div class="BRPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 60-->
<div class="BRDSX_page" style="text-align: left; margin: auto; line-height: initial; width: 468pt;"><a name="ny20042541x1_posasr_301-part2_pg6"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="BRDSX_page-content"><div class="BRDSX_block-main" style="width: 468pt; margin-left: 0pt;"><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6.75pt; margin-left: 0pt;"><tr><td style="width: 50pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold;">Item 17.<br></div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; text-align: left;"><font style="font-style: italic;">Undertakings</font><font style="font-weight: normal;"> </font></div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">(a)<br></div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">The undersigned registrant hereby undertakes: </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 40pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">(1)<br></div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">To file, during any period in which offers or sales are being made, a post-effective amendment to this registration statement: </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 60pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">(i)<br></div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">To include any prospectus required by Section 10(a)(3) of the Securities Act of 1933; </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 60pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">(ii)<br></div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">To reflect in the prospectus any facts or events arising after the effective date of the registration statement (or the most recent post-effective amendment thereof) which, individually or in the aggregate, represent a fundamental change in the information set forth in the registration statement. Notwithstanding the foregoing, any increase or decrease in volume of securities offered (if the total dollar value of securities offered would not exceed that which was registered) and any deviation from the low or high end of the estimated maximum offering range may be reflected in the form of prospectus filed with the Commission pursuant to Rule&#160;424(b) if, in the aggregate, the changes in volume and price represent no more than 20 percent change in the maximum aggregate offering price set forth in the &#8220;Calculation of Registration Fee&#8221; table in the effective registration statement; and </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 60pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">(iii)<br></div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">To include any material information with respect to the plan of distribution not previously disclosed in the registration statement or any material change to such information in the registration statement; </div></td></tr></table><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; margin-top: 6pt; margin-left: 40pt; text-align: justify;">provided, however<font style="font-style: normal;">, that paragraphs (a)(1)(i), (a)(1)(ii), and (a)(1)(iii) above do not apply if the information required to be included in a post-effective amendment by those paragraphs is contained in reports filed with or furnished to the Commission by the registrant pursuant to section 13 or section 15(d) of the Securities Exchange Act of 1934 that are incorporated by reference in the registration statement, or is contained in a form of prospectus filed pursuant to Rule 424(b) that is a part of the registration statement. </font></div><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 40pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">(2)<br></div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">That, for the purpose of determining any liability under the Securities Act of 1933, each such post-effective amendment shall be deemed to be a new registration statement relating to the securities offered therein, and the offering of such securities at that time shall be deemed to be the initial bona fide offering thereof. </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 40pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">(3)<br></div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">To remove from registration by means of a post-effective amendment any of the securities being registered which remain unsold at the termination of the offering. </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 40pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">(5)<br></div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">That, for the purpose of determining liability under the Securities Act of 1933 to any purchaser: </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 60pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">(A)<br></div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">Each prospectus filed by the registrant pursuant to Rule 424(b)(3) shall be deemed to be part of the registration statement as of the date the filed prospectus was deemed part of and included in the registration statement; and </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 60pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">(B)<br></div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">Each prospectus required to be filed pursuant to Rule 424(b)(2), (b)(5), or (b)(7) as part of a registration statement in reliance on Rule 430B relating to an offering made pursuant to Rule&#160;415(a)(1)(i), (vii), or (x) for the purpose of providing the information required by section&#160;10(a) of the Securities Act of 1933 shall be deemed to be part of and included in the registration statement as of the earlier of the date such form of prospectus is first used after effectiveness or the date of the first contract of sale of securities in the offering described in the prospectus. As provided in Rule 430B, for liability purposes of the issuer and any person that is at that date an underwriter, such date shall be deemed to be a new effective date of the registration statement relating to the securities in the registration statement to which that prospectus relates, and the offering of such securities at that time shall be deemed to be the initial bona fide offering thereof. <font style="font-style: italic;">Provided</font>, <font style="font-style: italic;">however</font>, that no statement made in a registration statement or prospectus that is part of the registration statement or made in a document incorporated or deemed incorporated by reference into the registration statement or prospectus that is part of the registration statement will, as to a purchaser with a time of contract of sale prior to such effective date, supersede or modify any statement that was made in the registration statement or prospectus that was part of the registration statement or made in any such document immediately prior to such effective date. </div></td></tr></table></div></div><div class="BRDSX_block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"><div class="BRDSX_unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">II-6<br></div></div></div>
<!--End Page 60-->
<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div class="BRPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 61-->
<div class="BRDSX_page" style="text-align: left; margin: auto; line-height: initial; width: 468pt;"><a name="ny20042541x1_posasr_301-part2_pg7"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="BRDSX_page-content"><div class="BRDSX_block-main" style="width: 468pt; margin-left: 0pt;"><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6.75pt; margin-left: 40pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">(6)<br></div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">That, for the purpose of determining liability of the registrant under the Securities Act of 1933 to any purchaser in the initial distribution of the securities: </div></td></tr></table><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 60pt; text-align: justify;">The undersigned registrant undertakes that in a primary offering of securities of the undersigned registrant pursuant to this registration statement, regardless of the underwriting method used to sell the securities to the purchaser, if the securities are offered or sold to such purchaser by means of any of the following communications, the undersigned registrant will be a seller to the purchaser and will be considered to offer or sell such securities to such purchaser: </div><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 80pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">(i)<br></div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">Any preliminary prospectus or prospectus of the undersigned registrant relating to the offering required to be filed pursuant to Rule 424; </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 80pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">(ii)<br></div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">Any free writing prospectus relating to the offering prepared by or on behalf of the undersigned registrant or used or referred to by the undersigned registrant; </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 80pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">(iii)<br></div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">The portion of any other free writing prospectus relating to the offering containing material information about the undersigned registrant or its securities provided by or on behalf of the undersigned registrant; and </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 80pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">(iv)<br></div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">Any other communications that is an offer in the offering made by the undersigned registrant to the purchaser. </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">(b)<br></div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">The undersigned registrant hereby undertakes that, for purposes of determining any liability under the Securities Act of 1933, each filing of the registrant&#8217;s annual report pursuant to Section 13(a) or Section&#160;15(d) of the Securities Exchange Act of 1934 (and, where applicable, each filing of an employee benefit plan&#8217;s annual report pursuant to section 15(d) of the Securities Exchange Act of 1934) that is incorporated by reference in the registration statement shall be deemed to be a new registration statement relating to the securities offered therein, and the offering of such securities at that time shall be deemed to be the initial <font style="font-style: italic;">bona fide</font> offering thereof. </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">(h)<br></div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">Insofar as indemnification for liabilities arising under the Securities Act of 1933 may be permitted to directors, officers and controlling persons of the registrant pursuant to the foregoing provisions, or otherwise, the registrant has been advised that in the opinion of the Securities and Exchange Commission such indemnification is against public policy as expressed in the Securities Act and is, therefore, unenforceable. In the event that a claim for indemnification against such liabilities (other than the payment by the registrant of expenses incurred or paid by a director, officer or controlling person of the registrant in the successful defense of any action, suit or proceeding) is asserted by such director, officer or controlling person in connection with the securities being registered, the registrant will, unless in the opinion of its counsel the matter has been settled by controlling precedent, submit to a court of appropriate jurisdiction the question whether such indemnification by it is against public policy as expressed in the Securities Act and will be governed by the final adjudication of such issue. </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">(j)<br></div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">The undersigned registrant hereby undertakes to file an application for the purpose of determining the eligibility of the trustee to act under subsection (a) of Section 310 of the Trust Indenture Act (the &#8220;Act&#8221;) in accordance with the rules and regulations prescribed by the SEC under section 305(b)(2) of the Act. </div></td></tr></table></div></div><div class="BRDSX_block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"><div class="BRDSX_unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">II-7<br></div></div></div>
<!--End Page 61-->
<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div class="BRPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 62-->
<div class="BRDSX_page" style="text-align: left; margin: auto; line-height: initial; width: 468pt;"><a name="ny20042541x1_posasr_302-sig_pg1"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="BRDSX_page-content"><div class="BRDSX_block-main" style="width: 468pt; margin-left: 0pt;"><div class="BRDSX_h1" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 6.75pt; text-align: center;">SIGNATURES </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Pursuant to the requirements of the Securities Act of 1933, as amended, the registrant certifies that it has reasonable grounds to believe that it meets all of the requirements for filing on Form S-3 and has duly caused this registration statement to be signed on its behalf by the undersigned, thereunto duly authorized, in the City of Murray, Utah, on February&#160;25, 2025. </div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 8pt; margin-left: 0pt; text-align: left;"> </div><table cellspacing="0" cellpadding="0" class="BRDSX_txttab" style="width: 468pt; margin-left: auto; margin-right: auto;"><tr class="BRDSX_boxspacer"><td style="height: 6pt; width: 216pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 240pt;" colspan="7"><div style="font-size: 1pt;">&#8194;</div></td></tr><tr><td style="width: 216pt; padding-bottom: 1.38pt; text-align: left; vertical-align: top;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td colspan="7" style="width: 240pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 0pt; margin-left: 0pt; text-align: left;">BEYOND, INC.<font style="font-weight: normal;"> </font></div></td></tr><tr><td style="width: 216pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: top;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 12pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 120pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 84pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td></tr><tr><td style="width: 216pt; padding-top: 1.01pt; padding-bottom: 2.13pt; text-align: left; vertical-align: top;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 12pt; padding-top: 1.01pt; padding-bottom: 2.13pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">By:</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td colspan="4" style="width: 216pt; padding-top: 1.01pt; padding-bottom: 2.13pt; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">/s/ David J. Nielsen </div></td></tr><tr><td style="width: 216pt; padding-top: 1.76pt; padding-bottom: 1.38pt; text-align: left; vertical-align: top;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 12pt; padding-top: 1.76pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 120pt; padding-top: 1.76pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">David J. Nielsen </div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 84pt; padding-top: 1.76pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td></tr><tr><td style="width: 216pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: top;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 12pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 120pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">President </div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 84pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td></tr><tr><td style="width: 216pt; padding-top: 1.01pt; text-align: left; vertical-align: top;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 12pt; padding-top: 1.01pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 120pt; padding-top: 1.01pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">(Principal Executive Officer)</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 84pt; padding-top: 1.01pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td></tr><tr class="BRDSX_boxspacer"><td style="height: 2.75pt; width: 216pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 12pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 120pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 84pt;"><div style="font-size: 1pt;">&#8194;</div></td></tr></table><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Pursuant to the requirements of the Securities Act of 1933, as amended, this registration statement has been signed below by the following persons on behalf of the registrant in the capacities and on the dates indicated. </div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 8pt; margin-left: 0pt; text-align: left;"> </div><table cellspacing="0" cellpadding="0" class="BRDSX_txttab" style="width: 468pt; margin-left: auto; margin-right: auto;"><tr class="BRDSX_boxspacer"><td style="height: 6pt; width: 120pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 228pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 96pt;"><div style="font-size: 1pt;">&#8194;</div></td></tr><tr class="BRDSX_header"><td style="width: 120pt; padding-bottom: 2.38pt; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Signature</div></td><td style="width: 6pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 228pt; padding-bottom: 2.38pt; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Title</div></td><td style="width: 6pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 96pt; padding-bottom: 2.38pt; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Date </div></td></tr><tr><td style="width: 120pt; padding-top: 2.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: top;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 228pt; padding-top: 2.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 96pt; padding-top: 2.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td></tr><tr><td style="width: 120pt; height: 14pt; padding-top: 1.01pt; padding-bottom: 2.13pt; text-align: left; vertical-align: top; border-bottom: 1pt solid #000000;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; text-align: center;">/s/ David J. Nielsen</div></td><td style="width: 6pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6pt;" rowspan="2"><div style="font-size: 1pt;">&#8194;</div></td><td rowspan="2" style="width: 228pt; height: 14pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: top;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; text-align: center;">President<br></div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; text-align: center;">(Principal Executive Officer)</div></td><td style="width: 6pt;" rowspan="2"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6pt;" rowspan="2"><div style="font-size: 1pt;">&#8194;</div></td><td rowspan="2" style="width: 96pt; height: 14pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: top;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; text-align: center;">February&#160;25, 2025 </div></td></tr><tr><td style="width: 120pt; padding-top: 1.76pt; padding-bottom: 1.38pt; text-align: left; vertical-align: top;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; text-align: center;">David J. Nielsen </div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td></tr><tr><td style="width: 120pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: top;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 228pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: top;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 96pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: top;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td></tr><tr><td style="width: 120pt; height: 14pt; padding-top: 1.01pt; padding-bottom: 2.13pt; text-align: left; vertical-align: top; border-bottom: 1pt solid #000000;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; text-align: center;">*</div></td><td style="width: 6pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6pt;" rowspan="2"><div style="font-size: 1pt;">&#8194;</div></td><td rowspan="2" style="width: 228pt; height: 14pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: top;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; text-align: center;">Executive Chairman of the Board of Directors</div></td><td style="width: 6pt;" rowspan="2"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6pt;" rowspan="2"><div style="font-size: 1pt;">&#8194;</div></td><td rowspan="2" style="width: 96pt; height: 14pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: top;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; text-align: center;">February&#160;25, 2025 </div></td></tr><tr><td style="width: 120pt; padding-top: 1.76pt; padding-bottom: 1.38pt; text-align: left; vertical-align: top;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; text-align: center;">Marcus A. Lemonis </div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td></tr><tr><td style="width: 120pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: top;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 228pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: top;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 96pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: top;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td></tr><tr><td style="width: 120pt; height: 14pt; padding-top: 1.01pt; padding-bottom: 2.13pt; text-align: left; vertical-align: top; border-bottom: 1pt solid #000000;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; text-align: center;">/s/ Adrianne B. Lee</div></td><td style="width: 6pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6pt;" rowspan="2"><div style="font-size: 1pt;">&#8194;</div></td><td rowspan="2" style="width: 228pt; height: 14pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: top;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; text-align: center;">Chief Financial &amp; Administrative Officer <br></div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; text-align: center;">(Principal Financial Officer and Principal Accounting <br></div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; text-align: center;">Officer)</div></td><td style="width: 6pt;" rowspan="2"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6pt;" rowspan="2"><div style="font-size: 1pt;">&#8194;</div></td><td rowspan="2" style="width: 96pt; height: 14pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: top;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; text-align: center;">February&#160;25, 2025 </div></td></tr><tr><td style="width: 120pt; padding-top: 1.76pt; padding-bottom: 1.38pt; text-align: left; vertical-align: top;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; text-align: center;">Adrianne B. Lee </div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td></tr><tr><td style="width: 120pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: top;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 228pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: top;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 96pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: top;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td></tr><tr><td style="width: 120pt; height: 14pt; padding-top: 1.01pt; padding-bottom: 2.13pt; text-align: left; vertical-align: top; border-bottom: 1pt solid #000000;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; text-align: center;">*</div></td><td style="width: 6pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6pt;" rowspan="2"><div style="font-size: 1pt;">&#8194;</div></td><td rowspan="2" style="width: 228pt; height: 14pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: top;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; text-align: center;">Director</div></td><td style="width: 6pt;" rowspan="2"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6pt;" rowspan="2"><div style="font-size: 1pt;">&#8194;</div></td><td rowspan="2" style="width: 96pt; height: 14pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: top;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; text-align: center;">February&#160;25, 2025 </div></td></tr><tr><td style="width: 120pt; padding-top: 1.76pt; padding-bottom: 1.38pt; text-align: left; vertical-align: top;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; text-align: center;">Joanna C. Burkey </div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td></tr><tr><td style="width: 120pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: top;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 228pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: top;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 96pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: top;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td></tr><tr><td style="width: 120pt; height: 14pt; padding-top: 1.01pt; padding-bottom: 2.13pt; text-align: left; vertical-align: top; border-bottom: 1pt solid #000000;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; text-align: center;">*</div></td><td style="width: 6pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6pt;" rowspan="2"><div style="font-size: 1pt;">&#8194;</div></td><td rowspan="2" style="width: 228pt; height: 14pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: top;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; text-align: center;">Director</div></td><td style="width: 6pt;" rowspan="2"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6pt;" rowspan="2"><div style="font-size: 1pt;">&#8194;</div></td><td rowspan="2" style="width: 96pt; height: 14pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: top;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; text-align: center;">February&#160;25, 2025 </div></td></tr><tr><td style="width: 120pt; padding-top: 1.76pt; padding-bottom: 1.38pt; text-align: left; vertical-align: top;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; text-align: center;">Barclay F. Corbus </div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td></tr><tr><td style="width: 120pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: top;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 228pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: top;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 96pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: top;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td></tr><tr><td style="width: 120pt; height: 14pt; padding-top: 1.01pt; padding-bottom: 2.13pt; text-align: left; vertical-align: top; border-bottom: 1pt solid #000000;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; text-align: center;">*</div></td><td style="width: 6pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6pt;" rowspan="2"><div style="font-size: 1pt;">&#8194;</div></td><td rowspan="2" style="width: 228pt; height: 14pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: top;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; text-align: center;">Director</div></td><td style="width: 6pt;" rowspan="2"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6pt;" rowspan="2"><div style="font-size: 1pt;">&#8194;</div></td><td rowspan="2" style="width: 96pt; height: 14pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: top;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; text-align: center;">February&#160;25, 2025 </div></td></tr><tr><td style="width: 120pt; padding-top: 1.76pt; padding-bottom: 1.38pt; text-align: left; vertical-align: top;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; text-align: center;">Joseph J. Tabacco, Jr. </div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td></tr><tr><td style="width: 120pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: top;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 228pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: top;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 96pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: top;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td></tr><tr><td style="width: 120pt; height: 14pt; padding-top: 1.01pt; padding-bottom: 2.13pt; text-align: left; vertical-align: top; border-bottom: 1pt solid #000000;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; text-align: center;">*</div></td><td style="width: 6pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6pt;" rowspan="2"><div style="font-size: 1pt;">&#8194;</div></td><td rowspan="2" style="width: 228pt; height: 14pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: top;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; text-align: center;">Director</div></td><td style="width: 6pt;" rowspan="2"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6pt;" rowspan="2"><div style="font-size: 1pt;">&#8194;</div></td><td rowspan="2" style="width: 96pt; height: 14pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: top;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; text-align: center;">February&#160;25, 2025 </div></td></tr><tr><td style="width: 120pt; padding-top: 1.76pt; padding-bottom: 1.38pt; text-align: left; vertical-align: top;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; text-align: center;">Robert J. Shapiro </div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td></tr><tr><td style="width: 120pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: top;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 228pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: top;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 96pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: top;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td></tr><tr><td style="width: 120pt; height: 14pt; padding-top: 1.01pt; padding-bottom: 2.13pt; text-align: left; vertical-align: top; border-bottom: 1pt solid #000000;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; text-align: center;">*</div></td><td style="width: 6pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6pt;" rowspan="2"><div style="font-size: 1pt;">&#8194;</div></td><td rowspan="2" style="width: 228pt; height: 14pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: top;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; text-align: center;">Director</div></td><td style="width: 6pt;" rowspan="2"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6pt;" rowspan="2"><div style="font-size: 1pt;">&#8194;</div></td><td rowspan="2" style="width: 96pt; height: 14pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: top;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; text-align: center;">February&#160;25, 2025</div></td></tr><tr><td style="width: 120pt; padding-top: 1.76pt; padding-bottom: 1.38pt; text-align: left; vertical-align: top;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; text-align: center;">William B. Nettles, Jr.</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td></tr><tr><td style="width: 120pt; padding-top: 1.01pt; text-align: left; vertical-align: top;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 228pt; padding-top: 1.01pt; text-align: left; vertical-align: top;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 96pt; padding-top: 1.01pt; text-align: left; vertical-align: top;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td></tr><tr class="BRDSX_boxspacer"><td style="height: 6pt; width: 120pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 228pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 96pt;"><div style="font-size: 1pt;">&#8194;</div></td></tr></table><table cellspacing="0" cellpadding="0" class="BRDSX_txttab" style="margin-top: 4pt; width: 473pt; margin-left: auto; margin-right: auto;"><tr class="BRDSX_boxspacer"><td style="height: 6pt; width: 24pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 24pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 149pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 132pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 96pt;"><div style="font-size: 1pt;">&#8194;</div></td></tr><tr><td style="width: 24pt; padding-bottom: 2.13pt; text-align: left; vertical-align: top;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 24pt; padding-bottom: 2.13pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">*By:</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 149pt; padding-bottom: 2.13pt; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">/s/ David J. Nielsen</div></td><td style="width: 6pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 132pt; padding-bottom: 2.13pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 96pt; padding-bottom: 2.13pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">February&#160;25, 2025 </div></td></tr><tr><td style="width: 24pt; padding-top: 1.76pt; padding-bottom: 1.38pt; text-align: left; vertical-align: top;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 24pt; padding-top: 1.76pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 149pt; padding-top: 1.76pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">David J. Nielsen</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 132pt; padding-top: 1.76pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 96pt; padding-top: 1.76pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td></tr><tr><td style="width: 24pt; padding-top: 1.01pt; text-align: left; vertical-align: top;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 24pt; padding-top: 1.01pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 149pt; padding-top: 1.01pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; margin-top: 0pt; margin-left: 0pt; text-align: left;">Attorney-in-Fact</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 132pt; padding-top: 1.01pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 96pt; padding-top: 1.01pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td></tr><tr class="BRDSX_boxspacer"><td style="height: 2.75pt; width: 24pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 24pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 149pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 132pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 96pt;"><div style="font-size: 1pt;">&#8194;</div></td></tr></table></div></div><div class="BRDSX_block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"><div class="BRDSX_unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">II-8<br></div></div></div>
<!--End Page 62-->
</body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-5.1
<SEQUENCE>2
<FILENAME>ny20042541x1_ex5-1.htm
<DESCRIPTION>EXHIBIT 5.1
<TEXT>
<html>
  <head>
    <title></title>
    <!-- Licensed to: Broadridge Financial Solutions, Inc.
         Document created using Broadridge PROfile 25.1.1.5279
         Copyright 1995 - 2025 Broadridge -->
  </head>
<body style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: #000000;" bgcolor="#ffffff">
  <div>
    <hr style="height: 4px; color: #000000; background-color: #000000; text-align: center; margin-left: auto; margin-right: auto; border: none;" align="center" noshade="noshade">
    <div>
      <div style="text-align: right; font-size: 12pt;"><font style="font-weight: bold; font-size: 10pt;"> Exhibit 5.1</font><font style="font-size: 10pt;"><br>
        </font></div>
      <div> <br>
      </div>
      <div style="font-size: 12pt;">
        <table id="z332165df42df442d851d78243c70eb83" style="font-family: 'Times New Roman'; font-size: 10pt; color: #000000; width: 100%;" border="0" cellpadding="0" cellspacing="0">

            <tr>
              <td style="width: 60%; text-align: left; vertical-align: middle;" rowspan="1">&#160;</td>
              <td rowspan="1" colspan="2">
                <div style="text-align: left;">1271 Avenue of the Americas</div>
                <div style="text-align: left;">New York, New York&#160; 10020-1401</div>
                <div style="text-align: left;">Tel: +1.212.906.1200&#160; Fax: +1.212.751.4864</div>
                <div style="text-align: left;">www.lw.com</div>
              </td>
            </tr>
            <tr>
              <td style="width: 60%; text-align: left; vertical-align: middle;" rowspan="1">&#160;</td>
              <td rowspan="1" colspan="2">&#160;</td>
            </tr>
            <tr>
              <td style="width: 60%; text-align: left; vertical-align: middle;" rowspan="1">&#160;</td>
              <td rowspan="1" colspan="2">
                <div style="text-align: left;">FIRM / AFFILIATE OFFICES</div>
              </td>
            </tr>
            <tr>
              <td style="width: 60%; text-align: left; vertical-align: top;">
                <div style="font-size: 12pt;">
                  <div><font style="font-size: 10pt;"><img src="ny20042541x1_ex5-1logo02.jpg" height="15" width="226"></font>
                    <div style="font-size: 10pt;"><br>
                    </div>
                    <div>
                      <div style="font-size: 10pt;">February 25, 2025</div>
                      <div style="font-size: 10pt;"><br>
                      </div>
                      <div style="font-size: 10pt;">Beyond, Inc.</div>
                      <div style="font-size: 10pt;">433 W. Ascension Way, 3<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">rd</sup> Floor</div>
                      <div style="font-size: 10pt;">Murray, Utah&#160; 84123</div>
                    </div>
                  </div>
                </div>
              </td>
              <td style="width: 12%;">
                <div style="text-align: left;">Austin<br>
                </div>
                <div style="text-align: left;">Beijing<br>
                </div>
                <div style="text-align: left;">Boston<br>
                </div>
                <div style="text-align: left;">Brussels<br>
                </div>
                <div style="text-align: left;">Century City</div>
                <div style="text-align: left;">Chicago</div>
                <div style="text-align: left;">Dubai</div>
                <div style="text-align: left;">D&#252;sseldorf</div>
                <div style="text-align: left;">Frankfurt</div>
                <div style="text-align: left;">Hamburg</div>
                <div style="text-align: left;">Hong Kong</div>
                <div style="text-align: left;">Houston</div>
                <div style="text-align: left;">London</div>
                <div style="text-align: left;">Los Angeles</div>
                <div style="text-align: left;">Madrid</div>
              </td>
              <td style="width: 28%; text-align: left; vertical-align: top;">
                <div>Milan</div>
                <div>Munich</div>
                <div>New York</div>
                <div>Orange County</div>
                <div>Paris</div>
                <div>Riyadh</div>
                <div>San Diego</div>
                <div>San Francisco</div>
                <div>Seoul</div>
                <div>Silicon Valley</div>
                <div>Singapore</div>
                <div>Tel Aviv</div>
                <div>Tokyo</div>
                <div>Washington, D.C.</div>
              </td>
            </tr>

        </table>
      </div>
      <div> <br>
      </div>
      <div>
        <table style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%;" id="z8fd1d6696b774e2a9cc5ae472ed06894" class="DSPFListTable" cellpadding="0" cellspacing="0">

            <tr style="vertical-align: top;">
              <td style="text-align: right; vertical-align: top; width: 36pt;">
                <div style="text-align: left;">Re:</div>
              </td>
              <td style="text-align: left; vertical-align: top; width: auto;">
                <div><u>Registration Statement on Form S-3</u></div>
              </td>
            </tr>

        </table>
      </div>
      <div>&#160;</div>
      <div>To the addressee set forth above:</div>
      <div>&#160;</div>
      <div style="text-indent: 36pt;">We have acted as special counsel to Beyond, Inc., a Delaware corporation (the &#8220;<font style="font-weight: bold; font-style: italic;">Company</font>&#8221;), in connection with its filing on the date hereof with the Securities
        and Exchange Commission (the &#8220;<font style="font-weight: bold; font-style: italic;">Commission</font>&#8221;) of a registration statement on Form S-3 (as amended, the &#8220;<font style="font-weight: bold; font-style: italic;">Registration Statement</font>&#8221;),
        including a base prospectus (the &#8220;<font style="font-weight: bold; font-style: italic;">Base Prospectus</font>&#8221;), which provides that it will be supplemented by one or more prospectus supplements (each such prospectus supplement, together with the
        Base Prospectus, a &#8220;<font style="font-weight: bold; font-style: italic;">Prospectus</font>&#8221;), under the Securities Act of 1933, as amended (the &#8220;<font style="font-weight: bold; font-style: italic;">Act</font>&#8221;), relating to the registration for
        issue and sale by the Company of up to $<font style="color: rgb(0, 0, 0);">156,128,866 </font>aggregate offering amount of (i) shares of the Company&#8217;s common stock, $0.0001 par value per share (&#8220;<font style="font-weight: bold; font-style: italic;">Common

          Stock</font>&#8221;), (ii) shares of one or more series of the Company&#8217;s preferred stock, $0.0001 par value per share (&#8220;<font style="font-weight: bold; font-style: italic;">Preferred Stock</font>&#8221;), (iii) one or more series of the Company&#8217;s debt
        securities (collectively, &#8220;<font style="font-weight: bold; font-style: italic;">Debt Securities</font>&#8221;) to be issued under an indenture to be entered into between the Company, as issuer, and a trustee (a form of which is included as Exhibit 4.3 to
        the Registration Statement) and one or more board resolutions, supplements thereto or officer&#8217;s certificates thereunder (such indenture, together with the applicable board resolution, supplement or officer&#8217;s certificate pertaining to the applicable
        series of Debt Securities, the &#8220;<font style="font-weight: bold; font-style: italic;">Applicable Indenture</font>&#8221;), (iv) warrants (&#8220;<font style="font-weight: bold; font-style: italic;">Warrants</font>&#8221;), (v) purchase contracts (&#8220;<font style="font-weight: bold; font-style: italic;">Purchase Contracts</font>&#8221;), and (vi) units (&#8220;<font style="font-weight: bold; font-style: italic;">Units</font>&#8221;). The Common Stock, Preferred Stock, Debt Securities, Warrants, Purchase Contracts and
        Units, plus any additional Common Stock, Preferred Stock, Debt Securities, Warrants, Purchase Contracts and Units that may be registered pursuant to any subsequent registration statement that the Company may hereafter file with the Commission
        pursuant to Rule 462(b) under the Act in connection with the offering by the Company contemplated by the Registration Statement are referred to herein collectively as the &#8220;<font style="font-weight: bold; font-style: italic;">Securities</font>.&#8221;</div>
      <div>&#160;</div>
      <div style="text-indent: 36pt;">We have also acted as special counsel to the Company in connection with the sale by the Company from time to time through JonesTrading Institutional Services LLC, as the sales agent or principal (the &#8220;<font style="font-weight: bold; font-style: italic;">Sales Agent</font>&#8221;), of shares of Common Stock (the &#8220;<font style="font-weight: bold; font-style: italic;">Sales Agreement Shares</font>&#8221;) having an aggregate offering price of up to $<font style="color: rgb(0, 0, 0);">156,128,866</font> pursuant to the Registration Statement, the Base Prospectus and the related prospectus supplement for the sale of the Sales Agreement Shares included in the Registration Statement (the Base
        Prospectus and such prospectus supplement, together, the &#8220;<font style="font-weight: bold; font-style: italic;">Sales Agreement Prospectus</font>&#8221;), and that certain Capital on Demand<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">TM</sup> Sales Agreement, dated June 10, 2024, by and between the Company and the Sales Agent (the &#8220;<font style="font-weight: bold; font-style: italic;">Sales Agreement</font>&#8221;).</div>
      <div>&#160;</div>
      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
        <div style="page-break-after: always;" class="BRPFPageBreak">
          <hr style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;" noshade="noshade"></div>
        <div class="BRPFPageHeader" style="width: 100%;">
          <table style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;" cellpadding="0" cellspacing="0">

              <tr>
                <td style="width: 100%; vertical-align: top;">
                  <div style="font-weight: bold;">February 25, 2025</div>
                  <div style="font-weight: bold;">Page <font class="BRPFPageNumber">2</font></div>
                </td>
              </tr>
              <tr>
                <td style="width: 100%; vertical-align: top;" rowspan="1">&#160;</td>
              </tr>
              <tr>
                <td style="width: 100%; vertical-align: top;" rowspan="1"><img src="ny20042541x1_ex5-1logo01.jpg"></td>
              </tr>

          </table>
        </div>
      </div>
      <div> </div>
      <div style="text-indent: 36pt;">This opinion is being furnished in connection with the requirements of Item 601(b)(5) of Regulation S-K under the Act, and no opinion is expressed herein as to any matter pertaining to the contents of the Registration
        Statement, the Sales Agreement Prospectus or any other related applicable Prospectus, other than as expressly stated herein with respect to the issue of the Securities.</div>
      <div>&#160;</div>
      <div style="text-indent: 36pt;">As such counsel, we have examined such matters of fact and questions of law as we have considered appropriate for purposes of this letter. With your consent, we have relied upon certificates and other assurances of
        officers of the Company and others as to factual matters without having independently verified such factual matters. We are opining herein as to the General Corporation Law of the State of Delaware (the &#8220;<font style="font-weight: bold; font-style: italic;">DGCL</font>&#8221;), and with respect to the opinions set forth in paragraphs 3 through 6 below, the internal laws of the State of New York, and we express no opinion with respect to the applicability thereto, or the effect thereon, of the
        laws of any other jurisdiction or, in the case of Delaware, any other laws, or as to any matters of municipal law or the laws of any local agencies within any state.</div>
      <div>&#160;</div>
      <div style="text-indent: 36pt;">Subject to the foregoing and the other matters set forth herein, it is our opinion that, as of the date hereof:</div>
      <div>&#160;</div>
      <div style="text-indent: 36pt;"><font style="color: rgb(0, 0, 0);">1.</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="color: rgb(0, 0, 0);">When an issuance of Common Stock has been duly authorized by all necessary corporate action of the Company, upon issuance,
          delivery and payment therefor in an amount not less than the par value thereof in the manner contemplated by the applicable Prospectus and by such corporate action, and in total amounts and numbers of shares that do not exceed the respective
          total amounts and numbers of shares (a) available under the certificate of incorporation, and (b) authorized by the board of directors in connection with the offering contemplated by the applicable Prospectus, such shares of Common Stock will be
          validly issued, fully paid and nonassessable. In rendering the foregoing opinion, we have assumed that the Company will comply with all applicable notice requirements regarding uncertificated shares provided in the DGCL.</font></div>
      <div>&#160;</div>
      <div style="text-indent: 36pt;"><font style="color: rgb(0, 0, 0);">2.</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="color: rgb(0, 0, 0);">When a series of Preferred Stock has been duly established in accordance with the terms of the Company&#8217;s certificate of
          incorporation and authorized by all necessary corporate action of the Company, upon issuance, delivery and payment therefor in an amount not less than the par value thereof in the manner contemplated by the applicable Prospectus and by such
          corporate action, and in total amounts and numbers of shares that do not exceed the respective total amounts and numbers of shares (a) available under the certificate of incorporation, and (b) authorized by the board of directors in connection
          with the offering contemplated by the applicable Prospectus, such shares of such series of Preferred Stock will be validly issued, fully paid and nonassessable.&#160; In rendering the foregoing opinion, we have assumed that the Company will comply
          with all applicable notice requirements regarding uncertificated shares provided in the DGCL.</font></div>
      <div>&#160;</div>
      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
        <div class="BRPFPageFooter" style="width: 100%;"></div>
        <div style="page-break-after: always;" class="BRPFPageBreak">
          <hr style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;" noshade="noshade"></div>
        <div class="BRPFPageHeader" style="width: 100%;">
          <table style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;" cellpadding="0" cellspacing="0">

              <tr>
                <td style="width: 100%; vertical-align: top;">
                  <div style="font-weight: bold;">February 25, 2025</div>
                  <div style="font-weight: bold;">Page <font class="BRPFPageNumber">3</font></div>
                </td>
              </tr>
              <tr>
                <td style="width: 100%; vertical-align: top;" rowspan="1">&#160;</td>
              </tr>
              <tr>
                <td style="width: 100%; vertical-align: top;" rowspan="1"><img src="ny20042541x1_ex5-1logo01.jpg"></td>
              </tr>

          </table>
        </div>
      </div>
      <div style="text-indent: 36pt;"><font style="color: rgb(0, 0, 0);">3.</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="color: rgb(0, 0, 0);">When the Applicable Indenture has been duly authorized, executed and delivered by all necessary corporate action of the Company,
          and when the specific terms of a particular series of Debt Securities have been duly established in accordance with the terms of the Applicable Indenture and authorized by all necessary corporate action of the Company, and such Debt Securities
          have been duly executed, authenticated, issued and delivered against payment therefor in accordance with the terms of the Applicable Indenture and in the manner contemplated by the applicable Prospectus and by such corporate action, such Debt
          Securities will be the legally valid and binding obligations of the Company, enforceable against the Company in accordance with their terms.</font></div>
      <div>&#160;</div>
      <div style="text-indent: 36pt;"><font style="color: rgb(0, 0, 0);">4.</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="color: rgb(0, 0, 0);">When the applicable warrant agreement has been duly authorized, executed and delivered by all necessary corporate action of the
          Company, and when the specific terms of a particular issuance of Warrants have been duly established in accordance with the terms of the applicable warrant agreement and authorized by all necessary corporate action of the Company, and such
          Warrants have been duly executed, authenticated, issued and delivered against payment therefor in accordance with the terms of the applicable warrant agreement and in the manner contemplated by the applicable Prospectus and by such corporate
          action (assuming the securities issuable upon exercise of such Warrants have been duly authorized and reserved for issuance by all necessary corporate action), such Warrants will be the legally valid and binding obligations of the Company,
          enforceable against the Company in accordance with their terms.</font></div>
      <div>&#160;</div>
      <div style="text-indent: 36pt;"><font style="color: rgb(0, 0, 0);">5.</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="color: rgb(0, 0, 0);">When the applicable purchase contract agreement has been duly authorized, executed and delivered by all necessary corporate
          action of the Company, and when the specific terms of a particular issue of Purchase Contracts have been duly authorized in accordance with the terms of the applicable purchase contract agreement and authorized by all necessary corporate action
          of the Company, and such Purchase Contracts have been duly executed, authenticated, issued and delivered against payment therefor in accordance with the terms of the applicable purchase contract agreement and in the manner contemplated by the
          applicable Prospectus and by such corporate action (assuming the securities issuable under such Purchase Contracts have been duly authorized and reserved for issuance by all necessary corporate action), such Purchase Contracts will be the legally
          valid and binding obligations of the Company, enforceable against the Company in accordance with their terms.</font></div>
      <div>&#160;</div>
      <div style="text-indent: 36pt; color: rgb(0, 0, 0);">6.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; When the applicable unit agreement has been duly authorized, executed and delivered by all necessary corporate action of the Company, and when the specific terms of a particular
        issuance of Units have been duly authorized in accordance with the terms of the applicable unit agreement and authorized by all necessary corporate action of the Company, and such Units have been duly executed, authenticated, issued and delivered
        against payment therefor in accordance with the terms of the applicable unit agreement and in the manner contemplated by the applicable Prospectus and by such corporate action (assuming the securities issuable upon exercise of such Units have been
        duly authorized and reserved for issuance by all necessary corporate action), such Units will be the legally valid and binding obligations of the Company, enforceable against the Company in accordance with their terms.</div>
      <div>&#160;</div>
      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
        <div class="BRPFPageFooter" style="width: 100%;"></div>
        <div style="page-break-after: always;" class="BRPFPageBreak">
          <hr style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;" noshade="noshade"></div>
        <div class="BRPFPageHeader" style="width: 100%;">
          <table style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;" cellpadding="0" cellspacing="0">

              <tr>
                <td style="width: 100%; vertical-align: top;">
                  <div style="font-weight: bold;">February 25, 2025</div>
                  <div style="font-weight: bold;">Page <font class="BRPFPageNumber">4</font></div>
                </td>
              </tr>
              <tr>
                <td style="width: 100%; vertical-align: top;" rowspan="1">&#160;</td>
              </tr>
              <tr>
                <td style="width: 100%; vertical-align: top;" rowspan="1"><img src="ny20042541x1_ex5-1logo01.jpg"></td>
              </tr>

          </table>
        </div>
      </div>
      <div style="text-indent: 36pt;"><font style="color: rgb(0, 0, 0);">7.</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="color: rgb(0, 0, 0);">Upon the completion of all Corporate Proceedings (as defined below) relating to the Sales Agreement Shares, when the Sales
          Agreement Shares shall have been duly registered on the books of the transfer agent and registrar therefor in the name or on behalf of the purchasers, or certificates representing the Sales Agreement Shares have been manually signed by an
          authorized officer of the transfer agent and registrar therefor, upon issuance, delivery and payment therefor (in an amount not less than the par value thereof) in accordance with the Corporate Proceedings and the terms of the Sales Agreement,
          the Sales Agreement Shares will be duly authorized by all necessary corporate action of the Company and such Sales Agreement Shares will be validly issued, fully paid and nonassessable. In rendering the foregoing opinion, we have assumed that (i)
          the Company will comply with all applicable notice requirements regarding uncertificated shares provided in the DGCL, (ii) upon the issue of any of the Sales Agreement Shares, the total number of shares of Common Stock issued and outstanding will
          not exceed the total number of shares of Common Stock that the Company is then authorized to issue under its certificate of incorporation and (iii) certain terms of the Sales Agreement Shares to be issued by the Company from time to time will be
          authorized and approved by the board of directors (the &#8220;<font style="font-weight: bold; font-style: italic;">Board</font>&#8221;) of the Company or one or more committees thereof established by the Board or other person or body designated by the Board
          having the authority to issue and sell Sales Agreement Shares pursuant to the Sales Agreement in accordance with the DGCL, the certificate of incorporation and the bylaws of the Company and certain resolutions of the Board (with such approvals
          referred to herein as the &#8220;<font style="font-weight: bold; font-style: italic;">Corporate Proceedings</font>&#8221;) prior to issuance thereof.</font></div>
      <div>&#160;</div>
      <div style="text-indent: 36pt;">Our opinions are subject to: (i) the effect of bankruptcy, insolvency, reorganization, preference, fraudulent transfer, moratorium or other similar laws relating to or affecting the rights and remedies of creditors;
        (ii) (a) the effect of general principles of equity, whether considered in a proceeding in equity or at law (including the possible unavailability of specific performance or injunctive relief), (b) concepts of materiality, reasonableness, good
        faith and fair dealing, and (c) the discretion of the court before which a proceeding is brought; and (iii) the invalidity under certain circumstances under law or court decisions of provisions providing for the indemnification of or contribution
        to a party with respect to a liability where such indemnification or contribution is contrary to public policy.&#160; We express no opinion as to (a) any provision for liquidated damages, default interest, late charges, monetary penalties, make-whole
        premiums or other economic remedies to the extent such provisions are deemed to constitute a penalty, (b) consents to, or restrictions upon, governing law, jurisdiction, venue, arbitration, remedies, or judicial relief, (c) waivers of rights or
        defenses, (d) any provision requiring the payment of attorneys&#8217; fees, where such payment is contrary to law or public policy, (e) any provision permitting, upon acceleration of any Debt Securities, collection of that portion of the stated principal
        amount thereof which might be determined to constitute unearned interest thereon, (f) the creation, validity, attachment, perfection, or priority of any lien or security interest, (g) advance waivers of claims, defenses, rights granted by law, or
        notice, opportunity for hearing, evidentiary requirements, statutes of limitation, trial by jury or at law, or other procedural rights, (h) waivers of broadly or vaguely stated rights, (i) provisions for exclusivity, election or cumulation of
        rights or remedies, (j) provisions authorizing or validating conclusive or discretionary determinations, (k) grants of setoff rights, (l) proxies, powers and trusts, (m) provisions prohibiting, restricting, or requiring consent to assignment or
        transfer of any right or property, (n) any provision to the extent it requires that a claim with respect to a security denominated in other than U.S. dollars (or a judgment in respect of such a claim) be converted into U.S. dollars at a rate of
        exchange at a particular date, to the extent applicable law otherwise provides, and (o) the severability, if invalid, of provisions to the foregoing effect.</div>
      <div>&#160;</div>
      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
        <div class="BRPFPageFooter" style="width: 100%;"></div>
        <div style="page-break-after: always;" class="BRPFPageBreak">
          <hr style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;" noshade="noshade"></div>
        <div class="BRPFPageHeader" style="width: 100%;">
          <table style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;" cellpadding="0" cellspacing="0">

              <tr>
                <td style="width: 100%; vertical-align: top;">
                  <div style="font-weight: bold;">February 25, 2025</div>
                  <div style="font-weight: bold;">Page <font class="BRPFPageNumber">5</font></div>
                </td>
              </tr>
              <tr>
                <td style="width: 100%; vertical-align: top;" rowspan="1">&#160;</td>
              </tr>
              <tr>
                <td style="width: 100%; vertical-align: top;" rowspan="1"><img src="ny20042541x1_ex5-1logo01.jpg"></td>
              </tr>

          </table>
        </div>
      </div>
      <div style="text-indent: 36pt;">With your consent, we have assumed (a) that each of the Debt Securities, Warrants, Purchase Contracts and Units and the Applicable Indenture, warrant agreements, purchase contract agreements and unit agreements
        governing such Securities (collectively, the &#8220;<font style="font-weight: bold; font-style: italic;">Documents</font>&#8221;) will be governed by the internal laws of the State of New York, (b) that each of the Documents has been or will be duly
        authorized, executed and delivered by the parties thereto, (c) that each of the Documents constitutes or will constitute legally valid and binding obligations of the parties thereto other than the Company, enforceable against each of them in
        accordance with their respective terms, and (d) that the status of each of the Documents as legally valid and binding obligations of the parties will not be affected by any (i) breaches of, or defaults under, agreements or instruments, (ii)
        violations of statutes, rules, regulations or court or governmental orders, or (iii) failures to obtain required consents, approvals or authorizations from, or to make required registrations, declarations or filings with, governmental authorities.</div>
      <div>&#160;</div>
      <div style="text-indent: 36pt;">This opinion is for your benefit in connection with the Registration Statement and may be relied upon by you and by persons entitled to rely upon it pursuant to the applicable provisions of the Act. We consent to your
        filing this opinion as an exhibit to the Registration Statement and to the reference to our firm contained in each of the Prospectus and the Sales Agreement Prospectus under the heading &#8220;Legal Matters.&#8221; We further consent to the incorporation by
        reference of this letter and consent into any registration statement or post-effective amendment to the Registration Statement filed pursuant to Rule 462(b) under the Act with respect to the Securities. In giving such consent, we do not thereby
        admit that we are in the category of persons whose consent is required under Section 7 of the Act or the rules and regulations of the Commission thereunder.</div>
      <div>&#160;</div>
      <table style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;" id="z6b1883d03b354a51a6fc40ac7a760ab9" border="0" cellpadding="0" cellspacing="0">

          <tr>
            <td colspan="1" style="width: 50%; vertical-align: top;"><br>
            </td>
            <td style="width: 50%; vertical-align: top;">
              <div>Sincerely,</div>
            </td>
          </tr>
          <tr>
            <td colspan="1" style="width: 50%; vertical-align: top;"><br>
            </td>
            <td style="width: 50%; vertical-align: top;"><br>
            </td>
          </tr>
          <tr>
            <td colspan="1" style="width: 50%; vertical-align: top;"><br>
            </td>
            <td style="width: 50%; vertical-align: top;">
              <div>/s/ Latham &amp; Watkins LLP</div>
            </td>
          </tr>

      </table>
      <div><br>
      </div>
      <div><br>
      </div>
      <div>
        <hr style="height: 2px; color: #000000; background-color: #000000; text-align: center; margin-left: auto; margin-right: auto; border: none;" align="center" noshade="noshade"></div>
    </div>
  </div>
  <div class="BRPFPageFooter" style="width: 100%;"></div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-23.2
<SEQUENCE>3
<FILENAME>ny20042541x1_ex23-2.htm
<DESCRIPTION>EXHIBIT 23.2
<TEXT>
<html>
  <head>
    <title></title>
    <!-- Licensed to: Broadridge Financial Solutions, Inc.
         Document created using Broadridge PROfile 25.1.1.5279
         Copyright 1995 - 2025 Broadridge -->
  </head>
<body style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: #000000;" bgcolor="#ffffff">
  <div>
    <hr style="height: 4px; color: #000000; background-color: #000000; text-align: center; margin-left: auto; margin-right: auto; border: none;" align="center" noshade="noshade">
    <div style="text-align: right;"><font style="font-weight: bold;">Exhibit 23.2</font><br>
    </div>
    <div style="text-align: right;"><font style="font-weight: bold;"> <br>
      </font></div>
    <div style="text-align: right;">
      <table style="font-family: 'Times New Roman'; font-size: 10pt; color: #000000; width: 100%;" border="0" cellpadding="0" cellspacing="0">

          <tr>
            <td style="width: 18%;">
              <div><img src="ny20042541x1_ex23-2logo01.jpg"> </div>
            </td>
            <td style="width: 82%;"><br>
            </td>
          </tr>
          <tr>
            <td rowspan="1" style="width: 18%;"><br>
            </td>
            <td rowspan="1" style="width: 82%;">
              <div style="text-align: left;">KPMG LLP</div>
              <div style="text-align: left;">Suite 1500</div>
              <div style="text-align: left;">15 W. South Temple Salt</div>
              <div style="text-align: left;"> Lake City, UT 84101</div>
            </td>
          </tr>

      </table>
      <font style="font-weight: bold;"> </font></div>
    <div> <br>
    </div>
    <div>
      <div style="font-weight: bold; font-family: 'Times New Roman',Times,serif; text-align: center;"> <br>
      </div>
      <div style="font-weight: bold; font-family: 'Times New Roman',Times,serif; text-align: center;"> <br>
      </div>
      <div style="font-weight: bold; font-family: 'Times New Roman',Times,serif; text-align: center;">Consent of Independent Registered Public Accounting Firm</div>
      <div>&#160;</div>
      <div>We consent to the use of our reports dated February 23, 2024, with respect to the consolidated financial statements of Beyond, Inc., and the effectiveness of internal control over financial reporting, incorporated herein by reference, and to the
        reference to our firm under the heading "Experts" in the prospectus.</div>
      <div><br>
      </div>
      <div>/s/ KPMG LLP</div>
      <div>Salt Lake City, Utah</div>
      <div>February 25, 2025</div>
      <div> <br>
      </div>
      <div> <br>
      </div>
    </div>
    <div>
      <div style="text-align: center; font-size: 8pt;">KPMG LLP, a Delaware limited liability partnership and a member firm of</div>
      <font style="font-size: 8pt;"> </font>
      <div style="text-align: center; text-indent: -0.05pt; margin-right: 5.2pt; margin-left: 1pt; font-size: 8pt;"> the KPMG global organization of independent member firms affiliated with</div>
      <font style="font-size: 8pt;"> </font>
      <div style="text-align: center; margin-left: 1pt; font-size: 8pt;">KPMG International Limited, a private English company limited by guarantee.</div>
      <div style="text-align: center; margin-left: 1pt;"> <br>
      </div>
      <div style="text-align: center; margin-left: 1pt;"> <br>
      </div>
    </div>
    <div>
      <hr style="height: 2px; color: #000000; background-color: #000000; text-align: center; margin-left: auto; margin-right: auto; border: none;" align="center" noshade="noshade"> </div>
  </div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-23.3
<SEQUENCE>4
<FILENAME>ny20042541x1_ex23-3.htm
<DESCRIPTION>EXHIBIT 23.3
<TEXT>
<html>
  <head>
    <title></title>
    <!-- Licensed to: Broadridge Financial Solutions, Inc.
         Document created using Broadridge PROfile 25.1.1.5279
         Copyright 1995 - 2025 Broadridge -->
  </head>
<body style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: #000000;" bgcolor="#ffffff">
  <div>
    <hr style="height: 4px; color: #000000; background-color: #000000; text-align: center; margin-left: auto; margin-right: auto; border: none;" align="center" noshade="noshade">
    <div style="font-weight: bold; text-align: right;">Exhibit 23.3<br>
    </div>
    <div style="font-weight: bold; text-align: right;"> <br>
    </div>
    <div style="font-weight: bold; text-align: right;">
      <table id="z4ac0ca5e4a8c495b949699c41c0984bb" style="font-family: 'Times New Roman'; font-size: 10pt; color: #000000; width: 100%;" border="0" cellpadding="0" cellspacing="0">

          <tr>
            <td style="width: 25%;">
              <div style="text-align: left;"> <img src="ny20042541x1_ex23-3logo01.jpg"> </div>
            </td>
            <td style="width: 75%;"><br>
            </td>
          </tr>
          <tr>
            <td rowspan="1" style="width: 25%;"><br>
            </td>
            <td rowspan="1" style="width: 75%;">
              <div>
                <div style="text-align: left;">KPMG LLP</div>
                <div style="text-align: left;">Suite 1500</div>
                <div style="text-align: left;">15 W. South Temple</div>
                <div style="text-align: left;"> Salt Lake City, UT 84101</div>
              </div>
            </td>
          </tr>

      </table>
    </div>
    <div> </div>
    <div>
      <div style="text-align: center; margin-left: 4.15pt; font-weight: bold;"> <br>
      </div>
      <div style="text-align: center; margin-left: 4.15pt; font-weight: bold;"> <br>
      </div>
      <div style="text-align: center; margin-left: 4.15pt; font-weight: bold;"> <br>
      </div>
      <div style="text-align: center; margin-left: 4.15pt; font-weight: bold;">Consent of Independent Auditors</div>
      <div>&#160;</div>
      <div style="margin-right: 5.2pt; margin-left: 5.9pt;">We consent to the use of our report dated February 15, 2022, with respect to the financial statements of Medici Ventures, L.P., incorporated herein by reference, and to the reference to our firm
        under the heading &#8220;Experts&#8221; in the prospectus.</div>
      <div><br>
      </div>
      <div>/s/ KPMG LLP</div>
      <div>Salt Lake City, Utah</div>
      <div>February 25, 2025</div>
      <div> <br>
      </div>
      <div>
        <div>&#160;</div>
        <div style="text-align: center; text-indent: -0.05pt; margin-right: 5.2pt; margin-left: 1pt; font-size: 8pt;">KPMG LLP, a Delaware limited liability partnership and a member firm of</div>
        <font style="font-size: 8pt;"> </font>
        <div style="text-align: center; text-indent: -0.05pt; margin-right: 5.2pt; margin-left: 1pt; font-size: 8pt;"> the KPMG global organization of independent member firms affiliated with</div>
        <font style="font-size: 8pt;"> </font>
        <div style="text-align: center; margin-left: 1pt; font-size: 8pt;">KPMG International Limited, a private English company limited by guarantee.</div>
        <font style="font-size: 8pt;"> </font>
        <div style="text-align: center; margin-left: 1pt;"> <font style="font-size: 8pt;"><br>
          </font> </div>
        <font style="font-size: 8pt;"> </font>
        <div style="text-align: center; margin-left: 1pt;"><font style="font-size: 8pt;"> </font><br>
        </div>
      </div>
      <div>
        <hr style="height: 2px; color: #000000; background-color: #000000; text-align: center; margin-left: auto; margin-right: auto; border: none;" align="center" noshade="noshade"> </div>
    </div>
  </div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-23.4
<SEQUENCE>5
<FILENAME>ny20042541x1_ex23-4.htm
<DESCRIPTION>EXHIBIT 23.4
<TEXT>
<html>
  <head>
    <title></title>
    <!-- Licensed to: Broadridge Financial Solutions, Inc.
         Document created using Broadridge PROfile 25.1.1.5279
         Copyright 1995 - 2025 Broadridge -->
  </head>
<body style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left; color: #000000;" bgcolor="#ffffff">
  <div>
    <div style="text-align: right; font-family: 'Times New Roman',Times,serif; font-weight: bold;">
      <hr style="height: 4px; color: #000000; background-color: #000000; text-align: center; margin-left: auto; margin-right: auto; border: none;" align="center" noshade="noshade">Exhibit 23.4<br>
    </div>
    <div style="text-align: center; font-weight: bold;"> <br>
    </div>
    <div style="text-align: center; font-weight: bold;">Consent of Independent Registered Public Accounting Firm</div>
    <div><br>
    </div>
    <div>We consent to the reference to our firm under the caption &#8220;Experts&#8221; in this Registration Statement (Form S-3 No. 333-280076) and related Prospectuses of
      Beyond, Inc. for the registration of common stock, preferred stock, debt securities, warrants, purchase contracts and units and to the incorporation by reference of our report dated February 14, 2023, with respect to the financial statements of
      Medici Ventures, L.P., included in the Annual Report (Form 10-K) of Beyond, Inc., for the year ended December 31, 2023, filed with the Securities and Exchange Commission.</div>
    <div><br>
    </div>
    <div>/s/ Ernst &amp; Young LLP</div>
    <div><br>
    </div>
    <div style="text-align: justify;">Salt Lake City, Utah</div>
    <div style="text-align: justify;">February 25, 2025</div>
    <div style="text-align: justify;"> <br>
    </div>
    <div>
      <hr style="height: 2px; color: #000000; background-color: #000000; text-align: center; margin-left: auto; margin-right: auto; border: none;" align="center" noshade="noshade"></div>
  </div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-23.5
<SEQUENCE>6
<FILENAME>ny20042541x1_ex23-5.htm
<DESCRIPTION>EXHIBIT 23.5
<TEXT>
<html>
  <head>
    <title></title>
    <!-- Licensed to: Broadridge Financial Solutions, Inc.
         Document created using Broadridge PROfile 25.1.1.5279
         Copyright 1995 - 2025 Broadridge -->
  </head>
<body style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left; color: #000000;" bgcolor="#ffffff">
  <div>
    <div style="text-align: right;">
      <hr style="height: 4px; color: #000000; background-color: #000000; text-align: center; margin-left: auto; margin-right: auto; border: none;" align="center" noshade="noshade"><font style="font-weight: bold;">Exhibit 23.5</font><br>
    </div>
    <div><br>
    </div>
    <div style="text-align: center; font-weight: bold;">Consent of Independent Registered Public Accounting Firm</div>
    <div><br>
    </div>
    <div>We consent to the reference to our firm under the caption &#8220;Experts&#8221; in this Registration Statement (Form S-3 No. 333-280076) and related Prospectuses of
      Beyond, Inc. for the registration of common stock, preferred stock, debt securities, warrants, purchase contracts and units and to the incorporation by reference of our report dated December 21, 2023, with respect to the financial statements of
      Medici Ventures, L.P., included in the Annual Report (Form 10-K) of Beyond, Inc., for the year ended December 31, 2023, filed with the Securities and Exchange Commission.</div>
    <div><br>
    </div>
    <div>/s/ Ernst &amp; Young LLP</div>
    <div><br>
    </div>
    <div style="text-align: justify;">Salt Lake City, Utah</div>
    <div style="text-align: justify;">February 25, 2025</div>
    <div><br>
    </div>
    <div>
      <hr style="height: 2px; color: #000000; background-color: #000000; text-align: center; margin-left: auto; margin-right: auto; border: none;" align="center" noshade="noshade"></div>
  </div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-23.6
<SEQUENCE>7
<FILENAME>ny20042541x1_ex23-6.htm
<DESCRIPTION>EXHIBIT 23.6
<TEXT>
<html>
  <head>
    <title></title>
    <!-- Licensed to: Broadridge Financial Solutions, Inc.
         Document created using Broadridge PROfile 25.1.1.5279
         Copyright 1995 - 2025 Broadridge -->
  </head>
<body bgcolor="#ffffff" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: #000000;">


  <div>
    <hr noshade="noshade" align="center" style="height: 4px; color: #000000; background-color: #000000; text-align: center; margin-left: auto; margin-right: auto; border: none;">
    <div>
      <div style="text-align: right; color: rgb(0, 0, 0); font-size: 12pt; font-weight: bold;"> <font style="font-size: 10pt;">Exhibit 23.6<br>
        </font></div>
      <div style="text-align: center; color: #000000; font-size: 12pt; font-weight: bold;"> <font style="font-size: 10pt;"><br>
        </font></div>
      <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">Consent of Independent Auditors</div>
      <div>&#160;</div>
      <div>We consent to the incorporation by reference in this Post-Effective Amendment No. 1 to the Registration Statement on Form S-3 of Beyond, Inc. of our reports
        dated October 14, 2024 and July 3, 2023 with respect to the consolidated financial statements of tZERO Group, Inc., and to the reference to our firm under the heading &#8220;Experts&#8221; in the prospectus.</div>
      <div>&#160;</div>
      <div style="color: #000000;">/s/ Baker Tilly US, LLP</div>
      <div>&#160;</div>
      <div style="color: #000000;">New York, New York</div>
      <div style="color: #000000;">February 25, 2025</div>
      <div><br>
      </div>
      <div><br>
      </div>
      <div>
        <hr noshade="noshade" align="center" style="height: 2px; color: #000000; background-color: #000000; text-align: center; margin-left: auto; margin-right: auto; border: none;"></div>
      <div>&#160;</div>
    </div>
  </div>


</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-FILING FEES
<SEQUENCE>8
<FILENAME>ny20042541x1_exfees.htm
<TEXT>
<XBRL>
<?xml version='1.0' encoding='ASCII'?>
<!-- Generated by CompSci Transform (tm) - http://www.compsciresources.com -->
<!-- Created: Fri Feb 21 19:29:36 UTC 2025 -->
<!-- Created by CompSci Resources, LLC on Fri Feb 21 03:52:50 UTC 2025 -->
<html xmlns:compsci="http://compsciresources.com" xmlns:dei="http://xbrl.sec.gov/dei/2024" xmlns:ffd="http://xbrl.sec.gov/ffd/2024q2" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2020-02-12" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:us-types="http://fasb.org/us-types/2024" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xl="http://www.xbrl.org/2003/XLink" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xs="http://www.w3.org/2001/XMLSchema-instance" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns="http://www.w3.org/1999/xhtml">
 <head>
  <title> </title>

<meta content="text/html" http-equiv="Content-Type"/>
</head>
 <body><div style="font-family: Times New Roman; font-size: 12pt;"><div>

  </div><hr style="border-top: 4px solid black; border-bottom: none; border-left: none; border-right: none; height: 0px; margin: 8px auto; width: 100%;"/><div>
  </div><div style="text-align: right; font-size: 10pt;"><span style="font-weight: 700; letter-spacing: normal; text-decoration-thickness: initial; text-decoration-style: initial; text-decoration-color: initial; float: none; display: inline !important;">Exhibit 107.1</span>&#160;
  </div><div>&#160;</div><div style="text-align: center;">
   <span style="font-size: 10.0pt; color: #000000; font-weight: bold;">Calculation of Filing Fee Tables</span>
  </div><div>
  </div><div style="text-align: center; font-size: 10pt;">&#160;
  </div><div>
  </div><div style="text-align: center;"> <span style="font-size: 10.0pt; color: #000000; font-weight: bold;">Form <ix:nonNumeric contextRef="c0" name="ffd:FormTp" id="ixv-573">S-3</ix:nonNumeric></span> </div><div>
  </div><div style="text-align: center;">
   <span style="font-size: 10.0pt; color: #000000;">(Form Type)</span>
  </div><div>
  </div><div style="text-align: center; font-size: 10pt;">&#160;
  </div><div>
  </div><div style="text-align: center;"> <ix:nonNumeric contextRef="c0" name="dei:EntityRegistrantName" id="ixv-27"><span style="font-size: 10.0pt; color: #000000; font-weight: bold;">Beyond, Inc.</span></ix:nonNumeric> </div><div>
  </div><div style="text-align: center;">
   <span style="font-size: 10.0pt; color: #000000;">(Exact Name of Registrant as Specified in its Charter)</span>
  </div><div>
  </div><div style="text-align: center; font-size: 10pt;">&#160;
  </div><div>
  </div><div style="text-align: center;">
   <span style="font-size: 10.0pt; color: #000000; font-weight: bold;">Table 1: Newly Registered and Carry Forward Securities </span>
  </div><div>
  </div><table style="font-size: 12pt; border-spacing: 0px; border-collapse: collapse; margin-left: -0.5pt; width: 100.16%;"> <tr style="height: 0px; font-size: 0px;"> <td style="width: 22.35pt;"> </td> <td style="width: 21.45pt;"> </td> <td style="width: 28.7pt;"> </td> <td style="width: 51.1pt;"> </td> <td style="width: 44.3pt;"> </td> <td style="width: 48.85pt;"> </td> <td style="width: 45.55pt;"> </td> <td style="width: 44.45pt;"> </td> <td style="width: 58.8pt;"> </td> <td style="width: 66.65pt;"> </td> <td style="width: 55.65pt;"> </td> <td style="width: 36.65pt;"> </td> <td style="width: 36.65pt;"> </td> <td style="width: 37.75pt;"> </td> <td style="width: 49.15pt;"> </td> </tr> <tr style="vertical-align: top;"> <td colspan="2" style="padding: 0; border-top: 1pt solid #000000; border-left: 1pt solid #000000; padding-top: 1.5pt; padding-bottom: 1.5pt; padding-left: 7.25pt; padding-right: 1.25pt; vertical-align: bottom; font-size: 0;">&#160; </td> <td style="padding: 0; width: 5.82%; border-top: 1pt solid #000000; border-left: 1pt solid #000000; border-right: 1pt solid #000000; padding-top: 0.75pt; padding-bottom: 0.75pt; padding-left: 0.75pt; padding-right: 0.75pt;"> <div style="text-align: center; font-size: 10pt;">&#160; </div> </td> <td style="padding: 0; width: 6.38%; border-top: 1pt solid #000000; border-bottom: 1pt solid #000000; border-left: 1pt solid #000000; padding-top: 1.5pt; padding-bottom: 1.5pt; padding-left: 1.5pt; padding-right: 1.25pt; vertical-align: bottom;"> <div style="text-align: center;"> <span style="font-size: 10.0pt; color: #000000;">Security</span> </div> <div style="text-align: center;"> <span style="font-size: 10.0pt; color: #000000;">Type</span> </div> </td> <td style="padding: 0; width: 7.4%; border-top: 1pt solid #000000; border-bottom: 1pt solid #000000; border-left: 1pt solid #000000; padding-top: 1.5pt; padding-bottom: 1.5pt; padding-left: 1.5pt; padding-right: 1.25pt; vertical-align: bottom;"> <div style="text-align: center;"> <span style="font-size: 10.0pt; color: #000000;">Security Class Title</span> </div> </td> <td style="padding: 0; width: 7.98%; border-top: 1pt solid #000000; border-bottom: 1pt solid #000000; border-left: 1pt solid #000000; padding-top: 1.5pt; padding-bottom: 1.5pt; padding-left: 1.5pt; padding-right: 1.25pt; vertical-align: bottom;"> <div style="text-align: center;"> <span style="font-size: 10.0pt; color: #000000;">Fee Calculation or</span> </div> <div style="text-align: center;"> <span style="font-size: 10.0pt; color: #000000;">Carry Forward Rule</span> </div> </td> <td style="padding: 0; width: 6.76%; border-top: 1pt solid #000000; border-bottom: 1pt solid #000000; border-left: 1pt solid #000000; padding-top: 1.5pt; padding-bottom: 1.5pt; padding-left: 1.5pt; padding-right: 1.25pt; vertical-align: bottom;"> <div style="text-align: center;"> <span style="font-size: 10.0pt; color: #000000;">Amount</span> </div> <div style="text-align: center;"> <span style="font-size: 10.0pt; color: #000000;">Registered</span> </div> </td> <td style="padding: 0; width: 5.4%; border-top: 1pt solid #000000; border-bottom: 1pt solid #000000; border-left: 1pt solid #000000; padding-top: 1.5pt; padding-bottom: 1.5pt; padding-left: 1.5pt; padding-right: 1.25pt; vertical-align: bottom;"> <div style="text-align: center;"> <span style="font-size: 10.0pt; color: #000000;">Proposed</span> </div> <div style="text-align: center;"> <span style="font-size: 10.0pt; color: #000000;">Maximum</span> </div> <div style="text-align: center;"> <span style="font-size: 10.0pt; color: #000000;">Offering</span> </div> <div style="text-align: center;"> <span style="font-size: 10.0pt; color: #000000;">Price Per</span> </div> <div style="text-align: center;"> <span style="font-size: 10.0pt; color: #000000;">Unit</span> </div> </td> <td style="padding: 0; width: 9.76%; border-top: 1pt solid #000000; border-bottom: 1pt solid #000000; border-left: 1pt solid #000000; padding-top: 1.5pt; padding-bottom: 1.5pt; padding-left: 1.5pt; padding-right: 1.25pt; vertical-align: bottom;"> <div style="text-align: center;"> <span style="font-size: 10.0pt; color: #000000;">Maximum</span> </div> <div style="text-align: center;"> <span style="font-size: 10.0pt; color: #000000;">Aggregate</span> </div> <div style="text-align: center;"> <span style="font-size: 10.0pt; color: #000000;">Offering</span> </div> <div style="text-align: center;"> <span style="font-size: 10.0pt; color: #000000;">Price</span> </div> </td> <td style="padding: 0; width: 10.84%; border-top: 1pt solid #000000; border-bottom: 1pt solid #000000; border-left: 1pt solid #000000; padding-top: 1.5pt; padding-bottom: 1.5pt; padding-left: 1.5pt; padding-right: 1.25pt; vertical-align: bottom;"> <div style="text-align: center;"> <span style="font-size: 10.0pt; color: #000000;">Fee</span> </div> <div style="text-align: center;"> <span style="font-size: 10.0pt; color: #000000;">Rate</span> </div> </td> <td style="padding: 0; width: 9.14%; border-top: 1pt solid #000000; border-bottom: 1pt solid #000000; border-left: 1pt solid #000000; padding-top: 1.5pt; padding-bottom: 1.5pt; padding-left: 1.5pt; padding-right: 1.25pt; vertical-align: bottom;"> <div style="text-align: center;"> <span style="font-size: 10.0pt; color: #000000;">Amount of</span> </div> <div style="text-align: center;"> <span style="font-size: 10.0pt; color: #000000;">Registration</span> </div> <div style="text-align: center;"> <span style="font-size: 10.0pt; color: #000000;">Fee</span> </div> </td> <td style="padding: 0; width: 5.4%; border-top: 1pt solid #000000; border-bottom: 1pt solid #000000; border-left: 1pt solid #000000; padding-top: 1.5pt; padding-bottom: 1.5pt; padding-left: 1.5pt; padding-right: 1.25pt; vertical-align: bottom;"> <div style="text-align: center;"> <span style="font-size: 10.0pt; color: #000000;">Carry</span> </div> <div style="text-align: center;"> <span style="font-size: 10.0pt; color: #000000;">Forward</span> </div> <div style="text-align: center;"> <span style="font-size: 10.0pt; color: #000000;">Form</span> </div> <div style="text-align: center;"> <span style="font-size: 10.0pt; color: #000000;">Type</span> </div> </td> <td style="padding: 0; width: 5.36%; border-top: 1pt solid #000000; border-bottom: 1pt solid #000000; border-left: 1pt solid #000000; padding-top: 1.5pt; padding-bottom: 1.5pt; padding-left: 1.5pt; padding-right: 1.25pt; vertical-align: bottom;"> <div style="text-align: center;"> <span style="font-size: 10.0pt; color: #000000;">Carry</span> </div> <div style="text-align: center;"> <span style="font-size: 10.0pt; color: #000000;">Forward</span> </div> <div style="text-align: center;"> <span style="font-size: 10.0pt; color: #000000;">File</span> </div> <div style="text-align: center;"> <span style="font-size: 10.0pt; color: #000000;">Number</span> </div> </td> <td style="padding: 0; width: 5.36%; border-top: 1pt solid #000000; border-bottom: 1pt solid #000000; border-left: 1pt solid #000000; padding-top: 1.5pt; padding-bottom: 1.5pt; padding-left: 1.5pt; padding-right: 1.25pt; vertical-align: bottom;"> <div style="text-align: center;"> <span style="font-size: 10.0pt; color: #000000;">Carry</span> </div> <div style="text-align: center;"> <span style="font-size: 10.0pt; color: #000000;">Forward</span> </div> <div style="text-align: center;"> <span style="font-size: 10.0pt; color: #000000;">Initial</span> </div> <div style="text-align: center;"> <span style="font-size: 10.0pt; color: #000000;">effective</span> </div> <div style="text-align: center;"> <span style="font-size: 10.0pt; color: #000000;">date</span> </div> </td> <td style="padding: 0; width: 7.32%; border-top: 1pt solid #000000; border-bottom: 1pt solid #000000; border-left: 1pt solid #000000; border-right: 1pt solid #000000; padding-top: 1.5pt; padding-bottom: 1.5pt; padding-left: 1.5pt; padding-right: 1.5pt; vertical-align: bottom;"> <div style="text-align: center;"> <span style="font-size: 10.0pt; color: #000000;">Filing Fee</span> </div> <div style="text-align: center;"> <span style="font-size: 10.0pt; color: #000000;">Previously</span> </div> <div style="text-align: center;"> <span style="font-size: 10.0pt; color: #000000;">Paid In</span> </div> <div style="text-align: center;"> <span style="font-size: 10.0pt; color: #000000;">Connection</span> </div> <div style="text-align: center;"> <span style="font-size: 10.0pt; color: #000000;">with</span> </div> <div style="text-align: center;"> <span style="font-size: 10.0pt; color: #000000;">Unsold</span> </div> <div style="text-align: center;"> <span style="font-size: 10.0pt; color: #000000;">Securities</span> </div> <div style="text-align: center;"> <span style="font-size: 10.0pt; color: #000000;">to be</span> </div> <div style="text-align: center;"> <span style="font-size: 10.0pt; color: #000000;">Carried</span> </div> <div style="text-align: center;"> <span style="font-size: 10.0pt; color: #000000;">Forward</span> </div> </td> </tr> <tr style="vertical-align: top;"> <td style="padding: 0; width: 3.6%; border-top: 1pt solid #000000; border-bottom: 1pt solid #000000; border-left: 1pt solid #000000; border-right: 1pt solid #000000; padding-top: 0.75pt; padding-bottom: 0.75pt; padding-left: 0.75pt; padding-right: 0.75pt;"> <div style="text-align: center; font-size: 10pt;">&#160; </div> </td> <td colspan="14" style="padding: 0; border-top: 1pt solid #000000; border-bottom: 1pt solid #000000; border-left: 1pt solid #000000; border-right: 1pt solid #000000; padding-top: 1.5pt; padding-bottom: 1.5pt; padding-left: 1.5pt; padding-right: 1.5pt; vertical-align: bottom;"> <div style="text-align: center;"> <span style="font-size: 10.0pt; color: #000000; font-weight: bold;">Newly Registered Securities</span> </div> </td> </tr> <tr style="vertical-align: top; height: 38.0pt;"> <td colspan="2" style="padding: 0; border-top: 1pt solid black; border-bottom: 1pt solid #000000; border-left: 1pt solid #000000; padding-top: 0.75pt; padding-bottom: 0.75pt; padding-left: 0.75pt; padding-right: 0.75pt; vertical-align: bottom;"> <div style="text-align: center; font-size: 10pt;">&#160; </div> </td> <td style="padding: 0; width: 5.82%; border-top: 1pt solid #000000; border-left: 1pt solid #000000; border-right: 1pt solid #000000; padding-top: 0.75pt; padding-bottom: 0.75pt; padding-left: 0.75pt; padding-right: 0.75pt;"> <div style="text-align: center; font-size: 10pt;">&#160; </div> </td> <td style="padding: 0; width: 6.38%; border-top: 1pt solid #000000; border-left: 1pt solid #000000; padding-top: 1.5pt; padding-bottom: 1.5pt; padding-left: 1.5pt; padding-right: 1.25pt; vertical-align: bottom;"> <div style="text-align: center;"> <ix:nonNumeric contextRef="c1" name="ffd:OfferingSctyTp" id="ixv-172"><span style="font-size: 10.0pt; color: #000000;">Equity</span></ix:nonNumeric> </div> </td> <td style="padding: 0; width: 7.4%; border-top: 1pt solid #000000; border-left: 1pt solid #000000; padding-top: 1.5pt; padding-bottom: 1.5pt; padding-left: 1.5pt; padding-right: 1.25pt; vertical-align: bottom;"> <div style="text-align: center;"> <ix:nonNumeric contextRef="c1" name="ffd:OfferingSctyTitl" id="ixv-176"><span style="font-size: 10.0pt; color: #000000;">Common Stock</span></ix:nonNumeric> </div> </td> <td style="padding: 0; width: 7.98%; border-top: 1pt solid #000000; border-left: 1pt solid #000000; padding-top: 1.5pt; padding-bottom: 1.5pt; padding-left: 1.5pt; padding-right: 1.25pt; vertical-align: bottom;"> <div style="text-align: center;"> <ix:nonNumeric contextRef="c1" format="ixt:fixed-true" name="ffd:Rule457oFlg" id="ixv-180"><span style="font-size: 10.0pt; color: #000000;">457(o)</span></ix:nonNumeric> </div> </td> <td style="padding: 0; width: 6.76%; border-top: 1pt solid #000000; border-left: 1pt solid #000000; padding-top: 1.5pt; padding-bottom: 1.5pt; padding-left: 1.5pt; padding-right: 1.25pt; vertical-align: bottom;"> <div style="text-align: center; font-size: 10pt;">&#160; </div> </td> <td style="padding: 0; width: 5.4%; border-top: 1pt solid #000000; border-left: 1pt solid #000000; padding-top: 1.5pt; padding-bottom: 1.5pt; padding-left: 1.5pt; padding-right: 1.25pt; vertical-align: bottom;"> <div style="text-align: center; font-size: 10pt;">&#160; </div> </td> <td style="padding: 0; width: 9.76%; border-top: 1pt solid #000000; border-left: 1pt solid #000000; padding-top: 1.5pt; padding-bottom: 1.5pt; padding-left: 1.5pt; padding-right: 1.25pt; vertical-align: bottom;"> <div style="text-align: center; font-size: 10pt;">&#160; </div> </td> <td style="padding: 0; width: 10.84%; border-top: 1pt solid #000000; border-left: 1pt solid #000000; padding-top: 1.5pt; padding-bottom: 1.5pt; padding-left: 1.5pt; padding-right: 1.25pt; vertical-align: bottom;"> <div style="text-align: center; font-size: 10pt;">&#160; </div> </td> <td style="padding: 0; width: 9.14%; border-top: 1pt solid #000000; border-left: 1pt solid #000000; padding-top: 1.5pt; padding-bottom: 1.5pt; padding-left: 1.5pt; padding-right: 1.25pt; vertical-align: bottom;"> <div style="text-align: center; font-size: 10pt;">&#160; </div> </td> <td style="padding: 0; width: 5.4%; border-top: 1pt solid #000000; border-left: 1pt solid #000000; padding-top: 1.5pt; padding-bottom: 1.5pt; padding-left: 1.5pt; padding-right: 1.25pt; vertical-align: bottom;"> <div style="text-align: center; font-size: 10pt;">&#160; </div> </td> <td style="padding: 0; width: 5.36%; border-top: 1pt solid #000000; border-left: 1pt solid #000000; padding-top: 1.5pt; padding-bottom: 1.5pt; padding-left: 1.5pt; padding-right: 1.25pt; vertical-align: bottom;"> <div style="text-align: center; font-size: 10pt;">&#160; </div> </td> <td style="padding: 0; width: 5.36%; border-top: 1pt solid #000000; border-left: 1pt solid #000000; padding-top: 1.5pt; padding-bottom: 1.5pt; padding-left: 1.5pt; padding-right: 1.25pt; vertical-align: bottom;"> <div style="text-align: center; font-size: 10pt;">&#160; </div> </td> <td style="padding: 0; width: 7.32%; border-top: 1pt solid #000000; border-left: 1pt solid #000000; border-right: 1pt solid #000000; padding-top: 1.5pt; padding-bottom: 1.5pt; padding-left: 1.5pt; padding-right: 1.5pt; vertical-align: bottom;"> <div style="text-align: center; font-size: 10pt;">&#160; </div> </td> </tr> <tr style="vertical-align: top; height: 23.6pt;"> <td colspan="2" style="padding: 0; border-top: 1pt solid black; border-bottom: 1pt solid #000000; border-left: 1pt solid #000000; padding-top: 0.75pt; padding-bottom: 0.75pt; padding-left: 0.75pt; padding-right: 0.75pt; vertical-align: bottom;"> <div style="text-align: center; font-size: 10pt;">&#160; </div> </td> <td style="padding: 0; width: 5.82%; border-top: 1pt solid #000000; border-left: 1pt solid #000000; border-right: 1pt solid #000000; padding-top: 0.75pt; padding-bottom: 0.75pt; padding-left: 0.75pt; padding-right: 0.75pt;"> <div style="text-align: center; font-size: 10pt;">&#160; </div> </td> <td style="padding: 0; width: 6.38%; border-top: 1pt solid #000000; border-left: 1pt solid #000000; padding-top: 1.5pt; padding-bottom: 1.5pt; padding-left: 1.5pt; padding-right: 1.25pt; vertical-align: bottom;"> <div style="text-align: center;"> <ix:nonNumeric contextRef="c2" name="ffd:OfferingSctyTp" id="ixv-207"><span style="font-size: 10.0pt; color: #000000;">Equity</span></ix:nonNumeric> </div> </td> <td style="padding: 0; width: 7.4%; border-top: 1pt solid #000000; border-left: 1pt solid #000000; padding-top: 1.5pt; padding-bottom: 1.5pt; padding-left: 1.5pt; padding-right: 1.25pt; vertical-align: bottom;"> <div style="text-align: center;"> <ix:nonNumeric contextRef="c2" name="ffd:OfferingSctyTitl" id="ixv-211"><span style="font-size: 10.0pt; color: #000000;">Preferred Stock</span></ix:nonNumeric> </div> </td> <td style="padding: 0; width: 7.98%; border-top: 1pt solid #000000; border-left: 1pt solid #000000; padding-top: 1.5pt; padding-bottom: 1.5pt; padding-left: 1.5pt; padding-right: 1.25pt; vertical-align: bottom;"> <div style="text-align: center;"> <ix:nonNumeric contextRef="c2" format="ixt:fixed-true" name="ffd:Rule457oFlg" id="ixv-215"><span style="font-size: 10.0pt; color: #000000;">457(o)</span></ix:nonNumeric> </div> </td> <td style="padding: 0; width: 6.76%; border-top: 1pt solid #000000; border-left: 1pt solid #000000; padding-top: 1.5pt; padding-bottom: 1.5pt; padding-left: 1.5pt; padding-right: 1.25pt; vertical-align: bottom;"> <div style="text-align: center; font-size: 10pt;">&#160; </div> </td> <td style="padding: 0; width: 5.4%; border-top: 1pt solid #000000; border-left: 1pt solid #000000; padding-top: 1.5pt; padding-bottom: 1.5pt; padding-left: 1.5pt; padding-right: 1.25pt; vertical-align: bottom;"> <div style="text-align: center; font-size: 10pt;">&#160; </div> </td> <td style="padding: 0; width: 9.76%; border-top: 1pt solid #000000; border-left: 1pt solid #000000; padding-top: 1.5pt; padding-bottom: 1.5pt; padding-left: 1.5pt; padding-right: 1.25pt; vertical-align: bottom;"> <div style="text-align: center; font-size: 10pt;">&#160; </div> </td> <td style="padding: 0; width: 10.84%; border-top: 1pt solid #000000; border-left: 1pt solid #000000; padding-top: 1.5pt; padding-bottom: 1.5pt; padding-left: 1.5pt; padding-right: 1.25pt; vertical-align: bottom;"> <div style="text-align: center; font-size: 10pt;">&#160; </div> </td> <td style="padding: 0; width: 9.14%; border-top: 1pt solid #000000; border-left: 1pt solid #000000; padding-top: 1.5pt; padding-bottom: 1.5pt; padding-left: 1.5pt; padding-right: 1.25pt; vertical-align: bottom;"> <div style="text-align: center; font-size: 10pt;">&#160; </div> </td> <td style="padding: 0; width: 5.4%; border-top: 1pt solid #000000; border-left: 1pt solid #000000; padding-top: 1.5pt; padding-bottom: 1.5pt; padding-left: 1.5pt; padding-right: 1.25pt; vertical-align: bottom;"> <div style="text-align: center; font-size: 10pt;">&#160; </div> </td> <td style="padding: 0; width: 5.36%; border-top: 1pt solid #000000; border-left: 1pt solid #000000; padding-top: 1.5pt; padding-bottom: 1.5pt; padding-left: 1.5pt; padding-right: 1.25pt; vertical-align: bottom;"> <div style="text-align: center; font-size: 10pt;">&#160; </div> </td> <td style="padding: 0; width: 5.36%; border-top: 1pt solid #000000; border-left: 1pt solid #000000; padding-top: 1.5pt; padding-bottom: 1.5pt; padding-left: 1.5pt; padding-right: 1.25pt; vertical-align: bottom;"> <div style="text-align: center; font-size: 10pt;">&#160; </div> </td> <td style="padding: 0; width: 7.32%; border-top: 1pt solid #000000; border-left: 1pt solid #000000; border-right: 1pt solid #000000; padding-top: 1.5pt; padding-bottom: 1.5pt; padding-left: 1.5pt; padding-right: 1.5pt; vertical-align: bottom;"> <div style="text-align: center; font-size: 10pt;">&#160; </div> </td> </tr> <tr style="vertical-align: top; height: 23.6pt;"> <td colspan="2" style="padding: 0; border-top: 1pt solid black; border-bottom: 1pt solid #000000; border-left: 1pt solid #000000; padding-top: 0.75pt; padding-bottom: 0.75pt; padding-left: 0.75pt; padding-right: 0.75pt; vertical-align: bottom;"> <div style="text-align: center; font-size: 10pt;">&#160; </div> </td> <td style="padding: 0; width: 5.82%; border-top: 1pt solid #000000; border-left: 1pt solid #000000; border-right: 1pt solid #000000; padding-top: 0.75pt; padding-bottom: 0.75pt; padding-left: 0.75pt; padding-right: 0.75pt;"> <div style="text-align: center; font-size: 10pt;">&#160; </div> </td> <td style="padding: 0; width: 6.38%; border-top: 1pt solid #000000; border-left: 1pt solid #000000; padding-top: 1.5pt; padding-bottom: 1.5pt; padding-left: 1.5pt; padding-right: 1.25pt; vertical-align: bottom;"> <div style="text-align: center;"> <ix:nonNumeric contextRef="c3" name="ffd:OfferingSctyTp" id="ixv-242"><span style="font-size: 10.0pt; color: #000000;">Debt</span></ix:nonNumeric> </div> </td> <td style="padding: 0; width: 7.4%; border-top: 1pt solid #000000; border-left: 1pt solid #000000; padding-top: 1.5pt; padding-bottom: 1.5pt; padding-left: 1.5pt; padding-right: 1.25pt; vertical-align: bottom;"> <div style="text-align: center;"> <ix:nonNumeric contextRef="c3" name="ffd:OfferingSctyTitl" id="ixv-246"><span style="font-size: 10.0pt; color: #000000;">Debt Securities</span></ix:nonNumeric> </div> </td> <td style="padding: 0; width: 7.98%; border-top: 1pt solid #000000; border-left: 1pt solid #000000; padding-top: 1.5pt; padding-bottom: 1.5pt; padding-left: 1.5pt; padding-right: 1.25pt; vertical-align: bottom;"> <div style="text-align: center;"> <ix:nonNumeric contextRef="c3" format="ixt:fixed-true" name="ffd:Rule457oFlg" id="ixv-250"><span style="font-size: 10.0pt; color: #000000;">457(o)</span></ix:nonNumeric> </div> </td> <td style="padding: 0; width: 6.76%; border-top: 1pt solid #000000; border-left: 1pt solid #000000; padding-top: 1.5pt; padding-bottom: 1.5pt; padding-left: 1.5pt; padding-right: 1.25pt; vertical-align: bottom;"> <div style="text-align: center; font-size: 10pt;">&#160; </div> </td> <td style="padding: 0; width: 5.4%; border-top: 1pt solid #000000; border-left: 1pt solid #000000; padding-top: 1.5pt; padding-bottom: 1.5pt; padding-left: 1.5pt; padding-right: 1.25pt; vertical-align: bottom;"> <div style="text-align: center; font-size: 10pt;">&#160; </div> </td> <td style="padding: 0; width: 9.76%; border-top: 1pt solid #000000; border-left: 1pt solid #000000; padding-top: 1.5pt; padding-bottom: 1.5pt; padding-left: 1.5pt; padding-right: 1.25pt; vertical-align: bottom;"> <div style="text-align: center; font-size: 10pt;">&#160; </div> </td> <td style="padding: 0; width: 10.84%; border-top: 1pt solid #000000; border-left: 1pt solid #000000; padding-top: 1.5pt; padding-bottom: 1.5pt; padding-left: 1.5pt; padding-right: 1.25pt; vertical-align: bottom;"> <div style="text-align: center; font-size: 10pt;">&#160; </div> </td> <td style="padding: 0; width: 9.14%; border-top: 1pt solid #000000; border-left: 1pt solid #000000; padding-top: 1.5pt; padding-bottom: 1.5pt; padding-left: 1.5pt; padding-right: 1.25pt; vertical-align: bottom;"> <div style="text-align: center; font-size: 10pt;">&#160; </div> </td> <td style="padding: 0; width: 5.4%; border-top: 1pt solid #000000; border-left: 1pt solid #000000; padding-top: 1.5pt; padding-bottom: 1.5pt; padding-left: 1.5pt; padding-right: 1.25pt; vertical-align: bottom;"> <div style="text-align: center; font-size: 10pt;">&#160; </div> </td> <td style="padding: 0; width: 5.36%; border-top: 1pt solid #000000; border-left: 1pt solid #000000; padding-top: 1.5pt; padding-bottom: 1.5pt; padding-left: 1.5pt; padding-right: 1.25pt; vertical-align: bottom;"> <div style="text-align: center; font-size: 10pt;">&#160; </div> </td> <td style="padding: 0; width: 5.36%; border-top: 1pt solid #000000; border-left: 1pt solid #000000; padding-top: 1.5pt; padding-bottom: 1.5pt; padding-left: 1.5pt; padding-right: 1.25pt; vertical-align: bottom;"> <div style="text-align: center; font-size: 10pt;">&#160; </div> </td> <td style="padding: 0; width: 7.32%; border-top: 1pt solid #000000; border-left: 1pt solid #000000; border-right: 1pt solid #000000; padding-top: 1.5pt; padding-bottom: 1.5pt; padding-left: 1.5pt; padding-right: 1.5pt; vertical-align: bottom;"> <div style="text-align: center; font-size: 10pt;">&#160; </div> </td> </tr> <tr style="vertical-align: top; height: 14.6pt;"> <td colspan="2" style="padding: 0; border-top: 1pt solid black; border-bottom: 1pt solid #000000; border-left: 1pt solid #000000; padding-top: 0.75pt; padding-bottom: 0.75pt; padding-left: 0.75pt; padding-right: 0.75pt; vertical-align: bottom;"> <div style="text-align: center; font-size: 10pt;">&#160; </div> </td> <td style="padding: 0; width: 5.82%; border-top: 1pt solid #000000; border-left: 1pt solid #000000; border-right: 1pt solid #000000; padding-top: 0.75pt; padding-bottom: 0.75pt; padding-left: 0.75pt; padding-right: 0.75pt;"> <div style="text-align: center; font-size: 10pt;">&#160; </div> </td> <td style="padding: 0; width: 6.38%; border-top: 1pt solid #000000; border-left: 1pt solid #000000; padding-top: 1.5pt; padding-bottom: 1.5pt; padding-left: 1.5pt; padding-right: 1.25pt; vertical-align: bottom;"> <div style="text-align: center;"> <ix:nonNumeric contextRef="c4" name="ffd:OfferingSctyTp" id="ixv-277"><span style="font-size: 10.0pt; color: #000000;">Other</span></ix:nonNumeric> </div> </td> <td style="padding: 0; width: 7.4%; border-top: 1pt solid #000000; border-left: 1pt solid #000000; padding-top: 1.5pt; padding-bottom: 1.5pt; padding-left: 1.5pt; padding-right: 1.25pt; vertical-align: bottom;"> <div style="text-align: center;"> <ix:nonNumeric contextRef="c4" name="ffd:OfferingSctyTitl" id="ixv-281"><span style="font-size: 10.0pt; color: #000000;">Warrants</span></ix:nonNumeric> </div> </td> <td style="padding: 0; width: 7.98%; border-top: 1pt solid #000000; border-left: 1pt solid #000000; padding-top: 1.5pt; padding-bottom: 1.5pt; padding-left: 1.5pt; padding-right: 1.25pt; vertical-align: bottom;"> <div style="text-align: center;"> <ix:nonNumeric contextRef="c4" format="ixt:fixed-true" name="ffd:Rule457oFlg" id="ixv-285"><span style="font-size: 10.0pt; color: #000000;">457(o)</span></ix:nonNumeric> </div> </td> <td style="padding: 0; width: 6.76%; border-top: 1pt solid #000000; border-left: 1pt solid #000000; padding-top: 1.5pt; padding-bottom: 1.5pt; padding-left: 1.5pt; padding-right: 1.25pt; vertical-align: bottom;"> <div style="text-align: center; font-size: 10pt;">&#160; </div> </td> <td style="padding: 0; width: 5.4%; border-top: 1pt solid #000000; border-left: 1pt solid #000000; padding-top: 1.5pt; padding-bottom: 1.5pt; padding-left: 1.5pt; padding-right: 1.25pt; vertical-align: bottom;"> <div style="text-align: center; font-size: 10pt;">&#160; </div> </td> <td style="padding: 0; width: 9.76%; border-top: 1pt solid #000000; border-left: 1pt solid #000000; padding-top: 1.5pt; padding-bottom: 1.5pt; padding-left: 1.5pt; padding-right: 1.25pt; vertical-align: bottom;"> <div style="text-align: center; font-size: 10pt;">&#160; </div> </td> <td style="padding: 0; width: 10.84%; border-top: 1pt solid #000000; border-left: 1pt solid #000000; padding-top: 1.5pt; padding-bottom: 1.5pt; padding-left: 1.5pt; padding-right: 1.25pt; vertical-align: bottom;"> <div style="text-align: center; font-size: 10pt;">&#160; </div> </td> <td style="padding: 0; width: 9.14%; border-top: 1pt solid #000000; border-left: 1pt solid #000000; padding-top: 1.5pt; padding-bottom: 1.5pt; padding-left: 1.5pt; padding-right: 1.25pt; vertical-align: bottom;"> <div style="text-align: center; font-size: 10pt;">&#160; </div> </td> <td style="padding: 0; width: 5.4%; border-top: 1pt solid #000000; border-left: 1pt solid #000000; padding-top: 1.5pt; padding-bottom: 1.5pt; padding-left: 1.5pt; padding-right: 1.25pt; vertical-align: bottom;"> <div style="text-align: center; font-size: 10pt;">&#160; </div> </td> <td style="padding: 0; width: 5.36%; border-top: 1pt solid #000000; border-left: 1pt solid #000000; padding-top: 1.5pt; padding-bottom: 1.5pt; padding-left: 1.5pt; padding-right: 1.25pt; vertical-align: bottom;"> <div style="text-align: center; font-size: 10pt;">&#160; </div> </td> <td style="padding: 0; width: 5.36%; border-top: 1pt solid #000000; border-left: 1pt solid #000000; padding-top: 1.5pt; padding-bottom: 1.5pt; padding-left: 1.5pt; padding-right: 1.25pt; vertical-align: bottom;"> <div style="text-align: center; font-size: 10pt;">&#160; </div> </td> <td style="padding: 0; width: 7.32%; border-top: 1pt solid #000000; border-left: 1pt solid #000000; border-right: 1pt solid #000000; padding-top: 1.5pt; padding-bottom: 1.5pt; padding-left: 1.5pt; padding-right: 1.5pt; vertical-align: bottom;"> <div style="text-align: center; font-size: 10pt;">&#160; </div> </td> </tr> <tr style="vertical-align: top; height: 23.6pt;"> <td colspan="2" style="padding: 0; border-top: 1pt solid black; border-bottom: 1pt solid #000000; border-left: 1pt solid #000000; padding-top: 0.75pt; padding-bottom: 0.75pt; padding-left: 0.75pt; padding-right: 0.75pt; vertical-align: bottom;"> <div style="text-align: center; font-size: 10pt;">&#160; </div> </td> <td style="padding: 0; width: 5.82%; border-top: 1pt solid #000000; border-left: 1pt solid #000000; border-right: 1pt solid #000000; padding-top: 0.75pt; padding-bottom: 0.75pt; padding-left: 0.75pt; padding-right: 0.75pt;"> <div style="text-align: center; font-size: 10pt;">&#160; </div> </td> <td style="padding: 0; width: 6.38%; border-top: 1pt solid #000000; border-left: 1pt solid #000000; padding-top: 1.5pt; padding-bottom: 1.5pt; padding-left: 1.5pt; padding-right: 1.25pt; vertical-align: bottom;"> <div style="text-align: center;"> <ix:nonNumeric contextRef="c5" name="ffd:OfferingSctyTp" id="ixv-312"><span style="font-size: 10.0pt; color: #000000;">Other</span></ix:nonNumeric> </div> </td> <td style="padding: 0; width: 7.4%; border-top: 1pt solid #000000; border-left: 1pt solid #000000; padding-top: 1.5pt; padding-bottom: 1.5pt; padding-left: 1.5pt; padding-right: 1.25pt; vertical-align: bottom;"> <div style="text-align: center;"> <ix:nonNumeric contextRef="c5" name="ffd:OfferingSctyTitl" id="ixv-316"><span style="font-size: 10.0pt; color: #000000;">Purchase Contracts</span></ix:nonNumeric> </div> </td> <td style="padding: 0; width: 7.98%; border-top: 1pt solid #000000; border-left: 1pt solid #000000; padding-top: 1.5pt; padding-bottom: 1.5pt; padding-left: 1.5pt; padding-right: 1.25pt; vertical-align: bottom;"> <div style="text-align: center;"> <ix:nonNumeric contextRef="c5" format="ixt:fixed-true" name="ffd:Rule457oFlg" id="ixv-320"><span style="font-size: 10.0pt; color: #000000;">457(o)</span></ix:nonNumeric> </div> </td> <td style="padding: 0; width: 6.76%; border-top: 1pt solid #000000; border-left: 1pt solid #000000; padding-top: 1.5pt; padding-bottom: 1.5pt; padding-left: 1.5pt; padding-right: 1.25pt; vertical-align: bottom;"> <div style="text-align: center; font-size: 10pt;">&#160; </div> </td> <td style="padding: 0; width: 5.4%; border-top: 1pt solid #000000; border-left: 1pt solid #000000; padding-top: 1.5pt; padding-bottom: 1.5pt; padding-left: 1.5pt; padding-right: 1.25pt; vertical-align: bottom;"> <div style="text-align: center; font-size: 10pt;">&#160; </div> </td> <td style="padding: 0; width: 9.76%; border-top: 1pt solid #000000; border-left: 1pt solid #000000; padding-top: 1.5pt; padding-bottom: 1.5pt; padding-left: 1.5pt; padding-right: 1.25pt; vertical-align: bottom;"> <div style="text-align: center; font-size: 10pt;">&#160; </div> </td> <td style="padding: 0; width: 10.84%; border-top: 1pt solid #000000; border-left: 1pt solid #000000; padding-top: 1.5pt; padding-bottom: 1.5pt; padding-left: 1.5pt; padding-right: 1.25pt; vertical-align: bottom;"> <div style="text-align: center; font-size: 10pt;">&#160; </div> </td> <td style="padding: 0; width: 9.14%; border-top: 1pt solid #000000; border-left: 1pt solid #000000; padding-top: 1.5pt; padding-bottom: 1.5pt; padding-left: 1.5pt; padding-right: 1.25pt; vertical-align: bottom;"> <div style="text-align: center; font-size: 10pt;">&#160; </div> </td> <td style="padding: 0; width: 5.4%; border-top: 1pt solid #000000; border-left: 1pt solid #000000; padding-top: 1.5pt; padding-bottom: 1.5pt; padding-left: 1.5pt; padding-right: 1.25pt; vertical-align: bottom;"> <div style="text-align: center; font-size: 10pt;">&#160; </div> </td> <td style="padding: 0; width: 5.36%; border-top: 1pt solid #000000; border-left: 1pt solid #000000; padding-top: 1.5pt; padding-bottom: 1.5pt; padding-left: 1.5pt; padding-right: 1.25pt; vertical-align: bottom;"> <div style="text-align: center; font-size: 10pt;">&#160; </div> </td> <td style="padding: 0; width: 5.36%; border-top: 1pt solid #000000; border-left: 1pt solid #000000; padding-top: 1.5pt; padding-bottom: 1.5pt; padding-left: 1.5pt; padding-right: 1.25pt; vertical-align: bottom;"> <div style="text-align: center; font-size: 10pt;">&#160; </div> </td> <td style="padding: 0; width: 7.32%; border-top: 1pt solid #000000; border-left: 1pt solid #000000; border-right: 1pt solid #000000; padding-top: 1.5pt; padding-bottom: 1.5pt; padding-left: 1.5pt; padding-right: 1.5pt; vertical-align: bottom;"> <div style="text-align: center; font-size: 10pt;">&#160; </div> </td> </tr> <tr style="vertical-align: top; height: 14.6pt;"> <td colspan="2" style="padding: 0; border-top: 1pt solid black; border-bottom: 1pt solid #000000; border-left: 1pt solid #000000; padding-top: 0.75pt; padding-bottom: 0.75pt; padding-left: 0.75pt; padding-right: 0.75pt; vertical-align: bottom;"> <div style="text-align: center; font-size: 10pt;">&#160; </div> </td> <td style="padding: 0; width: 5.82%; border-top: 1pt solid #000000; border-bottom: 1pt solid #000000; border-left: 1pt solid #000000; border-right: 1pt solid #000000; padding-top: 0.75pt; padding-bottom: 0.75pt; padding-left: 0.75pt; padding-right: 0.75pt;"> <div style="text-align: center; font-size: 10pt;">&#160; </div> </td> <td style="padding: 0; width: 6.38%; border-top: 1pt solid #000000; border-bottom: 1pt solid #000000; border-left: 1pt solid #000000; padding-top: 1.5pt; padding-bottom: 1.5pt; padding-left: 1.5pt; padding-right: 1.25pt; vertical-align: bottom;"> <div style="text-align: center;"> <ix:nonNumeric contextRef="c6" name="ffd:OfferingSctyTp" id="ixv-347"><span style="font-size: 10.0pt; color: #000000;">Other</span></ix:nonNumeric> </div> </td> <td style="padding: 0; width: 7.4%; border-top: 1pt solid #000000; border-bottom: 1pt solid #000000; border-left: 1pt solid #000000; padding-top: 1.5pt; padding-bottom: 1.5pt; padding-left: 1.5pt; padding-right: 1.25pt; vertical-align: bottom;"> <div style="text-align: center;"> <ix:nonNumeric contextRef="c6" name="ffd:OfferingSctyTitl" id="ixv-351"><span style="font-size: 10.0pt; color: #000000;">Units</span></ix:nonNumeric> </div> </td> <td style="padding: 0; width: 7.98%; border-top: 1pt solid #000000; border-bottom: 1pt solid #000000; border-left: 1pt solid #000000; padding-top: 1.5pt; padding-bottom: 1.5pt; padding-left: 1.5pt; padding-right: 1.25pt; vertical-align: bottom;"> <div style="text-align: center;"> <ix:nonNumeric contextRef="c6" format="ixt:fixed-true" name="ffd:Rule457oFlg" id="ixv-355"><span style="font-size: 10.0pt; color: #000000;">457(o)</span></ix:nonNumeric> </div> </td> <td style="padding: 0; width: 6.76%; border-top: 1pt solid #000000; border-bottom: 1pt solid #000000; border-left: 1pt solid #000000; padding-top: 1.5pt; padding-bottom: 1.5pt; padding-left: 1.5pt; padding-right: 1.25pt; vertical-align: bottom;"> <div style="text-align: center; font-size: 10pt;">&#160; </div> </td> <td style="padding: 0; width: 5.4%; border-top: 1pt solid #000000; border-bottom: 1pt solid #000000; border-left: 1pt solid #000000; padding-top: 1.5pt; padding-bottom: 1.5pt; padding-left: 1.5pt; padding-right: 1.25pt; vertical-align: bottom;"> <div style="text-align: center; font-size: 10pt;">&#160; </div> </td> <td style="padding: 0; width: 9.76%; border-top: 1pt solid #000000; border-bottom: 1pt solid #000000; border-left: 1pt solid #000000; padding-top: 1.5pt; padding-bottom: 1.5pt; padding-left: 1.5pt; padding-right: 1.25pt; vertical-align: bottom;"> <div style="text-align: center; font-size: 10pt;">&#160; </div> </td> <td style="padding: 0; width: 10.84%; border-top: 1pt solid #000000; border-bottom: 1pt solid #000000; border-left: 1pt solid #000000; padding-top: 1.5pt; padding-bottom: 1.5pt; padding-left: 1.5pt; padding-right: 1.25pt; vertical-align: bottom;"> <div style="text-align: center; font-size: 10pt;">&#160; </div> </td> <td style="padding: 0; width: 9.14%; border-top: 1pt solid #000000; border-bottom: 1pt solid #000000; border-left: 1pt solid #000000; padding-top: 1.5pt; padding-bottom: 1.5pt; padding-left: 1.5pt; padding-right: 1.25pt; vertical-align: bottom;"> <div style="text-align: center; font-size: 10pt;">&#160; </div> </td> <td style="padding: 0; width: 5.4%; border-top: 1pt solid #000000; border-bottom: 1pt solid #000000; border-left: 1pt solid #000000; padding-top: 1.5pt; padding-bottom: 1.5pt; padding-left: 1.5pt; padding-right: 1.25pt; vertical-align: bottom;"> <div style="text-align: center; font-size: 10pt;">&#160; </div> </td> <td style="padding: 0; width: 5.36%; border-top: 1pt solid #000000; border-bottom: 1pt solid #000000; border-left: 1pt solid #000000; padding-top: 1.5pt; padding-bottom: 1.5pt; padding-left: 1.5pt; padding-right: 1.25pt; vertical-align: bottom;"> <div style="text-align: center; font-size: 10pt;">&#160; </div> </td> <td style="padding: 0; width: 5.36%; border-top: 1pt solid #000000; border-bottom: 1pt solid #000000; border-left: 1pt solid #000000; padding-top: 1.5pt; padding-bottom: 1.5pt; padding-left: 1.5pt; padding-right: 1.25pt; vertical-align: bottom;"> <div style="text-align: center; font-size: 10pt;">&#160; </div> </td> <td style="padding: 0; width: 7.32%; border-top: 1pt solid #000000; border-bottom: 1pt solid #000000; border-left: 1pt solid #000000; border-right: 1pt solid #000000; padding-top: 1.5pt; padding-bottom: 1.5pt; padding-left: 1.5pt; padding-right: 1.5pt; vertical-align: bottom;"> <div style="text-align: center; font-size: 10pt;">&#160; </div> </td> </tr> <tr style="vertical-align: top; height: 32.6pt;"> <td colspan="2" style="padding: 0; border-top: 1pt solid black; border-bottom: 1pt solid #000000; border-left: 1pt solid #000000; padding-top: 0.75pt; padding-bottom: 0.75pt; padding-left: 0.75pt; padding-right: 0.75pt; vertical-align: bottom;"> <div style="text-align: center;"> <ix:nonNumeric contextRef="c7" format="ixt:fixed-false" name="ffd:PrevslyPdFlg" id="ixv-378"><ix:nonNumeric contextRef="c6" format="ixt:fixed-false" name="ffd:PrevslyPdFlg" id="ixv-379"><ix:nonNumeric contextRef="c5" format="ixt:fixed-false" name="ffd:PrevslyPdFlg" id="ixv-380"><ix:nonNumeric contextRef="c4" format="ixt:fixed-false" name="ffd:PrevslyPdFlg" id="ixv-381"><ix:nonNumeric contextRef="c3" format="ixt:fixed-false" name="ffd:PrevslyPdFlg" id="ixv-382"><ix:nonNumeric contextRef="c2" format="ixt:fixed-false" name="ffd:PrevslyPdFlg" id="ixv-383"><ix:nonNumeric contextRef="c1" format="ixt:fixed-false" name="ffd:PrevslyPdFlg" id="ixv-384"><span style="font-size: 10.0pt; color: #000000;">Fees to be paid</span></ix:nonNumeric></ix:nonNumeric></ix:nonNumeric></ix:nonNumeric></ix:nonNumeric></ix:nonNumeric></ix:nonNumeric> </div> </td> <td style="padding: 0; width: 5.82%; border-top: 1pt solid #000000; border-bottom: 1pt solid black; border-left: 1pt solid #000000; border-right: 1pt solid #000000; padding-top: 0.75pt; padding-bottom: 0.75pt; padding-left: 0.75pt; padding-right: 0.75pt; vertical-align: bottom;"> <div style="text-align: center;"> <span style="font-size: 10.0pt; color: #000000;">(1)</span> </div> </td> <td style="padding: 0; width: 6.38%; border-top: 1pt solid #000000; border-bottom: 1pt solid black; border-left: 1pt solid #000000; padding-top: 1.5pt; padding-bottom: 1.5pt; padding-left: 1.5pt; padding-right: 1.25pt; vertical-align: bottom;"> <div style="text-align: center;"> <ix:nonNumeric contextRef="c7" name="ffd:OfferingSctyTp" id="ixv-391"><span style="font-size: 10.0pt; color: #000000;">Unallocated (Universal) Shelf</span></ix:nonNumeric> </div> </td> <td style="padding: 0; width: 7.4%; border-top: 1pt solid #000000; border-bottom: 1pt solid black; border-left: 1pt solid #000000; padding-top: 1.5pt; padding-bottom: 1.5pt; padding-left: 1.5pt; padding-right: 1.25pt; vertical-align: bottom;"> <div style="text-align: center; font-size: 10pt;">&#160; </div> </td> <td style="padding: 0; width: 7.98%; border-top: 1pt solid #000000; border-bottom: 1pt solid black; border-left: 1pt solid #000000; padding-top: 1.5pt; padding-bottom: 1.5pt; padding-left: 1.5pt; padding-right: 1.25pt; vertical-align: bottom;"> <div style="text-align: center;"> <ix:nonNumeric contextRef="c7" format="ixt:fixed-true" name="ffd:Rule457oFlg" id="ixv-397"><span style="font-size: 10.0pt; color: #000000;">457(o)</span></ix:nonNumeric> </div> </td> <td style="padding: 0; width: 6.76%; border-top: 1pt solid #000000; border-bottom: 1pt solid black; border-left: 1pt solid #000000; padding-top: 1.5pt; padding-bottom: 1.5pt; padding-left: 1.5pt; padding-right: 1.25pt; vertical-align: bottom;"> <div style="text-align: center; font-size: 10pt;">&#160; </div> </td> <td style="padding: 0; width: 5.4%; border-top: 1pt solid #000000; border-bottom: 1pt solid black; border-left: 1pt solid #000000; padding-top: 1.5pt; padding-bottom: 1.5pt; padding-left: 1.5pt; padding-right: 1.25pt; vertical-align: bottom;"> <div style="text-align: center; font-size: 10pt;">&#160; </div> </td> <td style="padding: 0; width: 9.76%; border-top: 1pt solid #000000; border-bottom: 1pt solid black; border-left: 1pt solid #000000; padding-top: 1.5pt; padding-bottom: 1.5pt; padding-left: 1.5pt; padding-right: 1.25pt; vertical-align: bottom;"> <div style="text-align: center;"> <span style="font-size: 10.0pt; color: #000000;">$<ix:nonFraction contextRef="c7" decimals="INF" format="ixt:num-dot-decimal" name="ffd:MaxAggtOfferingPric" scale="0" unitRef="usd" id="ixv-574">156,128,866</ix:nonFraction></span> </div> </td> <td style="padding: 0; width: 10.84%; border-top: 1pt solid #000000; border-bottom: 1pt solid black; border-left: 1pt solid #000000; padding-top: 1.5pt; padding-bottom: 1.5pt; padding-left: 1.5pt; padding-right: 1.25pt; vertical-align: bottom;"> <div style="text-align: center;"> <span style="font-size: 10.0pt; color: #000000;"><ix:nonFraction contextRef="c7" decimals="8" format="ixt:num-dot-decimal" name="ffd:FeeRate" scale="0" unitRef="pure" id="ixv-575">0.00015310</ix:nonFraction></span> </div> </td> <td style="padding: 0; width: 9.14%; border-top: 1pt solid #000000; border-bottom: 1pt solid black; border-left: 1pt solid #000000; padding-top: 1.5pt; padding-bottom: 1.5pt; padding-left: 1.5pt; padding-right: 1.25pt; vertical-align: bottom;"> <div style="text-align: center;"> <span style="font-size: 10.0pt; color: #000000;">$<ix:nonFraction contextRef="c7" decimals="2" format="ixt:num-dot-decimal" name="ffd:FeeAmt" scale="0" unitRef="usd" id="ixv-576">23,903.33</ix:nonFraction></span> </div> </td> <td style="padding: 0; width: 5.4%; border-top: 1pt solid #000000; border-bottom: 1pt solid black; border-left: 1pt solid #000000; padding-top: 1.5pt; padding-bottom: 1.5pt; padding-left: 1.5pt; padding-right: 1.25pt; vertical-align: bottom;"> <div style="text-align: center; font-size: 10pt;">&#160; </div> </td> <td style="padding: 0; width: 5.36%; border-top: 1pt solid #000000; border-bottom: 1pt solid black; border-left: 1pt solid #000000; padding-top: 1.5pt; padding-bottom: 1.5pt; padding-left: 1.5pt; padding-right: 1.25pt; vertical-align: bottom;"> <div style="text-align: center; font-size: 10pt;">&#160; </div> </td> <td style="padding: 0; width: 5.36%; border-top: 1pt solid #000000; border-bottom: 1pt solid black; border-left: 1pt solid #000000; padding-top: 1.5pt; padding-bottom: 1.5pt; padding-left: 1.5pt; padding-right: 1.25pt; vertical-align: bottom;"> <div style="text-align: center; font-size: 10pt;">&#160; </div> </td> <td style="padding: 0; width: 7.32%; border-top: 1pt solid #000000; border-bottom: 1pt solid black; border-left: 1pt solid #000000; border-right: 1pt solid #000000; padding-top: 1.5pt; padding-bottom: 1.5pt; padding-left: 1.5pt; padding-right: 1.5pt; vertical-align: bottom;"> <div style="text-align: center; font-size: 10pt;">&#160; </div> </td> </tr> <tr style="vertical-align: top; height: 44.0pt;"> <td colspan="2" style="padding: 0; border-top: 1pt solid black; border-bottom: 1pt solid #000000; border-left: 1pt solid #000000; padding-top: 0.75pt; padding-bottom: 0.75pt; padding-left: 0.75pt; padding-right: 0.75pt; vertical-align: bottom;"> <div style="text-align: center;"> <ix:nonNumeric contextRef="c8" format="ixt:fixed-true" name="ffd:PrevslyPdFlg" id="ixv-423"><span style="font-size: 10.0pt; color: #000000;">Fees previously paid</span></ix:nonNumeric> </div> </td> <td style="padding: 0; width: 5.82%; border-top: 1pt solid #000000; border-left: 1pt solid #000000; border-right: 1pt solid #000000; padding-top: 0.75pt; padding-bottom: 0.75pt; padding-left: 0.75pt; padding-right: 0.75pt; vertical-align: bottom;"> <div style="text-align: center;"> <span style="font-size: 10.0pt; color: #000000;">(1)</span> </div> </td> <td style="padding: 0; width: 6.38%; border-top: 1pt solid #000000; border-left: 1pt solid #000000; padding-top: 1.5pt; padding-bottom: 1.5pt; padding-left: 1.5pt; padding-right: 1.25pt; vertical-align: bottom;"> <div style="text-align: center;"> <ix:nonNumeric contextRef="c8" name="ffd:OfferingSctyTp" id="ixv-430"><span style="font-size: 10.0pt; color: #000000;">Equity</span></ix:nonNumeric> </div> </td> <td style="padding: 0; width: 7.4%; border-top: 1pt solid #000000; border-left: 1pt solid #000000; padding-top: 1.5pt; padding-bottom: 1.5pt; padding-left: 1.5pt; padding-right: 1.25pt; vertical-align: bottom;"> <div style="text-align: center;"> <ix:nonNumeric contextRef="c8" name="ffd:OfferingSctyTitl" id="ixv-434"><span style="font-size: 10.0pt; color: #000000;">Common Stock, $0.0001 par value per share</span></ix:nonNumeric> </div> </td> <td style="padding: 0; width: 7.98%; border-top: 1pt solid #000000; border-left: 1pt solid #000000; padding-top: 1.5pt; padding-bottom: 1.5pt; padding-left: 1.5pt; padding-right: 1.25pt; vertical-align: bottom;"> <div style="text-align: center;"> <ix:nonNumeric contextRef="c8" format="ixt:fixed-true" name="ffd:Rule457oFlg" id="ixv-438"><span style="font-size: 10.0pt; color: #000000;">457(o)</span></ix:nonNumeric> </div> </td> <td style="padding: 0; width: 6.76%; border-top: 1pt solid #000000; border-left: 1pt solid #000000; padding-top: 1.5pt; padding-bottom: 1.5pt; padding-left: 1.5pt; padding-right: 1.25pt; vertical-align: bottom;"> <div style="text-align: center; font-size: 10pt;">&#160; </div> </td> <td style="padding: 0; width: 5.4%; border-top: 1pt solid #000000; border-left: 1pt solid #000000; padding-top: 1.5pt; padding-bottom: 1.5pt; padding-left: 1.5pt; padding-right: 1.25pt; vertical-align: bottom;"> <div style="text-align: center; font-size: 10pt;">&#160; </div> </td> <td style="padding: 0; width: 9.76%; border-top: 1pt solid #000000; border-left: 1pt solid #000000; padding-top: 1.5pt; padding-bottom: 1.5pt; padding-left: 1.5pt; padding-right: 1.25pt; vertical-align: bottom;"> <div style="text-align: center;"> <span style="font-size: 10.0pt; color: #000000;">$<ix:nonFraction contextRef="c8" decimals="INF" format="ixt:num-dot-decimal" name="ffd:MaxAggtOfferingPric" scale="0" unitRef="usd" id="ixv-577">156,128,866</ix:nonFraction> </span> </div> </td> <td style="padding: 0; width: 10.84%; border-top: 1pt solid #000000; border-left: 1pt solid #000000; padding-top: 1.5pt; padding-bottom: 1.5pt; padding-left: 1.5pt; padding-right: 1.25pt; vertical-align: bottom;"> <div style="text-align: center;"> <span style="font-size: 10.0pt; color: #000000;"><ix:nonFraction contextRef="c8" decimals="8" format="ixt:num-dot-decimal" name="ffd:FeeRate" scale="0" unitRef="pure" id="ixv-578">0.00014760</ix:nonFraction></span> </div> </td> <td style="padding: 0; width: 9.14%; border-top: 1pt solid #000000; border-left: 1pt solid #000000; padding-top: 1.5pt; padding-bottom: 1.5pt; padding-left: 1.5pt; padding-right: 1.25pt; vertical-align: bottom;"> <div style="text-align: center;"> <span style="font-size: 10.0pt; color: #000000;">$<ix:nonFraction contextRef="c8" decimals="2" format="ixt:num-dot-decimal" name="ffd:FeeAmt" scale="0" unitRef="usd" id="ixv-579">23,044.63</ix:nonFraction></span> </div> </td> <td style="padding: 0; width: 5.4%; border-top: 1pt solid #000000; border-left: 1pt solid #000000; padding-top: 1.5pt; padding-bottom: 1.5pt; padding-left: 1.5pt; padding-right: 1.25pt; vertical-align: bottom;"> <div style="text-align: center; font-size: 10pt;">&#160; </div> </td> <td style="padding: 0; width: 5.36%; border-top: 1pt solid #000000; border-left: 1pt solid #000000; padding-top: 1.5pt; padding-bottom: 1.5pt; padding-left: 1.5pt; padding-right: 1.25pt; vertical-align: bottom;"> <div style="text-align: center; font-size: 10pt;">&#160; </div> </td> <td style="padding: 0; width: 5.36%; border-top: 1pt solid #000000; border-left: 1pt solid #000000; padding-top: 1.5pt; padding-bottom: 1.5pt; padding-left: 1.5pt; padding-right: 1.25pt; vertical-align: bottom;"> <div style="text-align: center; font-size: 10pt;">&#160; </div> </td> <td style="padding: 0; width: 7.32%; border-top: 1pt solid #000000; border-left: 1pt solid #000000; border-right: 1pt solid #000000; padding-top: 1.5pt; padding-bottom: 1.5pt; padding-left: 1.5pt; padding-right: 1.5pt; vertical-align: bottom;"> <div style="text-align: center; font-size: 10pt;">&#160; </div> </td> </tr> <tr style="vertical-align: top;"> <td colspan="2" style="padding: 0; border-top: 1pt solid #000000; border-left: 1pt solid #000000; padding-top: 1.5pt; padding-bottom: 1.5pt; padding-left: 7.25pt; padding-right: 1.25pt; vertical-align: bottom; font-size: 0;">&#160; </td> <td style="padding: 0; width: 5.82%; border-top: 1pt solid #000000; border-left: 1pt solid #000000; border-right: 1pt solid #000000; padding-top: 0.75pt; padding-bottom: 0.75pt; padding-left: 0.75pt; padding-right: 0.75pt;"> <div style="text-align: center; font-size: 10pt;">&#160; </div> </td> <td colspan="4" style="padding: 0; border-top: 1pt solid #000000; border-bottom: 1pt solid #000000; border-left: 1pt solid #000000; padding-top: 1.5pt; padding-bottom: 1.5pt; padding-left: 1.5pt; padding-right: 1.25pt; vertical-align: bottom;"> <div style="text-align: right;"> <span style="font-size: 10.0pt; color: #000000;">Total Offering Amounts</span> </div> </td> <td style="padding: 0; width: 5.4%; border-top: 1pt solid #000000; border-left: 1pt solid #000000; padding-left: 1.5pt; padding-right: 1.25pt; vertical-align: middle; font-size: 0;">&#160; </td> <td style="padding: 0; width: 9.76%; border-top: 1pt solid #000000; border-left: 1pt solid #000000; padding-top: 1.5pt; padding-bottom: 1.5pt; padding-left: 1.5pt; padding-right: 1.25pt; vertical-align: bottom;"> <div style="text-align: center;"> <span style="font-size: 10.0pt; color: #000000;">$<ix:nonFraction contextRef="c0" decimals="INF" format="ixt:num-dot-decimal" name="ffd:TtlOfferingAmt" scale="0" unitRef="usd" id="ixv-580">156,128,866</ix:nonFraction> </span> </div> </td> <td style="padding: 0; width: 10.84%; border-top: 1pt solid #000000; border-left: 1pt solid #000000; padding-left: 1.5pt; padding-right: 1.25pt; vertical-align: middle; font-size: 0;">&#160; </td> <td style="padding: 0; width: 9.14%; border-top: 1pt solid #000000; border-left: 1pt solid #000000; padding-top: 1.5pt; padding-bottom: 1.5pt; padding-left: 1.5pt; padding-right: 1.25pt; vertical-align: bottom;"> <div style="text-align: center;"> <span style="font-size: 10.0pt; color: #000000;">$<ix:nonFraction contextRef="c0" decimals="2" format="ixt:num-dot-decimal" name="ffd:TtlFeeAmt" scale="0" unitRef="usd" id="ixv-581">23,903.33</ix:nonFraction></span> </div> </td> <td style="padding: 0; width: 5.4%; border-top: 1pt solid #000000; border-left: 1pt solid #000000; padding-left: 1.5pt; padding-right: 1.25pt; vertical-align: middle; font-size: 0;">&#160; </td> <td style="padding: 0; width: 5.36%; border-top: 1pt solid #000000; border-left: 1pt solid #000000; padding-left: 1.5pt; padding-right: 1.25pt; vertical-align: middle; font-size: 0;">&#160; </td> <td style="padding: 0; width: 5.36%; border-top: 1pt solid #000000; border-left: 1pt solid #000000; padding-left: 1.5pt; padding-right: 1.25pt; vertical-align: middle; font-size: 0;">&#160; </td> <td style="padding: 0; width: 7.32%; border-top: 1pt solid #000000; border-left: 1pt solid #000000; border-right: 1pt solid #000000; padding-top: 1.5pt; padding-bottom: 1.5pt; padding-left: 1.5pt; padding-right: 1.5pt; vertical-align: bottom; font-size: 0;">&#160; </td> </tr> <tr style="vertical-align: top;"> <td colspan="2" style="padding: 0; border-top: 1pt solid #000000; border-left: 1pt solid #000000; padding-top: 1.5pt; padding-bottom: 1.5pt; padding-left: 7.25pt; padding-right: 1.25pt; vertical-align: bottom; font-size: 0;">&#160; </td> <td style="padding: 0; width: 5.82%; border-top: 1pt solid #000000; border-left: 1pt solid #000000; border-right: 1pt solid #000000; padding-top: 0.75pt; padding-bottom: 0.75pt; padding-left: 0.75pt; padding-right: 0.75pt;"> <div style="text-align: center; font-size: 10pt;">&#160; </div> </td> <td colspan="4" style="padding: 0; border-top: 1pt solid #000000; border-bottom: 1pt solid #000000; border-left: 1pt solid #000000; padding-top: 1.5pt; padding-bottom: 1.5pt; padding-left: 1.5pt; padding-right: 1.25pt; vertical-align: bottom;"> <div style="text-align: right;"> <span style="font-size: 10.0pt; color: #000000;">Total Fees Previously Paid</span> </div> </td> <td style="padding: 0; width: 5.4%; border-top: 1pt solid #000000; border-left: 1pt solid #000000; padding-left: 1.5pt; padding-right: 1.25pt; vertical-align: middle; font-size: 0;">&#160; </td> <td style="padding: 0; width: 9.76%; border-top: 1pt solid #000000; border-left: 1pt solid #000000; padding-left: 1.5pt; padding-right: 1.25pt; vertical-align: middle; font-size: 0;">&#160; </td> <td style="padding: 0; width: 10.84%; border-top: 1pt solid #000000; border-left: 1pt solid #000000; padding-left: 1.5pt; padding-right: 1.25pt; vertical-align: middle; font-size: 0;">&#160; </td> <td style="padding: 0; width: 9.14%; border-top: 1pt solid #000000; border-left: 1pt solid #000000; padding-top: 1.5pt; padding-bottom: 1.5pt; padding-left: 1.5pt; padding-right: 1.25pt; vertical-align: bottom;"> <div style="text-align: center;"> <span style="font-size: 10.0pt; color: #000000;">$<ix:nonFraction contextRef="c0" decimals="2" format="ixt:num-dot-decimal" name="ffd:TtlPrevslyPdAmt" scale="0" unitRef="usd" id="ixv-582">23,044.63</ix:nonFraction></span> </div> </td> <td style="padding: 0; width: 5.4%; border-top: 1pt solid #000000; border-left: 1pt solid #000000; padding-left: 1.5pt; padding-right: 1.25pt; vertical-align: middle; font-size: 0;">&#160; </td> <td style="padding: 0; width: 5.36%; border-top: 1pt solid #000000; border-left: 1pt solid #000000; padding-left: 1.5pt; padding-right: 1.25pt; vertical-align: middle; font-size: 0;">&#160; </td> <td style="padding: 0; width: 5.36%; border-top: 1pt solid #000000; border-left: 1pt solid #000000; padding-left: 1.5pt; padding-right: 1.25pt; vertical-align: middle; font-size: 0;">&#160; </td> <td style="padding: 0; width: 7.32%; border-top: 1pt solid #000000; border-left: 1pt solid #000000; border-right: 1pt solid #000000; padding-top: 1.5pt; padding-bottom: 1.5pt; padding-left: 1.5pt; padding-right: 1.5pt; vertical-align: bottom; font-size: 0;">&#160; </td> </tr> <tr style="vertical-align: top;"> <td colspan="2" style="padding: 0; border-top: 1pt solid #000000; border-left: 1pt solid #000000; padding-top: 1.5pt; padding-bottom: 1.5pt; padding-left: 7.25pt; padding-right: 1.25pt; vertical-align: bottom; font-size: 0;">&#160; </td> <td style="padding: 0; width: 5.82%; border-top: 1pt solid #000000; border-left: 1pt solid #000000; border-right: 1pt solid #000000; padding-top: 0.75pt; padding-bottom: 0.75pt; padding-left: 0.75pt; padding-right: 0.75pt;"> <div style="text-align: center; font-size: 10pt;">&#160; </div> </td> <td colspan="4" style="padding: 0; border-top: 1pt solid #000000; border-bottom: 1pt solid #000000; border-left: 1pt solid #000000; padding-top: 1.5pt; padding-bottom: 1.5pt; padding-left: 1.5pt; padding-right: 1.25pt; vertical-align: bottom;"> <div style="text-align: right;"> <span style="font-size: 10.0pt; color: #000000;">Total Fee Offsets</span> </div> </td> <td style="padding: 0; width: 5.4%; border-top: 1pt solid #000000; border-left: 1pt solid #000000; padding-left: 1.5pt; padding-right: 1.25pt; vertical-align: middle; font-size: 0;">&#160; </td> <td style="padding: 0; width: 9.76%; border-top: 1pt solid #000000; border-left: 1pt solid #000000; padding-left: 1.5pt; padding-right: 1.25pt; vertical-align: middle; font-size: 0;">&#160; </td> <td style="padding: 0; width: 10.84%; border-top: 1pt solid #000000; border-left: 1pt solid #000000; padding-left: 1.5pt; padding-right: 1.25pt; vertical-align: middle; font-size: 0;">&#160; </td> <td style="padding: 0; width: 9.14%; border-top: 1pt solid #000000; border-left: 1pt solid #000000; padding-top: 1.5pt; padding-bottom: 1.5pt; padding-left: 1.5pt; padding-right: 1.25pt;"> <div style="text-align: center;"> <span style="font-size: 10.0pt; color: #000000;"><ix:nonFraction contextRef="c0" decimals="0" format="ixt:fixed-zero" name="ffd:TtlOffsetAmt" scale="0" unitRef="usd" id="ixv-583">&#8212;</ix:nonFraction></span> </div> </td> <td style="padding: 0; width: 5.4%; border-top: 1pt solid #000000; border-left: 1pt solid #000000; padding-left: 1.5pt; padding-right: 1.25pt; vertical-align: middle; font-size: 0;">&#160; </td> <td style="padding: 0; width: 5.36%; border-top: 1pt solid #000000; border-left: 1pt solid #000000; padding-left: 1.5pt; padding-right: 1.25pt; vertical-align: middle; font-size: 0;">&#160; </td> <td style="padding: 0; width: 5.36%; border-top: 1pt solid #000000; border-left: 1pt solid #000000; padding-left: 1.5pt; padding-right: 1.25pt; vertical-align: middle; font-size: 0;">&#160; </td> <td style="padding: 0; width: 7.32%; border-top: 1pt solid #000000; border-left: 1pt solid #000000; border-right: 1pt solid #000000; padding-top: 1.5pt; padding-bottom: 1.5pt; padding-left: 1.5pt; padding-right: 1.5pt; vertical-align: bottom; font-size: 0;">&#160; </td> </tr> <tr style="vertical-align: top;"> <td colspan="2" style="padding: 0; border-top: 1pt solid #000000; border-bottom: 1pt solid #000000; border-left: 1pt solid #000000; padding-top: 1.5pt; padding-bottom: 1.5pt; padding-left: 7.25pt; padding-right: 1.25pt; vertical-align: bottom; font-size: 0;">&#160; </td> <td style="padding: 0; width: 5.82%; border-top: 1pt solid #000000; border-bottom: 1pt solid #000000; border-left: 1pt solid #000000; border-right: 1pt solid #000000; padding-top: 0.75pt; padding-bottom: 0.75pt; padding-left: 0.75pt; padding-right: 0.75pt;"> <div style="text-align: center; font-size: 10pt;">&#160; </div> </td> <td colspan="4" style="padding: 0; border-top: 1pt solid #000000; border-bottom: 1pt solid #000000; border-left: 1pt solid #000000; padding-top: 1.5pt; padding-bottom: 1.5pt; padding-left: 1.5pt; padding-right: 1.25pt; vertical-align: bottom;"> <div style="text-align: right;"> <span style="font-size: 10.0pt; color: #000000;">Net Fee Due</span> </div> </td> <td style="padding: 0; width: 5.4%; border-top: 1pt solid #000000; border-bottom: 1pt solid #000000; border-left: 1pt solid #000000; padding-top: 1.5pt; padding-bottom: 1.5pt; padding-left: 1.5pt; padding-right: 1.25pt; vertical-align: bottom; font-size: 0;">&#160; </td> <td style="padding: 0; width: 9.76%; border-top: 1pt solid #000000; border-bottom: 1pt solid #000000; border-left: 1pt solid #000000; padding-top: 1.5pt; padding-bottom: 1.5pt; padding-left: 1.5pt; padding-right: 1.25pt; vertical-align: bottom; font-size: 0;">&#160; </td> <td style="padding: 0; width: 10.84%; border-top: 1pt solid #000000; border-bottom: 1pt solid #000000; border-left: 1pt solid #000000; padding-top: 1.5pt; padding-bottom: 1.5pt; padding-left: 1.5pt; padding-right: 1.25pt; vertical-align: bottom; font-size: 0;">&#160; </td> <td style="padding: 0; width: 9.14%; border-top: 1pt solid #000000; border-bottom: 1pt solid #000000; border-left: 1pt solid #000000; padding-top: 1.5pt; padding-bottom: 1.5pt; padding-left: 1.5pt; padding-right: 1.25pt; vertical-align: bottom;"> <div style="text-align: center;"> <span style="font-size: 10.0pt; color: #000000;">$<ix:nonFraction contextRef="c0" decimals="2" format="ixt:num-dot-decimal" name="ffd:NetFeeAmt" scale="0" unitRef="usd" id="ixv-584">858.70</ix:nonFraction></span> </div> </td> <td style="padding: 0; width: 5.4%; border-top: 1pt solid #000000; border-bottom: 1pt solid #000000; border-left: 1pt solid #000000; padding-top: 1.5pt; padding-bottom: 1.5pt; padding-left: 1.5pt; padding-right: 1.25pt; vertical-align: bottom; font-size: 0;">&#160; </td> <td style="padding: 0; width: 5.36%; border-top: 1pt solid #000000; border-bottom: 1pt solid #000000; border-left: 1pt solid #000000; padding-top: 1.5pt; padding-bottom: 1.5pt; padding-left: 1.5pt; padding-right: 1.25pt; vertical-align: bottom; font-size: 0;">&#160; </td> <td style="padding: 0; width: 5.36%; border-top: 1pt solid #000000; border-bottom: 1pt solid #000000; border-left: 1pt solid #000000; padding-top: 1.5pt; padding-bottom: 1.5pt; padding-left: 1.5pt; padding-right: 1.25pt; vertical-align: bottom; font-size: 0;">&#160; </td> <td style="padding: 0; width: 7.32%; border-top: 1pt solid #000000; border-bottom: 1pt solid #000000; border-left: 1pt solid #000000; border-right: 1pt solid #000000; padding-top: 1.5pt; padding-bottom: 1.5pt; padding-left: 1.5pt; padding-right: 1.5pt; vertical-align: bottom; font-size: 0;">&#160; </td> </tr> </table><div>
  </div><div>
   <span style="font-family: Arial; font-size: 10.0pt; color: #000000;">________________</span>
  </div><div>
  </div><div style="font-size: 10pt;">&#160;
  </div><div>
  </div><ix:nonNumeric contextRef="c7" continuedAt="_OfferingNote-c7_cont_1" escape="true" name="ffd:OfferingNote" id="ixv-537"><ix:nonNumeric contextRef="c8" continuedAt="_OfferingNote-c8_cont_1" escape="true" name="ffd:OfferingNote" id="ixv-538"><div style="text-indent: -22.5pt; padding-left: 22.5pt;"> <div style="float: left; width: 22.5pt; white-space: nowrap;"> <span style="font-size: 10.0pt; color: #000000;">(1)</span> </div> <div> <span style="font-size: 10.0pt;">There are being registered hereunder an unspecified number or aggregate principal amount (as applicable) of the registrant&#8217;s common stock, preferred stock, debt securities, warrants, purchase contracts and units as may from time to time be offered at unspecified prices, with the maximum aggregate offering price of such securities not to exceed $</span><span style="font-size: 10.0pt; color: #000000;">156,128,866</span><span style="font-size: 10.0pt;">. In addition, an unspecified number of additional shares of common stock is being registered as may be issued from time to time upon conversion of any debt securities that are convertible into common stock or pursuant to any anti-dilution adjustments with respect to any such convertible debt securities. The shares of common stock and preferred stock being registered hereunder also include rights to acquire shares of common stock or preferred stock under any shareholder rights plan then in effect, if applicable under the terms of any such plan.</span> </div> </div></ix:nonNumeric></ix:nonNumeric><div>
  </div><div style="margin-left: 22.5pt; font-size: 10pt; clear: both;">&#160;
  </div><div>
  </div><ix:continuation continuedAt="_OfferingNote-c7_cont_2" id="_OfferingNote-c7_cont_1"><ix:continuation continuedAt="_OfferingNote-c8_cont_2" id="_OfferingNote-c8_cont_1"><div style="margin-left: 22.5pt;">
   <span style="font-size: 10.0pt;">The proposed maximum aggregate offering price of each class of securities will be determined from time to time by the registrant in connection with the issuance by the registrant of the securities registered hereunder and is not specified as to each class of securities pursuant to Rule 457(o) under the Securities Act of 1933, as amended (the &#8220;Securities Act&#8221;).</span>
  </div></ix:continuation></ix:continuation><div>
  </div><div style="margin-left: 22.5pt; font-size: 10pt;">&#160;
  </div><div>
  </div><ix:continuation continuedAt="_OfferingNote-c7_cont_3" id="_OfferingNote-c7_cont_2"><ix:continuation continuedAt="_OfferingNote-c8_cont_3" id="_OfferingNote-c8_cont_2"><div style="margin-left: 22.5pt;">
   <span style="font-size: 10.0pt;">The maximum aggregate offering price indicated above is estimated solely for the purpose of calculating the registration fee pursuant to Rule 457(o) under the Securities Act.&#160;&#160;No separate consideration will be received for shares of common stock that are issued upon conversion of debt securities or upon exercise of warrants registered hereunder.</span>
  </div></ix:continuation></ix:continuation><div>
  </div><div style="margin-left: 22.5pt; font-size: 10pt;">&#160;
  </div><div>
  </div><ix:continuation id="_OfferingNote-c7_cont_3"><ix:continuation id="_OfferingNote-c8_cont_3"><div style="margin-left: 22.5pt;">
   <span style="font-size: 10.0pt;">The $156,128,866 of securities registered being registered hereunder includes $156,128,866 of common stock (the &#8220;Unsold Shares&#8221;) that remains available for issuance and sale under a Capital on Demand</span><sup style="font-size: 7.0pt;">TM</sup><span style="font-size: 10.0pt;"> Sales Agreement by and between the registrant and JonesTrading Institutional Services LLC (the &#8220;Sales Agreement&#8221;). In connection with the prospectus supplement previously filed by the registrant on June 10, 2024, the registrant paid a registration fee of $29,520 related to the $200,000,000 of common stock initially available for issuance and sale under the Sales Agreement. The portion of such registration fee related to the Unsold Shares is being applied to the registrant&#8217;s total registration fee hereunder.</span>
  </div></ix:continuation></ix:continuation><div>
 </div><div>&#160;</div><hr style="border-top: 2px solid black; border-bottom: none; border-left: none; border-right: none; height: 0px; margin: 8px auto; width: 100%;"/><div style="display: none"><ix:header>
<ix:hidden>
<ix:nonNumeric contextRef="c0" name="dei:EntityCentralIndexKey" id="ixv-587">0001130713</ix:nonNumeric>
<ix:nonNumeric contextRef="c0" name="ffd:FeeExhibitTp" id="ixv-588">EX-FILING FEES</ix:nonNumeric>
<ix:nonNumeric contextRef="c0" name="ffd:RegnFileNb" id="ixv-589">333-280076</ix:nonNumeric>
<ix:nonNumeric contextRef="c0" name="ffd:SubmissnTp" id="ixv-590">POSASR</ix:nonNumeric>
</ix:hidden>
<ix:references><link:schemaRef xlink:href="https://xbrl.sec.gov/ffd/2024q2/ffd-2024q2.xsd" xlink:type="simple"/></ix:references>
<ix:resources xmlns="http://www.xbrl.org/2003/instance"><xbrli:context xmlns="" id="c0">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001130713</xbrli:identifier>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2025-02-25</xbrli:startDate>
    <xbrli:endDate>2025-02-25</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c1">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001130713</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:typedMember dimension="ffd:OfferingAxis">
        <dei:lineNo>1</dei:lineNo>
      </xbrldi:typedMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2025-02-25</xbrli:startDate>
    <xbrli:endDate>2025-02-25</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c2">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001130713</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:typedMember dimension="ffd:OfferingAxis">
        <dei:lineNo>2</dei:lineNo>
      </xbrldi:typedMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2025-02-25</xbrli:startDate>
    <xbrli:endDate>2025-02-25</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c3">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001130713</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:typedMember dimension="ffd:OfferingAxis">
        <dei:lineNo>3</dei:lineNo>
      </xbrldi:typedMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2025-02-25</xbrli:startDate>
    <xbrli:endDate>2025-02-25</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c4">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001130713</xbrli:identifier>
    <xbrli:segment>
<!-- [WMV6][XcpuxYn59dz7vgYynUDuwG7r97K2jUTysl7vcz0lJt9uqgO9qQHmt9BQ98lPQIywLyErl6i3VNR0ovubfFn9GxbEx6/6JGjW8JGK/mVtNl2bqNB1Adtjm+A3xw1RUzep8SdyDrH0uYEYmYLYlvkPwCrR7MlsXShDOAF/+uXpr05vb1rA1lzPwCt6L6gR6UR3Ju9m7R6Qt5DfVBXqkWBh9r6UjBuTD9C4HRAsbo5s8eQ+eE8Rj24H6Mxs2/P/bAS9Cr41LyOWmJhP9hibecDQKT9ACngZRbaF/hFX5cfq/LQJg+S7Tea7PmtvL6DuQPZTaWB8z1p4p+IZ7zIy5TNudQ==] CSR-->
      <xbrldi:typedMember dimension="ffd:OfferingAxis">
        <dei:lineNo>4</dei:lineNo>
      </xbrldi:typedMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2025-02-25</xbrli:startDate>
    <xbrli:endDate>2025-02-25</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c5">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001130713</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:typedMember dimension="ffd:OfferingAxis">
        <dei:lineNo>5</dei:lineNo>
      </xbrldi:typedMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2025-02-25</xbrli:startDate>
    <xbrli:endDate>2025-02-25</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c6">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001130713</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:typedMember dimension="ffd:OfferingAxis">
        <dei:lineNo>6</dei:lineNo>
      </xbrldi:typedMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2025-02-25</xbrli:startDate>
    <xbrli:endDate>2025-02-25</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c7">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001130713</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:typedMember dimension="ffd:OfferingAxis">
        <dei:lineNo>7</dei:lineNo>
      </xbrldi:typedMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2025-02-25</xbrli:startDate>
    <xbrli:endDate>2025-02-25</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c8">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001130713</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:typedMember dimension="ffd:OfferingAxis">
        <dei:lineNo>8</dei:lineNo>
      </xbrldi:typedMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2025-02-25</xbrli:startDate>
    <xbrli:endDate>2025-02-25</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:unit xmlns="" id="usd">
  <xbrli:measure>iso4217:USD</xbrli:measure>
</xbrli:unit><xbrli:unit xmlns="" id="pure">
  <xbrli:measure>xbrli:pure</xbrli:measure>
</xbrli:unit></ix:resources></ix:header>

</div></div></body></html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>9
<FILENAME>logo_beyondv2.jpg
<TEXT>
begin 644 logo_beyondv2.jpg
M_]C_X  02D9)1@ ! 0$ P #   #_[0 V4&AO=&]S:&]P(#,N,  X0DE- ^T*
M4F5S;VQU=&EO;@     0 ,     !  $ P     $  ?_B"^!)0T-?4%)/1DE,
M10 ! 0  "]!N;VYE @   &UN=')21T(@6%E:( ?4  < %0 3  L (6%C<W
M         $E%0R!S4D="     0            #VU@ !     -,M2% @(
M
M$&1E<V,   %$    =&)865H   &X    %&)44D,   ',   (#&1M9&0   G8
M    B&=865H   I@    %&=44D,   ',   (#&QU;6D   IT    %&UE87,
M  J(    )&)K<'0   JL    %')865H   K     %')44D,   ',   (#'1E
M8V@   K4    #'9U960   K@    AW=T<'0   MH    %&-P<G0   M\
M*&-H860   ND    +&1E<V,         &G-21T(@245#-C$Y-C8M,BTQ('=I
M=&A"4$,
M                                                    6%E:(
M     "2@   /A   ML]C=7)V        !      %  H #P 4 !D '@ C "@
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M;W5R(%-P86-E("T@<U)'0@
M
M      !865H@        8ID  +>%   8VEA96B            !0
M;65A<P         !                               "6%E:(
M  ,6   #,P   J1865H@        ;Z(  #CU   #D'-I9R      0U)4(&1E
M<V,         +5)E9F5R96YC92!6:65W:6YG($-O;F1I=&EO;B!I;B!)14,@
M-C$Y-C8M,BTQ
M                                                          !8
M65H@        ]M8  0    #3+71E>'0     0V]P>7)I9VAT($AE=VQE='0@
M4&%C:V%R9"P@,C P- !S9C,R       !#$0   7?___S)@  !Y0  /V/___[
MH?___:(   /;  # =?_; $,  0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! ?_; $,! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! ?_  !$( '(!Y@,!(@ "$0$#$0'_Q  ?   !!0$!
M 0$! 0           0(#! 4&!P@)"@O_Q "U$  " 0,# @0#!04$!    7T!
M @, !!$%$B$Q008346$'(G$4,H&1H0@C0K'!%5+1\"0S8G*""0H6%Q@9&B4F
M)R@I*C0U-C<X.3I#1$5&1TA)2E-455976%E:8V1E9F=H:6IS='5V=WAY>H.$
MA8:'B(F*DI.4E9:7F)F:HJ.DI::GJ*FJLK.TM;:WN+FZPL/$Q<;'R,G*TM/4
MU=;7V-G:X>+CY.7FY^CIZO'R\_3U]O?X^?K_Q  ? 0 # 0$! 0$! 0$!
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M3NM$?Y)M%%%?W4?R@?ZS'[-__)N_P%_[(O\ "W_U!]"KVBO%_P!F_P#Y-W^
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MB3PWE6/Q678KZ_\ 6,'6E0K>SPL9T^>-K\LO;1YHZZ.RV>FU_P"_ZBOX ?\
MB)2_X*.?\^_[/O\ X:_5_P#YMZ/^(E+_ (*.?\^_[/O_ (:_5_\ YMZ]'_B
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MJ/GZ?;ZAI<LDPM9G^SN+M!%+ARK@;3_)9_Q$I?\ !1S_ )]_V??_  U^K_\
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M<Z^&PU:HZ6'6&A>^,QDDXRE&;3=&CS*$H)3FJBJ1A'_.Q_X*%?\ !/7XR?\
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MU33YY+6^T[4;&ZCBN;.]L[F*2"YMIXXY894>.1%92*_TZ?\ @GM_P4:^!_\
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M%E?^"F?A#P!_P3N\':M\"_%D-SXK_;<\*V]A\.M1L;F-=3T;X8:QI%K>^/\
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M<:AIMM=--=V=G=0VES<74T#W,OR8JL[*B*SNS!55069F8X5549)8D@  $DG
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M86^F:58I/=_#^XNYUM+&U@MUFNIY[B01AYII)&9VW/\ A^/_ ,%4/^CL]?\
M_#=?!K_YW-=3X1_X(-?\%,O'/A3PQXU\-_!;PO>>'?&'A[1?%.@W<OQ@^%=I
M)=:+X@TVVU;2[F2TNO%D5S;//8W<$KV]Q%'/"S&.:-)%91T/_$/C_P %3/\
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M]^P /BA\+M)_;:^&VB>;X[^#VFV_ASXOVNGVVZY\0_"R2[D;2_$\Z0J&GO/
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M4TR[GL=1TZ_M)4GM+VQO;62*YM+NVGC2:WN()(YH9462-U=01_:__P $>/\
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M?_U?/PMK^>^,/^3\T/\ LJ.#O_3&1G[!PS_R:Q_]B3B#_P!.YF?YM=?T,?\
M!LW_ ,I$?$W_ &;/\2O_ %-/A=7\\]?T,?\ !LW_ ,I$?$W_ &;/\2O_ %-/
MA=7]+^)/_)!<5_\ 8FQ?_I*/P[@K_DK,@_[&6'_-G]]%%%%?Y[']@'\MO_!T
M;\&-%U?]G;]GWX_0V4(\3^!OB[<?"ZZOHX@MS/X7^(7A37_$8BNIEPTMMIVM
M^ ;46<<F\6\VM7;0>7]IN/-_B1K^\7_@YV\4Z=I7[!_PS\,2RQG5O%?[3'@^
M2QM2ZK*;#0/A]\3;S4[U$)W/%:SW6E6LI4$(^I0EB,J#_!U7]P>!E;$5?#_!
M1K.3A1S#,J.&<FW;#K$>TM%O[*KU*Z2V5FEM8_EWQ4ITH<7XATU%2J8+!5*U
MDDW5]DX)RM]ITH4M7K:Q_6K_ ,&L7Q?:T\<?M4_ .YF>1->\*>#/B_HT#,WE
MVC>$=7F\&>))8U"[=^HCQMX429F;<%TN (N#(:*\E_X-;O 6K7_[5O[0WQ0B
MBD.A^%?V>F\!7\X"^3'JWC[XD>!_$.DQ.3\_F2V?PUUIX@OR[89=W(2BOYY\
M;:6'I>(>:N@USU<+EE7$I/X<0\#1@TUT<J,*,VNO-S:N5W^Q>&-6O4X/P"K7
MM3K8RE0;ZT(XF<E9O=*I*I%=E'E5DK+^82BBBO[F/Y7/[&_^"$O_  1U\/1Z
M#\/_ -NS]I;3-,\1WVMVFG>,?V>_AM<BWU+2=(L9MMWHGQ0\5P_O;6\UJ91%
MJ'@[19/,BT4&WUV_0:PMA#IGXQ?\%XO^4I?[2W^]\,?_ %4O@BO[E?\ @F!_
MRCL_8J_[-L^$W_J):;7\-7_!>+_E*7^TM_O?#'_U4O@BOYK\..(,TXA\6N*<
M1F>(=7ZIE6;8#!T8WC0PF$PV=Y?2I4:%.[44U'GJRUG5J.4YR;>G[?QGE. R
MCP\R6C@:*I*OC<NQ6(J.SJU\17R_$3J5:L[)SE>7+%:1A!1A!1BDC]P_^#7_
M .+/P&F^&_QK^#5IX<\/>'OVC;/Q!%XRUCQ$X3_A(_B/\,9XK6STN*WN;F62
MY:S\":TUU;7VE6"P6%NNO:;J;V\E[?7MR?T _P""S'_!*&+_ (*"> -&^(?P
MJDTO1?VF/A;I-Y8^%I-2EBL-)^(WA:2:2_E\!:YJ4F(]/O(+Z2XO?"FLW1^Q
MV%_>7MEJ#P:?J<U]8?P-_ CXZ?$_]FOXL>#/C7\'?$UWX3^('@35HM5T75+8
MEX)E ,5[I.K6;,(-4T+6;)Y]-UK2;H/:ZCIUS<6LZ%),C^_+_@GO_P %P/V6
M?VQ/"^D^'OB9XK\+_L_?'ZUL%7Q#X(\;ZW;:%X2\0W=M K7>J?#WQ=K<]OI>
MHV5R5DGC\.ZC?P>*+%$FC-IJ-I;?VI/P^)/"W%7"O%S\1.%GBL92JU(XC%J$
M:F+JX&K[*-&O1Q-!-U*N58FDK+D]S#)SI/V$88>;Z^"L^R'B#AY<'9ZJ&'JT
MZ?L*$9N&'AC*2G[2C5H5;1C#'T9V;3_>59159>U<JT8_P!?%_P""/Q=^ /C+
M4?A]\:?AQXO^&?C'2YY8;G0_%^AWVC7,JQ.4%WI\EU"EMJNF3C$EGJNF37>F
MWT#QW%G=3P21R-@?#_X<_$#XK^*M+\#?#'P5XJ^(/C+6YUM])\+^#=!U/Q'K
MNH2LP7;;:9I-M=7<BJ6!DD$7EQ+EY71 6']!/_!;C_@L)8_M:ZIJ'[,?[.MS
M:R_L^^%M94^*/B$+2%[_ .+.OZ5<!HSH%S<0FZTWP#I]W$)+*6W:WN?%$\4>
MH7!72Q:6\WSU_P $=O\ @K#J/[ 'Q E^'WQ-LV\0?LT_$76;>3Q;]BT^.Z\3
M?#K6)Q':_P#";>'GAB-_J>FQ1+'_ ,)'X8$DGVVSB-]H\2ZO#Y&H_L^%S[B^
MMP9_;D^%J$>(7AOK%+(7F%2$JM/E351\V$<Z.)G'FJPRR4I5;*-">+A7DX0_
M-*^3\-T^)EE4,_JO*/:JE/-?JE.<:55MITN=8A0J48NT)8^,%3C)N:H2HQ=1
M_P!!O_!$;_@CKKG['+R?M-_M)6-@G[0GB#0[C2?!?@B&>UU./X0^'=8@\O5I
M[_4;62>RN/'6O6;MIM]_9TT]KH>CRW>F1WES<:GJ*P;G_!R'\6_@/X2_8NT_
MX:>/O#?A[Q?\9?B/XKT]_@M;WH']N^!FT2\M+KQ?\0K&YMY(KZQL[?1@?#;Q
M>8+'6+[7+6TN[>[MK6X2'ZR_;(_X+0_L4_LH?#>U\3Z3\2_#/QT\?^*/#MMK
MOP^^&?PK\1:;X@OM:M]5L8[S1=3\3ZUISWVG>!_#]U%/;W,EWK935I[1I'T?
M1-5GC>!?X"/VNOVM?C#^VM\;?$OQT^-.M)J'B+6REEH^BV'GQ>'/!?AFTDE;
M2?"?A:PGFG:QT;35FE?YY9;J_OKB\U749[G4;ZZN)?Q#@7AOB[CKC.CQYQ1'
M%9?A,!B*=?#7A6P4L14PLG]6P&7T925:GE]&;D\35;<:UZM*4ZU:O7J0_4>*
ML[X?X3X:J<*Y&Z&*Q.*H3HU(J5/$JC"NE[?&8VHDX3Q56+O1A9.,N2:A"C2I
MP??_ /!-;_E(3^Q)_P!G3? S_P!6-X>K^M__ (+;_P#!'?P_^TKX8\5_M8_L
M^:3IOA_]H+PEHEWKOQ"\.P?9M-TKXQ^'="L7N;V]F9O*MK;XA:3IMJS66I2L
MB^([2W32M2D-W'I]U%_)!_P36_Y2$_L2?]G3? S_ -6-X>K_ $V/C9_R1GXN
M?]DQ\>_^HKJU>MXP<09IPUQUPAF>4XAT*\<NG1JP=Y4<3AZN8VJX;$T[I5:-
M16O%M2A-1J4Y0JPA./G>&^4X'.N%.(,#F%%5J,\<IQ>BJ4:L,'!TZU&=FZ=6
M#^&2W3<)*4)2B_\ )-HHHK^E#\0/]9C]F_\ Y-W^ O\ V1?X6_\ J#Z%7M%>
M+_LW_P#)N_P%_P"R+_"W_P!0?0J]HK_,K'_[]C?^PO$_^GIG]R4?X5+_ *]P
M_P#24%?Q(_\ !TU_R<A^S#_V1'Q%_P"IY?5_;=7\2/\ P=-?\G(?LP_]D1\1
M?^IY?5^H^!__ "<3+/\ L#S7_P!0*Q\'XG_\D;F7_7[+_P#U.PY_+;7^CA_P
M0&_Y12_LT?\ 80^-_P#ZO[XGU_G'U_4-_P $X/\ @O;\&?V)/V.OA3^S3XN^
M!'Q.\:Z_\/;GQ_/?>)/#FN^%;+1]07QA\2/%OC>U6UMM3F2]C-G:>(H+*X\Y
M0'N;>9X\Q,AK^B/&CA[.>)>%<%@,CP-3,,72S["8NI0IU*-.4</3P&9T9U7*
MO5I0M&I7I1:4G*\TTK)M?CGAEG&6Y)GV+Q>:8N&#P]3*,1AX5:D:DHRK3QF
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M$CG%?VQ53NM.T^]97O;"RNW12J-=6L%PR*3DJK2QN54GD@$ GGK7T? _%/\
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? HHHH **** "BBB@ HHHH **** "BBB@ HHHH __V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>10
<FILENAME>logo_beyondv2x1.jpg
<TEXT>
begin 644 logo_beyondv2x1.jpg
M_]C_X  02D9)1@ ! 0$ P #   #_[0 V4&AO=&]S:&]P(#,N,  X0DE- ^T*
M4F5S;VQU=&EO;@     0 ,     !  $ P     $  ?_B"^!)0T-?4%)/1DE,
M10 ! 0  "]!N;VYE @   &UN=')21T(@6%E:( ?4  < %0 3  L (6%C<W
M         $E%0R!S4D="     0            #VU@ !     -,M2% @(
M
M$&1E<V,   %$    =&)865H   &X    %&)44D,   ',   (#&1M9&0   G8
M    B&=865H   I@    %&=44D,   ',   (#&QU;6D   IT    %&UE87,
M  J(    )&)K<'0   JL    %')865H   K     %')44D,   ',   (#'1E
M8V@   K4    #'9U960   K@    AW=T<'0   MH    %&-P<G0   M\
M*&-H860   ND    +&1E<V,         &G-21T(@245#-C$Y-C8M,BTQ('=I
M=&A"4$,
M                                                    6%E:(
M     "2@   /A   ML]C=7)V        !      %  H #P 4 !D '@ C "@
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M;W5R(%-P86-E("T@<U)'0@
M
M      !865H@        8ID  +>%   8VEA96B            !0
M;65A<P         !                               "6%E:(
M  ,6   #,P   J1865H@        ;Z(  #CU   #D'-I9R      0U)4(&1E
M<V,         +5)E9F5R96YC92!6:65W:6YG($-O;F1I=&EO;B!I;B!)14,@
M-C$Y-C8M,BTQ
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MU=;7V-G:X>+CY.7FY^CIZO'R\_3U]O?X^?K_Q  ? 0 # 0$! 0$! 0$!
M     0(#! 4&!P@)"@O_Q "U$0 " 0($! ,$!P4$!  ! G<  0(#$00%(3$&
M$D%1!V%Q$R(R@0@40I&AL<$)(S-2\!5B<M$*%B0TX27Q%Q@9&B8G*"DJ-38W
M.#DZ0T1%1D=(24I35%565UA96F-D969G:&EJ<W1U=G=X>7J"@X2%AH>(B8J2
MDY25EI>8F9JBHZ2EIJ>HJ:JRL[2UMK>XN;K"P\3%QL?(R<K2T]35UM?8V=KB
MX^3EYN?HZ>KR\_3U]O?X^?K_V@ , P$  A$#$0 _ /Y]Z***_P!0#^%PHHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ K_3/_P"".'_*,?\
M8\_[)A-_ZEGB2O\ ,PK_ $S_ /@CA_RC'_8\_P"R83?^I9XDK^?_ *1'_)*Y
M+_V4%/\ ]5V8'[#X-_\ (YS;_L61_P#4JB?IC1117\?G]#A1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M^"8__0@?$_\ \.]XL_\ CM'_ !#J_P#!,?\ Z$#XG_\ AWO%G_QVOE/^(_\
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MWAZC3CJK\^O9=/\ 6THK_)+_ .%T_&/_ **S\3/_  O/%/\ \M:/^%T_&/\
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MR--8:O5I0KK#5$\-.[=.;E3J7BJG)42C'D9_JDT5_DE_\+I^,?\ T5GXF?\
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M99.>G/BZ,9X=2TT=;#SK.*;T4ZE.$$M9N"/[(J*^8OV6OVQOV=/VS? S^/\
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M'](C_DE<E_[*"G_ZKLP/U_P;_P"1SFW_ &+(_P#J51/TQHHHK^/S^APHHHH
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MSJ*_T,?^(=7_ ()C_P#0@?$__P .]XL_^.T?\0ZO_!,?_H0/B?\ ^'>\6?\
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M#%YGF-;ZO@<#1GB,57]G5K>RHTU><_94*=6M.R^S3ISD^D6?D^!P6*S'%X?
MX*E[;%8JI&C0I<].G[2I+X8\]6=.G&]MYSC%=6?GK17]@!_X-1S@X_;T!..
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M,D\\DDTCNWY;X[<;/*LKI\*9?6Y<?G%/VN92@_>P^5J5E1;3O&>/J1E!I?\
M,-2KQDDJT&_N_"GACZ]CI\08NE?"Y?-T\"I?#5Q[BG*IR_:CA:<DTW9>VJ0<
M6Y4I)=?7^8+_ ,%1_P!J2[_:Z_;>^./Q2AU:35?!UAXJO_ GPT82F6SB^'_@
MNZN-%T.XT\#Y$M=;:"Z\18559I-7=I-TA9C_ *('[?7Q3NO@I^Q5^U#\3].O
M6TW5O"WP4\>2Z%J*'$EAXAU30[G0_#UY$2RCS;;6]3L)HLG!D1001P?\KFOG
MOHZY)3E/B#B&I%2J4OJ^4X235^3VB^MXUIO[4DL%%-6:CSIZ3/8\9,SJ0I91
ME%.5J=9U\?B$GK+V3C1PR?\ =3EB)-.Z<HP>\0HHK[*_X)[_  "LOVG?VT/V
M=_@KK%L]WX;\7?$C1'\76Z!L7'A'0I&U_P 2VDCHZ/%'?Z1IEUI[SQL)(!=>
M:GSHH/\ 3..QE'+\%B\?B9..'P6%KXNO):M4<-2G6J-*ZNU"#LKJ[T/P_!X6
MKC<7AL'02=;%XBCAJ2>B=2O4C3A=]%S25WT5V?UF?\$#_P#@E=X7^#_PN\+_
M +9OQP\*IJ?QK^)-A!X@^$FFZW!OM_AK\.M5LHI='UZVTV:,HOB[QA:S-JR:
MO*7ET[P[<Z7;:;'93W.J3WO]-510006L$-M;0Q6]M;Q1P6]O!&D,$$$*".*&
M&*,+'%%%&JI'&BJB(H50% %2U_G5Q1Q)F/%F=8S.<RJ2E4Q%22H4.=RI8/"Q
MD_882@G91I48.S:C%U*CG6FG4J3;_LG(\EP>09;ALMP5.,:=&"]I4LE/$5VE
M[7$57O*I4DKZM\L5&G&T(12****^>/7$95=61U5T92K*P#*RL,,K*<@J02""
M""#@\5_$E_P<!?\ !*[0?@A?Q_MH?L]^&[71?AIXKUF'2?C+X%T2PCM-+\$^
M+-4E*Z1XRT*QLHH[6P\,^)IRVG:O81Q00:/K_P!CGMC+;:ZT&F?VW5X9^TS\
M#O#_ .TI\ /B[\"?$R0?V7\3_ GB#PJMS<1M+'IFJ7UC+_8>M!$(=I-$UI+#
M58U0@N]F$.58@_:<!<78O@[B+!9E1JSC@:E6GA\VPZ;=/$X"I-1K<T%HZM"+
M=?#SMS0JP2NX3G&7S7%?#V'XDR?$X&K"+Q$:<ZN K67/0Q<(MTW&72%1I4ZL
M;VE3D]I*,H_Y.5%:_B#0M5\+Z]K?AG7;.73M<\.ZOJ6A:SI\XQ-8ZKI%Y-I^
MHV<P&0);6\MYH) .CH:R*_T+C)2BI1:E&24HR3NFFKIIK1IK5-;H_CUIIM--
M--IIJS36C33U33T:>Q_0K_P;D_M6ZE\&/VS[CX$:OJTJ?#[]I7P]<:#_ &7-
M<(EE:_$OPM%/K?@W6X8Y$9C>7&G)XB\,20P/ +M-;MI[HSG2K-$_OKK_ ";/
MV:OBE/\ !']H7X)?%Z"XFMA\./BGX&\87<D#%)'TO1/$>GWNL6VX<[+W2H[R
MSE Y:*=U'6O]9($, RD%2 000001D$$<$$<@C@BOX_\ I!Y+2P7$F5YQ2@H?
MVUE]2GB&DE[3%99.E2E5E;>3PN)PE-M]*43^C/"',YXK(\;EU23D\LQD94DW
M\&'QL95(07E[>EB9?]O;'^?W_P ')'_*1FX_[(Q\-O\ T5JM?@)7[]_\')'_
M "D9N/\ LC'PV_\ 16JU^ E?T;X<_P#)"<)_]B/ ?^F8GXUQK_R5F?\ _8RQ
M'YH****^T/ES]2_^"9__  5-^-/_  3P^(-K%IUS?>-?@#XCUB&X^)7PBNKA
M6M[J&4+;W/B+P=/<MLT#Q?:0!)89XGBL-8%O'8:Q&\+I<6W^AI^S)^T_\&?V
MO?A)H'QI^!GBN#Q3X-UP/;R@I]EUGP_K-ND;:AX=\2Z4[-<:1KFFF6-;JSFR
MK))%<VLMQ9SP7$O^4!7V[^PI^WS\=/V!/BW8?$CX3:Q/?>'KN[M(_B#\+]3U
M&\@\'?$30XI-L]AJMM#YL5EK$5L\ZZ'XEAL[B_T.ZD$R0WEHUUI]W^->)GA/
M@N+Z57-LHC2P/$E.FVY6C3PV;*$?=HXRUE#$V2A1QFZ2C3Q'/24)4?TS@?Q!
MQ/#TZ>79E*IB<EG*T7[TZ^7N35YT-W/#]:F&Z:SH\L^:%7_4CHKXI_89_;S^
M!7[??PEM_B9\'M9C@U?3H[&W^(/PWU.]M)/&7PYUN]BE>+3M?LX&#26-XUM=
MG1->@A73=;AM+EK1UN+6]M;7[6K^+\?@,;E>,Q&7YAAJV#QN%J.EB,-7@X5:
M4U9VDGNI)J4)Q;A.$HSA*4)1D_Z4PN+PV.P]'%X2M3Q&&KP52C6I24H3B^J:
MZIW4HNTHR3C)*2:7^:Q_P6Z_Y2@_M5?]C/X5_P#5?>$Z_*:OU9_X+=?\I0?V
MJO\ L9_"O_JOO"=?E-7^B7!__))<+_\ 9/9-_P"J[#'\=\3_ /)2<0?]CK-/
M_4VN?7O_  3_ /\ D^+]DG_LX7X3_P#J9Z17^J'7^5Y_P3__ .3XOV2?^SA?
MA/\ ^IGI%?ZH=?SA](S_ )''#7_8MQO_ *E4S]G\&O\ D5YS_P!A]#_U'/S3
M_P""Q/\ RC*_;$_[)6?_ %)?#]?YE=?Z:G_!8G_E&5^V)_V2L_\ J2^'Z_S*
MZ^R^CO\ \DKG7_905/\ U79>?/>,G_(XRC_L6U/_ %*J!7]"O_!L_P#\I$?$
M/_9MWQ)_]2SX;U_/57]"O_!L_P#\I$?$/_9MWQ)_]2SX;U^D^)/_ "07%?\
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M]YX:O3H4<3.E.&'Q,ZT*%62M"M+#^S]LJ;?Q>S=6FI-:*4N6]U)(KV7X1?M
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MAKPJ\EY,UWJ_Q(_9V\.Z:&-S*Q:XNO$GPFT^Q52LC .VH^ [>UD::4_:/#;
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M08?_ -0,P/5\'?\ D?YE_P!BF?\ ZEX4_6BBBBOXY/Z,"BBB@ HHHH ****
M/Q)_X.$_^48GQ7_[';X5_P#J96%?YVM?Z)7_  <)_P#*,3XK_P#8[?"O_P!3
M*PK_ #M:_L[Z/W_)$8O_ +*#'?\ J'EQ_-GB_P#\E-A/^Q-AO_4O'A7];_\
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M,9KN6)9+)/%%Q!'?6?@2PN1)#*;SQ!&E[)9R&[TS2=45&2O\^G]M']LGXO\
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M<UJ%8[FW=T6:WN;>:)Y;34-.OK=X[K3]3L)[FPO[66.XM;B6)U8^95_IC?\
M!2;_ ()>?!/_ (*'?#F[MM;L]-\%?'30=+DA^&WQEM-.\W4])GC<W$&@^*(K
M9X)O$/@^]FW17-C/(]SI9G?4-'>*Y62"Z_SR/VJ?V4OC5^QM\7M=^#'QR\*W
M/AWQ-I3-<Z9J$:32^'O%V@O-+#9>)_">JR0PQ:QH=\89%CN(E62VN(Y[&]AM
MKVVGMX_[>\//$K*^.<&J3]G@<^P]-/&Y9*>DU%14L7@92=ZV%E)ZQ;=;#MJ%
M9.+IUJO\O\8\$8[A;$.K'GQ>4UIVPV-45>FVWRX?%J*2IUTEI-)4JRUIVES4
MX?.%%%%?I9\.?7O_  3_ /\ D^+]DG_LX7X3_P#J9Z17^J'7^5Y_P3__ .3X
MOV2?^SA?A/\ ^IGI%?ZH=?R;](S_ )''#7_8MQO_ *E4S^@_!K_D5YS_ -A]
M#_U'/S3_ ."Q/_*,K]L3_LE9_P#4E\/U_F5U_IJ?\%B?^497[8G_ &2L_P#J
M2^'Z_P RNOLOH[_\DKG7_905/_5=EY\]XR?\CC*/^Q;4_P#4JH%?T*_\&S__
M "D1\0_]FW?$G_U+/AO7\]5?T*_\&S__ "D1\0_]FW?$G_U+/AO7Z3XD_P#)
M!<5_]B;%_P#I*/AN"?\ DK<@_P"QC1_]N/[ZZ**X/Q_\4_AC\)]&E\1?%+XC
M>!/AMH$$;RS:YX^\7:!X/TB**,J'DDU+Q#J&G6:(K,JLS3 !F52<L ?\^:=*
MI6G&E1ISJU9OEA3IPE4G.3V4813E)OLDV?U[.<*<93J3C3A%7E.<E&,5WE*3
M22\VSO*_*'_@L9^W'H'[%7['OC>[L]>MK/XQ?%_2=:^'/P?T:*Y"ZS)J>JV!
MM/$'BZUMXY$N8]/\%Z5?"]GU-"D-GK%YH%LTGVF_M8I?G;]KG_@X1_8C^ 6C
MZMIWP:UQ_P!IOXD1PS1:7I?@26:R\ PW^&2*36/B!=V;V$UC#(8Y9#X:M-<:
MZB#1V\T;DR1_Q!_M;?M>?&W]M?XOZQ\:/CIXBCU?Q%?JUEH^C:9%/9>%O!OA
M])Y9[/PSX3TJ>ZO)-.T>R:9RHGN[R_O)FDO-3OKV^FFN9/W'PT\),YS?-,'F
MW$. KY9DF"K4L5[#&TI4<5F=2E)5*>'AAJB56GA9247B*U:$8U*5Z5'GE.4Z
M7Y?QKXA9;EF!Q&!RC%T<=FN)IRI1J8:<:U#!1J+EG6J5H-TY5E!R]C2A*4HS
MY9U5&*4:GS%1117]F'\TGZD?\$8_@=?_ !X_X*-?LZZ'!927>D>!O$DOQ9\4
M2"!Y8;+0OA[#_;"7%U(GRVL<^N?V+IMO<2_NSJ&H65OAI)XT8K^DG_@VQ_8G
MG^$WP.\8_M=>.="^R^,_C[':^'_AO-?0(M[IOPAT.\>YNKZR)43P6_CSQ-#;
MWL^]MEYI_A7P[=P*L4ADG*_B3QHXJ>;<9U\+@,1+ZKDF'AE?/2FU"KBZ=2I6
MQLDXO7V5>K]6?][#-IM-,_J+PSR.66<-4:N*I*.(S.M+,'&<?>A0J0IT\-%W
M5US4J<:R73VMFE),_ANHHHK^VS^70K_0O_X-T_\ E&1X"_[*C\7?_4I>O\]"
MO]"__@W3_P"49'@+_LJ/Q=_]2EZ_$/'_ /Y(:A_V/\O_ /47,#]2\(O^2IK_
M /8GQ?\ ZDX$_97XI_\ ),/B/_V(?B__ -1[4:_R.Z_UQ/BG_P DP^(__8A^
M+_\ U'M1K_([KY7Z.'^[<7?]?\E_]-YF>]XT?Q>'?^O>:?\ I6 "OH']F?\
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M2Z[M9K>#Q+\'=,EE0JE]9?";3)+JW)_Y:0IJ.HZA9,X["XLYT]4-?G=^TO\
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M]QZ'^LG$/_0]SC_PY8S_ .7'Z8?\/C/^"F/_ $=Y\4/^_P!HG_RHH_X?&?\
M!3'_ *.\^*'_ '^T3_Y45^9]%'^J?"__ $3>0_\ AHP'_P S^2^X/]9.(?\
MH>YQ_P"'+&?_ "X_U%/^"9/Q-\=_&7]@O]F3XG_$WQ)?^+_'OC+X>C5?$WB7
M4_)-_K&H#7=9M/M5T8(H8C+]GMH(R4B0$1@D9R3]V5^:_P#P1[_Y1G?L??\
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M*_U0Z_-/I&?\CCAK_L6XW_U*IGV_@U_R*\Y_[#Z'_J.?FG_P6)_Y1E?MB?\
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MI$CQ-<7&M>))_%VL10, 93!HWA6UN89KJ,$A;>YU:QAD88-W&OSU^^W[(/\
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M[%?_ "T^VO\ AY)^WO\ ]'<_'C_PX.M__)%'_#R3]O?_ *.Y^/'_ (<'6_\
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** /\?^BBBO]0#^
M%PHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ K_ $S_ /@C
MA_RC'_8\_P"R83?^I9XDK_,PK_3/_P"".'_*,?\ 8\_[)A-_ZEGB2OY_^D1_
MR2N2_P#904__ %79@?L/@W_R.<V_[%D?_4JB?IC1117\?G]#A1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
H0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110!__V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>11
<FILENAME>logo_jones.jpg
<TEXT>
begin 644 logo_jones.jpg
M_]C_X  02D9)1@ ! 0$ P #   #_[0 V4&AO=&]S:&]P(#,N,  X0DE- ^T*
M4F5S;VQU=&EO;@     0 ,     !  $ P     $  ?_B"^!)0T-?4%)/1DE,
M10 ! 0  "]!N;VYE @   &UN=')21T(@6%E:( ?4  < %0 3  L (6%C<W
M         $E%0R!S4D="     0            #VU@ !     -,M2% @(
M
M$&1E<V,   %$    =&)865H   &X    %&)44D,   ',   (#&1M9&0   G8
M    B&=865H   I@    %&=44D,   ',   (#&QU;6D   IT    %&UE87,
M  J(    )&)K<'0   JL    %')865H   K     %')44D,   ',   (#'1E
M8V@   K4    #'9U960   K@    AW=T<'0   MH    %&-P<G0   M\
M*&-H860   ND    +&1E<V,         &G-21T(@245#-C$Y-C8M,BTQ('=I
M=&A"4$,
M                                                    6%E:(
M     "2@   /A   ML]C=7)V        !      %  H #P 4 !D '@ C "@
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M;W5R(%-P86-E("T@<U)'0@
M
M      !865H@        8ID  +>%   8VEA96B            !0
M;65A<P         !                               "6%E:(
M  ,6   #,P   J1865H@        ;Z(  #CU   #D'-I9R      0U)4(&1E
M<V,         +5)E9F5R96YC92!6:65W:6YG($-O;F1I=&EO;B!I;B!)14,@
M-C$Y-C8M,BTQ
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MU=;7V-G:X>+CY.7FY^CIZO'R\_3U]O?X^?K_Q  ? 0 # 0$! 0$! 0$!
M     0(#! 4&!P@)"@O_Q "U$0 " 0($! ,$!P4$!  ! G<  0(#$00%(3$&
M$D%1!V%Q$R(R@0@40I&AL<$)(S-2\!5B<M$*%B0TX27Q%Q@9&B8G*"DJ-38W
M.#DZ0T1%1D=(24I35%565UA96F-D969G:&EJ<W1U=G=X>7J"@X2%AH>(B8J2
MDY25EI>8F9JBHZ2EIJ>HJ:JRL[2UMK>XN;K"P\3%QL?(R<K2T]35UM?8V=KB
MX^3EYN?HZ>KR\_3U]O?X^?K_V@ , P$  A$#$0 _ /[^**** "BBB@ HHHH
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M*\+_ (F5PG_1L>'O_"RGY?\ 4G\OR[:^[_Q+/B_^CH<1_P#A)5_^?/DON/\
M/JG^)_\ P4)MH9KFY^(?[9=O;V\4D]Q<3^+?C=%#!#$ADEFFEDU!8XHHD5GD
MD=E1$4LQ !->;?\ #6G[57_1S/[07_AYOB-_\TE?Z"'QL_Y(S\7/^R8^/?\
MU%=6K_-MK]Q\(.-\L\3\-GF(K\'9+D[R>O@*,8T88?&*NL93Q,W*3G@</[/V
M;PR224^;FU:Y5?\ #?&'@?-/"[$9#0P_&>>9PLYHX^K*5:IB,$\.\%4PD%&*
MAC\1[3VGUB[;<.7D22=]/]."BBBO\YS_ $</C+]N7]LSPS^PW\)O#WQ9\5^"
M]=\=:=XA^(FD_#N'2?#U_I^G7MO>ZMX:\7>)8]1EGU)6@>UA@\)7-L\2#S6E
MNX'4[$DK\JO^(B#X,_\ 1NWQ._\ "I\*_P#QNO3O^#@O_DS/X9_]G.>#/_55
M?&BOX\Z_L;P5\(.!.,^!L/G?$&68G%9C/,LQPTJU+,L?A8NEAZD(TH^RP^(I
MTTXIM.2BG*^K;M;^-?&SQAX\X+XZQ&1\/YGAL+EU/+<NQ,:-7+,!BIJKB*<Y
M59.KB*%2HU)I6BY6CT2/[?\ ]B/_ (*O_#W]MOXOZE\(/"WPF\9>"-2T[P-K
M/CE]8U_6]$U&QDM-&U;P_I,MBD&G(LXN)I/$$,T<A/EJEO*K#<R5^L-?QL_\
M$"?^3VO%'_9OOCK_ -3/X;5_9-7XMXV\)9'P7QO/).'\-4PF7QRK+\4J57$U
M\5/VV(]M[67M<14J5+2Y(VCS<L;:)79^U^"'%V><:\#PSOB'$T\7F+S;,,*Z
MM+#4,+#V.']A[*/LL/"G3O'GE>7+S2OJW8****_(C]?"BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "OY=?^#B[_D8O
MV3?^P+\9O_2[X95_457X$_\ !:_]C_\ :/\ VI=:_9VNO@+\,K[XA0>"M+^)
M]OXGDL]=\)Z,-*FUZ[\"2:0D@\3:]HK7!O$TC464V:W"Q?9F$YB,D0D_7? K
M,<ORKQ0X=QV:8[!Y;@J-/.56QF/Q-'!X6DZN1YC2I*IB,1.G1@ZE6<*4%*:Y
MZDXPC>4DG^0^.^79AFOA;Q)@,KP.,S+'5JF2NC@\!A:^,Q=94L^RRK4=+#X>
M%2M4]G2A.I/D@^2G"4Y6C%M?4G_!%O\ Y1V_!?\ [#7Q7_\ 5K>,:_5*OSZ_
MX)=_!OXE? /]BOX7_"[XN>%Y_!OCS0-4^(=QJ_AZYO\ 2-3FLX=:^(7B;6=,
M=KS0]0U33)1=:9?VETH@O96C681S".97C7]!:^3\0\3A\9QYQGB\)7HXK"XG
MBC/:^&Q.&JPKX?$4*N98F=*M0K4I2IU:56$HSIU*<I0G!J49--,^M\/,-B,'
MP%P7A,70K87%8;A7(*&)PV)I3H8C#UZ65X6%6C7HU8QJ4JM*<90J4ZD8SA-.
M,HIIH****^./L3S'XV?\D9^+G_9,?'O_ *BNK5_FVU_I)?&S_DC/Q<_[)CX]
M_P#45U:O\VVO[5^B;_R+N-O^PW)/_3&9'\3_ $MO^1AP/_V!Y[_Z?RL_TX**
M**_BH_M@_"O_ (."_P#DS/X9_P#9SG@S_P!55\:*_CSK^PS_ (."_P#DS/X9
M_P#9SG@S_P!55\:*_CSK_1/Z-?\ R;#"_P#8YS?_ -/4S_.;Z2W_ "='%_\
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MKV,,UO<R;7"_Z/'_  DGAW_H/Z+_ .#2Q_\ C]?S=?\ !PG\/O".J>&/V?\
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M[*^LVOWTR[FU32/[&5],T/69M2GBA_KV^$7QS^#WQ\\-1^+_ (-?$CPC\1]
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MP'\/-&U%HXC%=76HWFM^)/$ME!,8FG$EA%I?A2>ZC2:*)EU*S:2*X=8GMOZ
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M4L/6J49*2JX',<)4G0G4I^Y4<:595Z/-!U(4Y-(_J]_X)G_\%C)?C;X@T+X
M?M47&DZ7\3]<N;72OA]\4[*T@TC1_B+K5]<VUG8>$?$>AZ990Z5X>\8ZA<3-
M_8VIZ<NG^'/$4KIHB:9HNMIIR>)OZ#J_S*;&^O=+O;/4]-N[G3]1TZZM[ZPO
M[*>6UO+*]M)DN+6[M+F%DFM[FVGCCF@GB=)89422-E=01_HH_LF?%;4?CC^S
M+\"/BUK4UO<>(/'GPM\':[XGFM+5[*TD\5S:-:P^*6M+1XX_LUM_PD,.I"WA
M0/!'"$6WFN(!'/)_&WTB/#')^#\7EG$?#N&A@,LSNOB,+C,LI+EPN"S&G35>
MG/ T[6HX?%T57E+"Q:I8>I0?U>,:-6-*C_9OT=?$_..,<)F?#?$>)GC\SR3#
MX?%X+,ZKYL5C<NJ5'0J0QU1RO7Q&$K.A&.*<75Q%.NOK$I5J<JM;Z%HHHK^9
MS^FPHHHH **** /YXOBG_P %X8_@Q\>?C+\'O$G[.B^*M(^&?Q6\9^ ++Q5X
M=^([Z+?W=EX0\27?AVYN;SP_JG@[4X)K]I-/NY\P:[9VLCB.W5(XV-V//_''
M_!Q/HT=G<0?#7]F'4[J_FT]Q:ZIXX^)%K86>GZJRR"-[C0- \+:E-K.GP,(7
M>./Q)H5S=*TD2RV919G_ )NOBMXQE^(OQ1^)/Q!G.9_'7C[QCXQF/R\R^)_$
M6HZW(?DAMDY>^/W;>!?[L,0PB\#7^C^7_1^\,%ALNJXWAISQM/!X58R/]KYW
M&A6Q<:%-5JLZ,,QC!<U6,I.G35.B^9ITW%V/\V\P^D)XH?6<QHX'B:,,%4QF
M*>"F\GR2=>C@Y5ZCH4H5IY=*4N6BX152K[2LK)JHI*Y[?^T1^T-\4/VH_BMX
MA^,?Q=UF'5O%NOBUMEAL+;^S]#T'1M.B^SZ5X>\.Z6)9AIVC:9#N$,33W%W=
MW4UWJFJWNH:QJ&H:A=>(45]]_L&?L _%;]MKXB:?:Z3I>I:#\&M!UNQB^)OQ
M0FC6UT[2M.1HKK4-"\-7%W!-!K7C:\T]@EAIEK!>Q:7)>V&I>(%L]+EBDN/U
M3'8[(>#<AEBL74P>2Y%DV#A3A%*%##8;#T(*G0PV&I1LI3:C&CAL-2BZE6HX
M4J4)3DD_RC X'/\ C+/HX7"4\;G>?9UC)U)R;GB,3B<37FZE?$XFK+F<81<I
M5L3B:THTZ--3JU9QA&4E^_7_  0#^!^H>!_V</B-\;-6BDMY/CIXVM+'P_$W
MDM%=>#_A5_;>AVVK1NCM*DESXQUWQQI4MM-'&430X+E"\=VI7]ZZX_X?^ ?"
M/PL\$>%?ASX!T.T\-^#/!6AZ?X<\-Z)9>88-/TK3+=+>VB,T[RW-W<NJ&:]O
M[R:XO]1O)9[Z_N;B\N)YY.PK_+?CGB:IQEQ;GW$M2$J4<UQTZN'HSY?:4<#1
MA#"Y?0JN+<95:.!H8>E5E%\LJD)2C9-(_P!3^!>&*?!G".0<,TYQJRRK 0I8
MBM#F]G6QU:<\5F%>DI)25*MCJ^(JTHR7-&G.,9:IL_S_ +_@H?\ LM7/[(O[
M5'Q!^&-K:RP^!M5N!X[^%=RX)2Y^'GBBZO)M)LD=YIIII?"^H6VJ^#+RYN/*
MEOK[PY<:@L$=M>6^[X@K^]'_ (*/_L(:'^W+\&8= L+S3O#GQ?\  =Q>:Y\*
M?%^HQR&PBO+R*&/6?"/B*2WAGO(_"_BR&TLX[RZLHI;S1]7T[1=<BMM2@TZ\
MT35_X?\ XQ?!7XI? #QWJWPV^+_@O6O WC'1Y&$^F:Q;[8KRU$LL,.JZ+J,+
M2Z=KNB7C0R&PUK1[J]TN^1&:VNI K8_O[P8\3<#QYPW@\)B\937%658:GALV
MP=6HEB<9'#QC2AF]&+LZ]+%Q4)XJ5-6PV,E5I3C"G+#SJ_Y^>-'AACN N)<9
MB\)@ZKX4S7$U,5E&,I4Y/#8.6(E*K/)Z\U=4*V#DYPPL:DKXG!QI582G4CB(
M4?WS_P""5O\ P5N^&WP=^%VF_LY_M2ZYK&@Z)X.ENH_AC\35TG5O$FFV/AFY
MDDO%\%^*;?18-4\1P'2=0FGB\,:G::7J&GPZ-<P:)>_V+8Z#8SWGZO?%C_@L
M'^PA\,O"^IZSI7Q@M?B?XA@T[[7HO@OX>Z/K^J:GKMU+N6VL?[9N=)M/#&B'
M>I>]DUO6;*6SME=UM;FZ>ULKG^%VBO-XB^CMP)Q%Q%B.(:]7.<#+'8F6,S#+
MLOQ.$I8'%8FI-5*]2*JX*MB,/]:J.<\4J->*E*I*5#ZO*\GZ7#OTB^/>'.'<
M-P]0I9-CHX'#1P>7YEF&&Q57'X7#4X>SH4Y.EC:.&Q'U2FH0PTJU"3C&$8U_
MK$4HKUGX[?&CQK^T/\7O'OQI^(=U#=>+OB#KTVM:DMJLJ6&G6ZQ0V.D:%I4=
MQ-<7$6C^'=%M-/T+1X;BXN;F+3-.M$N+FXG62>3R:I(HI9Y8X((Y)III$BAA
MB1I)999&"1QQQH"\DDCD*B*"S,0J@D@5_2__ ,$JO^"2'B>P\3^'/VE?VKO"
MBZ/8Z,+/7OA9\(->CFCU^7Q!#/;WNE>,O'^DNJ#2;/2?+%SHOA'42VJ7>J&.
M\\16&FVFFQ:=K?Z#Q;Q?PUX:<-QQF/G0PN&P>%CA,FR?#RIT\1C986E"EALO
MR^@W?DIP5*$ZBBZ.$HVJ56HI)_GW"/!_$WB9Q(\'@(5\5B<;BI8O.<XQ$:E3
M#X*.)K2JXG,,PKK1SJ3E5G"GS*MBZUZ=).3;7ZU?\$M?V8]0_98_8]\!^$O$
MMI+8^/O'=Q=?%?X@V$\;PSZ3XA\866F)8^'[F":**>VO_#GA72_#FAZS;2&5
M(]>L-6>WE:WEB ^D?VM/^35?VF?^S??C-_ZKGQ)7T%7S[^UI_P FJ_M,_P#9
MOOQF_P#5<^)*_P TO[9QG$7&M+/<PDI8W-N(\/CL1RW4(SQ&84ZGLZ:?PTJ4
M6J5*/V:<(QZ'^F2R7!\.<$U,BR^+C@LIX<Q& P_-;GG##Y?4I^UJ-?%5K24J
MM67VJLYRZG^=#6UX;_Y&+0/^PUI7_I=!6+6UX;_Y&+0/^PUI7_I=!7^L-;^%
M5_Z]S_\ 26?Y,4/X]'_K[3_]+B?Z8U%%%?XYG^R9_FV_&S_DLWQ<_P"RG>/?
M_4JU:O,:].^-G_)9OBY_V4[Q[_ZE6K5YC7^P>6_\B[ ?]@6%_P#3%,_QTS+_
M )&./_[#<5_Z?J'^B]^R7_R:K^S-_P!F^_!G_P!5SX;K\M_^"[G[-5_\6/V;
M?#7QN\.6UW>^(?V=M8U.^UBQM(S,;GX<^.6T73O%-\T$,,ES/-X=U;1O"^L-
M*72UTOP^OBG4+D"-'EC_ %(_9+_Y-5_9F_[-]^#/_JN?#=>[:CIVGZQI]_I.
MK6%GJFE:I9W6G:GIFHVL%]I^HZ??0/;7MA?V5RDMM>6=W;2RV]U:W$4D%Q!(
M\4J/&[*?\M\KXFQ7!WB&N)<''VE;*N(<?6G1YN18G"U,3B</C<*YVER?6L'6
MKX?VG++V?M.=1;BD?ZGYKPQA.,O#Q\,XR?LZ.;</8"C"OR\[PV*IX?#8C!8I
M0O'G^JXRC0Q'L^:/M%3Y'**E=?YE=?>/[!W[??Q,_81\=Z[K_A31=-\;^"/&
MUMIMGX]^'NL7]UI5OK*Z/-<3:5JNC:U:PWCZ#XCTU;W4+2UU&;3-8L'LM2O8
M+W1[R3[%/8_6O_!3/_@E-XZ_9H\4Z_\ %[X&>&]6\8_LXZW>7VK3V.BVU[K&
MM_!9I!+?7.C>(X%:[U*Z\"6R).=!\;2^=#IUI%'HGC"ZMM432M7\5_BS7^D&
M7YCPAXI<*2G2^K9WD&;T(4\;@:SY:M"I&4*KPF-I4JBK8/'86M"$XN,X5*=2
M%/$X6K*#HUY?YLYAEW&'A9Q9&-7ZUD>?Y17G4P6.HQYJ->FU.DL7@JM6FZ&-
MP.*HSG"2G3G3J4YU,-BJ,9JM0C_:G\-_^"YG["WC#1;*]\::]X\^$NM21VZZ
MCHGB;P)X@\1QVER[,ES]CU7P!9^*H;^PMV7S8[F:WT^\N+:2)SID-R9K.#O-
M9_X+1_\ !.[2XYWL_C1K/B&2&(R);Z-\*OBI')<R!BIMX)-<\'Z+;>;@;P\U
MQ#:E2-MP3E1_#A17Y/6^B_X<U<1*M#&<4X>G*3DL)1S/ 2H03::A&5?*:^*<
M$KQ3GB9SL]9MZGZU1^E)XCTL/&C/!<*XFI&*B\76RS,(XB;2LYSCA\WH853;
MU:AAH0OM!+0_KJUO_@OQ\#;[XD^"/!7PU^$?C76_#/B#QGX;\.^)?B!X\UO1
MO MGH&BZIKUGI^J>(=+T&PB\776L06&FSS7T,.KZAX4D+Q[;E845MW[[5_F/
M@D$$$@@Y!'!!'0@]B*_TA_@)\09/BS\#/@U\4IHXH9_B/\*_A]XZN8(7,D=M
M=^*_">DZY=6JLS.Y-K<7TMNPD8R*T;+(=X:OQ#Q]\+^'. ,'PIB>&<)B*%#&
M3S3"9E6Q.+KXNKB,31C@JV"J3=:;ITY2IRQD91PU*A2M3BW#F;;_ '+P \4>
M(_$#&<68;B?%X>O7P4,KQF64<-@Z&$HX?#5I8VCC:<%1IJI.,:L<)*,L36KU
MFZLDIJ$4E\8_\%*/V\[W]@_P3\(_%>B>%="\=ZQXY^),NCZEX0UG4;[1I]1\
M":-X;U2]\37FB:Q90WBZ3J]EK5YX.MX;^]TO6K.*#4;B.32;AYHYK;RWX-?\
M%M_V&_B=96<?B_Q5XH^"7B*<V]O+HWQ#\+ZI=Z:UY)&C3M9>*O!D'B;1%TN*
M8O'%J'B&7PU-*B>;-I]J7$8_)/\ X.#_ (BZAK?[1_P<^&.YVT3P!\))_$L
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; "BBB@ HHHH **** "BBB@ HHHH **** /_9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>12
<FILENAME>logo_jonesx1.jpg
<TEXT>
begin 644 logo_jonesx1.jpg
M_]C_X  02D9)1@ ! 0$ P #   #_[0 V4&AO=&]S:&]P(#,N,  X0DE- ^T*
M4F5S;VQU=&EO;@     0 ,     !  $ P     $  ?_B"^!)0T-?4%)/1DE,
M10 ! 0  "]!N;VYE @   &UN=')21T(@6%E:( ?4  < %0 3  L (6%C<W
M         $E%0R!S4D="     0            #VU@ !     -,M2% @(
M
M$&1E<V,   %$    =&)865H   &X    %&)44D,   ',   (#&1M9&0   G8
M    B&=865H   I@    %&=44D,   ',   (#&QU;6D   IT    %&UE87,
M  J(    )&)K<'0   JL    %')865H   K     %')44D,   ',   (#'1E
M8V@   K4    #'9U960   K@    AW=T<'0   MH    %&-P<G0   M\
M*&-H860   ND    +&1E<V,         &G-21T(@245#-C$Y-C8M,BTQ('=I
M=&A"4$,
M                                                    6%E:(
M     "2@   /A   ML]C=7)V        !      %  H #P 4 !D '@ C "@
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M;W5R(%-P86-E("T@<U)'0@
M
M      !865H@        8ID  +>%   8VEA96B            !0
M;65A<P         !                               "6%E:(
M  ,6   #,P   J1865H@        ;Z(  #CU   #D'-I9R      0U)4(&1E
M<V,         +5)E9F5R96YC92!6:65W:6YG($-O;F1I=&EO;B!I;B!)14,@
M-C$Y-C8M,BTQ
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MU=;7V-G:X>+CY.7FY^CIZO'R\_3U]O?X^?K_Q  ? 0 # 0$! 0$! 0$!
M     0(#! 4&!P@)"@O_Q "U$0 " 0($! ,$!P4$!  ! G<  0(#$00%(3$&
M$D%1!V%Q$R(R@0@40I&AL<$)(S-2\!5B<M$*%B0TX27Q%Q@9&B8G*"DJ-38W
M.#DZ0T1%1D=(24I35%565UA96F-D969G:&EJ<W1U=G=X>7J"@X2%AH>(B8J2
MDY25EI>8F9JBHZ2EIJ>HJ:JRL[2UMK>XN;K"P\3%QL?(R<K2T]35UM?8V=KB
MX^3EYN?HZ>KR\_3U]O?X^?K_V@ , P$  A$#$0 _ /[^**** "BBB@ HHHH
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M::=T]4?P>_\ #6G[57_1S/[07_AYOB-_\TE'_#6G[57_ $<S^T%_X>;XC?\
MS25G_LPZ1I6O_M*_L\Z%KNF:?K>AZW\<OA+I&LZ-J]E;:EI6KZ5J7C[0+/4=
M,U/3KR*:SO\ 3[^SFFM;VRNH9;:ZMI98)XI(I&4_WI?\,3_L9_\ 1H_[,?\
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M (*X?LP_LU?#;]@_XM^,/AU^SS\#? /BW3=7^&<6G>*/!7PF\ ^%O$5A'?\
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MPU\*/_5K>#J_AQK^_OHM_P#)N\S_ .RNS'_U4Y$?Y^?2H_Y.+EG_ &2&6_\
MJVST_P!."BBBOX!/] PK^''_ (+2?\I$OC1_V!?A1_ZJGP=7]QU?PX_\%I/^
M4B7QH_[ OPH_]53X.K^DOHM_\G$S/_LD<Q_]6V1'\U_2G_Y-UEO_ &5V6_\
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ML7_B'Q3XIUC4?$'B+7=4G:YU'6-:U>[EO]2U*]N'^:6YO+N>6>9S@%W.T*N
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M6O=QC>,9-)V<X)[H_-BOK;]@C_D]K]D__LX+X4?^IGI%?)-?=_\ P3%\-_\
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M0RLK#*LK D,K @@@D$'(.*=7^.I_LB%?YUO[8F@Q^&/VM?VGO#T$$=M:Z/\
MM!?&.QLH(8HX(8]/A^(7B%=/$,$+-'!$;+R&B@0XA0K$0"A _P!%*O\ .R_;
M+UJ'Q%^UY^U+KEM<K=V>I_M$?&>ZL+E&A=)M.?XB^(O[.='MV>&1/L(MPDD;
MR+(H#B23=O;^L?HH.K_;W%J7\'^R, ZF]O:K&U/9>7PNMOKO;J?R5]+)4_[
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
)BB@ HHHH __9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>13
<FILENAME>ny20042541x1_ex5-1logo01.jpg
<TEXT>
begin 644 ny20042541x1_ex5-1logo01.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  8$!08%! 8&!08'!P8("A *"@D)
M"A0.#PP0%Q08&!<4%A8:'24?&ALC'!86("P@(R8G*2HI&1\M,"TH,"4H*2C_
MVP!# 0<'!PH("A,*"A,H&A8:*"@H*"@H*"@H*"@H*"@H*"@H*"@H*"@H*"@H
M*"@H*"@H*"@H*"@H*"@H*"@H*"@H*"C_P  1"  6 ,D# 2(  A$! Q$!_\0
M'P   04! 0$! 0$           $" P0%!@<("0H+_\0 M1   @$# P($ P4%
M! 0   %] 0(#  01!1(A,4$&$U%A!R)Q%#*!D:$((T*QP152T? D,V)R@@D*
M%A<8&1HE)B<H*2HT-38W.#DZ0T1%1D=(24I35%565UA96F-D969G:&EJ<W1U
M=G=X>7J#A(6&AXB)BI*3E)66EYB9FJ*CI*6FIZBIJK*SM+6VM[BYNL+#Q,7&
MQ\C)RM+3U-76U]C9VN'BX^3EYN?HZ>KQ\O/T]?;W^/GZ_\0 'P$  P$! 0$!
M 0$! 0        $" P0%!@<("0H+_\0 M1$  @$"! 0#! <%! 0  0)W  $"
M Q$$!2$Q!A)!40=A<1,B,H$(%$*1H;'!"2,S4O 58G+1"A8D-.$E\1<8&1HF
M)R@I*C4V-S@Y.D-$149'2$E*4U155E=865IC9&5F9VAI:G-T=79W>'EZ@H.$
MA8:'B(F*DI.4E9:7F)F:HJ.DI::GJ*FJLK.TM;:WN+FZPL/$Q<;'R,G*TM/4
MU=;7V-G:XN/DY>;GZ.GJ\O/T]?;W^/GZ_]H # ,!  (1 Q$ /P#Z'OO%EK9^
M.M,\+O!.UY?VLMVDHQY:JAP0><Y_"NBKQKQ_K>F>'_C_ .$K[6[^VL+,:/=(
M9KB0(@)88&37=WWCO04\%:MXGT[4;74=-TZ*1GDMI0ZEU7.S(_B.5'_ A0!1
MTGXE:-JGQ*U+P7;I<#4+*,L9V \F5E"%XU.<EEWC(QV--^)'Q!;P+&UQ<>&]
M8U'3HX!-->VBQF*++%=K;F!ST/3N*\%>W\4^%_"OAGQ;?>$;Z"]TG4Y-9U+5
M/M=NPN(KIL3#RU<N,J8QR.-IR!SCVOX_3Q77P-\2W%NZR02V:21NO1E+H01^
M% &WX9\93:QH>HZG>^'=6TB&TA\]5O0@,Z[2V4VL>P[XZBI]'\8V>J?#U/%T
M-O<)9-9/?"%L>9M4$D=<9^7UIUW_ ,DVF_[!+?\ HFO#_"'@K4KGX 1:I'XU
M\0P6YT::;^SXVB\@*$<[.4SM./7/- 'T!X3UN'Q+X:TS6K6.2*"_MTN(TDQN
M4,,@''&:YSP1\2M&\8>*-?T/34N$N=)<J7E "7"AV1GCP>5#+C)QU%<KI7B9
MO"7[,FD:K!DWBZ/!#:(.2\\BA(P!W^9@<>@->?6-OK/PXU3X>ZQJ'A6[T:QT
MU/[&U6]EO;>9;A)VW%R(W+ "5F?GU SZ@'NGQ1\>Z?\ #KPW'K.K6]S<027"
MVRQVX4N68,W<@<!2:C^(GQ$T?P/X/@\17PFN[2X>-+=+?!:;>"P(R0,;06^@
MKEOC)9P>(_'WP]\+7:[[2]FOKFY7T2.V91GZ^80*\O\ "-AJ7CC/@O6(W=?!
M&E:A93,1\LMQ)O@M^/\ 9B!(/M0!]0V.H6]YI-OJ,;A;6:!;A78@ (5W9)^A
MJMK6LPZ;X:OM:A1KZWM;9[H+;,&,JJI8[#G!) XYKS;P UWXL_9[\,)9;I=U
MM!;W"(X222*%_+D5&;@,1&>OYCJ.J\ Z;K%I:7]GKD+?8')-NLQC,KAV=I#,
M$)4.S/D[25(P0%SL !1\2_%71=!^&^F>,YX+N>PU 1&&"(*9274MM.3C*A6S
MS_":V-;\:V&F:CX6LTBFNY?$4QCM##C 0)O:0Y/W0I!X]:\"^&^B3>(?$T/P
M[U8.VF^#O[428L,B99CY<)_[YED8?2M+X S7OB3QOID.JJQ?P+I,NEOD'Y;E
MYWC!'_;&,#\* /7?B?\ $C2/AW!IDFL17,WV^<Q*ENH+(BC+R')'RKD9^HK;
M\5Z[/HFDQWMAHU_K;/(J"#3PC.%()W_,0-O []Q7BWBH:CXX^(WBQ[+PO=>(
M-&T^PD\.Q/!=V\*PSN T[CS7&7&57CTKN_V?==NM5^'=OI^KJT>M:%*^D7T;
M$%E>+@9/?Y=O/<@T 2?#_P")[>-;Z..R\*:[:V1DEA>^N%C\F-T!RK8<G.1C
MIU-:K?$+1X-8\8V6H&2RB\+QV\MY=38\MA-&779@Y)XQC&22 ,US?[-__(B:
MA_V&K[_T::\P\:Z'J&H?%WXC:O8VYU2UT.[T>_O-%;[E_&MJV>G5DY95.0><
M@\"@#WO3?&"W?@"?Q7<Z5?6-K':RWJVUP%$SQ(I8' ) + 9 )[C--N/&]E#\
M-!XT:VN38'3UU#R!M\W8RAMO7&>?6L_Q%XATWQ5\%M?UG1)Q/8W6C7;HW0K^
MY?*L.S \$>HKD-3_ .31T_[%F'_T4M '6Z7\4=$U3X8W?C>QCN)+&TB=Y[;"
MB:-D^\A&<;NAZ]"#6MXD\:Z7X=\(0>(=2%Q]FG6+R8(8]\TKR8V1JN>6.?7'
M%?.GQ*TVZ\!^$YM8TZ-W\-^+]%2VU&%!Q;WWD@QS =@YR#[EO]D5[?XFTOPW
MK'PJTFU\8W\>G:<8+5X[QKD6Y@F"#8RN> W7&: .B\(^(;S7EN3?>'=5T0P[
M"@OQ'^]#9^[L9NF.0<8R*Z&O(O@MXCU:_P#$GB/0Y-=3Q3H.F+$;36UC +LP
MR8F=?ED*C^(?CUP-G1=&\0Z?I/@^)].M'GT. 6LBB\XE @$>\'9QR.E 'HE%
M<EX)\)_V%=ZI?7$H:[O;NZDVQA0@CDNI94R0H+-AQDL3CH..O6T 4[[2]/OV
M5K^QM;EE&%,T*N0/;(I$TK3DLGLTL+1;1SN> 0J$8\<E<8/0?D*** +4\,4\
M+PSQI)$XVLCJ&5AZ$&HWM+:2S^R/;PM:[0GDE 4VCH-O3%%% $IC0Q^647R\
M;=N.,>F/2HX[6WCM?LT<$26VW9Y2H FWTQTQ110 UK&T:WB@:U@,$)!CC,8V
MH1T('08[4^ZMH+R!H+N&*>%L;HY4#*<'(R#Q110 -;0-<1W#01-/&"J2% 64
M'J >H%)#:V\$TTL,$4<LQ!E=$ +D="Q[_C110 MI;06<"P6D$4$*YVQQ(%49
MY. *EHHH ABM+>&XFGBMX8YYL>9(J ,^.FX]3^-);V=M;2326]O#%),V^5HT
M"F1O5B.IY/6BB@!UO;06RN+>&.(.YD81J%W,>I..I/K1#;0022R0011O,VZ1
MD0 N?4D=3110 6UM!:QE+:&*%"Q8K&@4$GJ<#O1';017$T\<,2338\V14 9\
M# W'J<#IFBB@"."PL[>VDMX+2WBMY,EXDC"J^1@Y &#D4\VEL;/[(;>$VNW9
MY)0;-OIMZ8]J** $GL[:XM?LL]O#+;8 \IT#)@=!@\<8%)<V-I=6PM[JU@FM
HQC$4D891CIP>*** 'VMM!9P+#:0100KTCB0*H_ 5+110 4444 ?_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>14
<FILENAME>ny20042541x1_ex5-1logo02.jpg
<TEXT>
begin 644 ny20042541x1_ex5-1logo02.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  $! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_
MVP!# 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_P  1" "Q"FD# 2(  A$! Q$!_\0
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M?0OV=-4^ 7^JW7^ /7^_Q0 4444 %%%% !1110 4444 %%%% !1110 4444
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M_:-G_P"$;^(&N?V=\0/V=[S^T_!OC7_A%?#G@[?\</!&G_\ "1_%C0O^$_\
M!W_"ROA_=?;_ /A$=-\%?\([\5_L'Q3\5?#3XB_\(!IW_" _\+2^&H!_'%X3
M_P"#PO\ X+ ^'(/#4.L7'[,'CV30O$&C:SJEUXL^"5[9S^--.TOX-6WPPOO"
M?B5? OCGP7;6OA_Q'XV@E_:+UFY\'6_A/Q5!\9;RYT/P]XET+]GQ;3X$VN!I
M'_!WE_P62TW^Q/MGC7X >(/[*_X1;[?_ &O\"="A_P"$F_X1_P#X47_:W]M_
MV#JFB>1_PG'_  J3Q]_PE/\ PCG_  C_ -D_X:@^.G_"%?\ "'_\(_\ LT?\
M,[_S T4 ?T_:1_P=Y?\ !9+3?[$^V>-?@!X@_LK_ (1;[?\ VO\  G0H?^$F
M_P"$?_X47_:W]M_V#JFB>1_PG'_"I/'W_"4_\(Y_PC_V3_AJ#XZ?\(5_PA__
M  C_ .S1_P ,[_Z/?_!*OXW_ !3_ &D_^"<?[&'QZ^-WBW_A._BU\6/@!X!\
M:^/_ !=_PIKQ'\!/[=\1ZQI:3WEY_P *Z\1O_N0_\)_X2M-'^%GQB\K_ (7!
M\&O#GACX2^._!7AW2_\ $&K_ &>O^" ^GZ/IG_!&W_@GM;:%J?P_U>RD^ &C
MZA/=?#37? GB+PY%K&KZ[KVJ^(M,U+4/AU\+?@_X?M_B!HGB"]U/1OBQH6H>
M$]7\=^%_BG8>,O#/Q2^*7QQ^)ND>+OC7\0 #]?J*** "BBB@ HHHH **** "
MO\X3_@K)_P '+?\ P5P_9)_X*"?M>?LN> =?^ '@GP9\(_B!XA\ ?#W^S_V>
MO&]MK%MX.N?#'Q4_X5]XUU/_ (7Y:V7B#6_B!<>'_C!\+_'.N^([+P_<_ GQ
MMX[^ /PM\3?!NS\5_LY>-OB'_P -$_Z/=?XLW_!=+0].\/?\%@?^"B-AI?@;
MQ!\/+:X_:?\ B)KDN@>)?!/BKP!J.H:CXGO8O$NL>.;;0O&/Q)^*VKW_ (?^
M)^KZM??$KPGXVM/$^E^%?B7X5\6Z-\1O OPV^#7@GQ5X>^$'@8 _1_5_^#O+
M_@LEJ7]M_8_&OP \/_VK_P )3]@_LCX$Z%-_PC/_  D'_"]/[)_L3^WM4UOS
M_P#A!_\ A;?@'_A%O^$C_P"$@^U_\,O_  +_ .$U_P"$P_X2#]I?_AHC?N?^
M#PO_ (+ SSZ--%<?LP6<>E^(/$NLWUK;?!*]:#Q'IVN_&7PG\3]+\)ZRUWXY
MNKF#P_X+\$^'-8_9T\-7/AZXT+Q5=?!KQ[XLUSQCXE\6?M!V?@7X[>"_Y8J*
M /\ 3[_X-FO^"T_[<7_!4SXI_M&> _VK;?X?ZWX?^"7P ^ D>B>+/ 'P]\6^
M#?M7CNR\1^/M&\4^-_&MSI'@3Q%\,I/B!\<;*_L-2\1Z/<?%KX/Z/IO_  JJ
MSD_9W_9OUKP_<?'3Q+\.?Z_:_P Z/_@Q]L-.D^/O[?.J2Z5X?FU>S^#_ ,%]
M/L=<N?@IXJUWQ5IVG:EXT\9W&J:5HW[1=I=)X)^%?A_6;G2='N_$OP4\0V-Q
MXJ^/VHZ%X3\=>#KJSTC]FOQU#??Z+E !1110 4444 %%%% !1110 4444 %%
M%% 'P!_P5._;6_X=V_\ !/O]J']L6VT#_A*/$'P?^'\'_"!Z%/I7]MZ/??%/
MX@>)] ^%OPE_X2[3(_%7@F]N?A_;?$WQMX3O/B+_ &-XGTSQ'#X$M_$5QX:^
MV^((M-T^[_SA/^(O+_@LE_PAW_",_P#":_ #^VO^BB?\*)T+_A,?^2$_\*B_
MX\O[4_X5_P#\E _XRC_Y$;_DNW_%/?\ )LO_ !CK7ZO?\'N'[7NHS^*OV./V
M"=#O?$%GI&E^']=_:\^)^G7.@^%6\*^(]1UW4?$OP9^!-[HWB=I;KQM!X@\%
MVWAS]HN#Q+H,,.A>%;K3O'OA/4+B7Q9J]G:IX+_@CH _I^U?_@[R_P""R6I?
MVW]C\:_ #P__ &K_ ,)3]@_LCX$Z%-_PC/\ PD'_  O3^R?[$_M[5-;\_P#X
M0?\ X6WX!_X1;_A(_P#A(/M?_#+_ ,"_^$U_X3#_ (2#]I?_ (:(W]5_X/"_
M^"P.H^*KKQ#:7'[,&A:1<>(-/UF'P+I7P2O9O"MCIUGJ/P4OKCPG:W>N>.=9
M\;/X?U:V^%?CK1]0N;[QC>>*H]._:4^-<NE^)=-U?0OV=-4^ 7\L5% ']KO[
M!G_!W=^WGXV_;0_9B\"_M:6_[,$?[-WC_P",&M?#CXOZM;:&_P &H/"'A7X_
M?%;0CX;^)VL_$G7_ !-XDTCPWX?_ &0=(N3I?AI;^ST[3O%_P:M_%EC\;O$'
MBSXHWVA?'CP3_I-U_@#U_ML_\$A?VK/%7[;G_!-']CC]ISQ[X@\/^+/B)\1_
M@_IMM\2O$_AH:C%IWB'XF> M5U;X:_$;6;FPO_AE\(;;0_$&H^-O!VO7?BSP
MUX7\$K\/?"_BJ76?#OPR\6?$?X=Z7X8^(WBL _1^BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ K^$/_@O/_P<??MQ?\$]_P#@HY\1_P!E;]E:^^ %_P"!
M? 7P_P#V7]0\1Z?XU\&>+?'/B/PYX[BU2]^-?C73+RZO="^%5EHO_"[?AEXR
M\"_#KQ_H6A^(OCCH^E?"RS\.>+OA+\4O@K\>O$7C_2O ']WE?XTO_!P[\3M1
M^+G_  6C_P""@'BK5/#_ (?\-7.D_&#2OAC%IWAKXC^%OBIIUSIWP3^'/@CX
M,Z/X@N?$_@YFTC2_$'BS2/ 5CXJ\6?#B[(\5?!SQ5K.L_"+QTJ>-O _B%% /
MN#3_ /@[R_X+)66CZGIESXU^ &KWM_\ #_7?!MKXBU#X$Z%'K&B>(M7\"?"W
MPCI_Q8TR#2M4TSP_+\0/"_B#X?\ BSXI:%INLZ%J_P ++CQW\<?BEI_B7X:>
M(OAEI'P4^'7P?W]5_P"#PO\ X+ ZCXJNO$-I<?LP:%I%QX@T_68? NE?!*]F
M\*V.G6>H_!2^N/"=K=ZYXYUGQL_A_5K;X5^.M'U"YOO&-YXJCT[]I3XURZ7X
METW5]"_9TU3X!?RQ44 ?U.Z5_P 'A?\ P6!T[Q5:^(;NX_9@UW2+?Q!J&LS>
M!=5^"5[#X5OM.O-1^-=];^$[J[T/QSHWC9/#^DVWQ4\"Z/I]S8^,;/Q5)IW[
M-?P4EU3Q+J6KZ[^T7JGQ]_H^_P"#9+_@O)^U!_P4O^,O[0W[,'[9%WX?\6?$
M3PA\'_ WQK^$WC;P1\.= \$Z<OA7P%!\/_@O\9]/\=SZ1K]K;3^(/&GC;Q'X
M ^+6@6NB>!UTZ'Q5XV^.-I;:KX0^'>E_![X7>%_\R2OT?_X)"_M>Z=^PA_P4
MN_8X_:D\0WOA_2?!/P\^,&FZ-\4==\2Z#XJ\3Z=X9^#7Q4TK5OA!\:/%EMH'
M@F5?%.J>(/"?PI\>^,?$GA.VT>UUF<^*M+T9Y?#7BJV2?PUJH!_MLT444 %%
M%% !1110 4444 %>?_%CXI>!/@=\+/B7\:_BEKO_  B_PR^#_P /_&7Q2^(O
MB7^S-9UO_A'? GP_\.:EXL\7:[_8WAW3]7\0:O\ V1X?TC4-0_LS0M*U/6+_
M .S_ &73-/O;V6"VD] K^4+_ (/ _P!L7P)\#O\ @F _[*VH6?\ ;'Q-_;@^
M('A3P[X1T_[1K.G_ /".^!/V?_'_ ,.OC7\1?B+]J@\,:OX?U?\ LCQ!I'PM
M^'7_  B.I^(O"6L7_P#PM?\ X2[0I]9LO OB+2I #^6&Y_X/"_\ @L#//HTT
M5Q^S!9QZ7X@\2ZS?6MM\$KUH/$>G:[\9?"?Q/TOPGK+7?CFZN8/#_@OP3X<U
MC]G3PU<^'KC0O%5U\&O'OBS7/&/B7Q9^T'9^!?CMX+-/_P"#PO\ X+ V>G:5
M8W%Q^S!JUSIWA_X*:-=ZQJ'P2O8]1UW4?A7XJNO$/CKQ9JL6E^.=-TB'Q!^T
MII%Q#X%^-=MH>EZ-X5T+PK8VMW^SIX:^ 7C9[[QC>?RQ44 ?U.Z'_P 'A?\
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M\H7_ (.\O@9_PJ3_ (+)>-?'_P#PE'_"0?\ #4'P ^!/QT_LG^Q/[*_X0?\
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M4W_",_\ "0?\+T_LG^Q/[>U36_/_ .$'_P"%M^ ?^$6_X2/_ (2#[7_PR_\
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M/Q.T;PA+8Z?I'@;Q!XATCXE^!?AMXE6Q.LZCXET[X-^$]6U3Q!);)H_ASPP
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M7G_PG^*7@3XX_"SX:?&OX6Z[_P )1\,OC!\/_!OQ2^'7B7^S-9T3_A(O GQ
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M\O\ @LE_PAW_  C/_":_ #^VO^BB?\*)T+_A,?\ DA/_  J+_CR_M3_A7_\
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MUX UVS\1:OK%I\+-3\1^+O'_ ,+?VQ?CUI'@K2M?_P!#RO\ &E_X-XFTY?\
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH _P  >BBB@ K_ '^*_P  >O\ ?XH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH ***\_P#BQ\4O GP.^%GQ+^-?Q2UW
M_A%_AE\'_A_XR^*7Q%\2_P!F:SK?_".^!/A_X<U+Q9XNUW^QO#NGZOX@U?\
MLCP_I&H:A_9FA:5J>L7_ -G^RZ9I][>RP6T@!_FR?\'GW[7NG?%[]O/X(?LC
M^'+WP_J6D?L=?!^\UGQC+;:#XJTWQ5H?QE_:4?PSXQ\0^$]9UC6)8/#?B/P_
M:_!OP7\ /%WAJY\(:9-!IVH^-_%FF:WXEU35[>7P]X._CBKZ?_;6_:@\5?MJ
M?M<?M&_M7^,4\06>K_'SXP>./B/:>'O$OC34?B'J/@7PKKNMW4O@7X8VWC'5
M+'2;G6?#_P *_!*>'OAQX3:+1M"TZR\*^%M&TW1_#^@Z19V.CV7S!0 4444
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M ?Y M%?Z_7_$+C_P0H_Z,:_\V9_;#_\ H@J/^(7'_@A1_P!&-?\ FS/[8?\
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MUMXG\/,VD:I:$@'^3+17^OU_Q"X_\$*/^C&O_-F?VP__ *(*C_B%Q_X(4?\
M1C7_ )LS^V'_ /1!4 ?Y M%?Z_7_ !"X_P#!"C_HQK_S9G]L/_Z(*C_B%Q_X
M(4?]&-?^;,_MA_\ T05 '^8)_P $G?\ E*;_ ,$T_P#L_P#_ &-__6BOAS7^
MWS7X@_"?_@W#_P"",?P.^*?PT^-?PM_8V_X1?XF_!_X@>#?BE\.O$O\ PT-^
MU7K?_".^._A_XCTWQ9X1UW^QO$7QRU?P_J_]D>(-(T_4/[,UW2M3T>_^S_9=
M3T^]LI9[:3]OJ "BBB@ HHHH *^8/VW9/"T7[%_[7<OCKQYX?^%?@F/]F#X^
MR>,?B?XL^$FG?'WPK\./"J?"GQ8WB'QYXE^!.L:;K.D?&KP_X/T@7?B'6?A+
MJFCZMIWQ'T[3KGP=?:;?6VLRVLOT_7C_ .T+<SV?P"^.%W:Z-X@\1W-K\'_B
M7<V_A[PGXE^,O@OQ5KL\'@O6I8=&\->,?V=/"?CW]H/PGX@U215L=&\2_ GP
M+XT^,NA:C/;:I\,/"?B/QM:Z'H]X ?X,]%%% !7^FW_P90>&M.M?^";?[2OC
M&*Y\0-J^N_MO^+O#-]9W/BSQ5>>%8-.\)_ ;X ZII=SHW@6[UF?P3X<\075S
MXTUB+Q+XL\/>'M+\5>--.L_">C^,=9UW2/ 7@6Q\.?YDE?Z;?_!E!X3\+6?_
M  3;_:5\=6GAGP_:^-O$?[;_ (N\)^(?&-MHVG0>*M=\*^"_@-\ =8\'>&M9
M\0Q6RZOJGA_PGJ_CWQUJGAK1KZ[GT[0M1\:>++[2[:UN?$>L2W@!_8[1110
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M%S_PJWX=:SJ_@3X?^9_PB?A'4[_P_I&GW4OG] !7^AY_P8Z7N_X6?\%$M/\
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ME=>+_P#A2GPG\/0>+K6]T30O#7B3_2[H **** "BBB@ HHHH **** "BBB@
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M &Q? GP._P""8#_LK:A9_P!L?$W]N#X@>%/#OA'3_M&LZ?\ \([X$_9_\?\
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MZ_X2KX@>*O[7T+X _ '0M6M=.\=_''QWIUK;33Z?I\\UMJ/_  BOP_\ "O\
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MJ<__  B?Q2\(_#_XF^%_-O=,GD_X1WXB^ _!/CO1-W]F^+O"/AOQ!;:AHUD
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M_P Z.OZ/O^#K/]I?_AHC_@LE\:O#NGZM\/\ Q!X2_9?^'_PL_9H\(Z[X O\
M^U?M?_"/Z%/\4OB+I/C74X->UO3)_B!X'^-OQ;^*7PZ\1V&F0>'_ /A&?^$/
ML_".NZ##XM\/^(M0U+^<&@ KZ _9.^!G_#4'[4_[-/[-'_"4?\(/_P -$?M
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MPIJ_TN_^#+C]L7QW\8/V-OVB/V//%UG]K\/_ +&?Q \'>(OA;XE^T:/;_9_
MG[3U]\4O%FH?#K^QM,\,:9>R_P#"+_$WX?\ Q%\=_P#"7>(O$_BG6-;_ .%M
M?\(O!!X?\/\ @/0K:] /[/:*** "BBB@ HHHH **** "BBB@ HHHH *_C"_X
M/9[W9^P+^RCI_P#PD?Q M?M7[7]O>?\ "(Z;X*^W_"S7/L'P7^*,'_"1^,OB
M+_P@&H_\(K\0/"O]H_V9\-/!7_"TO!W_  GWASQC\6-=_P"$ ^)/_"MO^$B^
M%']GM?QA?\'L][L_8%_91T__ (2/X@6OVK]K^WO/^$1TWP5]O^%FN?8/@O\
M%&#_ (2/QE\1?^$ U'_A%?B!X5_M'^S/AIX*_P"%I>#O^$^\.>,?BQKO_" ?
M$G_A6W_"1?"@ _S1**** "O]YC]GK5?%6N_ +X'ZYXZNO$%]XVUGX/\ PTU7
MQC?>+-/U'2?%5YXJU'P7HMWXANO$NEZQ\%/V:]7TWQ!<:O-=S:SI^J?LZ? +
M4;/47N;>^^"GPKN8Y? NA?X,]?[O/[)VD?\ "/\ [+'[-.@_V)_PC/\ 8GP
M^#>D?\(Y_P (M_P@_P#PC_\ 9OPZ\.6?]B?\(5_PHO\ 9?\ ^$/_ +*\G[!_
MPBW_  S1^SO_ ,(_Y']D_P#"B_A)]D_X0#P^ >_T444 %%%% !1110 4444
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MCX1C\:MX@\2?\+1\/^+_  GKOPZ_L;3[W_A-M'\4>'=3\,_VG9:WIL]S]?T
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M(_Q8O?[1^*?Q+U#_ (2/X?\ C'[?\0/&5Y_PEWPG\%?\*V^%GBK[5XCU*?\
MX2/X:?#K_A /A1_P@/P_US?_ &GX-\%?\*M^&W_"*^'+K3="_P"$ \'?8/\
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M._:G_;@U[^Q//_LWX ?#S2/^$C_X1;[7_97]M_$6>\_L3_A-?^%%^(/^$?\
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M_#9'[#W_  7W_9<MM)^'^K^(/CC\ /V=_ '@/_A:5A]O\":%\4]7\)?ME_\
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MN/#][\/_ (/^(-;\-?'K4-$\60Q^'+O6/A3H5W<ZOX6O;"P\7:  ?[/-%%%
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M_A%?C1X*UW[9\2_BE_PCGC'_ (5K\/[7[!Y_C+Q__P (CXJ_X0[PXFI>(O\
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M5WH46N6SGQCXF /YX:*** /[??\ @R&^%NCZO^U/^W!\:Y]"^(%QX@^'_P
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M_P#A6G_"P?\ BZ?_  CG_"V/^%._\4E_PO2@#_-$HHHH *_WF/V>M#U'PQ\
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M>+?"OP ^,GB/PM\4OL7PLU'_ (5KXBT/X=>(]3T3Q_\ V?\ '3QK\-O@E?\
M_"':G:VOB+['\8OB+X!^%EU_9WD?$'QKX5\)/J^NV'O]> ?M8ZO_ ,(_^RQ^
MTMKW]M_\(S_8GP ^,FK_ /"1_P#"4?\ "#_\(_\ V;\.O$=Y_;?_  FO_"]/
MV7_^$/\ [*\G[?\ \)3_ ,-+_L[_ /"/^1_:W_"]/A)]D_X3_P /@'^$-111
M0 5_IM_\&4'AK3K7_@FW^TKXQBN?$#:OKO[;_B[PS?6=SXL\57GA6#3O"?P&
M^ .J:7<Z-X%N]9G\$^'/$%U<^--8B\2^+/#WA[2_%7C33K/PGH_C'6==TCP%
MX%L?#G^9)7^FW_P90>$_"UG_ ,$V_P!I7QU:>&?#]KXV\1_MO^+O"?B'QC;:
M-IT'BK7?"O@OX#? '6/!WAK6?$,5LNKZIX?\)ZOX]\=:IX:T:^NY].T+4?&G
MBR^TNVM;GQ'K$MX ?V.T45_ '_P=3_\ !>/_ )*-_P $J?V0?&?_ $ =*_:Z
M^.?PT^(7_91M$^*?[%6I:0O@+_LFVJ_%CQ5X%^*__0Y?LW>/= _Y*IX6H _$
M'_@XA_X+?:S_ ,%5/CLOPE^#NJ>5^PQ^SY\0-?U/X%W,6C>._ WB/XRZQJ?@
M[P?X:U?XI?%;PGK?CC5_#^K_ -D>(-(^(,G[/^H77@/X?^._"7PL^)>M:;XP
MT+2?%'BCQ3HUE_.#110 5T'A/PGXJ\>^*O#7@7P+X9\0>-/&WC3Q!HWA/P=X
M.\)Z-J/B/Q5XL\5>(]1MM'\/>&O#7A[1[:\U?7?$&NZO>6FEZ-HVEVEUJ.J:
MC=6UC8VT]S/%$W/U_?Y_P:C_ /!"[_D%_P#!4#]M7X-?]"EXF_8#\&^.;G_L
M):C?_M1^(?AI>:'_ -BK-^RYX@U_7/\ H9OC1I7@;_DWOXL4 ?K_ /\ !LQ_
MP1>_X=L?LXW/[2'QK3[;^UU^UW\/_A_K?B7P[K'@;_A'=8_9M^%EQ:MXNT;X
M%QS^+/#6D?$W2/B!J][J^E:Q^TAI&H2:)X<_X3OP?X(\$6OA:^F^#]M\1?'?
M]/M%% !1110 4444 %%%% !1110 4444 ?S@_P#!V!>_9?\ @B5^T;!_PD?Q
M T/^T?B!^SO9_P!F>#?!7_"5>'/&.SXX>"-0_P"$<^+&N_\ " >,?^%;?#^U
M^P?\)=IOC7_A(OA1]O\ BGX5^&GPZ_X3_4?^$^_X5;\2?\D6O];K_@[ O?LO
M_!$K]HV#_A(_B!H?]H_$#]G>S_LSP;X*_P"$J\.>,=GQP\$:A_PCGQ8UW_A
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MOO\ BDO^%@?\(E_PE/\ :7_"]/\ BUG_  JS_A9?]D?\7M_X4[7]7M?RA?\
M!Y)J>LV'_!(_PW:Z9\4O^%?V6M_M?_!K3/$7A/\ M#QW9?\ "\='B\$?%_68
M/A;]F\(Z%J_A_5_[(\0:3H7QK_L_XI:AX7\"1_\ "G_[5T_7;CXFZ9\.O#7B
M( _RQ**** /O_P#X)._\I3?^":?_ &?_ /L;_P#K17PYK^IW_@\M_P""9^G?
M#SXF> O^"I_@76_#^GZ1\>/$'@#]G+XY>!;EO%4OBK5/C+X>^'OC.^^'WQ5T
M:[OM2UGPV_A_5O@W\*[/X=^)?#>EVG@:#PQJ/P[\)^(K&P\<:O\ $OQKJGA7
M^4+_ ()E:SJ/AS_@I)_P3Y\0Z/X3\0>/=7T+]M_]E#6=+\"^$[GPM9^*O&FH
MZ7\>? -]8^$_#5WXZ\2^"_!-KX@\1W,$6CZ-<^,?&/A/PK!J-Y;2^(?$NA:0
MMWJEK_LM?M^?L=>!/^"@'[&W[0G['GQ%O/[(\/\ QQ^']YX=T_Q-]GUF_P#^
M$'\=Z1?6'BSX6_$7^QM"\3^#+WQ+_P *W^)OA_PCX[_X1&?Q/I&C^,/^$=_X
M1?Q%/)X?U?4[:8 _PQJ*]@_:%^"GBK]FOX^_'#]G3QU?^']6\;? 'XP?$OX*
M>,=4\)W6HWWA74O%7PK\::UX%\0ZAX:OM8TK0M7O/#]YJ^A7=QHUUJFAZ-J-
MQITEM-?:5IUR\MI#X_0 5^G_ /P1_P#^"D_CO_@E;^W#\-OVF?#2_P!H_#_4
M?LOPM_:.\)P>%]'\5:QXV_9Q\5>+?">L_$K0O"-MJ^M>%?[.^(&G?\(KHWC'
MX=:G;>,/"MJ/'?A7P[IWBS4-1^'^H^+_  UKWY@44 ?[['A/Q9X6\>^%?#7C
MKP+XE\/^-/!/C3P_HWBSP=XQ\)ZSIWB/PKXL\*^(].MM8\/>)?#7B'1[F\TC
M7?#^NZ1>6FJ:-K.EW=UIVJ:==6U]8W,]M/%*W05_"'_P9U_\%7-'\0>!-1_X
M),_%JZ^P^+? G_"R/C!^RGXEU#5O FCZ/X@\":KK%EXL^)OP%TS1A;>'_%OB
M#X@>'_%OB#QY\=="NXYOB+K'B#P)K'Q2&I3>!/"7P7\/VWB#^[R@ HHHH *_
MSP_^#XN]W_%/_@G;I_\ PD?Q NOLOP__ &CKS_A$=2\%?8/A9H?V_P 1_""#
M_A(_!OQ%_P"$ T[_ (2KX@>*O[._LSXE^"O^%I>,?^$!\.>#OA/KO_" ?#;_
M (63_P )%\5_]#RO\\/_ (/B_P#A'?\ A:?_  3M^R_\+ _X2W_A7_[1W]M_
MVE_PM/\ X59_PCG_  D?P@_X1;_A#?[7_P"+)?\ "P/[3_X3#_A9?_"OO^+I
M_P#".?\ "I_^%Q?\4E_PHN@#^$.BBB@#]GO^#>+P'J/Q'_X+1_\ !/\ \/:7
MIOA_5;G3OC!JOCV6U\2R>%H].BT[X5_#GQO\3]8U*V;QC\)?C5I!\0:-I'@^
M^UCPG':>#M&\52^*K'1HO OQ:^ /C9_#WQV^''^RU7^-+_P;Q:'J/B'_ (+1
M_P#!/^PTOP-X?^(=S;_&#5=<ET#Q+X)\+>/].T_3O#'PY\;^)=8\<VVA>,?B
M3\*=(L/$'PPTC2;[XE>$_&UIXGU3Q5\-/%7A+1OB-X%^&WQE\;>%?#WP@\<_
M[+5 !1110 4444 %%%% '\\/_!U/HVHZI_P0Y_:YOK'Q9X@\.6WASQ!^S=K.
ML:/HUMX6GT[Q[IT_[37PB\/1>$_%DOB'PUKNKV?A^SU?7M+\=6USX%U3P7XJ
M;Q5X+\-6EWXENO!-UXQ\'>+/\B6O]GK_ (+\?!W_ (7G_P $;?\ @H3X*^R_
M:_[$^ &L?&+RO^$P_P"$'V?\,[Z[H/[0'VG^VO\ A7WQ-^V_8O\ A67VS_A#
M_P#A'--_X6%Y'_" ?\+!^$G_  DW_"UO!G^,+0 4444 ?Z+G_!D?^U!X6U3X
M!?MC_L77:>'])\;>!_C!H7[4'AZ2Y\::<?%7CWPK\5/!?AKX4^,4T;X=RV-M
MJZ^'_A'J_P '/ K>)?&ECJ>LZ<VH_&SPGH>J6/AJY31[CQ9_<Y7^(-_P3%_X
M*%_%/_@E_P#MD_##]KGX6Z9_PEO_  B7]L>'/B+\+;SQ5XC\)>'/B_\ "SQ;
M8MIGB[P!XCU#P[/_ -@_Q?X*O-=TCQ;X=\*?%/PEX \>ZGX*\6_\(E!H5[_L
M=?L+?MT_LX_\%%_V<?!G[4'[+_C/_A*OA_XJ\S3-9T;4XK73O'?PQ\=Z=:V-
MSXF^%OQ2\-6U]J/_  BOQ \*_P!HV+ZAIZ7VHZ/K.CZCH7C3P7KOBKX?^*O"
M?BS70#Z_HHHH **** "BBB@ HHHH **** "BBB@ K\H/^"Z5S/:_\$?O^"B,
MMOHWB#79&_9@^(ELUCX:\2_&7PGJ,$%Y916EUK-SJGP)\)^-/&UUX?\ #EM/
M-XA\6>&M<T>S^#7C3PKI>L^#OVB_%G@+]GS7?B?XZ\.?J_7Y0?\ !=+PG!XT
M_P""/W_!1'1[CPSX@\61V?[,'Q$\6+I?AK1O@WKNHVL_@*RB\=6OB6YL?CM;
M77@F#P_X+N?#D/C'Q9K.AQ+\9?#GA70M9\0_LZ7-G^T'I?PPNX #_%FK_8Z_
MX-O/^$=_X<E?L$?\(M_PK_\ LS_A7_Q!^U?\*T_X6G_PCG_"1_\ "\/BA_PF
M']I?\+B_XJW_ (6!_P );_;?_"V/[(_XM9_PM/\ X3+_ (47_P 62_X5]7^.
M+7^QU_P;>:[H_B+_ ((E?L$:AH6H?VG96_P_^(.A3W/_  JWP)\'_+UCPO\
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M6/$MSXA\':%X5NM.\>^$XO!WB7Q9J]GXZTOP6 ?R1?\ !)W_ )2F_P#!-/\
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M(?AQXL:71M=TZ]\*^*=9TW6/#^O:1>7VCWOS!10!_OL>$_%GA;Q[X5\->.O
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M (2J'Q5:_"7Q7:ZS!XD_9X_9\U3X8 '^VS17^-+JO_!P[_P6CUGQ5=>,;O\
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MKP+X%T;PYX)\%^'X+FZEBT;PGX.\/:%X5\.:<MMH_A[1M+TBSM+&#GZ "O\
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M;?'W6%\-:EX>^)_@_P *Z3ITOBRU\8^ _B/J^L^!?$/PK /])NBBB@ HHHH
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M%OBKQAXQU/4_&/C#Q5K!UCQ5J&G:=J&G>$M.\->&M! /Z/O^#0C_ (*N:/\
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MG5+NZU'5-1NKF^OKF>YGEE;_ %FO^#K/]I?_ (9W_P""-OQJ\.Z?JWQ \/\
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M!\%_%ESH'C:5?"VJ>'_"?Q6\>^#O$GBRVUBUUF ^%=+UEXO#7BJY2#PUJO\
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M#MSX?\$_\)MX@MOA;K/_  KK4_%FB:Q\4?\ A7__  DNA>'?%%E\'_$6I>$
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MX._X3[PYXQ^$^A?\)_\ $K_A6O\ PCOPH_S1*_N\_P"#=+_@H7X._P""7_\
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MI:AIFH?\*4^%NIZW\,O@_P#;;*X@N?\ A5OPZUG5_ GP_P#,_P"$3\(ZG?\
MA_2-/NI?/Z] ^+&IZSK?Q3^)>L^(OBE_PO'Q!JWQ \9:GKOQK_M#QWJ__"X-
M8O\ Q'J5UJ?Q2_M7XI:%X7^)NI_\+ O99_%G]H?$7PUX=\=WO]K_ &GQ=H6D
M>()-0T^W\_H *_T//^#'2SV?"S_@HEJ'_"-_#^U^U?$#]G&S_P"$NTWQK]O^
M*>N?8/#GQ?G_ .$<\9?#K_A/]1_X17X?^%?[1_M/X:>-?^%6^#O^$^\1^,?B
MQH7_  G_ ,2O^%:_\([\*/\ /#K_ $//^#'2]W_"S_@HEI__  D?P_NOLOQ
M_9QO/^$1TWP5]@^*>A_;_#GQ?@_X2/QE\1?^$ T[_A*OA_XJ_L[^S/AIX*_X
M6EXQ_P"$!\1^#OBQKO\ P@'PV_X63_PD7Q7 /[O**** "BBB@ HHHH ****
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MK^ -MJVL>!?VE/\ 1<K_ #A/^#(;2/._:G_;@U[^Q//_ +-^ 'P\TC_A(_\
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M+X<_LCXF_MG_ ! \2?'359]=^&7_  @OCO3OA9I$@^'7P4\+:AXBOY9?$'Q
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M##H7A6ZT[Q[X3U"XE\6:O9VJ>"P#^.+]NG]NG]H[_@HO^T=XS_:@_:@\9_\
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M'K.L:!=>"_B3!X5^(_A4 _Q9J_O<_P"#2'_@DC^R/\3=.M/^"C_Q?^*'P?\
MC]\=OAYX@%U\(OV8]!\3:)XGU']E+4;'Q5XK\.^%?C7^T%X),S:OI?Q@\6:O
MX"\2Z]^SMI6NZ5'X5\)>%=+L_C)H&H>*OB3J/A6[^!O\H7_!3#_@E9^UQ_P2
MA^,NB?"#]J3PYX?GMO&GA]?$WPR^+OPVO];\1_!KXIZ=:P::/%%MX)\5:]X<
M\)ZNWB#P%J^J6NA>.?"?B3PUX<\5:#/=:'K[Z-/X)\:> O%7BKQ_]A;]NG]H
M[_@G1^T=X,_:@_9?\9_\(K\0/"OF:9K.C:G%=:CX$^)W@34;JQN?$OPM^*7A
MJVOM._X2KX?^*O[.L7U#3TOM.UC1M8T[0O&G@O7?"OQ \*^$_%FA '^YS17X
MP_\ !(K_ (+C_LC_ /!7SPKXBL?A3#X@^$W[0?PX\/Z!KGQ3_9T^(]YHDOBJ
MPT[4-.T.'6O'/PQUS2;Q[;XJ?!_1O&VK7'@5O&T>E^%/%6F:C%X?N_B)\-OA
MQ'\0?A];^)?V>H _S1/^#T?]CKP)\'_VR?V=_P!L/PC>?9/$'[9GP_\ &/AW
MXI>&?L^LW'VCQW^S#8_"WPGI_P 1?[9U/Q/J=E%_PE'PR^('PZ\"?\(CX=\,
M>%M'T3_A4O\ PE$\^O\ B#QYKMS9?/\ _P &=?[0^L_"S_@JOJ/P4;Q3]B\)
M?M0? #XD>$;GP9J'BOQWI6C^(_'?PRCLOB]X3\1:9X4\->"_%OA+Q;\0/"7A
M+PE\3M/T*?XCZK\,M'\.>!/&'Q2NO#_Q%F\6WNC?"OXI_O\ ?\'L_P#PCO\
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MNZ7^S1_PBWV_^U]2_P"$F^U_\,[_ /":_P!M_8_#_D?\)A_PCG]D3?\ "/\
M]O:V ?T^T444 ?XXO_!QM^S1_P ,O_\ !9+]M3P[I^D_$"T\)?%OX@6?[2_A
M'7?']AY'_"8?\-$:%IWQ2^(NK>"M3@T'P_IGB#X?^'_C;X@^*7PZ\.7^F0:E
M_97_  @]YX1UW7M;\6^&?$6H3?B#7]_G_![S^RY_R8_^VMX?\#?]%#_9<^+O
MQ+_X2;_KA\6/V=/ W_"&WOB'_LZ/7_\ A)O#/A7_ *A7CGQ#_P D[TVOX Z
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M>'-9TB/Q'X=T?2-/T3Q+>:OX@L-2U>^_3^@ HHHH **** "BBB@ HHK\0?\
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MLZ1XC\/Z)'J?@D _T>Z*** "BBB@ HHHH **** "BBB@ K^.+_@]?N?%2_\
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M_P"%Z?LO_P#"'_V5Y/V__A*?^&E_V=_^$?\ (_M;_A>GPD^R?\)_X?\ ?Z\
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M[_A /BQ/_P )KX5_L[X?Z=_PBO\ PM+3;S^POB3O^*?PU^&FG_\ "%6'V_\
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M3/\ ;:_9?_L[6_"/_"%>&/[5^*?QC^!*7VH_\+%^!=GY'B;P_P#\)!_PC_\
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M1*_8(G_X2/X?^*MGP_\ B#9_VG\-/!7_  @/ARU_L[XX?%#3_P#A'-2T+_A
M/AM]O^('@[[+_P (C\6/&O\ PCNH_P#"R?BGH?C+XB_\)_\ %?\ X2K_ (6E
MXQ /V^HHHH **** "O\ /#_X/B[/9\4_^"=NH?\ "-_$"U^U?#_]HZS_ .$N
MU+QK]O\ A9KGV#Q'\()_^$<\&_#K_A/]1_X17X@>%?[1_M/XE^-?^%6^#O\
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M7G_Q8^%O@3XX_"SXE_!3XI:%_P )1\,OC!\/_&7PM^(OAK^T]9T3_A(O GQ
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M'B"34-/M_/Z] ^+&IZSK?Q3^)>L^(OBE_P +Q\0:M\0/&6IZ[\:_[0\=ZO\
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M$_\ "P/':_'#P1<ZAX1_X1K3/$6B67Q@^Q?#*W^(OCS_ (5UXBTWQ?H^F?\
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M/^&B/'__  BW_".?V5_P@_\ PC_P+_X0K_A'_P#AE_\ 9H_X5(:O_P $!_\
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MX0__ (47_9/]M_V]KVI?\)-]K_X9W\ ?\)3_ ,)'_:O_  G'_"0?'3_A-?\
MA(/^&H/VE_\ A;?/ZK_P;Q?\$7-9\*W7@Z\_X)__  ?ATB\\/Z?X9FO-*U7X
MC:%XJ33M-T[X*:7;W-KXZT/QOIWC:Q\026WP!\"RZAXLL?$-OXJU;4=>^->L
M:IK-YJ_[2G[1=]\5/V>HH _('_AP/_P1M_X3'_A.?^'>WP _MK_GQ_L?7?\
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MQ6 /]'OX3_"WP)\#OA9\-/@I\+="_P"$7^&7P?\ A_X-^%OPZ\-?VGK.M_\
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MB/X36+6==TZ]\*^*=&U+1_$&O:1>6.L7OS!0 5_H.?\ !D?^U[IT_A7]L?\
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M[&^N9[;PYX?NO&WC3QCXQN=&T>*STZ?Q5XL\2^(9;9M7UW5+NZ_UVJ_RA?\
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M_$/AKQ+X>UBVO-(UWP_KND7EWI>LZ-JEI=:=JFG75S8WUM/;3RQ, ?X0_P
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M!X>\*^$M._L[PEX5T'2?^)3H-A]L^P?;[_[5J=U>7EQ_H-_\&8/[!VH_"O\
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MGX6>'O"8TG6/$^G:!XJU_1O&/Q!^&7Q/^%/AKQ[X%US_ &&J "BBB@#\ ?\
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M\2:-X?\ BI\8WN_#'B7X<:IHG@^=]1_9Q\)^-;Y?%6D:SX*OM&_M=H ****
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M ^,FK_\ "1_\)1_P@_\ PC_]F_#KQ'>?VW_PFO\ PO3]E_\ X0_^RO)^W_\
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M\/\ AW7?@I\8/\D6O];K_@[ T+6=7_X(E?M&ZAIFG_;;+PO\0/V=]=\17/\
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M7_9_Q2U#POX$C_X4_P#VKI^NW'Q-TSX=>&O$0!_EB4444 %?[_%?X ]?[_%
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M **** "BBB@ HHHH **** "BBB@ KY@_:@_8I_9'_;4\*IX._:O_ &<O@_\
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M^$O&-M\'H/@_X:\9>,=8^&'@3X??#K6]9M/!_A+XE?#C0R ?T^T444 %%%%
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M_P#9IL_^$1^$_C7_ (5K\4_%7VKXT>"H/^$<^&GQ%_X3_P"%'_" _$#7-_\
M9G@WQK_PM+X:_P#"*^([K3==_P"$_P#!WV#_ (2+3O\ <YK_  QO^">W_"1_
M\-]?L/?\(?\ \+ _X2W_ (:__9I_X1;_ (5/_P *L_X6G_PD7_"Z/!7]B?\
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M3TB\\=:7XT_GAHH _H^\%?\ !V!_P6U\*_8_[=_:-^'_ ,2OLOQ \ >,I_\
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M_P"CZOYP?^#L#4]'L/\ @B5^T;:ZG\4O^%?WNM_$#]G?3/#OA/\ M#P)9?\
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MO/C!XMN_'6C6VEZ7XL\:6UUX?\.>-I_$/A[PGXEEUBSU'QIX5TO1O&.L>$_
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M?">IZ[_;/Q2^%WC;Q!;?:?#_ ()\,:?_ &99ZK;Z/#_9GVJWT^*]O=0N;O\
M,"B@#^A[Q+_P=3_\%QM=U&VOM+_:Y\/^"[:#P_X3T:71_#7[-W[,MUIUYJ/A
MSPKHWA[6/%ES+XQ^$7BS5U\0>/=7TN^\=>++:TU2U\*V?BKQ'K-IX%\->"_!
M,'A[P=H1X3_X.I_^"XWASQ5X:\0ZQ^USX?\ 'ND:%X@T;6=4\"^+/V;OV9;/
MPKXTT[2]1MKZ^\)^);OP+\(O!?C:U\/^([:"71]9N?!WC'PGXJ@TZ\N9?#WB
M70M76TU2U_GAHH _H>T;_@ZG_P""XVEZ=XLL;[]KGP_XCN?$?A^VT;1]8UG]
MF[]F6#4? 6HP>*O#7B&7Q9X3B\/?"+0M(O/$%YI&A:IX%N;;QUI?C3PJOA7Q
MIXEN[3PU:^-K7P=XQ\)ES_P=3_\ !<:?PKHWAZ+]KGP_9ZOI?B#Q+K-]XZMO
MV;OV96\5>(].UW3O"=CI?A/6;2[^$5UX)@\/^"[GPYK&L>&KGP]X.T+Q5=:C
MX]\61>,?$OBS2+/P+I?@O^>&B@#^A[PG_P '4_\ P7&\.>*O#7B'6/VN?#_C
MW2-"\0:-K.J>!?%G[-W[,MGX5\::=I>HVU]?>$_$MWX%^$7@OQM:^'_$=M!+
MH^LW/@[QCX3\50:=>7,OA[Q+H6KK::I:]!_Q%@?\%M?^$<_L3_AHWX?_ -I_
M\*__ .$-_P"$P_X9W^!__"1_\)%_PM/_ (6#_P +8^R_\(1_PB7_  L#_A$O
M^+%_V;_PBW_"K/\ A5G_ !-_^%:?\+M_XO%7\X-% !1110 5^O\ _P $&_VS
M/^&%_P#@JO\ LD?&#6?$7_"._#+Q3\0(/@7\:Y]3^)O_  JGP(GPL^.,9^'6
MJ^*?BEXBNHKCP_>_#_X/^(-;\-?'K4-$\60Q^'+O6/A3H5W<ZOX6O;"P\7:!
M^0%% '^_Q17Y@?\ !&#]L7QW^WS_ ,$P/V0?VJ?BE9_9_B;\0/A_K?AWXBZA
M]HT>7_A+?'?P?\?^+_@IXN^(OV7P[X8\&^']!_X6?X@^'>H?$7_A$="\.V6C
M^"O^$H_X1'3)]3LM$@U6^_3^@ HHHH **** "BBB@ K_ "1?^#L#XBZSXV_X
M+:_M&^&M3@\JR^#_ ,/_ -G?X=>'9/\ A(O'>M_:='U/X'^"/BU//_9OB[Q=
MXD\/^$-OB#XHZ[;?\([\+=&^'_@2Y^S_ /"6:AX1O?B;XH^(OCSQM_K=5_B#
M?\%6_B7_ ,+@_P""FO[?WQ%CTW^R++Q%^U_^T'_8VGS_  F_X4=K%OX<TCXG
M^)="\-?\)=\+;GP;\/\ Q!X7^($OA_3--G^(O_">>$=(^*>M^.Y/$7B+XM?;
M_B;J_BS4[T ^ **** /[7?\ @R/^"GBK7?VT/VQ_VB[2_P##\?@GX5_LP:%\
M%/$.EW-UJ*>*KSQ5\?OBMX:\=>#M0T:QBTJ;2+CP_IND?LU^.K?Q+=7VN:=J
M-GJ.K>$X=+TK6;:^UB[T+_2;K^$/_@QT^'6LZ9\+/^"B7Q;GGW>'_&WQ _9Q
M^'6F6W_".^.[;RM8^%WASXO^)M=G_P"$LU#PC9?#+6_M%E\8/#L?_".^$?'G
MB3QWX7^S?VE\1?"/@GP_XO\ A;K/Q _N\H **** /\R3_@\^_9#T[X0_MY_!
M#]KCPY9>']-TC]L7X/WFC>,8K;7?%6I>*M<^,O[-;^&?!WB'Q9K.CZQ%/X;\
M.>'[KX-^-/@!X1\-6WA#4X8-2U'P1XLU/6_#6EZO<2^(?&/\<5?Z[7_!T=^R
M'J/[6G_!'[XY7WAJR\0:KXV_94\0>&/VO?"NCZ-KOA70-.OM.^%=EXA\/?%V
M]\62^*HECU3P_P"$_P!GSQ[\7_'5MH.@:IHWBK6/%7A;PU9Z%+KERY\'>)O\
MB6@ KH/"?BSQ5X"\5>&O'7@7Q+X@\%^-O!?B#1O%G@[QCX3UG4?#GBKPGXJ\
M.:C;:QX>\2^&O$.CW-GJ^A>(-"U>SM-4T;6=+N[74=+U&UMKZQN8+F"*5>?H
MH _W&?\ @FA\?M1_:E_X)Z?L3_M!^(?B%X?^*GC;XJ?LP?!7Q+\4?'7AJ;PJ
M^G:O\97\ Z'8_&BVN;3P3!9^%M"\0:%\5K/QCX>\6>$]'T_28/!OBK2=9\*2
MZ-HUSHT^EVG\ ?\ P>??M>Z=\7OV\_@A^R/X<O?#^I:1^QU\'[S6?&,MMH/B
MK3?%6A_&7]I1_#/C'Q#X3UG6-8E@\-^(_#]K\&_!?P \7>&KGPAIDT&G:CXW
M\6:9K?B75-7MY?#W@[]WO^#,K]J/_A:__!./XK?LT:]XY_M[Q;^R=^T!K7_"
M.>"O^$9_LO\ X0'X$_'?2X?'_@K_ (J.S\/:=IGBK_A*OC;IW[2^K?Z?KWB/
MQCH?D_8-6_L?PE)X LW_ ,\/_@H'^TO_ ,-D?MP_M9_M1VVK?$#5_#_QQ_:
M^*/C_P !_P#"TK_[?X[T+X6:OXMU/_A4O@K7?+U[Q19:9_PK_P"&47A/P-IG
MAS1O$&K^'/"FC^'=/\,^&KR3P_I&FX /D"BBB@#^G[_@TJ_9+UG]H7_@JOX;
M^+5SX9^($_P__9*^'_B3XMZYX[\(_$/QW\+-'\+^.];C'@CX;>&O$6O^"?!V
ML?\ "=_\)W_;'BR.?X%:SX\^$FC_ !.\">'?B+J7B;Q!X_\ A_X'\<_ [XJ?
MZO5?R!?\&97[+G_"J/\ @G'\5OVE]>\#?V#XM_:R_: UK_A'/&O_  DW]J?\
M)]\"?@1I</@#P5_Q3EGXAU'3/"O_  BOQMU']I?2?]/T'PYXQUSSOM^K?VQX
M2C\ 7B?U^T %%%% '\X/_!V!\.M'\;?\$2OVC?$VIS^5>_!_X@?L[_$7P['_
M ,([X$UO[3K&I_'#P1\))X/[2\7>$?$GB#PAM\/_ !1UVY_X2+X6ZS\/_'=S
M]G_X1/4/%U[\,O%'Q%\!^-O\D6O]OG_@JW\+=9^-/_!,K]O[X8^&M"^('BKQ
M;XJ_9 _:#@\$^$_A;J?CO3O'?B_QWIWPP\2ZSX&\(Z%;?#;4-.\6^*O^$J\6
MZ=HWA_4_AU;-J.C_ !1T?4=0^''BSP[XJ\)>*M<\-:M_B#4 %%%% '^JW_P9
MZ?%O4?B/_P $?K?P=?2>('MO@%^T_P#&WX2Z.NLZEX6OM.BT[6;+P-\=I8_"
M=KX>\!^#]7T;P^=7^-6J2W.F^.O$/Q4\52^*I/$NL6GCS3O!.K>#OAA\./ZG
M:_@C_P"#'WXY:=/X5_;Y_9KU+7_#]GJ^E^(/@O\ ''P7X7N?'?BIO%7B/3M=
MT[QGX"^)VOZ-\,M5\;W7@F#P_P""[GPY\(].\2^._ ?PWT+Q5=:CX]\)^'_B
MUXW\6:19_!70?!?][E !1110 4444 %?R!?\'>__  31_P"&F?V-O#W[<_PM
M\)_VC\;?V+OM7_"Q?[!T+[9XC\:_LL>*KZ'_ (2[[?\ \([X#U[Q;XC_ .%$
M>+9-/^*.D_V[XN\*_#KX8?"S6OVE_&VI_:-3U&#/]?M<_P"+/"?A;Q[X5\2^
M!?'7AGP_XT\$^-/#^L^$_&/@[Q9HVG>(_"OBSPKXCTZYT?Q#X:\2^'M8MKS2
M-=\/Z[I%Y=Z7K.C:I:76G:IIUU<V-];3VT\L3 '^!/7^GW_P;\_\'(OP)_:H
M^%GP-_8J_;/\>_\ "LOVVO#_ /PA/P+^'7C+QKJ7C'Q!X<_:]^Q>'+C3?"/B
MF\^)?B*3Q!_PC_[0'B#_ (1^VT#Q_HGQ-\567_"W/BGX@\.:K\)=7\0>)?B;
M/\)_AY_-#_P<,_\ !O-XJ_X)H^*M7_:H_97TCQ!XT_8"\:>((([ZQDGU'Q'X
MJ_9*\5>(]1CM-+\!^/-4NY+S5]=^#^NZO>6VC?"7XMZS<W6HVNHW6F_"CXKZ
ME/X^G\"^.OC?_+%0!_O\45_D"_L+?\',7_!5?]@[P)X,^$/A/XF_#_X[_!+X
M;?#^3X=?#;X2?M(?#^/QCH_@71X]8L=2T.?1_'G@;6/AM\;;_P#X0[3+6Y\&
M>"/#OB;XJ:]X$\*>!+^/PIHWA&UTSPYX)C\+_O\ ?"W_ (/B]VL:%I_QK_X)
MV^5X?O?B!J?_  DOB[X6_M'?:-8\-_"S4_'>H3Z-_87PZ\6?!^VLO&WQ \$_
M#*YTK3-3_M#XI?#_ ,.?%'QWHFH:[:_\*?\ #_BBV\.^$ #^_P HK^"/Q+_P
M?)^%K74;:+P=_P $T_$&NZ0WA_PG<W=]XE_:ST[PGJ,'BJ\\*Z-=^.M&MM+T
MO]G/QI;77A_PYXVG\0^'O"?B676+/4?&GA72]&\8ZQX3\!:OKM]X%\.?G!^U
M'_P>:_\ !1WXK_\ "<Z#^S1\*?@!^R=X2U[_ (1G_A"O$?\ 8NJ?'?X[> ?[
M+_X1Z\\1_P#%:^/YM.^"7BK_ (2K4].UZP_XFW[-$/\ 8?@[Q'_9-AYGBW1[
M/Q^X!_H^?M+_ +57[./[&_PLU;XU_M1_&CX?_ [X9:1]O@_X27Q_K]KI']NZ
MQ8>'->\6?\(CX*T;,OB#X@?$#4_#_A?Q#J'ASX=>!M*\1>._%?\ 9%Y:^&?#
MNKWL?V8_XXO_  6,_;"_9Q_;Q_X*"?&S]J#]E;X'?\*(^$OQ*_X134UT;4_#
M5KX.\=^.O'<GAC3+GXG?%+XI>&O#_P 1_B3\/[#X@>,?B!=>(GU#4/AU?:#H
M_BO1[#0O&GB[0KKXM>(_B/XL\4?('[2_[57[1W[9'Q3U;XU_M1_&CX@?''XF
MZO\ ;X/^$E\?Z_=:O_86CW_B/7O%G_"(^"M&S%X?^'_P_P!,\0>*/$&H>'/A
MUX&TKP[X$\*?VO>6OAGP[I%E)]F'V_\ \$K/^"._[7'_  5>^,OASP=\(/!_
MB#P7\"8/$%_8?%W]J_Q+X/UNZ^#7PLT[PY!X<U+Q5I5MK(_LO2?'OQ@72/%G
MAJ7PG\%-"\0VOBK7I_$>C:QK]UX+^&T'BKXC^%0#\H*_K=_X(*_\'+WQ"_8,
MU'P-^R=^VIJ'B#XJ?L7ZIX@_L^T^+FLZW\3/B'\9?V8M.?PK\/O ?@72O">F
MZIXJ\0Z1J'[,'PTTCP-_I/P4\ ^"M)\5>'(/%7B7QEX!NO$^HZ-8_"7QI_1]
M^TS_ ,&D/[$OCK_@GIX._9\_9WM/#_PK_;0^%?A_3O$VD_M6W0\<)IWQU^,J
M> ?!_A;X@VWQK\.ZUXK^)FK^'?@_\7=7\%VWB'2O"?@O4-6@_9P\5:MJ'BOX
M5:-K.G:S\4_ 7Q@_SH_VZ?V%OVCO^"='[1WC/]E_]J#P9_PBOQ \*^7J>C:S
MIDEUJ/@3XG>!-1NKZV\-?%+X6^)KFQT[_A*OA_XJ_LZ^33]0>QT[6-&UC3M=
M\%^--"\*_$#PKXL\)Z$ ?[?/PM^+/PL^./@30OBE\%/B7\/_ (P?#+Q1_:?_
M  C7Q%^%OC+P[\0/ GB+^Q-8U#P[K/\ 87B[PGJ6K>']7_LCQ!I&JZ%J?]GZ
MA<?8-8TS4-,NO*O;*Y@C] K_ !AO^"4?_!:[]LG_ ()+^.[7_A3?B?\ X3;]
MG+Q)\0-(\:_&O]ESQ<]BW@3XF?9M'N?#.JWGAWQ#=:+K?B#X/_$"]\/W%EY'
MC_P#]F_M;6/"'PZ_X6AX<^*/@SP3I_@:?_7:_8O_ &O?@W^WI^S!\(/VN/@!
M>^(+SX4_&?P_>ZSX>B\6:#/X:\5:+J.A>(-8\'>,?"?B71Y9;JV@\0>"_&WA
MSQ'X1UFYT34]=\*ZEJ.B7.I^$/$OB?PM>:/XAU, ^GZ*** "BBB@ HHHH _E
M"_X/%/V:/^%P?\$J-.^.FE:3\/U\0?LD?M ?#?Q_K/BGQ%88\=V_PL^*,E[\
M"_$O@KX=:W;:#J=[%_PE'Q-^('P4\4^+O#EUJ_AOPYK>C_#F#6]0O-0\0>$/
M">D7O^6)7^YS_P % _V:/^&R/V'OVL_V7+;2?A_J_B#XX_ #XH^ / ?_  M*
MP^W^!-"^*>K^$M3_ .%2^-==\O0?%%[IG_"O_B;%X3\<Z9XCT;P]J_B/PIK'
MAW3_ !-X:LY/$&D:;C_#&H **** /]CK_@W)_:7_ .&H/^"-O[%?B+4-6^']
MWXM^$GP_O/V:/%VA> +_ ,__ (0__AG?7=1^%OPZTGQKID^O>(-3\/\ Q \0
M?!+P_P#"WXB^([#4Y]-_M7_A.+/Q=H6@Z)X2\3>'=/A_B"_X/%/VE_\ A<'_
M  57T[X%Z5JWQ 7P_P#LD? #X;^ -9\+>(K_ !X$M_BG\48[WXZ>)?&OPZT2
MVU[4[*+_ (2CX9?$#X*>%O%WB.ZTCPWXCUO6/AS!HE_9ZAX?\(>$]7O?W>_X
M,C_BWIVL_L7_ +8_P)BD\/G5_AQ^T_H7Q:OHK;4O%4OBI-.^-7PI\->#M+DU
MG1[OP'IW@FQ\/R7/P"UA?#6I>'OB?XP\5:MJ,7BRU\8^ _AQI&C>!?$/Q4_A
MC_X*J?M+^'?VP_\ @HY^V?\ M(>"M6_X2#X?_$W]H#Q]>?#/Q%]O^*=[_P )
M)\+/#^J/X1^%_B/R/C/KWB#X@>'_ /A(/A_X?\.:Q_PA5Y)X?\.> ?MO_"$>
M / 'PR^'_A_PO\.O"P!\ 4444 ?W^?\ !D-^RY_R?!^VMX@\#?\ 1//V7/A%
M\2_^$F_Z[_%C]HOP-_PAMEXA_P"S7-?_ .$F\3>%?^H5X&\0_P#)1--K^_RO
MPA_X-L/V0]._9!_X(_?LL6+V7A^/QM^T?X??]KWXC:QX:UWQ5K>G>(]1^/UE
MI?B'X:WMS%XGBLX]"\0:%^SY9_!GP+XLT'PQI>G>%;;Q5X1UF\TZ7Q%<WU_X
MQ\2?N]0 4444 %?Y,O\ P=L_"74?AQ_P6C^,/C&^C\0);?'[X/\ P ^+>CMK
M.F^%K'3I=.T;X<Z;\"99/"=UX>\>>,-7UGP^-7^"NJ17.I>.O#WPK\51>*H_
M$NCVG@/4?!.E>#OB?\1_]9JOXHO^#V#]E_Q5\0_V1_V2_P!J_P //X@U+2/V
M9_C!XZ^''CKP]HW@O4=;T[2_"O[2FB>$Y;3XG>+/&-C?&V\#^'_#7C;X)^#O
MAQ;+K&C3:=XG\5?&3PUIL7B#1M7M]+T?Q4 ?YLE%%% 'T_\ L1?&OPM^S7^V
MA^R)^T7XZT_Q!JW@GX!?M/\ P"^-?C'2_"=IIU]XJU+PK\*_BMX3\=>(=/\
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MKGP=?:;?6VLRVLOT_7@'[6.K_P#"/_LL?M+:]_;?_",_V)\ /C)J_P#PD?\
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M:SX.E\)V>D:%X?T+2+/P+?>&O$MCXZ\1ZCXLU'Q'XLTO5/"?@NV\%Z/K'CT
M_L=K^8+_ (.9_P#@B]_P\G_9QMOVD/@HGV+]KK]D3X?_ ! UOPUX=T?P-_PD
M6L?M)?"RWM5\7:S\"Y)_"?AK5_B;J_Q TB]TC5=8_9OTC3Y-;\.?\)WXP\;^
M"+KPM8S?&"Y^(O@3^GVB@#_ 'HK^WW_@[)_X(H^'?V?]8/\ P4Z_9?\ #']E
M_#+XI?$#4;#]KSP5I\?Q3\7ZQH_QV^+OCOQ_X_E_:7U/Q'KVL^,_#_AKX?\
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M%_P>2:[H^D?\$C_#>GZGJ'V*]\4?M?\ P:T+P[;?\*M\"?$#^U]8M_!'Q?\
M$L^G_P#"6>+M3L/$'P.\OP_X=UW5?^%I?"VUUOQWJ_\ 9G_"E-0TR+X9?&#X
MBZSI']7M?RA?\'DE[]E_X)'^&X/^$C^'^A_VC^U_\&K/^S/&7@K_ (2KQ'XQ
MV>"/B_J'_".?"?7?^$ \8_\ "MOB!:_8/^$NU+QK_P )%\*/M_PL\*_$OX=?
M\)_J/_"??\*M^)(!_EB4444 %?[_ !7^ /7^_P 4 %%%% !7C_Q^^ /P;_:E
M^#7Q"_9\_:#^'OA_XJ?!OXJ>'YO#/CKP+XEAG?3M7TYYX+ZTN;:\L9[/5]"\
M0:%J]GI_B'PGXL\/:AI/BKP;XJTG1O%?A36=&\2:-I>J6GL%% '^&-^WY^QU
MX[_X)_\ [9/[0G['GQ%O/[7\0? [X@7GAW3_ !-]GT>P_P"$X\":O8V'BSX6
M_$7^QM"\3^,[+PU_PLCX9>(/"/CO_A$9_$^KZQX/_P"$B_X1?Q%/'X@TC4[:
M'Y K_3[_ .#O?_@FC_PTS^QMX>_;G^%OA/\ M'XV_L7?:O\ A8O]@Z%]L\1^
M-?V6/%5]#_PEWV__ (1WP'KWBWQ'_P *(\6R:?\ %'2?[=\7>%?AU\,/A9K7
M[2_C;4_M&IZC!G_,$H **** /[_/^#,K_@I=_P E6_X)<?%CQ9_T&OC[^R5_
MPD.N_P#7'_A?/P5\,_\ "2^//^P;\<_ WPX^&GP^_P"CH_B;XRUG_45]O_\
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MJ^"GA.'^,/5_^#0W_@LEIO\ ;?V/P5\ /$']E?\ "4_8/[(^.VA0_P#"3?\
M"/\ _"]/[)_L3^WM+T3R/^$X_P"%2> ?^$6_X2/_ (1_[)_PU!\"_P#A-?\
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ML/3/^$_U+3_M_P +-1_X3'PY_P *M^)?Q*^R^+O^$5_TG/V(OA+J/P!_8O\
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M_"<?\+T_X37^V_MGAR;^U?\ A,/^&H/VE_\ A*?M_G_\)!_PT1\=/[6^U_\
M"V_'_P#PD !_A#45_NLZ?^Q%^Q?I.HZ5K&E_LA_LP:;J^A>(/@IXLT/5-/\
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MFO@W3/LOASQ5_P +*\?_ -NZ;?\ _"8^(O[1] U#]D[]EG5]8TSQ%JO[-/P
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M  L_X*):?_PD?P_NOLOQ _9QO/\ A$=-\%?8/BGH?V_PY\7X/^$C\9?$7_A
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M)7[1O]B?\+ _LS_A8'[._P#PF'_"&_\ "K/^$<_X1W_A>'@C[+_PMC_A8/\
MQ5O_  K_ /X2W_A%O[-_X47_ ,73_P"%I_\ "M/[7_XLE_PN*@#_ "1:***
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M_P#A( #_  AJ*_W6?%G[$7[%_CV?Q+=>.OV0_P!F#QI<^-/#^L^$_&-QXL^
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ML^)?QK^*6N_\(O\ #+X/_#_QE\4OB+XE_LS6=;_X1WP)\/\ PYJ7BSQ=KO\
M8WAW3]7\0:O_ &1X?TC4-0_LS0M*U/6+_P"S_9=,T^]O98+:3_!'K_:9_P""
MZ7Q;T[X*_P#!'[_@HCXQU23P_';:S^S!\1/A+$WB74O%6DZ<=1^/ME%\"='C
MMKKP=X#^(^KR^()=7^(]C%X3TV[\/:=X5UGQ4^C:/XZ\>?"OP3?>(?B?X/\
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M.M9^#_Q3^)?PD\13_:?$'PN^('C+X=:[<_\ ".^._"'VC6/!/B/4O#.IS_\
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MY O[4?\ P;%?\%DOV7_^$YU?_AF#_AHCX?\ @?\ X1G_ (N#^RYXOT+XM_\
M"8?\)-_PCUK_ ,4-\'?-\/\ [37B#_A']:\0?V)XF_XL7:?V5_8GB'Q3^_\
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MW3OAKXLU#Q=X0\-:KX$^/6CZQH5SI$'@2XOO'WPV\"_W>444 %%%% !1110
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M._L[X)>%?'^K?\4YKUAXQO/L'V#P5]J\6W6BV=Q_M\U_F"?\&97[+G_"U_\
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M%% !7\87_![/_P ([_PP+^RC]J_X6!_PEO\ PU_;_P!B?V;_ ,+3_P"%6?\
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M/^$9_L3X ?!O2/\ A'/^$6_X0?\ X1_^S?AUX<L_[$_X0K_A1?[+_P#PA_\
M97D_8/\ A%O^&:/V=_\ A'_(_LG_ (47\)/LG_" >'P#W^BBB@ HHHH ****
M "BBB@ HHHH *\ _:QU?_A'_ -EC]I;7O[;_ .$9_L3X ?&35_\ A(_^$H_X
M0?\ X1_^S?AUXCO/[;_X37_A>G[+_P#PA_\ 97D_;_\ A*?^&E_V=_\ A'_(
M_M;_ (7I\)/LG_"?^'_?Z\ _:QU?_A'_ -EC]I;7O[;_ .$9_L3X ?&35_\
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M^+)?\+ _M/\ X3#_ (67_P *^_XNG_PCG_"I_P#A<7_%)?\ "BZ /[/:***
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M-8\*Z/X)_:.\*^$O%FC?#77?%USI&B^*O[1^'^H_\)5K/@[XBZ9<^#_%5T?
MGBKQ%J/A/3].^(&G>$/$N@@'^*-17L'Q^^ /QE_9:^,OQ"_9\_:#^'OB#X5_
M&/X5^()O#/CKP+XEA@34=(U%((+ZSN;:\L9[S2-=\/Z[I%YI_B'PGXL\/:AJ
MWA7QEX5U;1O%?A36=9\-ZSI>J7?C] !7]_G_  :C_P#!='_D%_\ !,#]M7XR
M_P#0I>&?V _&7CFV_P"PEIM_^RYXA^)=YK?_ &*L/[+GA_7]#_Z&;X+Z5XY_
MY-[^$]?P!T4 ?[_%%?S@_P#!N;_P6N_X>J?LXZKX ^/WB?X?V7[<_P !-MA\
M1_#FA/\ V#K'QE^%EO:^'K/P_P#M+Z?X*71=(\/Z1_:_B#5Y_!7Q2T'X>WFM
M^'/"7CNPTSQ'-I/PQ\+_ !@^&/@"R_H^H **** "BBB@ HHHH **** /YP?^
M#L#_ (2/_AR5^T;_ &)_PL#^S/\ A8'[._\ PF'_  AO_"K/^$<_X1W_ (7A
MX(^R_P#"V/\ A8/_ !5O_"O_ /A+?^$6_LW_ (47_P 73_X6G_PK3^U_^+)?
M\+BK_)%K_6Z_X.P/^$=_X<E?M&_VW_PL#^T_^%@?L[_\(?\ \(;_ ,+3_P"$
M<_X2/_A>'@C[5_PMC_A7W_%)?\*__P"$2_X2G^S?^%Z?\6L_X6G_ ,*T_LC_
M (O;_P *=K_)%H **** /]KG_@BE9_8/^"1__!.6#_A&_B!X5W_L@? ^\_LS
MXE^-?^$^\1W7]H^"-+U#_A(]-UW_ (3_ .)7V#X?^,?M7_"7?"?P5_PD6G?\
M*U^%FN>#?AU_P@'PH_X17_A5O@[]/Z_,#_@BEXD_X2K_ ()'_P#!.74_^$^^
M'_Q*^R_L@? _PY_PD7PTLOL'AS3O^$.\$:7X1_X0#4H/^$U\?;_B!\*/[#_X
M5;\6+S^W;#^T?BGX.\9:A_PA7PV^U?\ "NO"OZ?T %%%% !1110 4444 %?R
MA?\ !Y)>_9?^"1_AN#_A(_A_H?\ :/[7_P &K/\ LSQEX*_X2KQ'XQV>"/B_
MJ'_".?"?7?\ A /&/_"MOB!:_8/^$NU+QK_PD7PH^W_"SPK\2_AU_P )_J/_
M  GW_"K?B3_5[7\H7_!Y)XD_L/\ X)'^&],_X3[X@>#O^$Q_:_\ @UX<_P"$
M=\&V7VKPY\5_LO@CXO\ B[_A /BQ/_PFOA7^SOA_IW_"*_\ "TM-O/["^)._
MXI_#7X::?_PA5A]O_P"%B^ 0#_+$HHHH *_W^*_P!Z_W^* "BBB@ HHHH *_
MQQ?^"^?_  2CUG_@E-^W#X@\$^&;7[5^S+\=_P#A)?C!^R_K.GZ1X[CT?PUX
M$O\ Q;JMM?? 74_$WC2YU[_A(_B!\"/,T;0]=N[;QSXQUC6O FO?"WXD^+)O
M#FM?$I_">B_['5?C#_P7:_X)>>%?^"HW[!GQ,^'FC^"?#^L_M1_"OP_KGQ'_
M &1_&-S8Z<GBK1_B9I*:=K&I_#'1O$.I^+_ >D:1X?\ V@](\/1?"GQ*WC'Q
M(_P]T+4=6\)_%3Q#X?UG7/A7X1ETT _QI:*Z#Q9X3\5> O%7B7P+XZ\,^(/!
M?C;P7X@UGPGXQ\'>+-&U'PYXJ\)^*O#FHW.C^(?#7B7P]K%M9ZOH7B#0M7L[
MO2]9T;5+2UU'2]1M;FQOK:"Y@EB7GZ "OT_^'?[<7V7_ ()'_M%_\$X=7D^'
M^A_VC^U_\(OVR?A]JOB'X:_\)5XC\8[/!%[\'/C%\/?#/CBZTOQC_P *V^(%
MK]@^!?C_ ,#>(-$TGX4?;_A9X5_:C\"^*?C3J/\ PGW@_P""WQ)_,"B@ HHH
MH _9[_@WBU7Q5HW_  6C_P""?]WX.NO$%GJ\WQ@U72KN;PUI^HZEJ+^%==^'
M/C?0_'5K<V^E_!3X^W,?A^^\$ZCXAL?%FH2^!="T[2?"MQK.J:Q\:_V:](L[
M[]HOX5_[+5?XPW_! ?2/[;_X+)?\$]K/^Q/^$@\G]H#1]7^P?\(M_P )AY'_
M  C^A:]KW]M_V3_PHO\ :(^R?\(S_9O_  D?_"4_\(!X?_X0?^RO^$U_X7I^
MR_\ \(__ ,-+_"3_ &>: "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ K
MX@_X*7_'+3OV:_\ @GI^VQ\<K_7_  _X<N?AU^S!\:M9\+W?B7QWXJ^&>G:E
M\0I_ .N:7\,O"=MXZ\!>-_AI\1/#WB#QS\1-0\,>"O"=S\-?B#X+^)EQXJU_
M1K'X<^)='\;76@WT/V_7\ ?_  >*?\%7/ FMZ/IW_!)GX277Q _X6!X2^('P
MW^,'[5GB73]6UCPEX$@T?_A!+WQ9\,O@+J>C&V@_X6W_ &W_ ,)QX#^.NNW<
MDW_"">!]8\)?"T:;-XM^('_"06WPD /X Z*** "O]!S_ (,??@I\3-/\*_M\
M_M&7=_X@TOX.>+?$'P7^"GA[2[:Z^'MQX5\<_$SX>:=XS\=>,=0UFQETJ_\
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M./(_L3_A'/\ A*?^$_\ VH/LG_"/_P#"%?\ "]/#_P#PA_\ PS1^SO\ T^T
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M(_Q8O?[1^*?Q+U#_ (2/X?\ C'[?\0/&5Y_PEWPG\%?\*V^%GBK[5XCU*?\
MX2/X:?#K_A /A1_P@/P_US?_ &GX-\%?\*M^&W_"*^'+K3="_P"$ \'?8/\
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M2+RTOI_M^BB@ HHHH *_G!_X.L_V:/\ AHC_ ((V_&KQ%I^D_$#Q!XM_9?\
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MT?L;?L]_M6?#KQ-_PE_A_P"+OP_L]0U#7/\ A7FL_";?X[\-WU_X)^*6F?\
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M  COQ7^P?%/Q5\-/B+_P@&G?\(#_ ,+2^&O^2+7^MU_P=@6?VK_@B5^T;/\
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MX@LM,T;X3Z%I_A/2/'?BCXIW_@WPS\+?BE\#OB;J_A'XU_#_ /V>: "BBB@
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M@F/P_?7.HZG<7.G^$=#_ &>M.@\5-XEFU/X*:IXIN/$/Q_\ CK^[U !1110
M5S_BSQ9X6\!>%?$OCKQUXE\/^"_!/@OP_K/BSQCXQ\6:SIWASPKX3\*^'-.N
M=8\0^)?$OB'6+FSTC0O#^A:19W>J:SK.J7=KIVEZ=:W-]?7,%M!+*O05^(/_
M  <(>#_VR?C-_P $X_&'[+/["WP=^('Q;^-O[7/Q \)_ O4+KP!\0;'X7_\
M"M_A9;Z7XH^,7Q2\4^-?&&NW.B>$H/A_XX\)?"2^_9^\1Z)XS\:>!_#OB[_A
M==GX2DU?7]3UO3/A]XU /\D7]JK]I?XI_MD?M'?&C]J/XUZM_:_Q-^./Q U_
MQ_XE\B_\1W^CZ%_:]T?[&\%>$?\ A+->\4>(-,^'_P /_#\6E>!OAUX<U#Q!
MJ_\ PBG@3P[X=\,VMY)9:1;8^?Z_7_2/^" __!9+6_[$^Q_\$]OV@(?^$@_X
M1;[!_:^CZ%X?\C_A,/\ A1?]D_VW_;VO:;_PC/V3_AHCP#_PE/\ PD?]E?\
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M /"1_#_Q5L_:_P#CA9_VG\-/!7_" ^'+7^SO&^J:?_PCFI:%_P (!\-OM_Q
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M_P"&7_VE_P#A4A_PX'_X+)?\(=_PG/\ P[V_: _L7_GQ_L?0O^$Q_P"2$_\
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M'A6?]F;PI\,-9\1_#;X[?L5Z7\1OQAU?_@@/_P %DM$_MO[9_P $]OV@)O\
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M+?&OXI>+M4U!_ EEH_P&TS5?'\&E:+H<?C?P9_G27/\ P0M_X+ VL&C7$O\
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M1S^U_#__  D'_"/_ /"0?VM_8G]O:)_:OV3[!_:^F^?]LA_PAJ_W^*_RI/\
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M?$MEX@_X3/X9?#?Q9X6TSPYK.D2>'/$6L:OI^B>);S2/#]_J6KV/H&K_ /!
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MBK2+W2/B!J_Q-U?X*6>A?:O#'B[PY?\ @1/BE;ZA_8'B!?">H2?Y@E?V^_\
M!R7_ ,$\/^"J_P#P4,_X*K^,O%GP4_8I^('Q#^"7PH^'_P %_P!F_P""WQ)\
M(Z''H>C^,M'$?PC\<^)]8\1:YXP\66^F7?\ 8OQM_;2U7PU/XWL+;PWX$LO
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MQ!<Z%XL_X0+XI>&O'7@37/['^TZ?I'A+XFZ;\.OBU\-_]CJO\8;5_P#@@/\
M\%DM$_MO[9_P3V_: F_X1_\ X2G[?_9&CZ%X@^T?\(?_ ,+T_M;^Q/[!U[4O
M^$F^U_\ #._C[_A%O^$<_M7_ (3C_A(/@7_PA7_"0?\ #4'[-'_"V_\ 6Z_8
M#\7?M'>-OV-OV>]9_; \._\ "+_M3V7P_L_"/[0FF^1=6_VGXN_#^^O_  'X
M[\1>6?AU\+O#[?\ "7^(/#=[XL\_X:^&M3^"=S_;?VGX#_$7XP?!B7P'\6O&
MP!]?T444 %%%% !1110 5_&%_P 'L_\ PCO_  P+^RC]J_X6!_PEO_#7]O\
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M_P )K_PO3]E__A#_ .RO)^W_ /"4_P##2_[._P#PC_D?VM_PO3X2?9/^$_\
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M (:@_9H_X6V ?K]_P:^?\%T?^&*OBG;_ +#O[8OQE_X1_P#8E^)O]H_\*?\
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M^SOB!^SO>?VGX-\:_P#"*^'/!V_XX>"-/_X2/XL:%_PG_@[_ (65\/[K[?\
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MKNH?VG>V_P"R!\#]"@N?^%6^._@_Y>C^%_!&E^&O#NG_ /")_$74]7\0:O\
MV1X?TC3-*_X6EI]U%X$^./V+_A=?PMTS1/AE\0/".C6'Z?U\ ?\ !*OX6_%[
MX'?\$X_V,/@I\>M"^('A?XP?!_X > ?A;X\\-?$O4_@GK?B/P[K'P_TM/":Z
M%INL_L]ZAJ_PRU?X?Z19:1::?\)]3AU74_'=_P#"RW\&W7Q@U"]^,$OCNYD^
M_P"@ HHHH **** "BBB@ K^4+_@\DL_M7_!(_P -S_\ "-_#_7/[._:_^#5Y
M_:?C+QK_ ,(KXC\';_!'Q?T__A(_A/H7_"?^#O\ A97Q NOM_P#PB.I>"O\
MA'?BO]@^%GBKXE_$7_A -._X0'_A:7PU_J]K^<'_ (.C?V8?VCOVOO\ @G'X
M%^!O[+GP[_X6K\3?%'[7_P #(?\ A!K/X5W7Q \1ZKH]YI?Q!T/[7X<\;?\
M"O\ Q9X?_9U_L+Q!K/A_7_&OQZ\<^-_@/X$T/X6:9X_\">)OC!%9?$/_ (5M
M\2 #_)%HK]7]5_X(6_\ !8'1O"MUXQN_^"=O[3\VD6?A_3_$TUGI7P[O==\5
M/IVI:=\%-4M[:U\"Z'+J/C:^\01VWQ^\"Q:AX3L?#UQXJTG4=!^->CZIHUGJ
M_P"S7^T78_"OH/\ AP/_ ,%DO^$Q_P"$&_X=[?M ?VU_S_?V/H7_  AW_)=O
M^&=/^2B?V]_PK_\ Y*!_Q4/_ ",W_)"?^,H_^39?^+NT ?D!7^_Q7^+-<_\
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M6:S>?#+X[^(_&WC3Q!/;6NF:/X:ME\8^&?"NA:==^+)=<\->,M7U7POJG@8
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@ !1110 4444 %%%% !1110 4444 %%%% !1110!__]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>15
<FILENAME>ny20042541x1_ex23-2logo01.jpg
<TEXT>
begin 644 ny20042541x1_ex23-2logo01.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  8$!08%! 8&!08'!P8("A *"@D)
M"A0.#PP0%Q08&!<4%A8:'24?&ALC'!86("P@(R8G*2HI&1\M,"TH,"4H*2C_
MVP!# 0<'!PH("A,*"A,H&A8:*"@H*"@H*"@H*"@H*"@H*"@H*"@H*"@H*"@H
M*"@H*"@H*"@H*"@H*"@H*"@H*"@H*"C_P  1"  F %X# 2(  A$! Q$!_\0
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M61/W]O\ =4C _"O0ZXO0?^1LC_[BG_I1;U=.<FGK_5F3.*NM#:_X1/P[_P!
M#2?_  #C_P */^$3\._] #2?_ ./_"MJBLO:3[E\L>QP'@?1=+U/3;>74M-L
MKN1;&R57N(%D('V=> 2#Q72_\(GX=_Z &D_^ <?^%9/PU_Y \/\ UY67_I.E
M=A6M:<E-I,BG%.*T.+\9>'-#M/#5[/:Z-IL$\85DDCM45E.X<@@9%3>'?#VB
MWMG=7%YI&G7%P^H7NZ66U1V;%U*.21D\5H>//^12U'_<7_T(5)X1_P"05/\
M]A"^_P#2J6GSR]E>_7] Y5SVMT#_ (1/P[_T -)_\ X_\*X;XP:!H]CX9MI;
M+2=/MI#>*I>&V1"1L?C('3@5ZG7GWQM_Y%6U_P"OU/\ T"2C#3DZL;L5:*Y'
MH9/[1_B*;P_X+LGT^Y>WU*6]3R'C.&7:K%F_+C_@5<9=?%34/"?PLTR*ZOWU
M#Q?JL37(:8AOLL3GY&/OMP5'J<GCKC_M(7EUXF^)>E>&-+4S36T:Q)&#C,TQ
M!//0?+Y?/;FN<^#YL)_B-#'XEM7U2\&5M[9$C4F=.@?S-HP IP-W4 8/2O7H
M8:"PT935[>];KY?(X:E:3K-1?D>U_!'3/&-S:KKOC/6;]XY5S:V$C8RI_P"6
MD@Q^0_$]J\KTS6_%?C?XIZI9>$-;:P@,MS+ Y/R1P[QD\ GYBJ'ZXKV_XD>+
M[K1? ^KW<FCZA9,8&BBGFDMRJ2/\JG"2LQP2#P#TKY]^$.A>/8HKK6_ 4=JR
M29M))Y#'VVL5 DQ_L\CT]JC#>_&I7ERJ^BVLBJONN--7?5]SH-1\6^-_A_X^
ML=+UGQ+_ &NS&)YH$42(RNV-A) 96QSQZ@\U+\;OB'XBM_B1<Z3X:U6YM+>S
MA2-TA/#/MWNQX[!L'_=JWX7^'6MV7BF;Q7\0-,GN6MI#>M]FFA;>Z_-N<M*,
M 8SM [ <#BN%\'QR^(_%'B[Q#+"]WML+ZZ?RL8A:5'4,V\K\H#-TR>. :Z(1
MHRE[2R?*M;6LVS.3J)<NJN_G8]G_ &;-7N+WP?JUUJM^)Q;W(C$K?*L<21+@
M<@8 %>3^/OB]XEU;Q)J%UX;U*ZL=%@810K'A05S@,V1]YCDX]/H:Y_1?%DNG
M?#J_\*Z9+BYU2]WS2*K<Q;%7RUP,Y8CGVXYSQI?$#03X0\%Z'H%Y;/9ZI=3/
M?WLDQ5A(0-D8386.U0S_ 'L<DGN<5##0A7<YJ[D]%Y=63*K*5)1B]MSU#P=X
MDU%_@/K6O>*]1FNVDG80M*1DJI10J^Y8-7(>&]3\:?%#4+RQT.\DL=,CFEN)
M,,\,4/FR,^UF1@SDDG P>G:JOQ2FN=+^%W@?PT\$UC!Y37<C3%2)W(!RNPL<
M9D<X8*>1QZ>A_!87^G_!UE\-Z3=7&HW@N)([M9(%B\[)12=T@;"[5SE>QQQ6
M$E&E2E6BE>4M.RZ?H:1;G-4VW9+7S.+\7>!?&W@VZL9M+N]5U9I0Q\S3$NG:
M)EQPP$G .>/7!KN_$&HZOJGP@T2Y\1VT]MJAO-DJ3P&%SM$H#%#R,@ ^_7O7
MEOBGQK\3?"VJ_P!FZYXB^SWNQ9/+"Q284].50CMTKVOQ18^(]=\%Z5IS:-J$
MNI0&*2XGFEME$C"-E8\2=R<XP*BOSQ5-U7%Z[K^D53Y7S*"?H>=?"?2Y_$/Q
MQU'Q!J+1-Y9GNXTR2020B#I_"K_H*S_CGX4FT'XE0:[H4T4#W16^ .08YU;D
MCCH2 WU)HHK6,VL8HK;EL0TGAW+K<Z7]H/5+O7_!/A:"W"0IJ"B^F4L< A!A
M1QR,N?R%>G_"#14T'X;Z%:*59WMQ<2,O=I/G/Y;L?A117#B?=PD(K:[_ %.F
MEK7DWV16^-MW/;?#/6$M"%FND6U#,< *[ -_X[N'XUYQ\$_#/V'X2^,;B5HV
MN=0BG@RI. B0G';U=OTHHIT&XX1VZR7Z"J*]?7L8/[.?@".[\33:UJC0RIIF
MTP0C)S*V<,<C^'!(]\'M2?'?2[GQ)\7K:T:2-+>-+>T&2<@,=Q/3_;/Y445V
MJI)XV3;V6GX'/RI8=6ZL]F^+'P^@\=^&H;".6.SO+1_,M9BFX+Q@H1_=(Q^0
M]*^9E\0>,?A1JUWH5AK$:!'W21QJ)8BW3(#KD'CMCH***SRE^UC*E/6/9EXY
M<C4XZ,Z3P7X7UWXD>,[37];N-.G FAENF<NCO&FWY551MSM&.PKZOHHKES5O
-VBCT2T-L$O<<NK/_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>16
<FILENAME>ny20042541x1_ex23-3logo01.jpg
<TEXT>
begin 644 ny20042541x1_ex23-3logo01.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  <%!08%! <&!08(!P<("A$+"@D)
M"A4/$ P1&!4:&1@5&!<;'B<A&QTE'1<8(BXB)2@I*RPK&B O,R\J,B<J*RK_
MVP!# 0<(" H)"A0+"Q0J'!@<*BHJ*BHJ*BHJ*BHJ*BHJ*BHJ*BHJ*BHJ*BHJ
M*BHJ*BHJ*BHJ*BHJ*BHJ*BHJ*BHJ*BK_P  1" !$ '\# 2(  A$! Q$!_\0
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M+Y!U:VF60#ZX)K-PDE=HOF3=KE.U_P"1YU3_ +!UG_Z,N:V:QK7_ )'G5/\
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MR:K%:-"\?ED-]H^X&"X[DJWT->@T5I/%^TIPA.-^7K^A$:'+*4HO<^=?V?\
MPQ=-XRO-7O[6:%;&VVQF6,KEY#C(S_LAOSKZ*HHK+$XAXBISM6-*-)4H<J/
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KRNT%%%%>>=04444 %%%% !1110 4444 %%%% !1110 4444 %%%% '__V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>18
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm46076771386912">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Submission<br></strong></div></th>
<th class="th"><div>Feb. 25, 2025</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_SubmissionLineItems', window );"><strong>Submission [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Central Index Key</a></td>
<td class="text">0001130713<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Registrant Name</a></td>
<td class="text">Beyond, Inc.<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_RegnFileNb', window );">Registration File Number</a></td>
<td class="text">333-280076<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_FormTp', window );">Form Type</a></td>
<td class="text">S-3<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_SubmissnTp', window );">Submission Type</a></td>
<td class="text">POSASR<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_FeeExhibitTp', window );">Fee Exhibit Type</a></td>
<td class="text">EX-FILING FEES<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_FeeExhibitTp">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_FeeExhibitTp</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>ffd:feeExhibitTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_FormTp">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_FormTp</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>ffd:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_RegnFileNb">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_RegnFileNb</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>ffd:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_SubmissionLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_SubmissionLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_SubmissnTp">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_SubmissnTp</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>ffd:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>19
<FILENAME>R2.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm46076769649536">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Offerings<br></strong></div></th>
<th class="th">
<div>Feb. 25, 2025 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_OfferingAxis=1', window );">Offering: 1</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_OfferingTable', window );"><strong>Offering:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_PrevslyPdFlg', window );">Fee Previously Paid</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_Rule457oFlg', window );">Rule 457(o)</a></td>
<td class="text">true<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_OfferingSctyTp', window );">Security Type</a></td>
<td class="text">Equity<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_OfferingSctyTitl', window );">Security Class Title</a></td>
<td class="text">Common Stock<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_OfferingAxis=2', window );">Offering: 2</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_OfferingTable', window );"><strong>Offering:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_PrevslyPdFlg', window );">Fee Previously Paid</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_Rule457oFlg', window );">Rule 457(o)</a></td>
<td class="text">true<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_OfferingSctyTp', window );">Security Type</a></td>
<td class="text">Equity<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_OfferingSctyTitl', window );">Security Class Title</a></td>
<td class="text">Preferred Stock<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_OfferingAxis=3', window );">Offering: 3</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_OfferingTable', window );"><strong>Offering:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_PrevslyPdFlg', window );">Fee Previously Paid</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_Rule457oFlg', window );">Rule 457(o)</a></td>
<td class="text">true<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_OfferingSctyTp', window );">Security Type</a></td>
<td class="text">Debt<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_OfferingSctyTitl', window );">Security Class Title</a></td>
<td class="text">Debt Securities<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_OfferingAxis=4', window );">Offering: 4</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_OfferingTable', window );"><strong>Offering:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_PrevslyPdFlg', window );">Fee Previously Paid</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_Rule457oFlg', window );">Rule 457(o)</a></td>
<td class="text">true<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_OfferingSctyTp', window );">Security Type</a></td>
<td class="text">Other<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_OfferingSctyTitl', window );">Security Class Title</a></td>
<td class="text">Warrants<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_OfferingAxis=5', window );">Offering: 5</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_OfferingTable', window );"><strong>Offering:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_PrevslyPdFlg', window );">Fee Previously Paid</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_Rule457oFlg', window );">Rule 457(o)</a></td>
<td class="text">true<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_OfferingSctyTp', window );">Security Type</a></td>
<td class="text">Other<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_OfferingSctyTitl', window );">Security Class Title</a></td>
<td class="text">Purchase Contracts<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_OfferingAxis=6', window );">Offering: 6</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_OfferingTable', window );"><strong>Offering:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_PrevslyPdFlg', window );">Fee Previously Paid</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_Rule457oFlg', window );">Rule 457(o)</a></td>
<td class="text">true<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_OfferingSctyTp', window );">Security Type</a></td>
<td class="text">Other<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_OfferingSctyTitl', window );">Security Class Title</a></td>
<td class="text">Units<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_OfferingAxis=7', window );">Offering: 7</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_OfferingTable', window );"><strong>Offering:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_PrevslyPdFlg', window );">Fee Previously Paid</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_Rule457oFlg', window );">Rule 457(o)</a></td>
<td class="text">true<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_OfferingSctyTp', window );">Security Type</a></td>
<td class="text">Unallocated (Universal) Shelf<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_MaxAggtOfferingPric', window );">Maximum Aggregate Offering Price</a></td>
<td class="nump">$ 156,128,866<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_FeeRate', window );">Fee Rate</a></td>
<td class="nump">0.01531%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_FeeAmt', window );">Amount of Registration Fee</a></td>
<td class="nump">$ 23,903.33<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_OfferingNote', window );">Offering Note</a></td>
<td class="text"><div style="text-indent: -22.5pt; padding-left: 22.5pt;"> <div style="float: left; width: 22.5pt; white-space: nowrap;"> <span style="font-size: 10.0pt; color: #000000;">(1)</span> </div> <div> <span style="font-size: 10.0pt;">There are being registered hereunder an unspecified number or aggregate principal amount (as applicable) of the registrant&#8217;s common stock, preferred stock, debt securities, warrants, purchase contracts and units as may from time to time be offered at unspecified prices, with the maximum aggregate offering price of such securities not to exceed $</span><span style="font-size: 10.0pt; color: #000000;">156,128,866</span><span style="font-size: 10.0pt;">. In addition, an unspecified number of additional shares of common stock is being registered as may be issued from time to time upon conversion of any debt securities that are convertible into common stock or pursuant to any anti-dilution adjustments with respect to any such convertible debt securities. The shares of common stock and preferred stock being registered hereunder also include rights to acquire shares of common stock or preferred stock under any shareholder rights plan then in effect, if applicable under the terms of any such plan.</span> </div> </div><div style="margin-left: 22.5pt;">
   <span style="font-size: 10.0pt;">The proposed maximum aggregate offering price of each class of securities will be determined from time to time by the registrant in connection with the issuance by the registrant of the securities registered hereunder and is not specified as to each class of securities pursuant to Rule 457(o) under the Securities Act of 1933, as amended (the &#8220;Securities Act&#8221;).</span>
  </div><div style="margin-left: 22.5pt;">
   <span style="font-size: 10.0pt;">The maximum aggregate offering price indicated above is estimated solely for the purpose of calculating the registration fee pursuant to Rule 457(o) under the Securities Act.&#160;&#160;No separate consideration will be received for shares of common stock that are issued upon conversion of debt securities or upon exercise of warrants registered hereunder.</span>
  </div><div style="margin-left: 22.5pt;">
   <span style="font-size: 10.0pt;">The $156,128,866 of securities registered being registered hereunder includes $156,128,866 of common stock (the &#8220;Unsold Shares&#8221;) that remains available for issuance and sale under a Capital on Demand</span><sup style="font-size: 7.0pt;">TM</sup><span style="font-size: 10.0pt;"> Sales Agreement by and between the registrant and JonesTrading Institutional Services LLC (the &#8220;Sales Agreement&#8221;). In connection with the prospectus supplement previously filed by the registrant on June 10, 2024, the registrant paid a registration fee of $29,520 related to the $200,000,000 of common stock initially available for issuance and sale under the Sales Agreement. The portion of such registration fee related to the Unsold Shares is being applied to the registrant&#8217;s total registration fee hereunder.</span>
  </div><span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_OfferingAxis=8', window );">Offering: 8</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_OfferingTable', window );"><strong>Offering:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_PrevslyPdFlg', window );">Fee Previously Paid</a></td>
<td class="text">true<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_Rule457oFlg', window );">Rule 457(o)</a></td>
<td class="text">true<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_OfferingSctyTp', window );">Security Type</a></td>
<td class="text">Equity<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_OfferingSctyTitl', window );">Security Class Title</a></td>
<td class="text">Common Stock, $0.0001 par value per share<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_MaxAggtOfferingPric', window );">Maximum Aggregate Offering Price</a></td>
<td class="nump">$ 156,128,866<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_FeeRate', window );">Fee Rate</a></td>
<td class="nump">0.01476%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_FeeAmt', window );">Amount of Registration Fee</a></td>
<td class="nump">$ 23,044.63<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_OfferingNote', window );">Offering Note</a></td>
<td class="text"><div style="text-indent: -22.5pt; padding-left: 22.5pt;"> <div style="float: left; width: 22.5pt; white-space: nowrap;"> <span style="font-size: 10.0pt; color: #000000;">(1)</span> </div> <div> <span style="font-size: 10.0pt;">There are being registered hereunder an unspecified number or aggregate principal amount (as applicable) of the registrant&#8217;s common stock, preferred stock, debt securities, warrants, purchase contracts and units as may from time to time be offered at unspecified prices, with the maximum aggregate offering price of such securities not to exceed $</span><span style="font-size: 10.0pt; color: #000000;">156,128,866</span><span style="font-size: 10.0pt;">. In addition, an unspecified number of additional shares of common stock is being registered as may be issued from time to time upon conversion of any debt securities that are convertible into common stock or pursuant to any anti-dilution adjustments with respect to any such convertible debt securities. The shares of common stock and preferred stock being registered hereunder also include rights to acquire shares of common stock or preferred stock under any shareholder rights plan then in effect, if applicable under the terms of any such plan.</span> </div> </div><div style="margin-left: 22.5pt;">
   <span style="font-size: 10.0pt;">The proposed maximum aggregate offering price of each class of securities will be determined from time to time by the registrant in connection with the issuance by the registrant of the securities registered hereunder and is not specified as to each class of securities pursuant to Rule 457(o) under the Securities Act of 1933, as amended (the &#8220;Securities Act&#8221;).</span>
  </div><div style="margin-left: 22.5pt;">
   <span style="font-size: 10.0pt;">The maximum aggregate offering price indicated above is estimated solely for the purpose of calculating the registration fee pursuant to Rule 457(o) under the Securities Act.&#160;&#160;No separate consideration will be received for shares of common stock that are issued upon conversion of debt securities or upon exercise of warrants registered hereunder.</span>
  </div><div style="margin-left: 22.5pt;">
   <span style="font-size: 10.0pt;">The $156,128,866 of securities registered being registered hereunder includes $156,128,866 of common stock (the &#8220;Unsold Shares&#8221;) that remains available for issuance and sale under a Capital on Demand</span><sup style="font-size: 7.0pt;">TM</sup><span style="font-size: 10.0pt;"> Sales Agreement by and between the registrant and JonesTrading Institutional Services LLC (the &#8220;Sales Agreement&#8221;). In connection with the prospectus supplement previously filed by the registrant on June 10, 2024, the registrant paid a registration fee of $29,520 related to the $200,000,000 of common stock initially available for issuance and sale under the Sales Agreement. The portion of such registration fee related to the Unsold Shares is being applied to the registrant&#8217;s total registration fee hereunder.</span>
  </div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_FeeAmt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total amount of registration fee (amount due after offsets).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_FeeAmt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>ffd:nonNegative1TMonetary2ItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_FeeRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The rate per dollar of fees that public companies and other issuers pay to register their securities with the Commission.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_FeeRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_MaxAggtOfferingPric">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The maximum aggregate offering price for the offering that is being registered.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_MaxAggtOfferingPric</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>ffd:nonNegative100TMonetary2ItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_OfferingNote">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_OfferingNote</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_OfferingSctyTitl">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The title of the class of securities being registered (for each class being registered).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_OfferingSctyTitl</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>ffd:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_OfferingSctyTp">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Type of securities: "Asset-backed Securities", "ADRs/ADSs", "Debt", "Debt Convertible into Equity", "Equity", "Face Amount Certificates", "Limited Partnership Interests", "Mortgage Backed Securities", "Non-Convertible Debt", "Unallocated (Universal) Shelf", "Exchange Traded Vehicle Securities", "Other"</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_OfferingSctyTp</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>ffd:securityTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_OfferingTable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_OfferingTable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_PrevslyPdFlg">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_PrevslyPdFlg</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_Rule457oFlg">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Checkbox indicating whether filer is using Rule 457(o) to calculate the registration fee due.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br> -Section 457<br> -Subsection o<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_Rule457oFlg</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_OfferingAxis=1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_OfferingAxis=1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_OfferingAxis=2">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_OfferingAxis=2</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_OfferingAxis=3">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_OfferingAxis=3</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_OfferingAxis=4">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_OfferingAxis=4</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_OfferingAxis=5">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_OfferingAxis=5</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_OfferingAxis=6">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_OfferingAxis=6</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_OfferingAxis=7">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_OfferingAxis=7</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_OfferingAxis=8">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_OfferingAxis=8</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>20
<FILENAME>R3.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm46076769735152">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Fees Summary<br></strong></div></th>
<th class="th">
<div>Feb. 25, 2025 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_FeesSummaryLineItems', window );"><strong>Fees Summary [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_TtlOfferingAmt', window );">Total Offering</a></td>
<td class="nump">$ 156,128,866<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_TtlPrevslyPdAmt', window );">Previously Paid Amount</a></td>
<td class="nump">23,044.63<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_TtlFeeAmt', window );">Total Fee Amount</a></td>
<td class="nump">23,903.33<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_TtlOffsetAmt', window );">Total Offset Amount</a></td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_NetFeeAmt', window );">Net Fee</a></td>
<td class="nump">$ 858.7<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_FeesSummaryLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_FeesSummaryLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_NetFeeAmt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_NetFeeAmt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_TtlFeeAmt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_TtlFeeAmt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>ffd:nonNegative1TMonetary2ItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_TtlOfferingAmt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_TtlOfferingAmt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>ffd:nonNegative1TMonetary2ItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_TtlOffsetAmt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_TtlOffsetAmt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>ffd:nonNegative1TMonetary2ItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_TtlPrevslyPdAmt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_TtlPrevslyPdAmt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>ffd:nonNegative1TMonetary2ItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>21
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
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M  #N-   &    'AL+W=O<FMS:&5E=',O<VAE970R+GAM;.U;VW+;.!)]WZ]
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M              "  <P!  !X;"]T:&5M92]T:&5M93$N>&UL4$L! A0#%
M  @ *()96LSQE,1B @  PP8  !@              ("!#0@  'AL+W=O<FMS
M:&5E=',O<VAE970Q+GAM;%!+ 0(4 Q0    ( "B"65K+O*@%Q @  .XT   8
M              " @:4*  !X;"]W;W)K<VAE971S+W-H965T,BYX;6Q02P$"
M% ,4    "  H@EE:X259]TP"  #<!0  &               @(&?$P  >&PO
M=V]R:W-H965T<R]S:&5E=#,N>&UL4$L! A0#%     @ *()96LL+%F D P
M%!(   T              ( !(18  'AL+W-T>6QE<RYX;6Q02P$"% ,4
M"  H@EE:EXJ[',     3 @  "P              @ %P&0  7W)E;',O+G)E
M;'-02P$"% ,4    "  H@EE:4G%OM5T!  !( P  #P              @ %9
M&@  >&PO=V]R:V)O;VLN>&UL4$L! A0#%     @ *()96KMLZNRZ    &@,
M !H              ( !XQL  'AL+U]R96QS+W=O<FMB;V]K+GAM;"YR96QS
M4$L! A0#%     @ *()96J;\2ELC 0  WP0  !,              ( !U1P
J %M#;VYT96YT7U1Y<&5S72YX;6Q02P4&      L "P#* @  *1X

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>22
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>23
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
.report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

.report table.authRefData a {
	display: block;
	font-weight: bold;
}

.report table.authRefData p {
	margin-top: 0px;
}

.report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

.report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

.report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

.report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
.pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
.report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

.report hr {
	border: 1px solid #acf;
}

/* Top labels */
.report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

.report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

.report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

.report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

.report td.pl div.a {
	width: 200px;
}

.report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
.report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
.report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
.report .re, .report .reu {
	background-color: #def;
}

.report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
.report .ro, .report .rou {
	background-color: white;
}

.report .rou td {
	border-bottom: 1px solid black;
}

.report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
.report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
.report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

.report .nump {
	padding-left: 2em;
}

.report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
.report .text {
	text-align: left;
	white-space: normal;
}

.report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

.report .text .more {
	display: none;
}

.report .text .note {
	font-style: italic;
	font-weight: bold;
}

.report .text .small {
	width: 10em;
}

.report sup {
	font-style: italic;
}

.report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>25
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.25.0.1</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>9</ContextCount>
  <ElementCount>19</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>1</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>2</UnitCount>
  <MyReports>
    <Report instance="ny20042541x1_exfees.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>995210 - Document - Submission</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://xbrl.sec.gov/ffd/role/document/submissionTable</Role>
      <ShortName>Submission</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report instance="ny20042541x1_exfees.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R2.htm</HtmlFileName>
      <LongName>995211 - Document - Offerings</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://xbrl.sec.gov/ffd/role/document/feesOfferingTable</Role>
      <ShortName>Offerings</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>2</Position>
    </Report>
    <Report instance="ny20042541x1_exfees.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R3.htm</HtmlFileName>
      <LongName>995215 - Document - Fees Summary</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://xbrl.sec.gov/ffd/role/document/feesSummaryTable</Role>
      <ShortName>Fees Summary</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>3</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File doctype="EX-FILING FEES" original="ny20042541x1_exfees.htm">ny20042541x1_exfees.htm</File>
  </InputFiles>
  <SupplementalFiles/>
  <BaseTaxonomies>
    <BaseTaxonomy items="2">http://xbrl.sec.gov/dei/2024</BaseTaxonomy>
    <BaseTaxonomy items="48">http://xbrl.sec.gov/ffd/2024q2</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>false</HasPresentationLinkbase>
  <HasCalculationLinkbase>false</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>28
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "version": "2.2",
 "instance": {
  "ny20042541x1_exfees.htm": {
   "dts": {
    "inline": {
     "local": [
      "ny20042541x1_exfees.htm"
     ]
    },
    "schema": {
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/lrr/arcrole/deprecated-2009-12-16.xsd",
      "https://www.xbrl.org/dtr/type/2022-03-31/types.xsd",
      "https://xbrl.sec.gov/dei/2024/dei-2024.xsd",
      "https://xbrl.sec.gov/ffd/2024q2/ffd-2024q2.xsd"
     ]
    }
   },
   "keyStandard": 19,
   "keyCustom": 0,
   "axisStandard": 1,
   "axisCustom": 0,
   "memberStandard": 1,
   "memberCustom": 0,
   "hidden": {
    "total": 4,
    "http://xbrl.sec.gov/dei/2024": 1,
    "http://xbrl.sec.gov/ffd/2024q2": 3
   },
   "contextCount": 9,
   "entityCount": 1,
   "segmentCount": 1,
   "elementCount": 107,
   "unitCount": 2,
   "baseTaxonomies": {
    "http://xbrl.sec.gov/ffd/2024q2": 48,
    "http://xbrl.sec.gov/dei/2024": 2
   },
   "report": {
    "R1": {
     "role": "http://xbrl.sec.gov/ffd/role/document/submissionTable",
     "longName": "995210 - Document - Submission",
     "shortName": "Submission",
     "isDefault": "true",
     "groupType": "Fee_Exhibit",
     "subGroupType": "",
     "menuCat": "Cover",
     "order": "1",
     "firstAnchor": {
      "contextRef": "c0",
      "name": "dei:EntityRegistrantName",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ny20042541x1_exfees.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c0",
      "name": "dei:EntityRegistrantName",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ny20042541x1_exfees.htm",
      "first": true,
      "unique": true
     }
    },
    "R2": {
     "role": "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable",
     "longName": "995211 - Document - Offerings",
     "shortName": "Offerings",
     "isDefault": "false",
     "groupType": "Fee_Exhibit",
     "subGroupType": "",
     "menuCat": "Cover",
     "order": "2",
     "firstAnchor": {
      "contextRef": "c1",
      "name": "ffd:PrevslyPdFlg",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ffd:PrevslyPdFlg",
       "ffd:PrevslyPdFlg",
       "ffd:PrevslyPdFlg",
       "ffd:PrevslyPdFlg",
       "ffd:PrevslyPdFlg",
       "ffd:PrevslyPdFlg",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ny20042541x1_exfees.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c1",
      "name": "ffd:PrevslyPdFlg",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ffd:PrevslyPdFlg",
       "ffd:PrevslyPdFlg",
       "ffd:PrevslyPdFlg",
       "ffd:PrevslyPdFlg",
       "ffd:PrevslyPdFlg",
       "ffd:PrevslyPdFlg",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ny20042541x1_exfees.htm",
      "first": true,
      "unique": true
     }
    },
    "R3": {
     "role": "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable",
     "longName": "995215 - Document - Fees Summary",
     "shortName": "Fees Summary",
     "isDefault": "false",
     "groupType": "Fee_Exhibit",
     "subGroupType": "",
     "menuCat": "Cover",
     "order": "3",
     "firstAnchor": {
      "contextRef": "c0",
      "name": "ffd:TtlOfferingAmt",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ny20042541x1_exfees.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c0",
      "name": "ffd:TtlOfferingAmt",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ny20042541x1_exfees.htm",
      "first": true,
      "unique": true
     }
    }
   },
   "tag": {
    "ffd_AggtRedRpPricFsclYr": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "AggtRedRpPricFsclYr",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/securities424iTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Aggregate Redeemed or Repurchased Price, Fiscal Year",
        "terseLabel": "Aggregate Redeemed or Repurchased, FY"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_AggtRedRpPricPrrFsclYr": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "AggtRedRpPricPrrFsclYr",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/securities424iTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Aggregate Redeemed or Repurchased Price, Prior Fiscal Year",
        "terseLabel": "Aggregate Redeemed or Repurchased, Prior FY"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_AggtSalesPricFsclYr": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "AggtSalesPricFsclYr",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/securities424iTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Aggregate Sales Price, Fiscal Year",
        "terseLabel": "Aggregate Sales Price"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_AmtRedCdts": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "AmtRedCdts",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/securities424iTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Amount of Redemption Credits",
        "terseLabel": "Redemption Credits"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_AmtSctiesRcvd": {
     "xbrltype": "nonNegativeDecimal2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "AmtSctiesRcvd",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Amount of Securities Received",
        "terseLabel": "Amount of Securities Received",
        "documentation": "Amount of securities to be received by the registrant (or cancelled upon issuance of securities to be registered on the form)"
       }
      }
     },
     "auth_ref": [
      "r6"
     ]
    },
    "ffd_AmtSctiesRegd": {
     "xbrltype": "nonNegativeDecimal2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "AmtSctiesRegd",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Amount of Securities Registered",
        "terseLabel": "Amount Registered",
        "documentation": "The amount of securities being registered."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_CeasedOprsDt": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "CeasedOprsDt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Ceased Operations Date",
        "terseLabel": "Ceased Operations Date"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_CfwdFormTp": {
     "xbrltype": "formTypeItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "CfwdFormTp",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Carry Forward Form Type",
        "terseLabel": "Carry Forward Form Type",
        "documentation": "The Form Type of the prior shelf registration statement from which unsold securities are carried forward under 415(a)(6). This should be an EDGAR submission type (S-3, S-3/A, S-3ASR, etc.), which means there is a fixed set of possible responses. Note that while the XBRL response should be an EDGAR submission type, the human-readable Ex. 107 could include a simpler label (e.g., \"Form S-3\" in the human-readable and \"S-3ASR\" in the XBRL)."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "ffd_CfwdPrevslyPdFee": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "CfwdPrevslyPdFee",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Carry Forward Previously Paid Fee",
        "terseLabel": "Filing Fee Previously Paid in Connection with Unsold Securities to be Carried Forward",
        "documentation": "The fee previously paid in connection with the securities being brought forward from the prior shelf registration statement on which unsold securities are carried forward under 415(a)(6)."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "ffd_CfwdPrrFctvDt": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "CfwdPrrFctvDt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Carry Forward Prior Effective Date",
        "terseLabel": "Carry Forward Initial Effective Date",
        "documentation": "The initial effective date of the prior shelf registration statement from which unsold securities are carried forward under 415(a)(6)."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "ffd_CfwdPrrFileNb": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "CfwdPrrFileNb",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Carry Forward File Number",
        "terseLabel": "Carry Forward File Number",
        "documentation": "The EDGAR File Number of the prior shelf registration statement from which unsold securities are carried forward under 415(a)(6). If the prior registration statement has a Securities Act File Number and an Investment Company Act File Number, the Securities Act File Number should be used."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "ffd_CmbndPrspctsItemAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "CmbndPrspctsItemAxis",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesByCmbndPrspctsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Combined Prospectus Item [Axis]",
        "terseLabel": "Combined Prospectus",
        "documentation": "A sequence number (1, 2, 3...) used to distinguish different references to earlier prospectuses on a single fee bearing submission."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_CmbndPrspctsLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "CmbndPrspctsLineItems",
     "lang": {
      "en-us": {
       "role": {
        "label": "Combined Prospectus [Line Items]",
        "terseLabel": "Combined Prospectus:"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_CmbndPrspctsTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "CmbndPrspctsTable",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesByCmbndPrspctsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Combined Prospectus [Table]",
        "terseLabel": "Combined Prospectus Table"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_CombinedProspectusTableNa": {
     "xbrltype": "naItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "CombinedProspectusTableNa",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Combined Prospectus Table [N/A]",
        "terseLabel": "Combined Prospectus Table N/A"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_CshPdByRegistrantInTx": {
     "xbrltype": "nonNegative100TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "CshPdByRegistrantInTx",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cash Paid by Registrant in Transaction",
        "terseLabel": "Cash Consideration Paid",
        "documentation": "Amount of cash consideration paid by registrant in connection with the exchange or other transaction being registered (in a 457(f) calculation)."
       }
      }
     },
     "auth_ref": [
      "r12"
     ]
    },
    "ffd_CshRcvdByRegistrantInTx": {
     "xbrltype": "nonNegative100TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "CshRcvdByRegistrantInTx",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cash Received by Registrant in Transaction",
        "terseLabel": "Cash Consideration Received",
        "documentation": "Amount of cash consideration received by registrant in connection with the exchange or other transaction being registered (in a 457(f) calculation)."
       }
      }
     },
     "auth_ref": [
      "r12"
     ]
    },
    "dei_EntityCentralIndexKey": {
     "xbrltype": "centralIndexKeyItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityCentralIndexKey",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Central Index Key",
        "terseLabel": "Central Index Key",
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK."
       }
      }
     },
     "auth_ref": [
      "r0"
     ]
    },
    "dei_EntityRegistrantName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityRegistrantName",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Registrant Name",
        "terseLabel": "Registrant Name",
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC."
       }
      }
     },
     "auth_ref": [
      "r0"
     ]
    },
    "ffd_FeeAmt": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "FeeAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable",
      "http://xbrl.sec.gov/ffd/role/document/securities424iTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fee Amount",
        "terseLabel": "Amount of Registration Fee",
        "documentation": "Total amount of registration fee (amount due after offsets)."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_FeeExhibitTp": {
     "xbrltype": "feeExhibitTypeItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "FeeExhibitTp",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fee Exhibit Type",
        "terseLabel": "Fee Exhibit Type"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_FeeIntrstAmt": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "FeeIntrstAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fee Interest Amount",
        "terseLabel": "Interest Amount"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_FeeNote": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "FeeNote",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/securities424iTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fee Note",
        "terseLabel": "Fee Note"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_FeeNoteMaxAggtOfferingPric": {
     "xbrltype": "nonNegative100TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "FeeNoteMaxAggtOfferingPric",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fee Note Maximum Aggregate Offering Price",
        "terseLabel": "Fee Note MAOP"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_FeeRate": {
     "xbrltype": "percentItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "FeeRate",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable",
      "http://xbrl.sec.gov/ffd/role/document/securities424iTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fee Rate",
        "terseLabel": "Fee Rate",
        "documentation": "The rate per dollar of fees that public companies and other issuers pay to register their securities with the Commission."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_FeesOthrRuleFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "FeesOthrRuleFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fees, Other Rule [Flag]",
        "terseLabel": "Other Rule",
        "documentation": "Checkbox indicating whether filer is using a rule other than 457(a), 457(o), or 457(f) to calculate the registration fee due."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_FeesSummaryLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "FeesSummaryLineItems",
     "lang": {
      "en-us": {
       "role": {
        "label": "Fees Summary [Line Items]",
        "terseLabel": "Fees Summary:"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_FnlPrspctsFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "FnlPrspctsFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Final Prospectus [Flag]",
        "terseLabel": "Final Prospectus"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_FormTp": {
     "xbrltype": "submissionTypeItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "FormTp",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Form Type",
        "terseLabel": "Form Type"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_GnlInstrIIhiFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "GnlInstrIIhiFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "General Instruction II.H,I [Flag]",
        "terseLabel": "General Instruction II.H,I"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_IssrBizAdrCity": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "IssrBizAdrCity",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Issuer Business Address, City",
        "terseLabel": "City"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_IssrBizAdrStatOrCtryCd": {
     "xbrltype": "stateOrCountryCodeItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "IssrBizAdrStatOrCtryCd",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Issuer Business Address, State or Country Code",
        "terseLabel": "State or Country Code"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_IssrBizAdrStrt1": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "IssrBizAdrStrt1",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Issuer Business Address, Street 1",
        "terseLabel": "Street 1"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_IssrBizAdrStrt2": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "IssrBizAdrStrt2",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Issuer Business Address, Street 2",
        "terseLabel": "Street 2"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_IssrBizAdrZipCd": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "IssrBizAdrZipCd",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Issuer Business Address, Zip Code",
        "terseLabel": "Zip Code"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_IssrNm": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "IssrNm",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Issuer Name",
        "terseLabel": "Issuer Name"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_MaxAggtOfferingPric": {
     "xbrltype": "nonNegative100TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "MaxAggtOfferingPric",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Maximum Aggregate Offering Price",
        "terseLabel": "Maximum Aggregate Offering Price",
        "documentation": "The maximum aggregate offering price for the offering that is being registered."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_MaxOfferingPricPerScty": {
     "xbrltype": "nonNegativeDecimal4lItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "MaxOfferingPricPerScty",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Maximum Offering Price per Security",
        "terseLabel": "Proposed Maximum Offering Price per Unit",
        "documentation": "The maximum offering price per share/unit being registered."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_NetFeeAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "NetFeeAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Fee Amount",
        "terseLabel": "Net Fee"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_NetSalesAmt": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "NetSalesAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/securities424iTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Sales Amount",
        "terseLabel": "Net Sales"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_NrrtvDsclsr": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "NrrtvDsclsr",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Narrative Disclosure",
        "terseLabel": "Narrative Disclosure"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_NrrtvMaxAggtAmt": {
     "xbrltype": "nonNegativeDecimal2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "NrrtvMaxAggtAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Narrative Disclosure, Maximum Aggregate Offering Amount",
        "terseLabel": "Narrative - Max Aggregate Offering Amount"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_NrrtvMaxAggtOfferingPric": {
     "xbrltype": "nonNegative100TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "NrrtvMaxAggtOfferingPric",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Narrative Disclosure, Maximum Aggregate Offering Price",
        "terseLabel": "Narrative - Max Aggregate Offering Price"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_OfferingAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "OfferingAxis",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offering [Axis]",
        "terseLabel": "Offering",
        "documentation": "A sequence number (1, 2, 3...) used to distinguish different security offerings on a single fee bearing submission."
       }
      }
     },
     "auth_ref": []
    },
    "ffd_OfferingLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "OfferingLineItems",
     "lang": {
      "en-us": {
       "role": {
        "label": "Offering [Line Items]",
        "terseLabel": "Offering:"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_OfferingNote": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "OfferingNote",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offering Note",
        "terseLabel": "Offering Note"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_OfferingSctyTitl": {
     "xbrltype": "securityTitleItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "OfferingSctyTitl",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable",
      "http://xbrl.sec.gov/ffd/role/document/securities424iTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offering Security Title",
        "terseLabel": "Security Class Title",
        "documentation": "The title of the class of securities being registered (for each class being registered)."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_OfferingSctyTp": {
     "xbrltype": "securityTypeItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "OfferingSctyTp",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offering Security Type",
        "terseLabel": "Security Type",
        "documentation": "Type of securities: \"Asset-backed Securities\", \"ADRs/ADSs\", \"Debt\", \"Debt Convertible into Equity\", \"Equity\", \"Face Amount Certificates\", \"Limited Partnership Interests\", \"Mortgage Backed Securities\", \"Non-Convertible Debt\", \"Unallocated (Universal) Shelf\", \"Exchange Traded Vehicle Securities\", \"Other\""
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_OfferingTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "OfferingTable",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offering [Table]",
        "terseLabel": "Offering:"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_OfferingTableNa": {
     "xbrltype": "naItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "OfferingTableNa",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offering Table [N/A]",
        "terseLabel": "Offering Table N/A"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_OffsetAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "OffsetAxis",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset [Axis]",
        "terseLabel": "Offset",
        "documentation": "A sequence number (1, 2, 3...) used to distinguish different offsets as applied to a fee bearing submission."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_OffsetClmInitlFilgDt": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "OffsetClmInitlFilgDt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Claim Initial Filing Date",
        "terseLabel": "Initial Filing Date",
        "documentation": "The initial filing date of the earlier registration statement with which the earlier (offsetting) fee was paid for a claimed offset. If the offset fee was paid with an amendment, do not provide the amendment date under this element; instead, provide the date of the initial filing (i.e. the \"parent\" filing) ."
       }
      }
     },
     "auth_ref": [
      "r5",
      "r8"
     ]
    },
    "ffd_OffsetClmdAmt": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "OffsetClmdAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Claimed Amount",
        "terseLabel": "Fee Offset Claimed",
        "documentation": "The amount of offsetting fees being claimed."
       }
      }
     },
     "auth_ref": [
      "r5",
      "r8"
     ]
    },
    "ffd_OffsetClmdInd": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "OffsetClmdInd",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Claimed Indicator",
        "terseLabel": "Offset Claimed"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_OffsetExpltnForClmdAmt": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "OffsetExpltnForClmdAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Explanation for Claimed Amount",
        "terseLabel": "Explanation for Claimed Amount"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_OffsetLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "OffsetLineItems",
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Offset:",
        "label": "Offset [Line Items]"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_OffsetNote": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "OffsetNote",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Note",
        "terseLabel": "Offset Note"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_OffsetPrrFeeAmt": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "OffsetPrrFeeAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Prior Fee Amount",
        "terseLabel": "Fee Paid with Fee Offset Source",
        "documentation": "The fee prevoiusly paid from which an offset is being derived."
       }
      }
     },
     "auth_ref": [
      "r5",
      "r8"
     ]
    },
    "ffd_OffsetPrrFileNb": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "OffsetPrrFileNb",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Prior File Number",
        "terseLabel": "File Number",
        "documentation": "The EDGAR File Number of the earlier registration statement with which the earlier (offsetting) fee was paid. If the offset filing for the offset has a Securities Act File Number and an Investment Company Act File Number, the Securities Act File Number should be used."
       }
      }
     },
     "auth_ref": [
      "r5",
      "r8"
     ]
    },
    "ffd_OffsetPrrFilerNm": {
     "xbrltype": "filerNameItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "OffsetPrrFilerNm",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Prior Filer Name",
        "terseLabel": "Registrant or Filer Name",
        "documentation": "The name of the registrant that filed the earlier registration statement with which the earlier (offsetting) fee was paid."
       }
      }
     },
     "auth_ref": [
      "r5",
      "r8"
     ]
    },
    "ffd_OffsetPrrFormTp": {
     "xbrltype": "formTypeItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "OffsetPrrFormTp",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Prior Form Type",
        "terseLabel": "Form or Filing Type",
        "documentation": "The Form Type of the offset filing."
       }
      }
     },
     "auth_ref": [
      "r5",
      "r8"
     ]
    },
    "ffd_OffsetPrrNbOfUnsoldScties": {
     "xbrltype": "nonNegativeIntegerItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "OffsetPrrNbOfUnsoldScties",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Prior Unsold Number of Securities",
        "terseLabel": "Unsold Securities Associated with Fee Offset Claimed",
        "documentation": "The number of unsold securities registered on the prior registration statement that are associated with the claimed offset."
       }
      }
     },
     "auth_ref": [
      "r5",
      "r8"
     ]
    },
    "ffd_OffsetPrrSctyTitl": {
     "xbrltype": "securityTitleItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "OffsetPrrSctyTitl",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Prior Security Title",
        "terseLabel": "Security Title Associated with Fee Offset Claimed",
        "documentation": "The title of the class of securities from which offset fees were derived."
       }
      }
     },
     "auth_ref": [
      "r5",
      "r8"
     ]
    },
    "ffd_OffsetPrrSctyTp": {
     "xbrltype": "securityTypeItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "OffsetPrrSctyTp",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Prior Security Type",
        "terseLabel": "Security Type Associated with Fee Offset Claimed",
        "documentation": "Type of securities: \"Asset-backed Securities\", \"ADRs/ADSs\", \"Debt\", \"Debt Convertible into Equity\", \"Equity\", \"Face Amount Certificates\", \"Limited Partnership Interests\", \"Mortgage Backed Securities\", \"Non-Convertible Debt\", \"Unallocated (Universal) Shelf\", \"Exchange Traded Vehicle Securities\", \"Other\""
       }
      }
     },
     "auth_ref": [
      "r5",
      "r8"
     ]
    },
    "ffd_OffsetPrrUnsoldOfferingAmt": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "OffsetPrrUnsoldOfferingAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Prior Unsold Offering Amount",
        "terseLabel": "Unsold Aggregate Offering Amount Associated with Fee Offset Claimed",
        "documentation": "The aggregate offering amount of unsold securities registered on the prior registration statement that are associated with the claimed offset."
       }
      }
     },
     "auth_ref": [
      "r5",
      "r8"
     ]
    },
    "ffd_OffsetSrcFilgDt": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "OffsetSrcFilgDt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Source Filing Date",
        "terseLabel": "Filing Date",
        "documentation": "The filing date of the earlier registration statement with which the earlier (offsetting) fee was paid in an offset."
       }
      }
     },
     "auth_ref": [
      "r5",
      "r8"
     ]
    },
    "ffd_OffsetTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "OffsetTable",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Offset Payment:",
        "label": "Offset [Table]"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_OffsetTableNa": {
     "xbrltype": "naItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "OffsetTableNa",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Table [N/A]",
        "terseLabel": "Offset Table N/A"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_PrevslyPdFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "PrevslyPdFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable",
      "http://xbrl.sec.gov/ffd/role/document/securities424iTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fee Previously Paid [Flag]",
        "terseLabel": "Fee Previously Paid"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_RegnFileNb": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "RegnFileNb",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Registration File Number",
        "terseLabel": "Registration File Number"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_RptgFsclYrEndDt": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "RptgFsclYrEndDt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Reporting Fiscal Year End Date",
        "terseLabel": "Reporting FY End Date"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_Rule011Flg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "Rule011Flg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 0-11 [Flag]",
        "terseLabel": "Rule 0-11"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_Rule011a2OffsetFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "Rule011a2OffsetFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Rule 0-11(a)(2) Offset",
        "label": "Rule 0-11(a)(2) Offset [Flag]"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_Rule415a6Flg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "Rule415a6Flg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 415(a)(6) [Flag]",
        "terseLabel": "Rule 415(a)(6)",
        "documentation": "Checkbox indicating whether filer is claiming a 415(a)(6) carryforward."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "ffd_Rule429AggtOfferingAmt": {
     "xbrltype": "nonNegative100TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "Rule429AggtOfferingAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesByCmbndPrspctsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 429 Aggregate Offering Amount",
        "terseLabel": "Maximum Aggregate Offering Price of Securities Previously Registered",
        "documentation": "The maximum aggregate offering amount of unsold securities registered on the prior registration statement that are carried forward under Rule 429. Only applicable if 457(o) was used in the fee calculation for the prior registration statement."
       }
      }
     },
     "auth_ref": [
      "r3"
     ]
    },
    "ffd_Rule429CmbndPrspctsFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "Rule429CmbndPrspctsFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesByCmbndPrspctsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 429 Combined Prospectus [Flag]",
        "terseLabel": "Rule 429",
        "documentation": "Checkbox indicating whether filer is using a combined prospectus under Rule 429."
       }
      }
     },
     "auth_ref": [
      "r3"
     ]
    },
    "ffd_Rule429EarlierFileNb": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "Rule429EarlierFileNb",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesByCmbndPrspctsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 429 Earlier File Number",
        "terseLabel": "File Number",
        "documentation": "The Securities Act File Number of the earlier effective registration statement(s) from which securities may be offered and sold using the combined prospectus pursuant to Rule 429."
       }
      }
     },
     "auth_ref": [
      "r3"
     ]
    },
    "ffd_Rule429EarlierFormTp": {
     "xbrltype": "formTypeItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "Rule429EarlierFormTp",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesByCmbndPrspctsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 429 Earlier Form Type",
        "terseLabel": "Form Type",
        "documentation": "The Form Type of the earlier registration statement from which unsold securities are carried forward under Rule 429. This should be an EDGAR submission type (S-3, S-3/A, S-3ASR, etc.), which means there is a fixed set of possible responses. Note that while the XBRL response should be an EDGAR submission type, the human-readable Ex. 107 could include a simpler label (e.g., \"Form S-3\" in the human-readable and \"S-3ASR\" in the XBRL)."
       }
      }
     },
     "auth_ref": [
      "r3"
     ]
    },
    "ffd_Rule429InitlFctvDt": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "Rule429InitlFctvDt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesByCmbndPrspctsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 429 Initial Effective Date",
        "terseLabel": "Initial Effective Date",
        "documentation": "The filing date of the earlier registration statement from which unsold securities are carried forward under Rule 429."
       }
      }
     },
     "auth_ref": [
      "r3"
     ]
    },
    "ffd_Rule429NbOfUnsoldScties": {
     "xbrltype": "nonNegativeDecimal2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "Rule429NbOfUnsoldScties",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesByCmbndPrspctsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 429 Number Of Unsold Securities",
        "terseLabel": "Amount of Securities Previously Registered",
        "documentation": "The number of securities registered on the prior registration statement that are carried forward under Rule 429."
       }
      }
     },
     "auth_ref": [
      "r3"
     ]
    },
    "ffd_Rule429PrspctsNote": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "Rule429PrspctsNote",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesByCmbndPrspctsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 429 Prospectus Note",
        "terseLabel": "Combined Prospectus Note"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_Rule429SctyTitl": {
     "xbrltype": "securityTitleItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "Rule429SctyTitl",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesByCmbndPrspctsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 429 Security Title",
        "terseLabel": "Security Class Title"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_Rule429SctyTp": {
     "xbrltype": "securityTypeItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "Rule429SctyTp",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesByCmbndPrspctsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 429 Security Type",
        "terseLabel": "Security Type"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_Rule457aFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "Rule457aFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 457(a) [Flag]",
        "terseLabel": "Rule 457(a)",
        "documentation": "Checkbox indicating whether filer is using Rule 457(a) to calculate the registration fee due."
       }
      }
     },
     "auth_ref": [
      "r4"
     ]
    },
    "ffd_Rule457bOffsetFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "Rule457bOffsetFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 457(b) Offset [Flag]",
        "terseLabel": "Rule 457(b) Offset",
        "documentation": "Checkbox indicating whether filer is claiming an offset under Rule 457(b) or 0-11(a)(2)."
       }
      }
     },
     "auth_ref": [
      "r5"
     ]
    },
    "ffd_Rule457fFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "Rule457fFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 457(f) [Flag]",
        "terseLabel": "Rule 457(f)",
        "documentation": "Checkbox indicating whether filer is using Rule 457(f) to calculate the registration fee due."
       }
      }
     },
     "auth_ref": [
      "r6"
     ]
    },
    "ffd_Rule457oFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "Rule457oFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 457(o) [Flag]",
        "terseLabel": "Rule 457(o)",
        "documentation": "Checkbox indicating whether filer is using Rule 457(o) to calculate the registration fee due."
       }
      }
     },
     "auth_ref": [
      "r7"
     ]
    },
    "ffd_Rule457pOffsetFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "Rule457pOffsetFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 457(p) Offset [Flag]",
        "terseLabel": "Rule 457(p) Offset",
        "documentation": "Checkbox indicating whether filer is claiming an offset under Rule 457(p)."
       }
      }
     },
     "auth_ref": [
      "r8"
     ]
    },
    "ffd_Rule457rFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "Rule457rFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 457(r) [Flag]",
        "terseLabel": "Rule 457(r)"
       }
      }
     },
     "auth_ref": [
      "r9"
     ]
    },
    "ffd_Rule457sFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "Rule457sFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 457(s) Flag",
        "terseLabel": "Rule 457(s)"
       }
      }
     },
     "auth_ref": [
      "r10"
     ]
    },
    "ffd_Rule457uFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "Rule457uFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 457(u) [Flag]",
        "terseLabel": "Rule 457(u)",
        "documentation": "Checkbox indicating whether filer is using Rule 457(u) to calculate the registration fee due."
       }
      }
     },
     "auth_ref": [
      "r11"
     ]
    },
    "ffd_Scties424iAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "Scties424iAxis",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/securities424iTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Securities, 424I [Axis]",
        "terseLabel": "Securities, 424I"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_Scties424iLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "Scties424iLineItems",
     "lang": {
      "en-us": {
       "role": {
        "label": "Securities, 424I [Line Items]",
        "terseLabel": "Securities, 424I:"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_Scties424iTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "Scties424iTable",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/securities424iTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Securities, 424I [Table]",
        "terseLabel": "Securities, 424I Table"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_Securities424iTableNa": {
     "xbrltype": "naItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "Securities424iNa",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Securities 424I [N/A]",
        "terseLabel": "Securities 424I N/A"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_SubmissionLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "SubmissionLineItems",
     "lang": {
      "en-us": {
       "role": {
        "label": "Submission [Line Items]",
        "terseLabel": "Items"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_SubmissnTp": {
     "xbrltype": "submissionTypeItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "SubmissnTp",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Submission Type",
        "terseLabel": "Submission Type"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_TermntnCmpltnWdrwl": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "TermntnCmpltnWdrwl",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Termination / Completion / Withdrawal Statement",
        "terseLabel": "Termination / Withdrawal Statement"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_TtlFeeAmt": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "TtlFeeAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Total Fee Amount",
        "terseLabel": "Total Fee Amount"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_TtlFeeAndIntrstAmt": {
     "xbrltype": "nonNegativeDecimal2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "TtlFeeAndIntrstAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Total Fee and Interest Amount",
        "terseLabel": "Total Fee and Interest Amount"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_TtlOfferingAmt": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "TtlOfferingAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Total Offering Amount",
        "terseLabel": "Total Offering"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_TtlOffsetAmt": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "TtlOffsetAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Total Offset Amount",
        "terseLabel": "Total Offset Amount"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_TtlPrevslyPdAmt": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "TtlPrevslyPdAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Total Previously Paid Amount",
        "terseLabel": "Previously Paid Amount"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_TtlTxValtn": {
     "xbrltype": "nonNegative100TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "TtlTxValtn",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Total Transaction Valuation",
        "terseLabel": "Total Transaction Valuation"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_TxValtn": {
     "xbrltype": "nonNegative100TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "TxValtn",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Transaction Valuation",
        "terseLabel": "Transaction Valuation"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_ValSctiesRcvd": {
     "xbrltype": "nonNegative100TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "ValSctiesRcvd",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Value of Securities Received",
        "terseLabel": "Value of Securities Received",
        "documentation": "Value of securities to be received by the registrant (or cancelled upon issuance of securities to be registered on the form)"
       }
      }
     },
     "auth_ref": [
      "r6"
     ]
    },
    "ffd_ValSctiesRcvdPerShr": {
     "xbrltype": "nonNegativeDecimal4lItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "ValSctiesRcvdPerShr",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Value of Securities Received, Per Share",
        "terseLabel": "Value of Securities Received, Per Share",
        "documentation": "Value per share of securities to be received by the registrant (or cancelled upon issuance of securities to be registered on the form). This is included in the explanation of 457(f) fee calculation."
       }
      }
     },
     "auth_ref": [
      "r6"
     ]
    }
   }
  }
 },
 "std_ref": {
  "r0": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r1": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230"
  },
  "r2": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "415",
   "Subsection": "a"
  },
  "r3": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "429"
  },
  "r4": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "457"
  },
  "r5": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "457",
   "Subsection": "b"
  },
  "r6": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "457",
   "Subsection": "f"
  },
  "r7": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "457",
   "Subsection": "o"
  },
  "r8": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "457",
   "Subsection": "p"
  },
  "r9": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "457",
   "Subsection": "r"
  },
  "r10": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "457",
   "Subsection": "s"
  },
  "r11": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "457",
   "Subsection": "u"
  },
  "r12": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Subsection": "f",
   "Section": "457"
  }
 }
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>29
<FILENAME>0001140361-25-005858-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001140361-25-005858-xbrl.zip
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M U&.5=<FE&#G"#TH-KL>/@U<6^TK#O8\@*WWP-+4O!H!/CG(4$:H:UL&HL3
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J,# T,C4T,7@Q7V5X9F5E<RYH=&U02P4&      $  0!%    %!4

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>30
<FILENAME>ny20042541x1_exfees_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:dei="http://xbrl.sec.gov/dei/2024"
  xmlns:ffd="http://xbrl.sec.gov/ffd/2024q2"
  xmlns:iso4217="http://www.xbrl.org/2003/iso4217"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xbrldi="http://xbrl.org/2006/xbrldi"
  xmlns:xlink="http://www.w3.org/1999/xlink">
    <link:schemaRef
      xlink:href="https://xbrl.sec.gov/ffd/2024q2/ffd-2024q2.xsd"
      xlink:type="simple"/>
    <context id="c0">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001130713</identifier>
        </entity>
        <period>
            <startDate>2025-02-25</startDate>
            <endDate>2025-02-25</endDate>
        </period>
    </context>
    <context id="c1">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001130713</identifier>
            <segment>
                <xbrldi:typedMember dimension="ffd:OfferingAxis">
                    <dei:lineNo>1</dei:lineNo>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-02-25</startDate>
            <endDate>2025-02-25</endDate>
        </period>
    </context>
    <context id="c2">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001130713</identifier>
            <segment>
                <xbrldi:typedMember dimension="ffd:OfferingAxis">
                    <dei:lineNo>2</dei:lineNo>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-02-25</startDate>
            <endDate>2025-02-25</endDate>
        </period>
    </context>
    <context id="c3">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001130713</identifier>
            <segment>
                <xbrldi:typedMember dimension="ffd:OfferingAxis">
                    <dei:lineNo>3</dei:lineNo>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-02-25</startDate>
            <endDate>2025-02-25</endDate>
        </period>
    </context>
    <context id="c4">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001130713</identifier>
            <segment>
                <xbrldi:typedMember dimension="ffd:OfferingAxis">
                    <dei:lineNo>4</dei:lineNo>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-02-25</startDate>
            <endDate>2025-02-25</endDate>
        </period>
    </context>
    <context id="c5">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001130713</identifier>
            <segment>
                <xbrldi:typedMember dimension="ffd:OfferingAxis">
                    <dei:lineNo>5</dei:lineNo>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-02-25</startDate>
            <endDate>2025-02-25</endDate>
        </period>
    </context>
    <context id="c6">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001130713</identifier>
            <segment>
                <xbrldi:typedMember dimension="ffd:OfferingAxis">
                    <dei:lineNo>6</dei:lineNo>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-02-25</startDate>
            <endDate>2025-02-25</endDate>
        </period>
    </context>
    <context id="c7">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001130713</identifier>
            <segment>
                <xbrldi:typedMember dimension="ffd:OfferingAxis">
                    <dei:lineNo>7</dei:lineNo>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-02-25</startDate>
            <endDate>2025-02-25</endDate>
        </period>
    </context>
    <context id="c8">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001130713</identifier>
            <segment>
                <xbrldi:typedMember dimension="ffd:OfferingAxis">
                    <dei:lineNo>8</dei:lineNo>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-02-25</startDate>
            <endDate>2025-02-25</endDate>
        </period>
    </context>
    <unit id="usd">
        <measure>iso4217:USD</measure>
    </unit>
    <unit id="pure">
        <measure>pure</measure>
    </unit>
    <ffd:FormTp contextRef="c0" id="ixv-573">S-3</ffd:FormTp>
    <dei:EntityRegistrantName contextRef="c0" id="ixv-27">Beyond, Inc.</dei:EntityRegistrantName>
    <ffd:OfferingSctyTp contextRef="c1" id="ixv-172">Equity</ffd:OfferingSctyTp>
    <ffd:OfferingSctyTitl contextRef="c1" id="ixv-176">Common Stock</ffd:OfferingSctyTitl>
    <ffd:Rule457oFlg contextRef="c1" id="ixv-180">true</ffd:Rule457oFlg>
    <ffd:OfferingSctyTp contextRef="c2" id="ixv-207">Equity</ffd:OfferingSctyTp>
    <ffd:OfferingSctyTitl contextRef="c2" id="ixv-211">Preferred Stock</ffd:OfferingSctyTitl>
    <ffd:Rule457oFlg contextRef="c2" id="ixv-215">true</ffd:Rule457oFlg>
    <ffd:OfferingSctyTp contextRef="c3" id="ixv-242">Debt</ffd:OfferingSctyTp>
    <ffd:OfferingSctyTitl contextRef="c3" id="ixv-246">Debt Securities</ffd:OfferingSctyTitl>
    <ffd:Rule457oFlg contextRef="c3" id="ixv-250">true</ffd:Rule457oFlg>
    <ffd:OfferingSctyTp contextRef="c4" id="ixv-277">Other</ffd:OfferingSctyTp>
    <ffd:OfferingSctyTitl contextRef="c4" id="ixv-281">Warrants</ffd:OfferingSctyTitl>
    <ffd:Rule457oFlg contextRef="c4" id="ixv-285">true</ffd:Rule457oFlg>
    <ffd:OfferingSctyTp contextRef="c5" id="ixv-312">Other</ffd:OfferingSctyTp>
    <ffd:OfferingSctyTitl contextRef="c5" id="ixv-316">Purchase Contracts</ffd:OfferingSctyTitl>
    <ffd:Rule457oFlg contextRef="c5" id="ixv-320">true</ffd:Rule457oFlg>
    <ffd:OfferingSctyTp contextRef="c6" id="ixv-347">Other</ffd:OfferingSctyTp>
    <ffd:OfferingSctyTitl contextRef="c6" id="ixv-351">Units</ffd:OfferingSctyTitl>
    <ffd:Rule457oFlg contextRef="c6" id="ixv-355">true</ffd:Rule457oFlg>
    <ffd:PrevslyPdFlg contextRef="c7" id="ixv-378">false</ffd:PrevslyPdFlg>
    <ffd:PrevslyPdFlg contextRef="c6" id="ixv-379">false</ffd:PrevslyPdFlg>
    <ffd:PrevslyPdFlg contextRef="c5" id="ixv-380">false</ffd:PrevslyPdFlg>
    <ffd:PrevslyPdFlg contextRef="c4" id="ixv-381">false</ffd:PrevslyPdFlg>
    <ffd:PrevslyPdFlg contextRef="c3" id="ixv-382">false</ffd:PrevslyPdFlg>
    <ffd:PrevslyPdFlg contextRef="c2" id="ixv-383">false</ffd:PrevslyPdFlg>
    <ffd:PrevslyPdFlg contextRef="c1" id="ixv-384">false</ffd:PrevslyPdFlg>
    <ffd:OfferingSctyTp contextRef="c7" id="ixv-391">Unallocated (Universal) Shelf</ffd:OfferingSctyTp>
    <ffd:Rule457oFlg contextRef="c7" id="ixv-397">true</ffd:Rule457oFlg>
    <ffd:MaxAggtOfferingPric contextRef="c7" decimals="INF" id="ixv-574" unitRef="usd">156128866</ffd:MaxAggtOfferingPric>
    <ffd:FeeRate contextRef="c7" decimals="8" id="ixv-575" unitRef="pure">0.0001531</ffd:FeeRate>
    <ffd:FeeAmt contextRef="c7" decimals="2" id="ixv-576" unitRef="usd">23903.33</ffd:FeeAmt>
    <ffd:PrevslyPdFlg contextRef="c8" id="ixv-423">true</ffd:PrevslyPdFlg>
    <ffd:OfferingSctyTp contextRef="c8" id="ixv-430">Equity</ffd:OfferingSctyTp>
    <ffd:OfferingSctyTitl contextRef="c8" id="ixv-434">Common Stock, $0.0001 par value per share</ffd:OfferingSctyTitl>
    <ffd:Rule457oFlg contextRef="c8" id="ixv-438">true</ffd:Rule457oFlg>
    <ffd:MaxAggtOfferingPric contextRef="c8" decimals="INF" id="ixv-577" unitRef="usd">156128866</ffd:MaxAggtOfferingPric>
    <ffd:FeeRate contextRef="c8" decimals="8" id="ixv-578" unitRef="pure">0.0001476</ffd:FeeRate>
    <ffd:FeeAmt contextRef="c8" decimals="2" id="ixv-579" unitRef="usd">23044.63</ffd:FeeAmt>
    <ffd:TtlOfferingAmt contextRef="c0" decimals="INF" id="ixv-580" unitRef="usd">156128866</ffd:TtlOfferingAmt>
    <ffd:TtlFeeAmt contextRef="c0" decimals="2" id="ixv-581" unitRef="usd">23903.33</ffd:TtlFeeAmt>
    <ffd:TtlPrevslyPdAmt contextRef="c0" decimals="2" id="ixv-582" unitRef="usd">23044.63</ffd:TtlPrevslyPdAmt>
    <ffd:TtlOffsetAmt contextRef="c0" decimals="0" id="ixv-583" unitRef="usd">0</ffd:TtlOffsetAmt>
    <ffd:NetFeeAmt contextRef="c0" decimals="2" id="ixv-584" unitRef="usd">858.7</ffd:NetFeeAmt>
    <ffd:OfferingNote contextRef="c7" id="ixv-537">&lt;div style="text-indent: -22.5pt; padding-left: 22.5pt;"&gt; &lt;div style="float: left; width: 22.5pt; white-space: nowrap;"&gt; &lt;span style="font-size: 10.0pt; color: #000000;"&gt;(1)&lt;/span&gt; &lt;/div&gt; &lt;div&gt; &lt;span style="font-size: 10.0pt;"&gt;There are being registered hereunder an unspecified number or aggregate principal amount (as applicable) of the registrant&#x2019;s common stock, preferred stock, debt securities, warrants, purchase contracts and units as may from time to time be offered at unspecified prices, with the maximum aggregate offering price of such securities not to exceed $&lt;/span&gt;&lt;span style="font-size: 10.0pt; color: #000000;"&gt;156,128,866&lt;/span&gt;&lt;span style="font-size: 10.0pt;"&gt;. In addition, an unspecified number of additional shares of common stock is being registered as may be issued from time to time upon conversion of any debt securities that are convertible into common stock or pursuant to any anti-dilution adjustments with respect to any such convertible debt securities. The shares of common stock and preferred stock being registered hereunder also include rights to acquire shares of common stock or preferred stock under any shareholder rights plan then in effect, if applicable under the terms of any such plan.&lt;/span&gt; &lt;/div&gt; &lt;/div&gt;&lt;div style="margin-left: 22.5pt;"&gt;
   &lt;span style="font-size: 10.0pt;"&gt;The proposed maximum aggregate offering price of each class of securities will be determined from time to time by the registrant in connection with the issuance by the registrant of the securities registered hereunder and is not specified as to each class of securities pursuant to Rule 457(o) under the Securities Act of 1933, as amended (the &#x201c;Securities Act&#x201d;).&lt;/span&gt;
  &lt;/div&gt;&lt;div style="margin-left: 22.5pt;"&gt;
   &lt;span style="font-size: 10.0pt;"&gt;The maximum aggregate offering price indicated above is estimated solely for the purpose of calculating the registration fee pursuant to Rule 457(o) under the Securities Act.&#160;&#160;No separate consideration will be received for shares of common stock that are issued upon conversion of debt securities or upon exercise of warrants registered hereunder.&lt;/span&gt;
  &lt;/div&gt;&lt;div style="margin-left: 22.5pt;"&gt;
   &lt;span style="font-size: 10.0pt;"&gt;The $156,128,866 of securities registered being registered hereunder includes $156,128,866 of common stock (the &#x201c;Unsold Shares&#x201d;) that remains available for issuance and sale under a Capital on Demand&lt;/span&gt;&lt;sup style="font-size: 7.0pt;"&gt;TM&lt;/sup&gt;&lt;span style="font-size: 10.0pt;"&gt; Sales Agreement by and between the registrant and JonesTrading Institutional Services LLC (the &#x201c;Sales Agreement&#x201d;). In connection with the prospectus supplement previously filed by the registrant on June 10, 2024, the registrant paid a registration fee of $29,520 related to the $200,000,000 of common stock initially available for issuance and sale under the Sales Agreement. The portion of such registration fee related to the Unsold Shares is being applied to the registrant&#x2019;s total registration fee hereunder.&lt;/span&gt;
  &lt;/div&gt;</ffd:OfferingNote>
    <ffd:OfferingNote contextRef="c8" id="ixv-538">&lt;div style="text-indent: -22.5pt; padding-left: 22.5pt;"&gt; &lt;div style="float: left; width: 22.5pt; white-space: nowrap;"&gt; &lt;span style="font-size: 10.0pt; color: #000000;"&gt;(1)&lt;/span&gt; &lt;/div&gt; &lt;div&gt; &lt;span style="font-size: 10.0pt;"&gt;There are being registered hereunder an unspecified number or aggregate principal amount (as applicable) of the registrant&#x2019;s common stock, preferred stock, debt securities, warrants, purchase contracts and units as may from time to time be offered at unspecified prices, with the maximum aggregate offering price of such securities not to exceed $&lt;/span&gt;&lt;span style="font-size: 10.0pt; color: #000000;"&gt;156,128,866&lt;/span&gt;&lt;span style="font-size: 10.0pt;"&gt;. In addition, an unspecified number of additional shares of common stock is being registered as may be issued from time to time upon conversion of any debt securities that are convertible into common stock or pursuant to any anti-dilution adjustments with respect to any such convertible debt securities. The shares of common stock and preferred stock being registered hereunder also include rights to acquire shares of common stock or preferred stock under any shareholder rights plan then in effect, if applicable under the terms of any such plan.&lt;/span&gt; &lt;/div&gt; &lt;/div&gt;&lt;div style="margin-left: 22.5pt;"&gt;
   &lt;span style="font-size: 10.0pt;"&gt;The proposed maximum aggregate offering price of each class of securities will be determined from time to time by the registrant in connection with the issuance by the registrant of the securities registered hereunder and is not specified as to each class of securities pursuant to Rule 457(o) under the Securities Act of 1933, as amended (the &#x201c;Securities Act&#x201d;).&lt;/span&gt;
  &lt;/div&gt;&lt;div style="margin-left: 22.5pt;"&gt;
   &lt;span style="font-size: 10.0pt;"&gt;The maximum aggregate offering price indicated above is estimated solely for the purpose of calculating the registration fee pursuant to Rule 457(o) under the Securities Act.&#160;&#160;No separate consideration will be received for shares of common stock that are issued upon conversion of debt securities or upon exercise of warrants registered hereunder.&lt;/span&gt;
  &lt;/div&gt;&lt;div style="margin-left: 22.5pt;"&gt;
   &lt;span style="font-size: 10.0pt;"&gt;The $156,128,866 of securities registered being registered hereunder includes $156,128,866 of common stock (the &#x201c;Unsold Shares&#x201d;) that remains available for issuance and sale under a Capital on Demand&lt;/span&gt;&lt;sup style="font-size: 7.0pt;"&gt;TM&lt;/sup&gt;&lt;span style="font-size: 10.0pt;"&gt; Sales Agreement by and between the registrant and JonesTrading Institutional Services LLC (the &#x201c;Sales Agreement&#x201d;). In connection with the prospectus supplement previously filed by the registrant on June 10, 2024, the registrant paid a registration fee of $29,520 related to the $200,000,000 of common stock initially available for issuance and sale under the Sales Agreement. The portion of such registration fee related to the Unsold Shares is being applied to the registrant&#x2019;s total registration fee hereunder.&lt;/span&gt;
  &lt;/div&gt;</ffd:OfferingNote>
    <dei:EntityCentralIndexKey contextRef="c0" id="ixv-587">0001130713</dei:EntityCentralIndexKey>
    <ffd:FeeExhibitTp contextRef="c0" id="ixv-588">EX-FILING FEES</ffd:FeeExhibitTp>
    <ffd:RegnFileNb contextRef="c0" id="ixv-589">333-280076</ffd:RegnFileNb>
    <ffd:SubmissnTp contextRef="c0" id="ixv-590">POSASR</ffd:SubmissnTp>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
